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Estefanı́a Valero-Cases, Débora Cerdá-Bernad, Joaquı́n-Julián Pastor and Marı́a-José Frutos
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Abstract: In recent years, plant-origin bio-active compounds in foods (staple crops, fruit, vegetables,
and others) have been gaining interest, and processes to consider them for public health
recommendations are being presented and discussed in the literature. However, at times, it may
be challenging to demonstrate causality, and there often is not a single compound–single effect
relationship. Furthermore, it was suggested that health benefits may be due to metabolites produced
by the host or gut microbiome rather than the food constituent per se. Over the years, compounds
that were investigated were shown to increase gut microbial diversity, improve endothelial function,
improve cognitive function, reduce bone loss, and many others. More recently, an additional and
significant body of evidence further demonstrated the nutritional role and potential effects that
plant-origin bio-active compounds might have on intestinal functionality (specifically the duodenal
brush border membrane, morphology, and the abundance of health-promoting bacterial populations).
Hence, the special issue “Dietary Plant-Origin Bio-Active Compounds, Intestinal Functionality,
and Microbiome” comprises 11 peer-reviewed papers on the most recent evidence regarding the
potential dietary intake and effects of plant-origin bio-active compounds on intestinal functionality,
primarily in the context of brush border functional proteins (enzymes and transporters), mineral
(and other nutrients) dietary bioavailability, and the intestinal microbiome. Original contributions
and literature reviews further demonstrated the potential dietary relevance that plant bio-active
compounds hold in human health and development. This editorial provides a brief and concise
overview that addresses and summarizes the content of the Dietary Plant-Origin Bio-Active Compounds,
Intestinal Functionality, and Microbiome special issue.
Keywords: plant origin; bio-active compounds; intestine; microbiome
The purpose of the current special issue is to further expand and add research knowledge of the
vital role dietary plant-origin bio-active compounds hold in various nutrition-related physiological and
metabolic pathways. In addition, the purpose is to further contribute to the knowledge regarding the
relationship between plant-origin bio-active compounds, the intestinal morphology and functionality,
and potential effects on the intestinal microbiome.
Plant-based diets contain a plethora of metabolites that may impact on health and
disease prevention. Most are focused on the potential bioactivity and nutritional relevance of
several classes of phytochemicals, such as polyphenols, flavonoids, carotenoids, phyto-estrogens,
and frucrooligo-saccharides [1]. These compounds are found in fruit, vegetables, and herbs [2].
Daily intakes of some of these compounds may exceed 100 mg. Moreover, intestinal bacterial activity
may transform complex compounds such as anthocyanins, procyanidins, and isoflavones into simple
phenolic metabolites [3]. The colon is thus a rich source of potentially active phenolic acids that may
impact both locally and systemically on gut health. Furthermore, non-digestible fiber (prebiotics)
are dietary substrates that selectively promote proliferation and/or activity of health-promoting
bacterial populations in the colon [4]. Prebiotics, such as inulin, raffinose, and stachyose, have a
proven ability to promote the abundance of intestinal bacterial populations, which may provide
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additional health benefits to the host [5–10]. Furthermore, various pulse seed soluble (fiber) extracts
are responsible for improving gastrointestinal motility, intestinal functionality and morphology,
and mineral absorption [9,11]. Studies have indicated that the consumption of seed-origin soluble
extracts can up-regulate the expression of brush border membrane (BBM) proteins that contribute
for digestion and absorption of nutrients. The soluble extracts can positively affect intestinal health
by increasing the mucus production, goblet cells number/diameter, villus surface area, and crypt
depth [9,10]. These functional and morphological effects appear to occur due to the increased motility
of the digestive tract, leading to hyperplasia and/or hypertrophy of muscle cells. Plant-origin soluble
extracts may act, directly or indirectly, as a factor that increases mineral solubility and, therefore,
dietary bioavailability. This occurs due to fiber fermentation and bacterial production of short chain
fatty acids (SCFA) that reduces intestinal pH, inhibits the growth of potentially pathogenic bacterial
population and increases the solubility and, therefore, absorption of minerals. The SCFA can increase the
proliferation of epithelial cells, which, in return, increase the absorptive surface area, which contributes
to the absorption of nutrients [12,13]. Several phenolic acids and other phytochemicals affect the
expression and activity of enzymes involved in the production of inflammatory mediators of pathways
thought to be important in the development of gut disorders including colon cancer. However, it is
still unclear as to which of these compounds are beneficial to gut health. Hence, the aim of the current
special issue is to further explore the interactions between dietary plant-origin bio-active compounds,
their potential effects on the intestinal bacterial populations, and overall intestinal functionality and
gut health.
This monograph, based on a special issue of Nutrients, contains 11 manuscripts—1 review
and 10 original publications—that reflect the wide spectrum of currently conducted research in
the field of dietary plant-origin bio-active compounds, intestinal functionality, and microbiome.
The manuscripts in this special issue collection include contributors and researchers from multiple
countries, including USA, Canada, Australia, Brazil, Poland, Finland, Belgium, Netherlands, and Spain.
The presented manuscripts cover a wide variety and range of topics in the field of dietary plant-origin
bio-active compounds, intestinal functionality, and microbiome, with emphasis on diet and intestinal
well-being and compositions of fecal microbiota and short chain fatty acids in oat and by using
subjects with celiac disease or gluten sensitivity [14]. The demonstration of low phytate peas
(Pisum sativum L.)-based diets improve iron status, gut microbiome, and brush border membrane
functionality in vivo (Gallus gallus) [15]. The presentation of novel non-digestible, carrot-derived
polysaccharide (cRG-I) and how it selectively modulates the human gut microbiota while promoting gut
barrier integrity (an integrated in vitro approach) [16]. The in vitro evaluation of prebiotic properties of
a commercial artichoke inflorescence extract revealed bifidogenic effects [17]. The discussion of possible
protective effects of traumatic acid (TA) on the cancerous effect of mesotrione [18]. Is Acrylamide as a
harmful as we think? A new look at the impact of Acrylamide on the viability of beneficial intestinal
bacteria of the genus Lactobacillus [19] The biological activity of new cichoric acid–metal complexes in
bacterial strains, yeast-like fungi, and human cell cultures in vitro [20]. The presentation of how soluble
extracts from chia seed (Salvia hispanica L.) affect brush border membrane functionality, morphology
and intestinal bacterial populations in vivo (Gallus gallus) [21]. The fructose consumption by adult rats
exposed to dexamethasone in utero changes the phenotype of intestinal epithelial cells and exacerbates
intestinal gluconeogenesis [22]. Alterations in the intestinal morphology, gut microbiota, and trace
mineral status following intra-amniotic administration (Gallus gallus) of teff (Eragrostis tef) seed
extracts [23]. Non-dairy fermented beverages as potential carriers to ensure probiotics, prebiotics,
and bio-active compounds arrival to the gut and their health benefits [24]. These wide spectra of
topics further demonstrate the importance and relevance of dietary plant-origin bio-active compounds,
and their effects on intestinal functionality and microbiome.
This special issue and collection of manuscripts is a useful summary of progress in various areas
related to dietary plant-origin bio-active compounds, intestinal functionality, and microbiome. It also
points to additional research needs, including recommendations for future research in the field, and to
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better understand the dietary role that dietary plant-origin bio-active compounds hold and regarding
human nutrition and overall health.
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Abstract: Fructose consumption by rodents modulates both hepatic and intestinal lipid metabolism
and gluconeogenesis. We have previously demonstrated that in utero exposure to dexamethasone
(DEX) interacts with fructose consumption during adult life to exacerbate hepatic steatosis in rats.
The aim of this study was to clarify if adult rats born to DEX-treated mothers would display differences
in intestinal gluconeogenesis after excessive fructose intake. To address this issue, female Wistar
rats were treated with DEX during pregnancy and control (CTL) mothers were kept untreated.
Adult offspring born to CTL and DEX-treated mothers were assigned to receive either tap water
(Control-Standard Chow (CTL-SC) and Dexamethasone-Standard Chow (DEX-SC)) or 10% fructose
in the drinking water (CTL-fructose and DEX-fructose). Fructose consumption lasted for 80 days.
All rats were subjected to a 40 h fasting before sample collection. We found that DEX-fructose rats
have increased glucose and reduced lactate in the portal blood. Jejunum samples of DEX-fructose
rats have enhanced phosphoenolpyruvate carboxykinase (PEPCK) expression and activity, higher
facilitated glucose transporter member 2 (GLUT2) and facilitated glucose transporter member 5
(GLUT5) content, and increased villous height, crypt depth, and proliferating cell nuclear antigen
(PCNA) staining. The current data reveal that rats born to DEX-treated mothers that consume
fructose during adult life have increased intestinal gluconeogenesis while recapitulating metabolic
and morphological features of the neonatal jejunum phenotype.
Keywords: intrauterine growth restriction (IUGR); fructose; dexamethasone; intestinal gluconeogenesis
1. Introduction
The consumption of fructose-sweetened beverages has significantly increased during the last
decades and a great number of observational studies have associated this nutritional habit with
increased cardiometabolic risk [1]. In accordance with this hypothesis, experimental studies have
described that rats consuming high amounts of fructose or sucrose develop glucose intolerance and
increased hepatic gluconeogenesis [2–4].
The mechanisms underlying the metabolic effects of excessive fructose intake rely on its hepatic as
well as its intestinal metabolism [5]. The small intestine absorbs fructose through a facilitated glucose
Nutrients 2020, 12, 3062; doi:10.3390/nu12103062 www.mdpi.com/journal/nutrients5
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transporter member 5 (GLUT5)-dependent mechanism and partially metabolizes it into lactate, glucose,
and fatty acids that are sequentially secreted to the portal circulation [6,7]. However, intestinal fructose
metabolism capacity is limited and when high amounts of fructose are consumed, a considerable fraction
reaches the liver [7]. Hepatic metabolism of fructose, in turn, produces glyceraldehyde-3-phosphate
that is driven to either gluconeogenesis or de novo lipogenesis (DNLG) [8].
Besides its metabolism to intermediates that feed gluconeogenesis and DNLG, fructose was described
to modulate the expression of key metabolic genes [5]. Fructose consumption increased the expression of
GLUT5 and gluconeogenic enzymes glucose-6-phosphatae (G6Pase) and fructose-1,6-bisphosphatase
(FBP1) in the small intestine [9,10]. Excessive fructose intake was also reported to increase the hepatic
expression of the gluconeogenesis enzymes G6Pase, FBP1, and phosphoenolpyruvate carboxykinase
(PEPCK) [11–14], and the DNLG enzymes acetyl-CoA carboxylase (ACC), fatty acid synthase (FAS),
and stearoyl-CoA desaturase-1 (SCD1) [15].
We have recently demonstrated that the modulation of key metabolic genes induced by fructose
in the liver can interact with other factors, such as birth weight. Fructose supplementation of rats
born small due to maternal treatment with dexamethasone (DEX) induced an expected increase in the
expression of PEPCK, FAS, and ACC, but failed to increase the expression of genes involved in very low
density lipoproteins (VLDL) assembly and secretion, leading to an exacerbation in hepatic steatosis [16].
In addition to low birth weight, in utero exposure to DEX is recognized to program the energy
metabolism during adult life. Offspring born to DEX-treated mothers develop glucose intolerance
and increased hepatic PEPCK expression as soon as the 21st day of life [17]. Additionally, pancreatic
postnatal development of rats born to DEX-treated mothers is hallmarked by lower pancreatic b-cell
mass and higher pancreatic a-cell mass and glucagon levels [18]. Treatment of pregnant mice with DEX
was also described to epigenetically impair brown adipose tissue (BAT) thermogenesis and energy
expenditure in the offspring, leading to increased adiposity and insulin resistance [19].
Aside from the liver, several studies have reported the expression of G6Pase and PEPCK in the
small intestine of humans and rats, deeming this organ relevant in endogenous glucose production
(EGP) [20–22]. Significant contribution of the small intestine to EGP is particularly relevant after a
fasting period of at least 40 h, the period of time necessary for an increase in both G6Pase and PEPCK
in the jejunum [23–25].
The present study has been undertaken to evaluate if prenatal exposure to DEX and excessive
consumption of fructose during adult life could interact to modulate small intestine gluconeogenesis.
To achieve this aim, we have evaluated key enzymatic and biochemical end-points indicative of
intestinal gluconeogenesis as well as morphological aspects of the jejunum in 40 h fasted rats born to
DEX-treated mothers and/or exposed to liquid fructose during adulthood.
2. Materials and Methods
2.1. Experimental Design and Diet
Eight-week-old nulliparous Wistar rats were acquired from the Animal Breeding Center at the
Institute of Biomedical Sciences, University of Sao Paulo (Protocol # 5367250619). The animals were
housed and mated with male rats as previously described [16].
After mating, pregnant rats were randomly assigned to receive 0.1 mg/kg/day dexamethasone (DEX)
diluted in the drinking water from the 14th to the 19th day of pregnancy or remain untreated (CTL).
On the 80th day of life, male offspring of DEX-treated and CTL dams were divided into two additional
groups that were either kept with tap water or 10% fructose (w/v) solution ad libitum for the next 80 days.
All offspring received standard chow ad libitum from the weaning to the 160th day of life.
The different groups were thereafter designed as follows: offspring born to CTL mothers that
received only standard chow (SC) and tap water during adult life (CTL-SC); offspring born to DEX-treated
mothers that received only SC and tap water during adult life (DEX-SC); offspring born to CTL mothers
that received SC plus 10% fructose during adult life (CTL-fructose); and offspring born to DEX-treated
mothers that received SC plus 10% fructose during adult life (DEX-fructose). On the 160th day of life,
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the animals were subjected to a 40 h fasting before euthanasia. During fasting, standard chow was
removed and 10% fructose was replaced by tap water.
2.2. Pyruvate Tolerance Test (PTT)
Rats were fasted for 40 h and a 20% sodium pyruvate solution was injected intraperitoneal (i.p.)
at a dosage of 2 g/kg of body mass. Glucose concentration was determined in blood extracted from
the tail before (0 min) and 15, 30, 60, and 90 min after pyruvate injection (tail blood samples were
chosen as representative of systemic blood). The area under the curve (AUC) of tail blood glucose
levels vs. time was calculated using each individual baseline (basal glycemia) to estimate whole-body
gluconeogenesis. We also collected portal blood samples at the end of the PTT (90 min after pyruvate
challenge) to estimate the ability of the small intestine to convert pyruvate into glucose.
2.3. Tissue Sampling and Preparation
The rats were anesthetized with isoflurane. Proper level of anesthesia was assured by loss of
pedal reflex. The abdominal cavity then was opened and portal blood was punctured. Euthanasia
was performed by rupture of the diaphragm (with surgical scissors) followed by immediate cardiac
puncture of the systemic blood. Systemic and portal blood samples were collected in EDTA-coated
tubes and centrifuged at 2000 rpm for 20 min at 4 ◦C. Plasma samples were removed and used for
biochemical analysis.
Intestinal segments were harvested from the proximal jejunum (5 cm beyond the ligament of
Treitz), opened at the mesenteric border, pinned flat on a cork mat, and gently washed in ice-cold 0.1 M
phosphate-buffered saline solution (PBS). The time elapsed between euthanasia and jejunum samples
harvesting was approximately 2 min. The segments were transversally cut into two samples. In one
sample, the mucosa was scraped and frozen under −80 ◦C for subsequent molecular and biochemical
analyses (described below).
The second jejunum sample was immediately fixed with 10% buffered formaldehyde for 24 h,
dehydrated in alcohol, diaphanized in xylol, and embedded in paraffin. Nonserial longitudinal sections
(5–7 μm thick) were subjected to hematoxylin–eosin (HE) staining for morphometric analysis. In some
rats, the entire small intestine was dissected and its length (cm) was measured and expressed as the
relative length to tibia length [26].
2.4. Analysis of Blood Parameters
Plasma glucose, triglycerides, lactate, and cholesterol determinations were performed using
commercially available kits (Labtest Diagnóstica SA, Lagoa Santa, MG, Brazil).
2.5. Enzymatic Activity
The activities of phosphoenolpyruvate carboxykinase (PEPCK; EC 4.1.1.32), glucose-6-phosphatase
(G6Pase; EC 3.1.3.9), and hexokinase (HK; EC 2.7.1.1) were measured using spectrophotometric assays at
340 nm, following standard methods described elsewhere [27–29]. Protein concentration of each sample
was determined by the Bradford method, and enzymatic activities were normalized by protein content.
2.6. Molecular Analyses
Scraped mucosal cells were processed for both qPCR and Western blotting (WB), as previously
described [16]. The nitrocellulose membranes for WB were stained with Ponceau S before incubation
with the primary antibodies. The stained membranes were allowed to dry at room temperature, scanned,
and subjected to optical density (OD) quantification. All the lanes (from the top to the bottom) of
labeled proteins were scanned to better represent the total amount of protein actually loaded in the gel.
Subsequently, these values were applied to normalize the OD data of the target proteins detected in the
respective membranes. This method was validated as an appropriate loading control [30]. The primary
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antibodies used were as follows: anti-GLUT2 (cat. # sc-9117) from Santa Cruz Biotechnology (Santa Cruz,
CA, USA) and anti-GLUT5 (cat. # IM-0292) from Rhea Biotech (Campinas, SP, Brazil).
Total RNA was extracted using QIAzol reagent and used for reverse transcription with random primers
for the analysis of mRNA expression. The primer sequences and accession numbers were as follows:
G6pc (NM_013098) 5′-ACCTTCTTCCTGTTTGGTTTCGC-3′ and 5′-CGGTACATGCTGGAGTTGAGGG-3′;
Pck1 (NM_198780) 5′-TGGTCTGGACTTCTCTGCCAAG-3′ and 5′-AATGATGACCGTCTTGCTTTCG-3′;
Ggt1 (NM_053840) 5′-ACCCGACTTCATCGCTGTG-3′ and 5′-GCATGTTCTCCAGAGTCCCAC-3′; Rpl37a
(X14069) 5′-CAAGAAGGTCGGGATCGTCG-3′; and 5′-ACCAGGCAAGTCTCAGGAGGTG-3′. Values of
mRNA expression were normalized using the internal control gene Rpl37a. Fold changes were calculated by
the 2−ΔDDCT method.
2.7. Morphometric Analysis of the Jejunum Wall
The morphometric analyses were performed blindly using AxioVision Release 4.8-SP2 software
(Carl Zeiss Microscopy, Jena, Germany) and consisted of the evaluation of the villus height and crypt
depth. The height of each villus was measured from the top of the villus to the crypt transition, and the
crypt depth was defined as the invagination between two villi. These analyses were performed in
five fields at 100×magnification from different jejunum regions, including 2–3 villus/crypt per field,
totaling 10–15 villus/crypt per animal [31].
2.8. Immunohistochemical Evaluation of Cell Proliferation
Antigen retrieval was performed in citric acid (10 mM, pH 6.0) at 95 ◦C for 40 min, followed
by cooling for 30 min. After antigen retrieval, sections were incubated with 3% hydrogen peroxide
diluted in methanol for 30 min to quench endogenous peroxidase, then rinsed with deionized water
followed by PBS, pH 7.4. Sections then were incubated with 6% defatted milk for 30 min, at 37 ◦C,
to block nonspecific staining. The anti-PCNA monoclonal antibody, from Dako-Agilent (Santa Clara,
CA, USA; Cat. No. M0879), was diluted 1:1000 in PBS plus 1% bovine serum albumin (BSA) and
incubated on sections overnight at 4 ◦C. All sections were washed three times in PBS for 5 min each
time, then incubated with secondary antibody conjugated with horseradish peroxidase labeled polymer
(EnVision +Dual link System-HRP) for 30 min at room temperature. 3,3′-diaminobenzidine (DAB) was
used to visualize the antigen/antibody complex and the specimens were then lightly counterstained
with hematoxylin. Negative control samples were performed by substituting the primary antibody
with antibody diluent. We analyzed 10 crypts from each section under a 400× magnification [32].
Cell proliferation rate was expressed as percentage of PCNA-positive cells.
2.9. Statistical Analyses
Comparisons were performed using two-way ANOVA, followed by a Tukey’s multiple comparison
test. The two factors considered for the two-way ANOVA were in utero exposure to DEX (either
exposed or not) and treatment of 10% fructose during adulthood (either treated or not). When making
comparisons between two groups, the unpaired Student’s t-test was used. Statistical analyses were
conducted using GraphPad Prism software version 8.4.3 (GraphPad Software, Inc., San Diego, CA,
USA). All results are presented as the means ± standard error of the mean (SEM). Results with p values
lower than 0.05 were considered significant.
3. Results
3.1. Consumption of Fructose by Rats Born to DEX-Treated Mothers Modifies Body Composition but Does Not
Modulate Small Intestine Length
As reported by us in previous studies [16,33], rats born to DEX-treated mothers displayed reduced
birth weight (18% lower than CTL; p = 0.033) (Figure 1A). The body weights of the 40 h fasted offspring
with 160 days of age were influenced by both in utero exposure to DEX and treatment with 10%
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fructose (p < 0.0001 and p = 0.0002, respectively). The post hoc analysis revealed that DEX-SC were
lighter (9%; p < 0.01) while CTL-fructose were heavier (10%; p < 0.001) when compared to age-matched
CTL-SC. In addition, DEX-fructose rats were lighter than the SC-fructose group (13%; p < 0.0001)
(Figure 1B).
Figure 1. Morphometrical parameters of rats exposed to dexamethasone (DEX) in utero. Body weight
was measured at birth (A) and at the end of treatment (B) in nonfasted rats. Fasted rats were euthanized
at the end of the 80th day of fructose consumption, and the small intestine length relative to tibia length
(C), and fat pads (mesenteric, (D); epidydimal, (E); retroperitoneal, (F)) and liver (G) masses relative
to body weight were also measured. Results are presented as mean ± standard error of the mean
(S.E.M.). * p < 0.05, ** p < 0.01 (n = 10–20). Offspring born to control (CTL) mothers that received only
standard chow (SC) and tap water during adult life (CTL-SC); offspring born to DEX-treated mothers
that received only SC and tap water during adult life (DEX-SC); offspring born to CTL mothers that
received SC plus 10% fructose during adult life (CTL-fructose); and offspring born to DEX-treated
mothers that received SC plus 10% fructose during adult life (DEX-fructose).
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Small intestine length, relative to tibia length, was influenced by in utero exposure to DEX
(p = 0.0035). The post hoc analysis revealed that both DEX-SC and DEX-fructose had shorter small
intestine when compared to CTL-SC (respectively 8% and 7% shorter; p < 0.05) (Figure 1C).
Mesenteric adiposity was influenced by the factor in utero exposure to DEX in the 40 h fasted
offspring (p = 0.0264). However, the post hoc analysis revealed a specific increase of mesenteric
adiposity in 40 h fasted DEX-SC (42% higher than CTL-SC; p < 0.05) (Figure 1D). The treatments
had no effect on epididymal adiposity (Figure 1E). Retroperitoneal adiposity of the 40 h fasted adult
offspring presented changes that were similar to those seen for mesenteric adiposity. The post hoc
analysis revealed a specific increase of retroperitoneal adiposity of the 40 h fasted DEX-SC (50% higher
than CTL-SC; p < 0.01) (Figure 1F). The relative weight of the liver was not affected by the treatments
(Figure 1G).
3.2. Biochemical Changes Detected in Rats Born to DEX-Treated Mothers That Consume Fructose during
Adulthood Indicates Increased Intestinal Gluconeogenesis
Both in utero exposure to DEX and treatment with 10% fructose during adulthood affected
systemic glucose levels after a 40 h fasting (p = 0.046 and p = 0.039, respectively). However, the post hoc
analysis revealed that systemic glucose levels were increased exclusively in 40 h fasted DEX-fructose
(28% higher than CTL-SC; p < 0.05) (Figure 2A). Similarly, in utero exposure to DEX and treatment with
10% fructose during adulthood influenced systemic triglyceride levels after a 40 h fast (p = 0.0025 and
p < 0.0001, respectively). In regard to this, the post hoc analysis indicated that systemic triglyceride
levels were increased in 40 h fasted DEX-fructose when compared to CTL-SC, DEX-SC, and CTL-fructose
(respectively 108%, 62%, and 36%; p < 0.0001, p < 0.001, and p < 0.05). Systemic triglycerides were also
increased in 40 h fasted CTL-fructose (52% higher than CTL-SC; p < 0.05) (Figure 2B). Total systemic
cholesterol levels after 40 h fasting were not altered in any of the four groups studied (Figure 2C).
Both in utero exposure to DEX and treatment with 10% fructose during adulthood also modified
portal glucose levels after a 40 h fasting (p < 0.0001 and p = 0.045, respectively). Our post hoc analysis
revealed that portal glucose levels were increased in 40 h fasted DEX-fructose (144% higher than
CTL-SC and 83% higher than CTL-fructose; p < 0.0001 and p < 0.01). The portal glucose levels were also
increased in 40 h fasted DEX-SC (102% higher than CTL-SC; p < 0.05) (Figure 2D). Portal lactate levels
detected after a 40 h fasting were only influenced by in utero exposure to DEX (p < 0.05). The post hoc
analysis revealed a specific reduction of portal lactate levels in 40 h fasted DEX-fructose rats (26% lower
than CTL-SC; p < 0.05) (Figure 2E).
Figure 2. Cont.
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Figure 2. Effects of fructose on biochemical parameters of systemic and portal blood in rats exposed
to dexamethasone (DEX) in utero. Systemic blood samples were collected to measure glucose (A),
triacylglycerol (B), and total cholesterol (C). Portal hepatic vein samples were collected to measure
glucose (D) and lactate (E). Results are presented as mean ± standard error of the mean (S.E.M.).
* p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001 (n = 8–12). Offspring born to control (CTL) mothers
that received only standard chow (SC) and tap water during adult life (CTL-SC); offspring born to
DEX-treated mothers that received only SC and tap water during adult life (DEX-SC); offspring born to
CTL mothers that received SC plus 10% fructose during adult life (CTL-fructose); and offspring born to
DEX-treated mothers that received SC plus 10% fructose during adult life (DEX-fructose).
3.3. Rats Born to DEX-Treated Mothers That Consume Fructose during Adulthood Display Increased Portal
Glucose Levels after Challenge with Exogenous Pyruvate
We next performed the pyruvate tolerance test with the attempt to clarify if the higher portal
glucose levels seen in 40 h fasted DEX-fructose rats were due to increased gluconeogenesis. The glucose
levels in tail blood samples were assessed at different time points after pyruvate injection (Figure 3A).
Treatment with 10% fructose during adulthood influenced the area under the curve (AUC) values
in 40 h fasted rats (p < 0.0001). Our post hoc analysis indicated that whole-body gluconeogenesis is
increased in fructose-treated rats irrespective of maternal treatment with DEX. This can be concluded
because the AUC values of both CTL-fructose and DEX-fructose rats were similar to each other and
higher than those of CTL-SC (respectively 174% and 227% higher; p = 0.0227 and p = 0.0016) (Figure 3B).
Figure 3. Cont.
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Figure 3. Whole-body and intestinal use of pyruvate as a gluconeogenesis substrate by rats exposed
to dexamethasone (DEX) in utero and treated with fructose during adult life. The 40 h fasted rats
received an i.p. injection containing sodium pyruvate. The blood from the tail was collected before and
15, 30, 60, and 90 min after intraperitoneal (i.p.) injection for glucose measurements (A) and the area
under the curve (AUC) was calculated above each individual baseline (B). Glucose levels were also
measured in portal blood at the end of the pyruvate tolerance test (PTT) (C). Results are presented as
mean ± standard error of the mean (S.E.M.) * p < 0.05, ** p < 0.01, **** p < 0.0001 (n = 8). Offspring
born to control (CTL) mothers that received only standard chow (SC) and tap water during adult life
(CTL-SC); offspring born to DEX-treated mothers that received only SC and tap water during adult
life (DEX-SC); offspring born to CTL mothers that received SC plus 10% fructose during adult life
(CTL-fructose); and offspring born to DEX-treated mothers that received SC plus 10% fructose during
adult life (DEX-fructose).
Glucose levels in portal blood 90 min after challenge with pyruvate were influenced by both in
utero exposure to DEX and treatment with 10% fructose during adulthood (p = 0.0043 and p = 0.0001,
respectively). In contrast to the changes in whole-body gluconeogenesis, our post hoc analysis
revealed increased portal glucose levels after challenge with pyruvate exclusively in DEX-fructose rats
(65% higher than CTL-SC, 26% higher than CTL-fructose, and 39% higher than DEX-SC; p < 0.001,
p = 0.0301, and p = 0.0055) (Figure 3C).
3.4. Rats Born to DEX-Treated Mothers That Consume Fructose during Adulthood Display Increased PEPCK
Expression and Activity in the Jejunum
The expression of G6pc (the gene that encodes G6Pase) in the jejunum was not affected in any of
the four groups after a 40 h fasting (Figure 4A). The activity of G6Pase in the jejunum of the 40 h fasted
rats was influenced by in utero exposure to DEX (p = 0.035) but no specific differences were found in
the post hoc analysis (Figure 4B).
The expression of Pck1 (the gene that encodes PEPCK) in the jejunum of the 40 h fasted rats was
modulated by in utero exposure to DEX (p = 0.005). In this case, our post hoc analysis indicated a
marked increase of Pck1 expression in the jejunum of the 40 h DEX-fructose (88% higher than CTL-SC;
p < 0.05) (Figure 4C). As with changes in expression, PEPCK activity in the jejunum of the 40 h fasted
rats was regulated by in utero exposure to DEX (p = 0.043). Our post hoc analysis indicated a specific
increase of PEPCK activity in the jejunum of the 40 h fasted DEX-fructose group (14% higher than
CTL-SC; p < 0.05) (Figure 4D). The expression of fructose 1,6-bisphosphatase (Fbp1) was also evaluated
but no differences were found among the groups (data not shown).
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Figure 4. Expression and activity of enzymes involved in intestinal gluconeogenesis. Scraped
epithelium of jejunum fragments was isolated and processed for qPCR detection of G6pc (A) and Pck1
(C) gene expression, as well as for maximum activities of the corresponding enzymes G6Pase (B) and
PEPCK (D). Results are presented as mean ± standard error of the mean (S.E.M.). * p < 0.05 (n = 6–12).
Offspring born to control (CTL) mothers that received only standard chow (SC) and tap water during
adult life (CTL-SC); offspring born to dexamethasone (DEX)-treated mothers that received only SC
and tap water during adult life (DEX-SC); offspring born to CTL mothers that received SC plus 10%
fructose during adult life (CTL-fructose); and offspring born to DEX-treated mothers that received SC
plus 10% fructose during adult life (DEX-fructose).
3.5. Rats Born to DEX-Treated Mothers That Consume Fructose during Adulthood Display Reduced HK
Activity and Increased GLUT5 and GLUT2 Expression in the Jejunum
Both in utero exposure to DEX and treatment with 10% fructose during adulthood influenced
hexokinase (HK) activity in the jejunum of the 40 h fasted rats (p = 0.0362 and p = 0.0004, respectively).
The post hoc analysis revealed that reductions in HK activity in the jejunum of the 40 h fasted rats
were specific for the DEX-fructose group (46% lower than CTL-SC, 51% lower than DEX-SC, and 44%
lower than CTL-fructose; p < 0.001, p < 0.0001, and p < 0.01) (Figure 5A).
The expression of glutathione S-transferase 1 (Gtt1) in the jejunum of the 40 h fasted rats was
influenced by in utero exposure to DEX (p < 0.0001). The post hoc analysis revealed that 40 h fasted
DEX-SC rats had increased expression of Gtt1 in the jejunum (90% higher than CTL-SC; p < 0.05).
Increased expression of Gtt1 in the jejunum was also found in 40 h fasted DEX-fructose (170% higher
than CTL-fructose and 156% higher than CTL-SC; p < 0.001) (Figure 5B).
The content of facilitated glucose transporter member 2 (GLUT2) in the jejunum of the 40 h fasted
rats was altered by treatment with 10% fructose during adulthood (p = 0.0017). The post hoc analysis
revealed that the increase of GLUT2 content in the jejunum of the 40 h fasted rats was specific for
DEX-fructose (60% higher than CTL-SC and 73% higher than DEXA-SC; p < 0.01) (Figure 5C).
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The content of GLUT5 in the jejunum of the 40 h fasted rats was also influenced by in utero
exposure to DEX (p = 0.0299). The post hoc analysis revealed a specific increase of GLUT5 content in
the jejunum of the 40 h fasted DEX-fructose (75% higher than CTL-fructose; p < 0.05) (Figure 5D).
Figure 5. In utero dexamethasone (DEX) exposure alters glucose metabolism and phenotypic features
of the jejunum epithelia. Scraped epithelium of jejunum fragments was isolated and processed for
measurement of maximum hexokinase activity (A), expression of glutathione S-transferase 1 (Ggt1) by
quantitative polymerase chain reaction (qPCR) (B), and Western blot of facilitated glucose transporter
member 2 (GLUT2) (C) and facilitated glucose transporter member 5 (GLUT5) (D). Results are presented
as mean ± standard error of the mean (S.E.M.). * p < 0.05, *** p < 0.001, **** p < 0.0001 (n = 6–12).
Offspring born to control (CTL) mothers that received only standard chow (SC) and tap water during
adult life (CTL-SC); offspring born to DEX-treated mothers that received only SC and tap water during
adult life (DEX-SC); offspring born to CTL mothers that received SC plus 10% fructose during adult life
(CTL-fructose); and offspring born to DEX-treated mothers that received SC plus 10% fructose during
adult life (DEX-fructose).
14
Nutrients 2020, 12, 3062
3.6. Rats Born to DEX-Treated Mothers That Consume Fructose during Adulthood Display Morphological
Changes in the Jejunum Epithelium
We have also assessed the mean crypt depth and the mean villous height, two aspects of the
jejunum epithelium that are vital for its absorptive capacity. Images of the HE-stained jejunum sections
are shown from each of the four different groups of 40 h fasted adult offspring (Figure 6A–D).
Figure 6. Morphometric analysis of the jejunum wall. The figure shows representative sections of villus
and crypts of the four experimental groups (A–D). The height of each villus was measured from the top
of the villus to the crypt transition (E), and the crypt depth was defined as the invagination between
two villi (F). Results are presented as mean ± standard error of the mean (S.E.M.). * p < 0.05, ** p < 0.01
(n = 5). Offspring born to control (CTL) mothers that received only standard chow (SC) and tap water
during adult life (CTL-SC); offspring born to dexamethasone (DEX)-treated mothers that received only
SC and tap water during adult life (DEX-SC); offspring born to CTL mothers that received SC plus 10%
fructose during adult life (CTL-fructose); and offspring born to DEX-treated mothers that received SC
plus 10% fructose during adult life (DEX-fructose).
The mean crypt depth in the jejunum epithelium of 40 h fasted rats was modulated by in utero
exposure to DEX (p = 0.0119). On the other hand, the post hoc analysis revealed that crypt depth was
only increased in the jejunum epithelium of 40 h fasted DEX-fructose rats (25% higher than DEX-SC
and 43% higher than CTL-fructose; p < 0.05 and p < 0.01) (Figure 6E).
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Villous height was influenced by treatment with 10% fructose during adulthood (p = 0.0017).
Similar to crypt depth, the post hoc analysis revealed that villous height was only increased in the
jejunum epithelium of 40 h fasted DEX-fructose (27% higher than CTL-SC and 39% higher than DEX-SC;
p < 0.05 and p < 0.01) (Figure 6F).
The proliferative potential in the jejunum epithelium was evaluated by assessing the relative
number of PCNA-positive cells. Representative images of the jejunum sections stained with anti-PCNA
antibody are shown from each of the four different groups of 40 h fasted adult offspring (Figure 7A–D).
The hematoxylin-counterstained section that served as a negative control (by omission of the primary
antibody) is shown in Figure 7E.
Figure 7. Jejunum was removed for immunohistochemical detection of proliferating cell nuclear antigen
(PCNA). The figure shows representative sections of PCNA staining (A–D) and negative control sample
(E). Sections were used to calculate the percentage of PCNA-positive cells in crypt cells (F). Results are
presented as mean ± standard error of the mean (S.E.M.). **** p < 0.0001 (n = 5). Offspring born to
control (CTL) mothers that received only standard chow (SC) and tap water during adult life (CTL-SC);
offspring born to dexamethasone (DEX)-treated mothers that received only SC and tap water during
adult life (DEX-SC); offspring born to CTL mothers that received SC plus 10% fructose during adult life
(CTL-fructose); and offspring born to DEX-treated mothers that received SC plus 10% fructose during
adult life (DEX-fructose).
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Both factors, in utero exposure to DEX and treatment with 10% fructose during adulthood,
influenced cell proliferation rate in the jejunum epithelium of the 40 h fasted rats (p = 0.0158 and
p < 0.0001, respectively). The post hoc analysis revealed a particular increase in the cell proliferation
rate of the jejunum epithelium of 40 h fasted DEX-fructose (48% higher than CTL-SC, 78% higher than
DEX-SC, and 43% higher than CTL-fructose; p < 0.0001) (Figure 7F).
4. Discussion
In utero exposure to DEX is well known for programming metabolic changes in the adult offspring
of rats. The metabolic imprinting caused by excessive exposure to DEX during fetal life is hallmarked
by glucose intolerance, increased whole-body gluconeogenesis, and upregulation of PEPCK expression
in the liver [17,33,34]. Recently, we have also described that in utero exposure to DEX exacerbates
hepatic steatosis caused by fructose consumption during adult life [16]. The present study further
contributes to this topic by revealing that rats born to DEX-treated mothers present exacerbated
intestinal gluconeogenesis after consuming excessive fructose during adult life.
Changes in key endpoints support the above claim; increased PEPCK expression and activity in the
jejunum and increased portal glucose levels were detected after a 40 h fasting in rats born to DEX-treated
mothers that consumed fructose during adult life. An additional finding that supports the proposition
that in utero exposure to DEX increases gluconeogenesis capacity is the higher portal glucose levels
detected in DEX-fructose rats 90 min after the challenge with pyruvate, a known gluconeogenesis
substrate. The 40 h fasting that preceded our sample collection and the PTT was performed because
it has been previously described that intestinal gluconeogenesis does not significantly occur during
shorter periods of food deprivation [25].
Another finding that supports the notion that intestinal gluconeogenesis is increased in rats born
to DEX-treated mothers that consume fructose during adulthood is the increase in GLUT2 content
in the jejunum of DEX-fructose rats, with parallel reduction in HK activity. GLUT2 is classically
recognized for mediating the basolateral transport of glucose to the capillary vessels that feed the
portal vein [35]. Our interpretation is that enterocytes of DEX-fructose rats have increased ability to
synthesize glucose de novo (due to increased PEPCK) and release the newly synthesized glucose to the
portal bloodstream (due to increased GLUT2 expression). Lower HK activity in the enterocytes of the
DEX-fructose rats may contribute to the increased intestinal glucose release by reducing their rate of
conversion of newly synthesized glucose back to glucose-6-phosphate.
In parallel with the above-mentioned biochemical changes that evidence increased intestinal
gluconeogenesis, DEX-fructose rats exhibited lower portal lactate levels. This is particularly relevant
because 10% fructose solution was replaced by water during the 40 h fasting. Thus, the current
experiments do not support the notion that in utero exposure to DEX increases intestinal conversion of
fructose into glucose but instead indicate that the jejunum of 40 h fasted adult DEX-fructose rats may
increase the use of lactate as substrate for gluconeogenesis.
Interestingly, previous studies have reported that the small intestine of the fasted adult rat
preferentially uses glutamine and glycerol, instead of lactate, as substrates for gluconeogenesis [23].
On the other hand, the small intestine of suckling rats is able to convert lactate into glucose [36].
Considering this, our data suggest that the small intestine of the offspring born to DEX-treated mothers
that chronically consume fructose during adult life preserves a metabolic feature of the newborn
small intestine.
Although it is challenging to presume the functional relevance of the increased GLUT5 in the
jejunum of DEX-fructose rats after a 40 h fasting, this particular result reinforces the proposition that
the small intestine of the adult offspring born to DEX-treated mothers preserves phenotypic features
of the newborn after chronic exposure to fructose. Supporting this suggestion, it was previously
demonstrated that DEX exacerbates GLUT5 expression induced by fructose in samples of small intestine
of neonatal rats [37]. It is important to note that in utero exposure to DEX alone is not sufficient to
stimulate GLUT5 content in the jejunum of the offspring. Such findings have also been previously
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reported in other studies [38] and support the notion that the two factors together (both in utero
exposure to DEX and fructose consumption) seem to be necessary for enhancing jejunal GLUT5 content.
With regard to the morphological impact of DEX on the small intestine early in life, it has been
previously reported that the lactating pups treated with DEX during lactation exhibit transitory
changes in the small intestine epithelial architecture. Pups treated with DEX between the 11th and the
21st days of life display increased villous height and crypt depth in the jejunum soon after weaning.
These changes are no longer detected by the age of 50 days [39]. Hence, we conclude that aside from
the metabolic/biochemical features, morphological changes transiently described in the lactating pups
exposed to DEX during early life are sustained in the adult offspring born to DEX-treated mothers only
after consumption of excessive fructose.
We have also found that the frequency of PCNA-positive cells in the jejunum epithelial surface, a
parameter that spontaneously reduces in the jejunum of the adult rat as the age advances beyond 90 days
of life [40], is exacerbated in the 160-day-old DEX-fructose rats. Instead, Ggt1 expression, an enzyme
that plays a crucial role in de novo synthesis of intracellular GSH and ROS removal [41], is increased in
the jejunum of adult rats born to DEX-treated mothers, irrespective of fructose consumption. Notably,
GGT1 inhibition was associated with increased apoptosis in smooth muscle cells [42]. Thus, intestinal
epithelial cells of the adult DEX-fructose offspring are unique in such a way that they combine long-term
pro-proliferative and antiapoptotic adaptations.
Another interesting metabolic feature exhibited in the 40 h fasted DEX-fructose rats is the increased
circulating triglyceride levels. Although we are not able to discern the hepatic or the intestinal origin of
the lipoproteins that contribute to this phenomenon, it is important to take into account that intestinal
production of triglyceride-enriched lipoprotein accounts for up to 40% of the triglycerides in fasting
rats [43]. Moreover, chronic consumption of a fructose-enriched diet was described to increase the
intestinal production of chylomicrons during fasting periods [44].
In summary, the present study supports the proposition that consumption of fructose by adult rats
exposed to DEX during fetal life leads to an exacerbation in intestinal gluconeogenesis and retention
of morphological features in the jejunum that are commonly found during neonatal life. These data
provide a new mechanism to explain the increased prevalence of metabolic disturbances in humans
that are born with low birth weight.
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Abstract: The consumption of teff (Eragrostis tef ), a gluten-free cereal grain, has increased due to its
dense nutrient composition including complex carbohydrates, unsaturated fatty acids, trace minerals
(especially Fe), and phytochemicals. This study utilized the clinically-validated Gallus gallus intra
amniotic feeding model to assess the effects of intra-amniotic administration of teff extracts versus
controls using seven groups: (1) non-injected; (2) 18Ω H2O injected; (3) 5% inulin; (4) teff extract 1%;
(5) teff extract 2.5%; (6) teff extract 5%; and (7) teff extract 7.5%. The treatment groups were compared
to each other and to controls. Our data demonstrated a significant improvement in hepatic iron (Fe)
and zinc (Zn) concentration and LA:DGLA ratio without concomitant serum concentration changes,
up-regulation of various Fe and Zn brush border membrane proteins, and beneficial morphological
changes to duodenal villi and goblet cells. No significant taxonomic alterations were observed
using 16S rRNA sequencing of the cecal microbiota. Several important bacterial metabolic pathways
were differentially enriched in the teff group, likely due to teff’s high relative fiber concentration,
demonstrating an important bacterial-host interaction that contributed to improvements in the
physiological status of Fe and Zn. Therefore, teff appeared to represent a promising staple food crop
and should be further evaluated.
Keywords: teff; staple food crops; prebiotics; probiotics; iron deficiency; zinc deficiency;
gut microbiota
1. Introduction
Iron (Fe) and zinc (Zn) deficiencies are prevalent public health crises worldwide but especially
so in Africa, Latin America, and other parts of the developing world [1,2]. The etiology of these
deficiencies includes a lack of substantial meat consumption in combination with a reliance on relatively
poor sources of dietary Fe and Zn including grains and cereals. As it pertains to the latter, intrinsic
dietary factors that limit Fe and Zn bioavailability such as phytic acid and polyphenolic compounds
are often present in increased quantities in staple food crops [3–5]. Despite this, other intrinsic dietary
factors such as prebiotic-like compounds have the potential to offset the inhibitor-like effects of phytate
and polyphenols, thus improving mineral bioavailability [6].
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Teff (Eragrostis tef ), a staple cereal grain mainly consumed by peoples of Eritrea and Ethiopia, is
gaining notoriety due to its dense nutrient composition including complex carbohydrates, unsaturated
fatty acids, trace minerals (especially Fe), and phytochemicals [7,8]. Teff contains high amounts of
phytates and polyphenols, although this amount varies by species and is comparable to values reported
for other wholegrain cereals. Despite this, a recent study demonstrated that the prevalence of Fe and Zn
deficiencies was much lower in Ethiopia relative to other African nations such as Kenya, Nigeria, and
South Africa, likely due to the disproportionate dietary intake of teff relative to other cereal grains [9].
Furthermore, as teff is a gluten free cereal grain with high levels of trace minerals, it is well tolerated
by individuals with food allergies and other gastrointestinal disorders, such as inflammatory bowel
diseases, which negatively impact gut mineral absorption [7].
In addition to its favorable micronutrient profile, the fiber content of teff is uniquely high, especially
when compared to other staple food crops such as sorghum, rice, maize, and wheat [7]. Constituents of
fiber, such as the prebiotics inulin and raffinose, survive initial digestion in the upper gastrointestinal
tract and become subsequently fermented by specific resident commensal bacteria in the colon [10].
This fermentation leads to the production of short-chain fatty acids (SCFA) [11]. SCFAs inhibit the
growth of harmful pathogens, decrease intestinal pH, upregulate epithelial cell differentiation, thus
increasing villus surface area, and upregulate brush-border membrane (BBM) gene expression [12].
In sum, these effects enhance gut mineral bioavailability and absorption [6,13–16]. Additionally, it
has been suggested that specific polyphenolic compounds found in teff—such as ferulic acid, vanillic
acid, cinnamic acid, and coumaric acid—exert a prebiotic effect and may improve trace mineral gut
absorption [17].
The consumption of teff continues to rise as demand for well-tolerated, highly nutritious staple
food crops continues to increase worldwide, especially as it pertains to biofortification efforts and
other population-wide strategies for combating Fe and Zn deficiency [18]. Given the nutritional
advantages of teff, especially its high concentration of trace minerals, it is important to evaluate
other intrinsic factors that influence absorption and bioavailability. Therefore, using the validated,
well-established Gallus gallus in vivo model [6,12–15,19,20], we sought to assess the effects of the
intra-amniotic administration of teff seed extracts on serum and tissue Fe and Zn status, as well
as on multiple parameters that influence trace mineral absorption and bioavailability, i.e., intrinsic
phytate and polyphenolic concentration, enterocyte gene expression of various trace mineral dependent
proteins, and brush border membrane morphology. Additionally, 16S rRNA gene sequencing of cecal
contents was utilized to analyze potential alterations in intestinal microbiota structure and function
from teff extracts. We hypothesize that intra-amniotic administration of teff extracts will indeed exert a
prebiotic effect leading to increased serum and tissue Fe and Zn concentrations, favorable alterations
in brush border membrane function and morphology, and positively restructure the gut microbiota.
2. Materials and Methods
2.1. Sample Preparation
Teff seeds (Eragrostis tef ), purchased at a local grocer in Ithaca, NY were used in the study (Bob’s
Red Mill, Milwaukie, OR, USA). To obtain flour, seeds were ground up in three replicates, using a
Kinematica Polymix PX-MFC 90 D analytical mill (Kinematica, Luzern, Switzerland) to a particle size
of 50 μm.
2.2. Extraction of Prebiotics From Teff
The extraction of prebiotics was performed [6,20,21]. Briefly, the teff flour samples were dissolved
in distilled water (50 g/L) (60 ◦C, 60 min) and then centrifuged at 3000× g (4 ◦C) for 25 min to remove
particulate matter. The supernatant was collected and dialyzed (MWCO 12–14 kDa) exhaustively
against distilled water for 48 h. The dialysate was collected and then lyophilized to yield a fine
off-white powder.
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2.3. Iron, Zinc, Calcium and Magnesium Analysis
Either a 500 mg sample of teff flour, a 100 mg sample of liver tissue (wet weight), or 50 μL of
serum were pre-digested in boro-silicate glass tubes with 3 mL of a concentrated ultra-pure nitric acid
and perchloric acid mixture (60:40 v/v) for 16 h at room temperature. Samples were then placed in a
digestion block (Martin Machine, Ivesdale, IL, USA) and heated incrementally over 4 h to a temperature
of 120 ◦C with refluxing. After incubating at 120 ◦C for 2 h, 2 mL of concentrated ultra-pure nitric acid
was subsequently added to each sample before raising the digestion block temperature to 145 ◦C for
an additional 2 h. The temperature of the digestion block was then raised to 190 ◦C and maintained
for at least 10 minutes before samples were allowed to cool at room temperature. Digested samples
were re-suspended in 20 mL of ultrapure water prior to analysis using ICP-AES (inductively coupled
plasma-atomic emission spectroscopy; Thermo iCAP 6500 Series, Thermo Scientific, Cambridge, United
Kingdom) with quality control standards (High Purity Standards, Charleston, SC, USA) following
every 10 samples. Yttrium purchased from High Purity Standards (10M67-1) was used as an internal
standard. All samples were digested and measured with 0.5 μg/mL of Yttrium (final concentration) to
ensure batch-to-batch accuracy and to correct for matrix inference during digestion. Serum LA:DGLA
ratio, a novel measure of Zn status, was determined as previously published [21].
2.4. Phytate Analysis
A 500 mg sample from teff flour and teff extract were first extracted in 10 mL of 0.66 M hydrochloric
acid under constant motion for 16 h at room temperature. A 1 mL aliquot of total extract was collected
using a wide bore pipet tip and then centrifuged (16,000× g) for 10 min to pellet debris. A 0.5 mL
sample of supernatant was then neutralized with 0.5 mL 0.75 M sodium hydroxide and stored at −20 ◦C
until the day of analysis. A phytate/total phosphorous kit (K-PHYT; Megazyme International, Ireland)
was used to measure liberated phosphorous by phytase and alkaline phosphatase. Phosphorous
was quantified by colorimetric analysis as molybdenum blue with phosphorous standards read at a
wavelength of 655 nm against the absorbance of a reagent blank. Total phytate concentrations were
calculated with Mega-Calc™ by subtracting free phosphate concentrations in the extracts from the
total amount of phosphorous that is exclusively released after enzymatic digestion.
2.5. Protein and Fiber Analysis
Protein and fiber analyses were performed as previously published by Wiesinger et al. [22]. Briefly,
the total nitrogen concentrations were measured in a 500 mg sample of teff flour or teff extract by the
Dumas combustion method at A&L Great Lakes Laboratories (Fort Wayne, IN, USA) in accordance
with AOAC method 968.06. Complete methodology is indicated in the supplementary materials.
2.6. Polyphenol Extraction
Next, 5 mL of methanol:water (50:50 v/v) was added to either 500 mg of teff flour or teff extract, and
vortexed for one minute before incubating in a sonication water bath for 20 min at room temperature.
Samples were again vortexed and placed on a compact digital Rocker (Labnet International, Inc., Edison,
NJ, USA) at room temperature for 60 min before centrifuging at 4000× g for 15 min. Supernatants were
filtered with a 0.2 μm Teflon™ syringe filter and stored at −20 ◦C until chemical analysis.
Liquid Chromatography-Mass Spectroscopy (LC-MS) Analysis of Polyphenols
Extracts and standards were analyzed as previously published [23]. Briefly, samples were analyzed
with an Agilent 1220 Infinity Liquid Chromatograph (LC; Agilent Technologies, Inc., Santa Clara, CA,
USA) coupled to an Advion expressionL® compact mass spectrometer (CMS; Advion Inc., Ithaca, NY,
USA). Advion Mass Express™ software was used to control the LC and CMS instrumentation and
data acquisition. Individual polyphenols were identified and confirmed by comparison of m/z and LC
retention times with authentic standards. Polyphenol standard curves for flavonoids were derived
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from integrated areas under UV absorption peaks from 5 replications. Standard curves for caffeic acid,
ferulic, and protocatechuic acids were constructed from MS ion intensities using 5 replications. The
complete methodology is indicated in the supplementary materials.
2.7. Animals and Study Design
Cornish-cross fertile broiler eggs (n = 79) were obtained from a commercial hatchery (Moyer’s
chicks, Quakertown, PA, USA). The eggs were incubated under optimal conditions at the Cornell
University Animal Science poultry farm incubator. All animal protocols were approved by Cornell
University Institutional Animal Care and Use committee (ethic approval code: 2007-0129). Prebiotics
in powder form were separately diluted in 18 MΩ H2O to determine the concentrations necessary to
maintain an osmolarity value (OSM) of less than 320 OSM to ensure that the Gallus gallus embryos
would not be dehydrated upon injection of the solution. At day 17 of embryonic incubation, eggs
containing viable embryos were weighed and divided into 7 groups (n = 11–15). All treatment groups
were assigned eggs of similar weight frequency distribution. Each group was then injected with the
specified solution (1 mL per egg) with a 21-gauge needle into the amniotic fluid, which was identified
by candling. The 7 groups were assigned as follows: (1) non-injected; (2) 18Ω H2O; (3) 5% inulin; (4)
teff extract 1%; (5) teff extract 2.5%; (6) teff extract 5%; and (7) teff extract 7.5%. After all eggs were
injected, the injection holes were sealed with cellophane tape and the eggs were placed in hatching
baskets such that each treatment was equally represented at each incubator location. Immediately after
hatch (21 days) and from each treatment group, chicks were euthanized by CO2 exposure and their
small intestine, blood, pectoral muscle, cecum, and liver were collected.
2.8. Blood Analysis and Hb Measurements
Blood was collected using micro-hematocrit heparinized capillary tubes (Fisher Scientific,
Waltham, MA, USA). Blood Hb concentrations were determined spectrophotometrically using the
QuantiChrom™ Hemoglobin Assay (DIHB-250, BioAssay Systems, Hayward, CA, USA) following the
kit manufacturer’s instructions.
2.9. Isolation of Total RNA From Duodenum and Liver Tissue Samples
Total RNA was isolated as previously published [23]. Briefly, total RNA was extracted from 30
mg of the proximal duodenal tissue or liver tissue (n = 8) using Qiagen RNeasy Mini Kit (RNeasy Mini
Kit, Qiagen Inc., Valencia, CA, USA) according to the manufacturer’s protocol. All steps were carried
out under RNase free conditions. RNA was quantified by absorbance at A 260/280. Integrity of the
18S ribosomal RNAs was verified by 1.5% agarose gel electrophoresis followed by ethidium bromide
staining. DNA contamination was removed using TURBO DNase treatment and removal kit from
AMBION (Austin, TX, USA). The complete methodology is indicated in the supplementary materials.
2.10. Real-Time Polymerase Chain Reaction (RT-PCR)
RT-PCR was performed as previously published [23]. Briefly, in order to create the cDNA, a 20 μL
reverse transcriptase (RT) reaction was completed in a BioRad C1000 touch thermocycler using the
Improm-II Reverse Transcriptase Kit (Catalog #A1250; Promega, Madison, WI, USA). The concentration
of cDNA obtained was determined by measuring the absorbance at 260 nm and 280 nm using an
extinction coefficient of 33 (for single stranded DNA). Genomic DNA contamination was assessed
using a real-time RT-PCR assay for the reference of genes samples. The complete methodology is
indicated in the supplementary materials.
2.10.1. Primer Design
Primer design was conducted as previously published [13] and as indicated in the supplementary
materials. The sequences and the description of primers used in this study are summarized in Table 1.
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Table 1. DNA Sequences of the primers used in this study.
Analyte Forward Primer (5'→3') Reverse Primer (5'→3') Base Pair GI Identifier
Calcium Metabolism
TRPV6 GCTCCCAGAACCTTCTCTATTT CCAGGTAATCCTGAGCTCTAATG 123 418307
PMCA1b TGCAGATGCTGTGGGTAAAT CCATAAGGCTTCCGCAATAGA 100 374244
NXC1 CCTGACGGAGAAATAAGGAAGA CCCAGGAGAAGACACAGATAAA 114 395760
Iron Metabolism
DMT1 TTGATTCAGAGCCTCCCATTAG GCGAGGAGTAGGCTTGTATTT 101 206597489
Ferroportin CTCAGCAATCACTGGCATCA ACTGGGCAACTCCAGAAATAAG 98 61098365
DcytB CATGTGCATTCTCTTCCAAAGTC CTCCTTGGTGACCGCATTAT 103 20380692
Inflammatory Response
IL-1β CTCACAGTCCTTCGACATCTTC TGTTGAGCCTCACTTTCTGG 119 88702685
IL-6 ACCTCATCCTCCGAGACTTTA GCACTGAAACTCCTGGTCTT 105 302315692
TNF-α GACAGCCTATGCCAACAAGTA TTACAGGAAGGGCAACTCATC 109 53854909
Magnesium Metabolism
MRS2 GCTGGTAACCGGGATTATGT GCAGGAACATGAGGAGGTAAT 105 420820
TRPM6 ACAGATGCTGCTGACTGATATG AAGATAGTGGGTGGTAGGAGAA 99 100859603
TRPM7 GCGTGGGATAGAGTTGACATT TCACAAGGGCATCCAACATAG 100 427502
Zinc Metabolism
ZnT1 GGTAACAGAGCTGCCTTAACT GGTAACAGAGCTGCCTTAACT 105 54109718
ZnT7 GGAAGATGTCAGGATGGTTCA CGAAGGACAAATTGAGGCAAAG 87 56555152
ZIP9 CTAAGCAAGAGCAGCAAAGAAG CATGAACTGTGGCAACGTAAAG 100 237874618
Δ6 desaturase GGCGAAAGTCAGCCTATTGA AGGTGGGAAGATGAGGAAGA 93 261865208
Hypertension
ACE CATGGCCTTGTCTGTCTCC GAGGTATCCAAAGGGCAGG 142 424059
AT1R TCATCTGGCTCCTTGCTGG AACCTAGCCCAACCCTCAG 138 396065
BBM Functionality
AP CGTCAGCCAGTTTGACTATGTA CTCTCAAAGAAGCTGAGGATGG 138 45382360
SI CCAGCAATGCCAGCATATTG CGGTTTCTCCTTACCACTTCTT 95 2246388
SGLT1 GCATCCTTACTCTGTGGTACTG TATCCGCACATCACACATCC 106 8346783
18s rRNA GCAAGACGAACTAAAGCGAAAG TCGGAACTACGACGGTATCT 100 7262899
2.10.2. Real-Time qPCR Design
All procedures were conducted as previously described [23]. Briefly, cDNA was used for each 10 μL
reaction together with 2×BioRad SSO Advanced Universal SYBR Green Supermix (Cat #1725274, Hercules,
CA, USA), which included buffer, Taq DNA polymerase, dNTPs, and SYBR green dye. The data on the
expression levels of the genes were obtained as Cp values based on the “second derivative maximum”
(automated method) as computed by Bio-Rad CFX Maestro 1.1 (Version 4.1.2433.1219, Hercules, CA, USA).
The specificity of the amplified real-time RT-PCR products were verified by a melting curve analysis (60–95
◦C) after 40 cycles, which should result in a number of different specific products, each with a specific
melting temperature. The complete methodology is indicated in the supplementary materials.
2.11. Collection of Microbial Samples and Intestinal Contents DNA Isolation
The ceca were sterilely removed and contents were treated as described previously [23]. A full
description of the method is indicated in the supplementary materials.
16S rRNA Gene Amplification, Sequencing and Analysis
16S rRNA gene amplification, sequencing, and analysis was performed as previously described [11].
Briefly, microbial genomic DNA was extracted from cecal samples using the PowerSoil DNA isolation
kit, as described by the manufacturer (MoBio Laboratories Ltd., Carlsbad, CA, USA). Bacterial 16S
rRNA gene sequences were PCR-amplified from each sample using the 515F-806R primers for the V4
hypervariable region of the 16S rRNA gene, including 12-base barcodes. The complete methodology is
indicated in the supplementary materials.
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2.12. Glycogen Analysis
Glycogen analysis was obtained from pectoralis muscle as previously described [8,23]. Briefly, the
pectoral muscle samples were then homogenized in 8% perchloric acid. Samples were then centrifuged
at 12,000× g at 4 ◦C for 15 min. The supernatant was removed and 1.0 mL of petroleum ether was
added to each tube. After mixing, the petroleum ether fraction was removed and samples from the
bottom layer were transferred to a new tube containing 300 μL of color reagent. All samples were read
at a wavelength of 450 nm in ELISA reader and the amount of glycogen was calculated according to a
standard curve. The amount of glycogen present in pectoral sample was determined by multiplying
the weight of the tissue by the amount of glycogen per 1 g of wet tissue. A full description of the
method is described in the supplementary materials.
2.13. Liver Ferritin Analysis
Liver ferritin analysis was conducted as previously described [8,23]. Briefly, 1 g of sample was
diluted into 1 mL of 50 mM Hepes buffer, pH 7.4, and homogenized on ice for 2 min (5000× g). One
mL of each homogenate was subjected to heat treatment for 10 min at 75 ◦C to aid isolation of ferritin
(other proteins are not stable at that temperature). Subsequently, samples were immediately cooled
down on ice for 30 min. Thereafter, samples were centrifuged for 30 min (13,000× g) at 4 ◦C until a
clear supernatant was obtained and the pellet containing most of the insoluble denatured proteins was
discarded. Native polyacrylamide gel electrophoresis was conducted using a 6% separating gel and a
5% stacking gel. Samples were run at a constant voltage of 100 V. Thereafter, gels were treated with
either of the two stains: Coomasie blue G-250 stain, specific for proteins, or potassium ferricyanide
(K3Fe (CN)6) stain, specific for Fe. The corresponding band found in the protein and Fe stained gel
was considered to be ferritin. Measurements of the bands were conducted using the Quantity-One-1-D
analysis program (Bio-Rad, Hercules, CA, USA). A full description of the method is described in the
supplementary materials.
2.14. Tissue Morphology Examination
Villus epithelium analysis was performed as was previously described [23]. Samples were fixed
in fresh 4% (v/v) buffered formaldehyde, dehydrated, cleared, and embedded in paraffin. Serial
sections were cut at 5 μm and placed on glass slides. Intestinal sections were deparaffinized in xylene,
rehydrated in a graded alcohol series, stained with Alcian Blue/Periodic acid-Schiff, and examined
by light microscopy. The following variables were measured in the intestine: villus height, villus
width, depth of crypts, paneth cells, goblet cell number, goblet cell diameter, types of goblet cells in the
villi epithelium, goblet cells within the crypts, and the mucus layer thickness in each segment were
performed with a light microscope using EPIX XCAP software (Standard version, Olympus, Waltham,
MA, USA). The complete methodology is indicated in the supplementary materials.
2.15. Statistical Analysis
All values are expressed as means and standard deviation. Experimental treatments for the intra
amniotic administration assay were arranged in a completely randomized design. The results were
analyzed by ANOVA. For significant p-values, a post-hoc Duncan test was used to compare test groups.
Statistical analysis was carried out using SPSS version 20.0 software. The level of significance was
established at p < 0.05. For the microbiome results, Faith’s Phylogenetic Diversity [24] was used to
calculate bacterial richness within each sample. Differences between groups were analyzed by ANOVA.
Beta diversity (between samples) was calculated using Jaccard distances and analyzed using a pairwise
PERMANOVA test. Predictive metagenomic analysis (PICRUST) [25] was used to identify significant
differences in predicted metabolic pathways between the groups. Statistically significant p-values
associated with microbial clades and functions identified by LEfSe [26] were corrected for multiple
comparisons using the Benjamini–Hochberg false discovery rate (FDR) correction.
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3. Results
3.1. Concentration of Calcium, Iron, Magnesium, and Zinc in Teff Flour and in Teff Flour Extract
Fe and Zn concentrations were higher in the teff extract compared to the teff seed (p < 0.05,
Table 2), whereas Ca and Mg concentrations were higher in the teff seed compared to the teff extract
(p < 0.05, Table 2). The soluble fiber and total fiber content were higher in the teff extract compared
to the teff seed, however the insoluble fiber content was higher in the teff seed compared to the teff
extract (p < 0.05, Table 3). There were no significant differences in protein or phytic acid between the
two groups. However, the content of phytate:Fe ratio was significantly greater in the teff seed relative
to teff extract (p < 0.05).










Teff seed 2259.32 ± 24.73 a 60.64 ± 0.92 b 2023.49 ± 18.93 a 42.87 ± 0.42 b
Teff seed extract 2052.07 ± 123.95 b 128.23 ± 11.60 a 1088.87 ± 42.24 b 53.84 ± 4.50 a
1 Values are means ± SEM, n = 5. a,b Treatment groups not indicated by the same letter are significantly different
(p < 0.05).















Teff seed 8.32 ± 0.23 a 2.10 ± 0.12 b 10.43 ± 0.11b 10.02± 0.39 a 0.14± 0.02 a 1.74 ± 0.03 a
Teff seed extract 6.15 ± 0.61 b 6.98 ± 0.91 a 13.13 ± 0.30 a 10.86± 0.88 a 0.17± 0.11 a 0.41 ± 0.05 b
1 Values are means ± SEM, n = 5. a,b Treatment groups not indicated by the same letter are significantly different
(p < 0.05).
3.2. Polyphenol Profile of the Teff Seed Flour and Extract
The concentration of the five most prevalent polyphenolic compounds found in the teff variety
are presented in Table 4. Teff seeds contained high levels of ferulic acid.















Protocatechuic Acid 154.12 155.128 153.112 1.621 NEG NEG
Caffeic Acid 180.16 181.168 179.152 2.958 POS/NEG ND
Vanillic Acid 168.15 169.158 167.142 3.094 POS ND
p- Coumaric Acid 164.16 165.168 164.152 3.895 POS/NEG ND
Ferulic Acid 194.18 195.188 193.172 4.428 POS/NEG POS
1 Values are means ± SEM, n = 5. MAU: milli absorbance unit; min: minutes. Da: Dalton; M +H: Mass +Hydrogen;
M − H: Mass − Hydrogen; MS: Mass Spectrometry; ND: Not Determined; POS: Positive. NEG: Negative.
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3.3. Hemoglobin, Body Weight, Cecum Weight, and Cecum:Body Weight Ratio
There were no significant differences in hemoglobin concentrations between any of the treatment
groups. The body weight of the non-injected group was significantly lower than all other groups
(p < 0.05, Table 5). Among cecum weights and cecum:body weight ratio, the non-injected and 2.5% teff
groups demonstrated significantly lower values when compared to all other groups (p < 0.05).










NI 8.747 ± 0.797 a 45.4 ± 1.3 b 0.5 ± 0.1 b 0.010 ± 0.002 b
18Ω H2O 10.603 ± 0.591 a 46.9 ± 1.2 a 0.5 ± 0.1 a 0.011 ± 0.001 a
5% Inulin 8.860 ± 0.690 a 49.7 ± 0.9 a 0.6 ± 0.1 a 0.012 ± 0.001 a
1% Teff 9.575 ± 1.138 a 47.0 ± 1.0 a 0.6 ± 0.1 a 0.012 ± 0.001 a
2.5% Teff 8.410 ± 0.920 a 47.1 ± 1.1 a 0.5 ± 0.0 b 0.010 ± 0.001 b
5% Teff 8.501 ± 0.874 a 46.5 ± 1.3 a 0.7 ± 0.1 a 0.015 ± 0.002 a
7.5% Teff 9.569 ± 0.633 a 47.4 ± 1.4 a 0.6 ± 0.0 a 0.012 ± 0.001 a
1 Values are means ± SEM, n = 8. a,b Treatment groups not indicated by the same letter are significantly different
(p < 0.05). NI = non-injected.
3.4. Hepatic, Serum Fe, and Zn Concentrations: LA:DGLA Ratio
Liver Fe concentration was significantly higher in the inulin and 7.5% teff group compared to the
non-injected control group (p < 0.05, Table 6). The 18ΩH2O, 1% teff, 2.5% teff, and 5% teff groups had
higher liver Fe concentration than the control group, although they were not significantly different
from each other. The concentration of Zn in the liver was the highest in the 7.5% teff group (similar to
the 5% inulin group), and significantly different from all other groups (p < 0.05). Serum Fe and Zn
concentrations did not different amongst groups (p > 0.05). Figure 1 depicts the LA:DGLA ratio for the
NI, 18ΩH2O, and 7.5% teff groups. The 7.5% teff group demonstrated a significantly lower LA:DGLA
ratio, signifying a relative increase in Zn status, compared to both control groups (p < 0.05). We have
previously demonstrated the LA:DGLA ratio as a novel physiological biomarker of zinc status [19,21].
Table 6. Fe and Zn concentrations in liver and serum 1.
Treatment Groups
Liver Serum
Iron (μg/g) Zinc (μg/g) Iron (μg/g) Zinc (μg/g)
NI 32.47 ± 2.83 b 15.79 ± 0.95 c 2.09 ± 0.24 a 0.86 ± 0.08 a
18Ω H2O 37.93 ± 4.93 ab 16.12 ± 0.96 c 2.00 ± 0.27 a 0.84 ± 0.07 a
5% Inulin 48.96 ± 4.39 a 18.23 ± 0.88 abc 2.76 ± 0.33 a 0.97 ± 0.08 a
1% Teff 37.40 ± 3.67 ab 17.61 ± 0.91 bc 2.22 ± 0.40 a 0.91 ± 0.08 a
2.5% Teff 36.39 ± 3.54 ab 22.82 ± 2.42 ab 2.09 ± 0.22 a 0.89 ± 0.06 a
5% Teff 39.40 ± 3.89 ab 23.37 ± 3.10 ab 2.83 ± 0.28 a 0.81 ± 0.07 a
7.5% Teff 46.44 ± 5.83 a 24.14 ± 3.33 a 2.88 ± 0.38 a 1.02 ± 0.07 a
1 Values are means ± SEM, n = 8. a,b,c Treatment groups not indicated by the same letter are significantly different
(p < 0.05). NI = non-injected.
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Figure 1. Effect of the intra-amniotic administration of experimental solutions and control on the
Linoleic acid (LA): Dihomo-γ-linolenic acid (DGLA) ratio. Values are the means ± SEM, n = 8.
a,b Treatment groups not indicated by the same letter are significantly different (p < 0.05).
3.5. Pectoral Muscle Glycogen Concentration
There were no significant differences in glycogen concentration observed between any of the
treatment and control groups (p > 0.05, Table 7).
Table 7. Glycogen and liver ferritin concentrations 1.
Treatment Group Glycogen (mg/g) Liver Ferritin (AU)
NI 0.034 ± 0.011 a 1.974 ± 0.005 a
18Ω H2O 0.022 ± 0.003 a 1.534 ± 0.519 a
5% Inulin 0.029 ± 0.005 a 0.148 ± 0.005 b
1% Teff 0.035 ± 0.006 a 1.491 ± 0.299 a
2.5% Teff 0.022 ± 0.007 a 0.275 ± 0.245 b
5% Teff 0.044 ± 0.017 a 0.031± 0.001 b
7.5% Teff 0.021 ± 0.007 a 0.034 ± 0.001 b
1 Values are means ± SEM, n = 8. a,b Treatment groups not indicated by the same letter are significantly different
(p < 0.05). NI = non-injected.
3.6. Liver Ferritin Concentration
The non-injected, water, and 1% teff groups had significantly greater levels of liver ferritin
compared to all other treatment groups (p < 0.05, Table 7).
3.7. Duodenal Gene Expression of Relevant Proteins
Figure 2 depicts the gene expression of various proteins involved either directly involved in
mineral metabolism or indirectly involved requiring these trace minerals as cofactors.
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Figure 2. Effect of the intra-amniotic administration of experimental solutions on duodenal gene
expression. Values are the means (AU: arbitrary units) ± SEM, n = 8. a–d Per gene, treatments groups
not indicated by the same letter are significantly different (p < 0.05). DMT1, Divalent metal transporter
1; DcytB, Duodenal cytochrome b; ZnT1, Zinc transporter 1; ZnT7, Zinc transporter 7; ZIP9, Zinc
transporter 9; TRPV6, Transient Receptor Potential Cation Channel Subfamily V Member 6; PMCA1b,
Plasma Membrane Calcium ATP-pump; NCX1, Sodium Calcium Exchanger 1; MRS2, Magnesium
transporter MRS2; TRPM6, Transient Receptor Potential Cation Channel Subfamily M member 6;
TRPM7, Transient Receptor Potential Cation Channel Subfamily M member 7.
3.7.1. Fe-Related Proteins
For the proteins responsible directly for Fe uptake at the brush border membrane (BBM), ferroportin,
and DMT1, the expression was higher in the 5% inulin group and 1% teff group, respectively. The
expression of these proteins was lower in the animals receiving the higher teff concentrations. The
expression of DctyB was also higher in the 5% inulin group, and decrease in a dose-dependent fashion
in the groups receiving increasing teff concentration.
3.7.2. Zn-Related Proteins
The expression of proteins related to cellular Zn uptake, transport and storage—ZnT1, ZnT7,
and ZIP9—was greatest in the non-injected and 5% inulin groups and was significantly lower in all
concentrations of teff groups.
3.7.3. Ca-Related Proteins
The expression of proteins related to cellular Ca regulation—TRPV6, PMCA1b, and NXC1—were
differentially expressed across groups. TRPV6, a BBM protein involved in the initial steps of Ca
absorption in the gut, was highest in the 5% inulin group. The Ca efflux proteins, PMCA1b and NXC1,
were expressed highest in the 5% teff group.
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3.7.4. Mg-Related Proteins
The expression of the cellular membrane Mg influx proteins TRPM6 and TRPM7 was increased in
the 1% teff and 5% teff groups, respectively. MRS2, a Mg-specific protein in the cellular mitochondria,
was increased in both 1% and 5% teff groups.
3.7.5. Inflammatory Cytokines and BBM Proteins
Figure 3 depicts a panel of inflammatory cytokines and BBM proteins evaluated amongst the
treatment groups. As a whole, the 5% inulin group had greater expression of all three cytokines relative
to the control group, while a decreased expression was seen in the higher concentration teff groups
(p < 0.05). Both aminopeptidase and sucrose isomaltase were expressed at a higher amount in the 5%
inulin group. Likewise, the highest concentration teff group (7.5%) showed the lowest expression. For
sodium-glucose transport protein 1, the 5% teff group had the highest expression, with the lowest
expression observed in the 5% inulin group.
Figure 3. Effect of the intra-amniotic administration of experimental solutions on intestinal and heart
gene expression. Values are the means (AU: arbitrary units) ± SEM, n = 8. a–c Per gene, treatments
groups not indicated by the same letter are significantly different (p < 0.05). IL-1β, Interleukin 1 beta;
IL-6, Interleukin 6; TNF-α, Tumor Necrosis Factor Alpha; AP, Amino peptidase; SGLT1, Sodium-Glucose
transport protein 1; SI, Sucrose isomaltase.
3.8. Morphometric Analysis of Duodenal Villi, Depth of Crypts and Goblet Cells
Table 8 depicts the morphometric measurements for villi length and diameter, crypt depth, and
mucus layer width. As a whole, the teff groups showed the most significant response with the 2.5%
and 7.5% teff groups with the longest villus length, the 1% teff group with the greatest villus diameter,
and the 1% teff group had the greatest intestinal crypt depth.
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Table 8. Effect of the intra-amniotic administration of experimental teff solutions on duodenal villus
and crypts measurements 1.
Treatment Group Villus Length (μm) Villus Diameter (μm) Depth of Crypts (μm)
NI 223.29 ± 3.44 ab 53.15 ± 0.73 b 66.30 ± 1.33 b
18Ω H2O 224.14 ± 4.10 ab 46.84 ± 0.69 c 53.42 ± 1.11 c
5% Inulin 274.11 ± 3.92 b 43.66 ± 0.64 d 51.30 ± 1.06 c
1% Teff 266.85 ± 4.39 a 56.22 ± 0.78 a 73.62 ± 1.40 a
2.5% Teff 263.66 ± 3.85 a 53.44 ± 0.75 ab 65.74 ± 1.26 b
5% Teff 302.83 ± 2.95 ab 54.80 ± 0.67 ab 67.75 ± 1.43 b
7.5% Teff 290.86 ± 3.12 a 50.00 ± 0.02 ab 66.38 ± 1.25 b
1 Values are the means ± SEM, n = 5. a–d Treatment groups not indicated by the same letter are significantly different
(p < 0.05). NI = non-injected.
Table 9 depicts the morphometric measurements of duodenal goblet cells. As above, the teff
treatment groups demonstrated greatest benefit with the 2.5% teff group showing greatest goblet cell
diameter, 1% and 2.5% teff groups showing greatest crypt goblet cell count per unit area, and 1% teff
group with the greatest villus goblet cell count per unit area (p < 0.05). The NI and 5% inulin groups
had significantly greater numbers of acidic villus goblet cells than did all other groups (p < 0.05). The
quantity of neutral goblet cells was significantly greater in the NI group. However, the 2.5% teff group
had the greatest amount of mixed villus goblet cell types (p < 0.05).












Villus Goblet Cell Number
Acidic Neutral Mixed
NI 6.50 ± 0.06 cd 9.53 ± 0.32 b 51.32 ± 1.34 b 10.22 ± 0.26 a 0.12 ± 0.03 a 0.13 ± 0.03 c
18Ω H2O 6.37 ± 0.06 de 10.01 ± 0.22 b 44.83 ± 1.16 c 9.46 ± 0.23 b 0.00 ± 0.00 b 0.05 ± 0.03 d
5% Inulin 6.06 ± 0.04 f 12.27 ± 0.33 a 54.56 ± 1.40 b 10.65 ± 0.25 a 0.00 ± 0.00 b 0.02 ± 0.01 d
1% Teff 6.82 ± 0.05 b 12.15 ± 0.28 a 61.76 ± 1.56 a 9.37 ± 0.24 b 0.00 ± 0.00 b 0.22 ± 0.03 b
2.5% Teff 7.54 ± 0.05 a 11.81 ± 0.24 a 54.27 ± 1.20 b 6.21 ± 0.15 d 0.00 ± 0.00 b 0.32 ± 0.04 a
5% Teff 6.29 ± 0.06 e 10.11 ± 0.27 b 42.54 ± 0.93 c 8.33 ± 0.20 c 0.00 ± 0.00 b 0.18 ± 0.03 bc
7.5% Teff 6.64 ± 0.06 bc 9.51 ± 0.24 b 43.12 ± 0.98 c 7.81 ± 0.19 c 0.00 ± 0.00 b 0.16 ± 0.03 bc
1 Values are the means ± SEM, n = 5. a–f Treatment groups not indicated by the same letter are significantly different
(p < 0.05). NI = non-injected.
3.9. Analysis of the Gut Microbiota
Figure 4 represents the observed differences in gut microbial diversity among treatment groups.
No significant differences were found in α-diversity using Faith’s phylogenetic diversity (PD) among
treatment groups (Figure 4A, p > 0.05). Variation between samples (β-diversity) was calculated by
using Jaccard distances. The chick microbiotas in the Inulin treatment group were the least similar
(biggest distances between samples) to one another compared to the other groups (Figure 4B,C, p< 0.01).
The distances within the teff treatment groups, except 2.5%, were not significantly different from both
the NI control and 18Ω H2O groups, which indicates the constant influence of the treatment on the
microbial population.
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Figure 4. Microbial diversity of the cecal microbiome. (A) Measure of α- diversity using Faith’s
Phylogenetic Diversity; (B) Box-plots of Jaccard distances within the different groups; (C) Principal
Coordinates Analysis (PCoA) based on Jaccard distances. Each dot represents one animal, and the
colors represent the different treatment groups. n = 5, * = p < 0.05, ** = p < 0.01.
Although there were observed cecal microbiota shifts at the phylum and genera level, these
differences were not significant (Figure 5, p > 0.05).
Figure 5. Compositional changes of the gut microbiota. (A) Phylum-level differences between the
intra-amniotic administration measured at day of hatch (day 21); (B) Genus-level differences between
the intra-amniotic administration groups as measure at day of hatch (day 21).
We also analyzed whether the genetic capacity of the microbiota could be affected by experimental
teff solutions. Metagenome functional predictive analysis was carried out using PICRUSt software,
feature abundance was normalized by 16S rRNA gene copy number, identified using the Greengenes
database, and Kyoto Encyclopedia of Genes and Genomes (KEGG) orthologs prediction was calculated.
Differentially-expressed pathways are displayed in Figure 6. In all but one bacterial metabolic pathway,
mineral absorption and relative abundance were greater in teff treatment groups when compared to
both NI control and 18Ω H2O groups. Bacterial mineral absorption pathway was upregulated in the
inulin group when compared to controls and teff treatment groups.
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Figure 6. Predictive functional capacity of the cecal microbiota collected at hatch. (A) Bacterial
processes; (B) metabolic processes; (C) cellular processes; and (D) human diseases. Treatment groups
are indicated by their names and groups not indicated by the same letter are significantly different
(p < 0.05).
4. Discussion
The implementation of teff as an advantageous staple food crop is rapidly growing due to
its relative ease of cultivation, sensory quality of teff-based products, and favorable macro- and
micronutrient composition [3,18,27]. Compared to other crops, teff does contain notable antinutrients,
such as a higher concentration of phytic acid; however, processing methods such as fermentation
can drastically lower phytic acid concentration and thus mineral inaccessibility. Despite this, the
total polyphenolic content of many teff verities is lower than other food crops including sorghum
and cowpea, while specific polyphenols have been shown to aid in mineral bioavailability, including
ferulic, caffeic, and protocatechuic acids, which have been found in relatively higher quantities [4,7,8].
Polyphenolic analysis of the teff samples used in this study corroborated previous data demonstrating
presence of ferulic, caffeic, and protocatechuic acids. The prevailing wisdom has been that phytate and
polyphenolic compounds as a whole disproportionately limit trace mineral bioavailability despite the
presence of other promoter-like compounds, such as prebiotics, which can counteract this effect [28–30].
We suggest a revised approach to this notion given the favorable physiologic and nutritional benefits
afforded by intra-amniotic teff extract administration despite higher phytate concentration.
We have evaluated the effect of intra-amniotic teff extract administration on mineral status and
other pertinent physiologic parameters. To our knowledge, ours is the first study to evaluate the effect
of teff seed extract on mineral status, duodenal brush border membrane development, and functionality,
as well as cecal microbiota. Intra-amniotic teff extract administration increased hepatic Fe and Zn
concentrations, although serum Fe and Zn concentrations were not affected. Gene expression analysis
demonstrated that teff extract up-regulated certain duodenal mineral transporters, such as DMT1
(BBM major Fe transporter) and ferroportin (BLM major Fe exporter), relative to control. Additionally,
hepatic ferritin, the animal’s primary form of cellular Fe storage, was decreased in all teff treatment
groups except the 1% concentration, which could be explained by the prioritization of developing an
embryo for hemoglobin synthesis versus storage. Indeed, previous intra-amniotic feeding trials have
been unable to demonstrate a significant difference in Fe and Zn status, which are secondary to the
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relatively short treatment exposure time [6,13,23] that carries over to results for serum mineral status.
However, the LA:DGLA ratio, a sensitive and specific biomarker of Zn status, was significantly lower
in the higher concentration teff extract group demonstrating relative Zn repletion in this group [21,31].
Therefore, it appears that despite the short treatment exposure time, the significant increases in the
hepatic Fe and Zn concentrations combined with lower LA:DGLA ratio in the 7.5% concentration group
suggest that teff has potentially greater influence on mineral status than other intra amniotic nutritional
solutions and purified extracts we have previously tested and thus may demonstrate superiority in
delivering bioavailable Fe and Zn [13,32].
Further, the duodenal morphometric analysis demonstrated a significant (p < 0.05) effect
on villus length, diameter, and crypt depth in all experimental teff groups. This effect was not
concentration-dependent. Additionally, a significant (p < 0.05) increase in neutral and mixed duodenal
goblet cells was observed in all teff groups when compared to both water-injected and non-injected
controls. Increased number and size of duodenal goblet cells is a surrogate for increased luminal mucin
production and secretion, which serves as a defensive barrier to pathogens and promotes epithelial cell
function. Additionally, an improvement in villus architecture yields an increased surface area, thus
improving the digestive enzyme and absorptive capacity [21,33,34]. The brush border gene expression
analysis was mixed, with teff groups showing upregulated SGLT-1 expression while the inulin group
showing a relative increase in SI and AP expression. Taken as a whole, this data demonstrates that the
intra-amniotic administration of teff extract can modulate brush border membrane development and
functionality. These results are in accordance with other intra amniotic administration trials that used
isolated prebiotic polysaccharide compounds [12–15,32].
Together with beneficial changes in physiological parameters and brush border membrane
functionality occurring as a result of intra-amniotic administration of teff extracts, we found low
inter-individual variation among the different teff treatment groups (except of 2.5%) compared to the
Inulin treatment. Significant differences in the composition of the cecal microbiotas were not observed.
Using KEGG analysis, for the exception of bacterial mineral absorption, the functional capacity of
the cecal microbiota demonstrated up-regulation in all bacterial metabolic pathways in the higher
concentration teff groups. Given that brush border absorptive capacity was significantly increased
in the teff groups, lower bacterial mineral metabolism in the teff group was likely due to less free Fe
and Zn present in cecal contents for bacteria to utilize, and hence a compensatory upregulation in the
bacterial mineral absorption pathway.
Several notable pathways upregulated in the teff groups included bacterial energy metabolism,
sugar/carbohydrate metabolism, fatty acid biosynthesis, and protein synthesis. This was likely due,
in part, to the large fiber content present in teff [7]. Indeed, relative to other staple food crops such
as wheat, sorghum, and maize, teff contains several folds higher concentration of crude fiber, total,
and soluble dietary fiber [7]. Fiber delivered to cecal bacteria exerts a prebiotic-like effect by allowing
for the proliferation of butyrate- and other SCFA-producing bacteria. We demonstrated that bacterial
fatty acid production was significantly increased in the teff extract groups. SCFAs have been shown to
promote the proliferation and differentiation of intestinal mucosal epithelial cells [35,36]. Additionally,
in the presence of increased dietary fiber, an overall increase in bacterial fermentation, reduction in
intestinal luminal pH, and improvement in the solubilization of minerals such as Fe and Zn was
observed in vivo [6,12,14]. Although we did not observe significant taxonomic shifts in the cecal
microbiota of the animals receiving teff extract, the upregulation of many bacterial pathways relevant
to Fe and Zn metabolism is a profound and novel finding. Additional studies are now warranted to
assess cecal microbiota shifts post hatch and during a longer feeding trial.
5. Conclusions
The present study demonstrates that teff contains high amounts of fiber, phytic acid, and the
polyphenols ferulic, caffeic, and protocatechuic acids, which have been shown to improve micronutrient
absorption. Intra-amniotic administration of various concentrations of teff extract improved brush
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border membrane functionality through increases in villus architecture, surface area, and goblet cell
expansion and related mucin production. Consequently, this contributed to increased relative expression
of various duodenal enzymes responsible for mineral absorption and transport, and increased levels
of hepatic Fe and Zn concentration, although serum concentrations remained unchanged. Although
we did not observe significant alterations in the taxonomy of the cecal microbiota, various relevant
bacterial metabolic pathways, such as fatty acid synthesis, were upregulated, which may demonstrate
that teff administration positively influences the metagenome of the cecal microbiota, thus maximizing
the solubilization and absorption of micronutrients in the gut. Given these findings, teff appears to
represent a promising staple food crop and should be further evaluated in both long-term animal and
controlled human efficacy trials.
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Abstract: A gluten-free diet may result in high fat and low fiber intake and thus lead to unbalanced
microbiota. This study characterized fecal microbiota profiles by 16S MiSeq sequencing among
oat-using healthy adult subjects (n = 14) or adult subjects with celiac disease (CeD) (n = 19) or
non-celiac gluten sensitivity (NCGS) (n = 10). Selected microbial metabolites, self-reported 4d food
diaries and perceived gut symptoms were compared. Subjects with NCGS experienced the highest
amount of gut symptoms and received more energy from fat and less from carbohydrates than
healthy and CeD subjects. Oat consumption resulted in reaching the lower limit of the recommended
fiber intake. Frequent consumption of gluten-free pure oats did not result in microbiota dysbiosis in
subjects with CeD or NCGS. Thus, the high number of gut symptoms in NCGS subjects was not linked
to the microbiota. The proportion of fecal acetate was higher in healthy when compared to NCGS
subjects, which may be linked to a higher abundance of Bifidobacterium in the control group compared
to NCGS and CeD subjects. Propionate, butyrate and ammonia production and β-glucuronidase
activity were comparable among the study groups. The results suggest that pure oats have great
potential as the basis of a gluten-free diet and warrant further studies in minor microbiota disorders.
Keywords: oats; celiac disease; non-celiac gluten sensitivity; intestinal microbiota; gluten-free; SCFAs
1. Introduction
Gluten-related disorders form an umbrella for all conditions related to gluten ingestion.
These include, most importantly, celiac disease (CeD) and non-celiac gluten sensitivity (NCGS).
The prevalence of these disorders has increased over the past 50 years, which makes them emerging
health problems worldwide. Celiac disease is a chronic, systemic autoimmune disorder caused by
gluten proteins in genetically susceptible individuals. In addition to CeD patients, NCGS subjects also
require treatment with a gluten-free diet (GFD). These individuals develop adverse reactions such as
gastrointestinal and extra-intestinal symptoms after exposure to gluten [1,2]. A life-long exclusion
of gluten from the diet is currently the only effective treatment in alleviating the symptoms of these
disorders. The adherence to a GFD and the following recovery from mucosal damage can be assumed
to improve the nutritional status of the CeD patients observed at diagnosis. However, a long-term,
strict GFD may be challenging to maintain due to social and economic burdens. Even when maintained,
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GFD may be restricted and nutritionally suboptimal, since many gluten-free products have high
fat and sugar but low fiber content. Such a diet predisposes patients to constipation, obesity and
cardiovascular diseases [3–5].
The use of nutritious and fiber-rich whole-grain oats would diversify the GFD and improve the
palatability, texture and fiber-content of the diet. Pure oats are being grown and produced following
strict agricultural practices to minimize the contamination with other cereals. In Finland, oats are a
major ingredient in the traditional daily diet and since the year 2000, pure oats have been considered
suitable for the gluten-free diet [6]. Nowadays, oat products are widely used among Finnish celiac
disease patients [7]. Although the inclusion of oats on GFD is recommended in Nordic countries, it is
still not globally applied, possibly due to the debate regarding the safety of oats for CeD patients [8,9].
The intestinal microbiota primes the immune system and provides enzymes that expand the
metabolic capacity of the host. The conversion of dietary components, such as dietary fiber, that escape
the digestion of the host enzymes, support also the growth of microbes themselves. Intestinal microbiota
and its metabolites play a major role in defining the antigen milieu of enterocytes, since they are able
to interfere with the cells of the intestinal epithelium and modulate the signaling pathways through
specific receptors [10]. It is assumed that a decreased microbiota diversity and relative abundances of
specific bacterial taxa may lead to functional imbalance where the mutualistic relationship between the
host and his microbes is disturbed. Indeed, deviations in the microbiota community structure have
been associated with several local and systemic diseases, possibly contributing to the pathogenesis
and/or clinical manifestation of these diseases (reviewed in [11]). In addition, GFD as such has been
associated with potentially harmful alterations in microbiota, such as decreased microbiota richness,
decreased amounts of bifidobacteria, lactobacilli as well as Faecalibacterium prausnitzii and increased
amounts of Proteobacteria [12,13]. However, currently, the majority of the studies published on the
fecal microbiota of celiac disease patients have been conducted with pediatric patients or by using
conventional methods with limited throughput (reviewed in [14]).
To our understanding, the present study is one of the first on the gastrointestinal well-being and
intestinal microbiota of persons with NCGS and within the few evaluating the intestinal microbiota
of adult oat-using CeD subjects. The aim of this study was to evaluate the effect of oat consumption
on the dietary status and gut well-being among adult subjects with gluten-related disorders who
consume oat products on daily basis compared to healthy, oat consuming controls by using fecal
microbiota signatures and its metabolites (short-chain fatty acids (SCFAs), ammoniacal nitrogen and
β-glucuronidase activity) as biomarkers.
2. Materials and Methods
2.1. Subjects and Study Design
Celiac disease patients on a remission state (on a GFD at least 1 year), subjects with non-celiac
gluten sensitivity (self-reported symptoms occurring after consuming a gluten-containing diet and
adherence to a GFD for least 1 year) and healthy controls were recruited to the study. We decided not
to test our NCGS subjects according to the Salerno criteria involving a separate gluten challenge trial
for reasons discussed in later chapters [15]. The total number of the subjects recruited was 74, of which
49 completed the whole study period. After analyzing the food diary data, 6 subjects from NCGS group
were excluded due to the consumption of gluten-containing food products. Thus, samples from celiac
disease (CeD) patients (n = 19), non-celiac gluten sensitive subjects (n = 10) and healthy subjects (n = 14)
were available for the further analyses. Based on food frequency questionnaire (FFQ) and 4d food
diaries, all study subjects reported consumption of oat products daily. Demographic characteristics of
study groups are presented in Table 1. Study subjects were recruited to the study from Turku region,
Finland during the period August 2017–April 2018. Exclusion criteria were BMI below 18 or above
30, antibiotic treatment within the previous 6 months, use of any medication with gastrointestinal
effects (e.g., laxatives or proton pump inhibitors) and blood donation or participation to another
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clinical study within a month. Before the study entry, the volunteers were interviewed to assess the
eligibility of the study. The subjects were ascertained to be in good health by means of self-reporting
and normal results in screening blood tests (total blood count, fasting glucose and liver, kidney and
thyroid functions, wheatspecific immunoglobulin E (IgE), total immunoglobulin A (IgA) and IgA
antibodies to tissue transglutaminase (tTGAbA)). After the screening tests, the study subjects were
enrolled in the study and were instructed to keep gut symptom diaries for 30 days. Study subjects
consumed their habitual diet throughout the study period and were asked to fulfill food diaries during
the last four days of the study. In addition, volunteers were asked to fulfill an FFQ of their dietary
habits. Based on the FFQ, The Index of Diet Quality was calculated as explained in detail by Leppälä
et al. [16] to assess the adherence to a health-promoting diet. Fecal samples for the microbiota, SCFAs,
β-glucuronidase and ammoniacal nitrogen analyses were collected on the last day of the study period.
The study protocol was approved by the Ethics Committee of the Hospital District of Southwest
Finland (Identifier: ETMK:42/1801/2016) and subjects were enrolled in the study after written informed
consent was obtained. The study was registered at ClinicalTrials.gov (Identifier: NCT02761785).
Table 1. Basic characteristics and dietary intake of study subjects.
GROUP CeD (n = 19) NCGS (n = 10) CTRL (n = 14) p-Value
Subjects (n) 19 10 14 n.s.
Male/Female 1 4/15 1/9 6/9 n.s.
Age (year) 2 51 (24, 65) a 34 (22, 61) b 34 (24, 63) b 0.020
BMI (kg/m2) 24.6 (3.2) 23.0 (2.6) 24.4 (2.6) n.s.
Proteins (E %) 17.1 (3.6) 16.5 (3.4) 15.8 (3.1) n.s.
Carbohydrates (E %) 41.9 (4.9) a,b 40.3 (6.1) a 45.8 (4.8) b 0.045
Fat (E %) 36.4 (5.7) a,b 41.0 (6.2) a 34.7 (4.6) b 0.025
Dietary fiber (g) 25.5 (9.1) 27.6 (7.7) 26.0 (7.4) n.s.
Saccharose (g) 46.2 (19.3) 40.8 (12.3) 52.5 (23.0) n.s.
Diet Quality Index 10.9 (1.7) 10.2 (2.2) 10.3 (1.5) n.s.
Dietary data are presented as an average of 4d intake based on food diaries. Values are mean (SD), unless otherwise
stated. CeD subjects with celiac disease, NCGS non-celiac gluten sensitivity, CTRL healthy controls. 1 Pearson
Chi-Square. Others One-way ANOVA. 2 median (min, max) Values with different letters differ from one another in
each row.
2.2. Dietary Intake Using Food Diaries
Subjects were given written and oral instructions on filling the food diaries during the four days
preceding the last study visit (including at least 1 weekend day). Kitchen scales were provided to ensure
accuracy. Mean daily intakes of energy and macronutrients were calculated by using computerized
software (AivoDiet 2.0.2.3; Aivo, Turku, Finland) utilizing the food composition database provided by
the Finnish National Institute for Health and Welfare [17].
The quality of overall diet was assessed by FFQ validated for the evaluation of diet quality index [16].
The questionnaire contains 18 questions regarding the frequency and amount of consumption of food
products during the preceding week. The quality of the diet was defined as poor when index points
were less than 10 out of the maximum 15 points and good when points were 10 or more.
2.3. Gut Symptom Diaries
For the 30 day report of perceived gut symptoms, the study subjects were asked to mark down
the type of the symptom (upper abdominal pain, lower abdominal pain, cramping, bloating, flatulence,
bowel movement, diarrhea or constipation), the severity of the symptom in a scale of 1 to 3 (one meaning
mild pain, two being moderate pain and three being intense pain), and the duration of the symptom.
The diary was divided into time slots of three hours, except night time, which was marked as six hours
slot (from midnight until 6 a.m.).
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2.4. Fecal Samples and DNA Extraction
Fecal samples were frozen immediately after collection (20 ◦C) and stored at −70 ◦C once arrived
in the research laboratory which was typically during the defecation day. Microbial DNA was extracted
from fecal samples using the repeated bead—beating with KingFisher®—method as described in
detailed previously [18]. The quality and quantity of the received DNA were measured by using a
Nanodrop 1000 spectrophotometer (Thermo Scientific, Wilmington, DE). The quality of the DNA was
good in all samples (OD 260/280 ratio ≥ 1.8).
2.5. 16S Library Preparation
The library preparation was started from 12.5 ng of total DNA. For NGS (Next-Generation
Sequencing) library preparation, the recommended protocol for preparing 16S ribosomal RNA gene
amplicons for the Illumina MiSeq system was used (Illumina 2013). The suggested universal bacterial
primers were utilized for amplifying the V3 and V4 hypervariable regions of the bacterial 16S rRNA
gene with polymerase chain reaction (PCR) using the KAPA Hifi HotStart Ready Mix (Roche Diagnostics
Deutschland, Mannheim, Germany). PCR products were purified, and dual indices and Illumina
sequencing adapters were attached using the Nextera XT index kit, Illumina. Finally, the libraries were
purified once more with AMPure XP beads, Agencourt. The high quality of libraries was ensured
using Advanced Analytical Fragment Analyzer and the concentrations of the libraries were quantified
with Qubit® Fluorometric Quantitation (Life Technologies, Invitrogen division, Darmstadt, Germany).
In a second PCR sample-specific “barcode”—primers and adapter sequences were attached. Up to
96 libraries were normalized and pooled for an Illumina MiSeq sequencing run using the MiSeq
Reagent Kit version (v.) 3 with marginally overlapping 300 base pairs (bp) paired-end reads.
2.6. 16S rDNA Sequencing
The libraries were normalized and pooled for the automated cluster preparation, which was
carried out by Illumina MiSeq instrument. Phix control library was added to the sequencing pool to
balance the sequencing run. The libraries were sequenced in a single 2 × 300 bp run with Illumina
MiSeq instrument using v3 sequencing chemistry. The sequencing run used paired-end sequencing
chemistry with 8 bp dual index run.
2.7. Short Chain Fatty Acids Assay
The amounts of fecal short-chain fatty acids (SCFAs) were measured by solid-phase microextraction
coupled to gas chromatography and mass spectrometry (SPME-GC-MS) to evaluate the microbial
metabolic activity. Fecal samples (0.1 g) were weighted and suspended into 5 mL of deionized water
by vortexing. 1.5 mL of fecal suspension was added into 10 mL vial with 0.5 g of NaH2PO4 [19].
Acetic acid, propanoic acid and butyric acid (Sigma-Aldrich, WGK Germany) were used as external
standards in order to control the daily variation of instrument and sample preparation. The SPME fiber
used was 75 μm CAR/PDMS, Fused Silica (Supelco, Bellefonte, PA, USA). The SPME-GC-MS analysis
was carried out with Thermo Trace 1310—TSQ 8000 Evo equipped with an autosampler (Thermo
Scientific, Wilmington, DE, USA). Compounds were separated by Supelco fused silica capillary column
SPB-624, (30 m × 0.25 mm × 1.4 μm) under a carrier gas (helium) 1 mL/min with a splitless mode.
The oven temperature program was as follows: 40 ◦C hold for 2 min and then 5 ◦C/min rise until
200 ◦C, hold for 10 min. A voltage of 70 eV was set in the EI. The system was operated using Xcalibur
4.0 (Thermo Scientific, Wilmington, DE, USA). Compounds were identified by the NIST library [20]
and quantified by comparison to external standards. To optimize the SPME analysis, five commercial
fibers were screened: 50/30 μm DVB/CAR/PDMS, 65 μm PDMS/DVB Stableflex, 65 μm PDMS/DVB
Fused Silica, 100 μm PDMS and 75 μm CAR/PDMS. 75 μm CAR/PDMS was evaluated by comparison
of SCFA standard runs as the most suitable for SCFA detection and chosen for the analysis.
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2.8. β-Glucuronidase and Ammoniacal Nitrogen Assays
The activity of β-glucuronidase enzyme and the amount of ammoniacal nitrogen were measured
from fecal samples to evaluate differences in these potentially harmful microbial metabolic activities.
Ammoniacal nitrogen assay was carried out by an indophenol blue method reported in detail
elsewhere [21]. Briefly, 0.1 g of wet fecal sample was diluted with 5 mL of deionized water, shaken for
60 min, and centrifuged at 3000× g for 3 min. Ammoniacal nitrogen concentration was measured
from supernatant based on absorbance measured at 630 nm (Hidex Sense microplate reader, Hidex Oy,
Turku, Finland). β-glucuronidase assay was carried out by the protocol of Shen [22]. Briefly, 0.1 g of
wet fecal sample was diluted with 5 mL of deionized water and shaken for 60 min. 0.1 mL of diluted
sample was added into Eppendorf tube® with 0.4 mL of 2 mM p-nitrophenyl-β-d-glucuronide solution
(Sigma Aldrich, WGK Germany). Suspensions were incubated in anaerobic conditions at 37 ◦C for
60 min, followed by addition of 0.5 mL of 0.5 M NaOH. This suspension was centrifuged at 3200×
g for 10 min and absorbance was measured on 405 nm (Hidex Sense microplate reader, Hidex Oy,
Turku, Finland).
2.9. Statistical and Data Analyses
Statistical analyses of food diary and microbial metabolites data were carried out using IBM SPSS
Statistics 25 software. Normal distribution of data was tested with Shapiro–Wilks test and ANOVA
with contrast test were used to determine the statistical differences between study groups.
In the preprocessing of the MiSeq sequencing reads, the workflow proposed by [23] was
adapted. In summary, the reads were trimmed from the left at 25 bp and 10 bp for the forward
and reverse reads, respectively; and from right at 245 bp and 230 bp based on manual inspection
of the read quality summaries. The sequence variant table was constructed from the reads with
DADA2 [24] based on DADA2-formatted training FASTA files that were derived from the Ribosomal
Database Project’s Training Set 16 and the 11.5 release of the RDP database [25]. The chimeras were
removed. The phylogenetic tree was constructed with the DECIPHER [26] and phangorn R packages.
The preprocessed data were converted into a phyloseq R object [27], and aggregated to the genus level
with the microbiome R package (function aggregate_taxa). The full details are available in the source
code that is openly deposited at Zenodo.
The Principal Coordinates Analysis (PCoA) was done for compositional data based on Bray–Curtis
dissimilarity. Alpha diversity (Shannon index) was estimated with the microbiome [28] and vegan [29]
R packages. For standard data manipulation and visualization, the tidyverse and ggplot2 R packages
were used, respectively. Beta diversity was done with PERMANOVA using the vegan R package and
999 permutations. The analyses were done with genus-level clr-transformed abundance tables unless
otherwise mentioned. The group-level comparisons for individual genera were done with DESeq2.
3. Results
3.1. Dietary Intake and the Quality of Diet
Based on the food diary data (4 days), NCGS subjects received a higher proportion of their energy
(E %) from fat and lower proportion (E %) from carbohydrates when compared to healthy controls
(p = 0.025 and p = 0.045, respectively) (Table 1). Additionally, the gluten-sensitive subjects tended to
get more energy than celiac disease patients when adjusted per body weight (kcal/kg of body weight,
p = 0.09, data not shown). The mean intake of dietary fiber was at the lower end of the recommendation
level in the three groups (Table 1). The dietary quality assessed by the validated index of diet quality
questionnaire was considered good in most of the study subjects, average diet quality indices being
higher than 10 in most of the study subjects (Table 1).
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3.2. Gut Symptom Diaries
The highest amounts of gut symptoms per subject was reported by the NCGS groups subjects
(61.4) when compared to CeD and healthy controls (39.1 and 19.7, respectively) (p = 0.045). In all study
groups, the most often reported symptoms were flatulence, bloating and lower abdominal pain.
3.3. Intestinal Microbiota Signatures
The total microbiota profiles were comparable between CeD, NCGS and healthy controls (Figure 1).
No statistically significant differences were observed in microbiota richness (Figure 2) or diversity
(data not shown) between the study groups. Phylum-level microbial abundances were characterized
by a high inter-individual variation and no statistically significant differences were observed between
the study groups (Figure 3). However, the abundance of Bifidobacterium tended to be higher in the
control group compared to CeD and NCGS (p = 0.067), (Figure 4).
3.4. Microbial Metabolic Activity
In CeD subjects, the amount of SCFAs was comparable to other groups (Table 2). However,
the relative amount of acetate (% of total SCFAs) was higher in the control group compared to the
NCGS group (p = 0.03). No statistically significant differences were observed in the proportions of
propionate or butyrate between the groups. In addition, the amounts of ammoniacal nitrogen and
β-glucuronidase activity were comparable between the study groups (Table 2).
Figure 1. Total microbiota profiles of study subjects were comparable between the groups as assessed by
Principal Component Analysis (PCoA). CED celiac disease (n = 19), NCGS non-celiac gluten sensitivity
(n = 10) and CTRL healthy controls (n = 14).
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Figure 2. Microbiota richness was comparable in subjects with celiac disease (CED) (n = 19), non-celiac
gluten sensitivity (NCGS) (n = 10) and healthy controls (CTRL) (n = 14). The box extends from 25th
percentile to 75th percentile, with a line at median.
Figure 3. Relative abundances of bacterial phyla (% of total reads) in subjects with celiac disease (CED)
(n = 19), healthy controls (CTRL) (n = 14) and subjects with non-celiac gluten sensitivity (NCGS) (n = 10).
No statistically significant differences were observed between the study groups.
Table 2. Production of short-chain fatty acids (SCFAs), ammonia and the activity of β-glucuronidase in
subjects with celiac disease (CeD), non-celiac gluten sensitivity (NCGS) and healthy controls (CTRL).
CeD (n = 19) NCGS (n = 10) CTRL (n = 14)
Concentration % of Total SCFA Concentration % of Total SCFA Concentration % of Total SCFA
Fecal acetic acid (μg) 2144 (1228) 63 a,b 2149 (1205) 59 a 2789 (1473) 71 b
Fecal propionic acid (μg) 806 (607) 23 948 (451) 28 698 (521) 19
Fecal butyric acid (μg) 337 (128) 14 456 (258) 13 424 (327) 10
Total SCFA (μg) 3287 (1786) 3553 (1680) 3912 (2072)
Fecal ammonia (μmol) 18.0 (6.5) 18.5 (4.8) 15.7 (7.2)
Fecal β-glucuronidase (U) 30.0 (15.0) 25.9 (15.0) 29.9 (18.0)
Concentrations are presented per g of fecal wet weight. Values are presented as mean (SD). Values with different
letters differ from one another in each row.
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Figure 4. The mean relative abundance of Bifidobacterium in subjects with celiac disease (CED) (n = 19),
healthy controls (CTRL) (n = 14) and subjects with non-celiac gluten sensitivity (NCGS) (n = 10).
The difference between the three was borderline significant (p = 0.067; Kruskal–Wallis test).
4. Discussion
Currently, the only treatment for celiac disease and other gluten-related disorders is a life-long
adherence to a GFD. Due to the shortage of whole-grain products in the diet, GFD often results in
inadequate intake of nutrients and dietary fiber [30,31] while in our study the average intake of dietary
fiber intake was at the lower end of recommendation in all three groups, and did not differ between
them. The difference may result from the fact that our subjects consumed oat products as a part of
their habitual diet. Pure oats suitable for the gluten-free diet are grown, milled and handled without
contamination by other cereals. Recently, it was suggested that the current confounding clinical
findings on the safety of oat consumption in CeD subjects [32] could be caused by contaminated oats
assessed as “pure” [8]. Indeed, a decade ago, gluten cross-contamination was shown to exist in oat
supply chains in Europe, the United States and Canada [33]. Yet, our results suggest a great potential
for pure oats as a source of fiber to GFD.
While persons diagnosed with CeD receive professional dietary advice in Finland (The Finnish
Medical Society Duodecim 2018), many NCGS subjects are self-educated in GFD. In our study,
the dietary composition of CeD subjects was comparable with healthy controls while subjects with
NCGS obtained more energy from fat (>40 E %) and less energy from carbohydrates when compared to
healthy controls. In addition, the food diaries in this study revealed that a large number of volunteers
initially assigned to the NCGS group (6/16) consumed gluten, most often from rye or barley. This may
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be an indication that they are not aware of the composition of GFD. According to a recent survey study
of Potter et al. [34], 24% of responded Australians avoided gluten completely or partially, while 14% had
self-reported non celiac wheat sensitivity and 1% had celiac disease. Others avoided gluten for “general
health” or as a treatment of abdominal pain, without being diagnosed with CeD or NCGS. The authors
considered that gluten avoidance may be due to the current well-being trend and that NCGS may
overlap with other gastrointestinal disorders [34]. Additionally, we observed that the NCGS group
reported more gut symptoms per subjects when compared to CeD and healthy controls (p = 0.045).
This finding is in line with a recent study by Tovoli et al. [35], where a significant proportion (66%) of
gluten-sensitive subjects, diagnosed according to Salerno criteria, reported intestinal symptoms even
years after the beginning of GFD. Compared to CeD patients following the same diet, subjects with
NCGS reported a higher amount of symptoms (33%). Additionally, Skodje et al. (2019) reported a high
number of gastrointestinal complaints among subjects with self-reported NCGS on a GFD.
The existence of NCGS as a condition has been recently challenged and intake of other non-gluten
wheat components such as fructans [36] and amylase–trypsin inhibitors have been suggested to lie
behind the symptoms instead of gluten as such [37]. Even a term change from NCGS to non-celiac
wheat sensitivity has been suggested [38]. Still, NCGS has its defenders among consumers and
researchers. The Salerno criteria [15] have been proposed for standardization of the diagnosis of NCGS.
Criteria based investigation involves reporting of symptoms during 6 weeks on gluten-containing diet
followed by 6 weeks of GFD and a further 1 week of test period containing GFD supplemented with
either gluten test meals or placebo, 1-week washout and another test period in a cross-over manner.
For the status of NCGS, 30% variation of symptoms between GFD and gluten containing diet periods
is required. Such a gluten challenge was not imposed on the NCGS subjects in our trial due to limited
resources and burden on the volunteers to participate on multiple clinical investigations. More so,
our aim of this study was not to investigate which proportion of our self-reported NCGS volunteers
would fulfil the Salerno criteria nor to limit our volunteers only to those getting gastrointestinal
problems in the gluten challenge but to include subjects who self-reported their need for gluten-free
diet despite lack of diagnosis for CeD or wheat allergy. Instead, the subjects were screened for negative
celiac serology, specific immunoglobulin E (IgE) and wheat allergy. Generally, CeD patients are
screened to ensure the remission state of their disease and NCGS patients to exclude the celiac disease
before landing on NCGS diagnosis. However, once the GFD is initiated, testing for celiac disease is no
longer accurate, which may lead to false-negative results in the case of self-diagnosed NCGS patients.
Previously, the majority of the studies analyzing the fecal microbiota of celiac disease patients have
been conducted with pediatric patients or by using conventional methods with limited throughput [14].
The most often reported hallmarks of CeD microbiota have been increased abundances of Gram-negative
bacteria, such as Proteobacteria and Bacteroidetes and reduced abundances of Bifidobacterium spp. and
Lactobacillus spp. [14]. Similar changes have been also reported in studies examining the microbiota
of healthy subjects after 1 month on GFD [12,13]. Moreover, some studies have reported persistent
microbiota dysbiosis in CeD subjects in remission and on a GFD [39–41]. Of these studies [12,13,39–41],
only Wacklin et al. (2014) report that the subjects consumed oats. Likewise, the studies reviewed by
Marasco et al. (2016) concerning the microbiota composition of CeD patients or subjects following
GFD, do not report oat consumption of the subjects, apart from the mentioned study of Wacklin et al.
(2014). Our study on pure-oat consuming CeD subjects did not detect any signs of microbiota dysbiosis
typically observed in CeD subjects with active disease nor detected any major GFD related changes
in microbiota on NCGS or CeD subjects. The mean abundance of Bifidobacterium was higher in the
control group compared to CeD and NCGS subjects but the difference was only marginally significant
(p = 0.067). One of the CeD subjects had a high level of Bifidobacterium (9.7%). The abundance is within
the typical range of variation for this genus, although it was unexpected to observe in the CeD group
which has been associated with a reduced level of Bifidobacterium. This, combined with the moderate
sample size of our study, may partially explain the only marginally significant difference between the
groups. Therefore, our results do not support the hypothesis that a significant intestinal microbiota
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dysbiosis would be the reason for the increased gastrointestinal symptoms reported by the NCGS group.
The obtained results of microbiota composition agree with another Finnish study, where the CeD status
of children who had consumed pure oats for 2 years was evaluated [42]. Small intestinal biopsies of
these children showed normal histology and they had normal serological markers. Follow-up was
continued for 7 years and all the markers remained normal during this period, suggesting that oats
were well tolerated [42].
SCFAs are an important energy source for enterocytes and have been associated with several
health-promoting effects including antipathogenic effects [43,44]. Their production varies among the
individual microbiota compositions and by the type and amount of carbohydrates consumed [45].
We found that the relative amount of acetate (% of total SCFAs) was higher in the control group
compared to NCGS group (p = 0.03), which may be linked to the higher abundance of Bifidobacterium
in the control group compared to CeD and NCGS groups (p = 0.067) [46]. Proportions of propionate
or butyrate did not differ between the groups. Thus, the intestinal microbiota of oat-using CeD
and NCGS subjects was capable of producing similar amounts of propionate and butyrate than that
of healthy controls. Previously, clinical studies assessing the SCFA levels have focused mainly on
healthy adults [47–49], whereas adult celiac disease patients in remission have not been studied so
far. Di Cagno et al. [50] analyzed volatile compounds from fecal samples of treated CeD children by
SPME-GC-MS. The samples showed lower levels of SCFAs, such as butyric, isocaproic, and propanoic
acids, when compared to healthy controls. However, the dietary habits of their subjects were not
reported. It should be noted that SCFAs are rapidly absorbed in the colon and thus the fecal SCFA
reflects losses rather than the amount of production in situ [43]. However, access to the proximal colon
to quantify SCFA production rates is invasive and not possible in most study settings. Therefore,
measurement of the fecal SCFAs is currently the only feasible way to estimate the production of
compounds by gut microbiota. In this study, the interindividual variation of free-living human
volunteers was large, but within the range observed previously [47–49]. The variation could possibly
have been influenced by restrictions on the other parts of the diet than oats, but such were not applied
in this study.
β-glucuronidase enzymes expressed by the intestinal microbiota mediate the reactivation of
molecules important in human health and disease. For example, microbial glucuronidases regenerate
toxic carcinogens whose increased activities in the GI tract have been associated with a higher
incidence of gastrointestinal diseases such as colon cancer, Crohn’s disease and colitis as well as to
high-fat diets [51]. In rodent studies, high consumption of dietary fiber has been associated with
decreased activity of β-glucuronidase [22,52]. In addition, a clinical crossover trial with 28 overweight
male subjects demonstrated significantly decreased β-glucuronidase activity after consumption of
wholegrain wheat and rye, when compared to low fiber control diet [53]. Our results show that CeD
and NCGS subjects, who consume oat products on a daily basis, have similar β-glucuronidase activity
levels than healthy controls.
No differences were seen in the ammonia production among the study groups. Ammoniacal
nitrogen is a microbial end product produced by the deamination of amino acids. It is harmful to the
host in high amounts, and previously the consumption of dietary fiber has been detected to decrease
its production [53–55]. A study comparing the impact of diet on in vitro fermentation properties of
whole grain flours and brans from corn, oats, rye and wheat reported significantly reduced ammonia
concentrations after fermentation of oats and rye when compared to corn or wheat [54]. In general,
ammonia concentrations of all groups studied were in line with previous results measured from healthy
adults [47,56–60].
The strengths of this study were accurate analyses of fecal microbiota composition and metabolites
of adult CeD and NCGS subjects, which has only received limited attention. A unique strength of the
study was also the comparison of biological data to perceived symptoms by utilizing the gut symptom
diaries. Moreover, the reliability of the results increased/enhanced the understanding of individual
dietary habits of study subjects by analyzing 4d-food diaries as well as food frequency questionnaires
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assessing the overall quality of the study subject’s diet. Additionally, the suitability of the study
subjects was ensured by a detailed interview and screening at the recruitment to this study. The lack
of non-oat-using CeD subjects can be considered as a limitation of this study since the inclusion of
these subjects would have enabled a more accurate evaluation of the effect of the oat consumption on
microbial biomarkers in celiac disease. However, the recruitment of non-oat using CeD subjects for the
current study proved to be impossible. In Finland, the consumption of oats has been allowed for adult
CeD subjects since 1997 and for pediatric patients since 2000 [6,61], and currently, most of the Finnish
CeD subjects consume oats as part of their GFD [6,61].
To conclude, this study evaluated the influence of daily pure oat consumption on perceived and
measured gut well-being in adult subjects with celiac disease and with subjects with non-celiac gluten
sensitivity compared to healthy volunteers. No microbiota dysbiosis was detected among CeD nor
NCGS subjects. However, further studies with metagenomic approaches should be conducted to
assess the potential differences in microbiota composition and function in celiac patients consuming
oats. The results of this study suggest that pure oats in a gluten-free diet represent a good alternative.
We also demonstrate the need for further studies in NCGS subjects focusing on diet and microbiota
interactions, and nutrition counseling to identify the causes of perceived gut symptoms.
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Abstract: The inclusion of pulses in traditional wheat-based food products is increasing as the
food industry and consumers are recognizing the nutritional benefits due to the high protein,
antioxidant activity, and good source of dietary fiber of pulses. Iron deficiency is a significant global
health challenge, affecting approximately 30% of the world’s population. Dietary iron deficiency is the
foremost cause of anemia, a condition that harms cognitive development and increases maternal and
infant mortality. This study intended to demonstrate the potential efficacy of low-phytate biofortified
pea varieties on dietary iron (Fe) bioavailability, as well as on intestinal microbiome, energetic status,
and brush border membrane (BBM) functionality in vivo (Gallus gallus). We hypothesized that the
low-phytate biofortified peas would significantly improve Fe bioavailability, BBM functionality,
and the prevalence of beneficial bacterial populations. A six-week efficacy feeding (n = 12) was
conducted to compare four low-phytate biofortified pea diets with control pea diet (CDC Bronco),
as well as a no-pea diet. During the feeding trial, hemoglobin (Hb), body-Hb Fe, feed intake, and body
weight were monitored. Upon the completion of the study, hepatic Fe and ferritin, pectoral glycogen,
duodenal gene expression, and cecum bacterial population analyses were conducted. The results
indicated that certain low-phytate pea varieties provided greater Fe bioavailability and moderately
improved Fe status, while they also had significant effects on gut microbiota and duodenal brush
border membrane functionality. Our findings provide further evidence that the low-phytate pea
varieties appear to improve Fe physiological status and gut microbiota in vivo, and they highlight
the likelihood that this strategy can further improve the efficacy and safety of the crop biofortification
and mineral bioavailability approach.
Keywords: pea; phytate; iron; bioavailability; bio active compound; in vivo; Gallus gallus; brush border
membrane; microbiome
1. Introduction
Micronutrient malnutrition affects more than half of the global population, primarily in developing
regions [1,2]. Iron (Fe), zinc (Zn), and vitamin A deficiencies are prominent health constraints
worldwide [3]. In low-income countries, plants are the significant source of food. In crude cereal and
legume foods, the low bioavailability of Fe and Zn leads to metabolic disorders that are associated with
these nutritional factors. Hence, increasing the nutritional value of such types of dietary ingredients
will contribute to the nutritional status of the target population. Mineral, phosphorous, and phytate
content is much higher in bran than whole grain [4–6].
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Field pea (Pisum sativum L.) is a main pulse crop grown for human consumption as a source of
protein, carbohydrates, minerals, and bioactive plant-origin bioactive compounds, contributing to better
metabolic health. In 2014, the global production of peas was 11.2 million tons [7]. The main component
of pea is starch, which includes two polymers of d-glucose: amylose and amylopectin [8,9]. Because of
the alterations in physiochemical characteristics between pulses and cereal starches, starch from pulses
can deliver some specific features to food systems as high gelation temperature, resistance to shear
thinning, increased elasticity, and high concentration of resistant starch [10].
In addition, field peas include bioactive compounds such as oligosaccharides, polyphenols,
and phytate [11]. Water-soluble carbohydrates in peas comprise mostly disaccharides and
oligosaccharides. The raffinose group of oligosaccharides (RFOs) is the most targeted in pea research.
These factors include galactose molecules (linked by α-d-1, 6-glycosidic bonds) attached to sucrose [12].
Humans lack the essential enzymes that are essential to break down these RFOs, and this results in these
oligosaccharides being digested by intestinal bacterial populations via fermentation, leading to elevated
short-chain fatty acid production [13]. Furthermore, a recent study indicated that intra-amniotic
administration of raffinose upregulated the expression of brush border membrane (BBM) functional
proteins, downregulated the expression of Fe-related proteins (indicating improvement of dietary iron
bioavailability), and elevated villus surface area. Furthermore, raffinose increased the richness and
composition of probiotic populations, and it reduced that of pathogenic bacterial species. Overall,
raffinose improved microbial population, dietary Fe bioavailability, and BBM functionality in vivo [14].
The main phenolic compounds found in peas comprise condensed tannins, flavonoids,
and phenolic acids [15]. These phenolic compounds are found specifically in the seed coat and
are biosynthesized via the phenylpropanoid pathway, with condensed tannin molecules being
responsible for the seed-coat coloring [16]. In dark-colored hulls, tannin and flavonoid compounds
are the majority of phenolic compounds; however, in seeds with clear hulls, phenolic acids are the
main compounds [17]. Polyphenols in the seed coat present antioxidant and anti-mutagenic activity,
shielding the seed from oxidative stress [18]. In field conditions, these compounds also deliver
chemical resistance against pathogens and insect pests during the growing process of the plant [19].
Polyphenols in peas appear mostly as insoluble or bound forms, covalently bonded to structural
components of the cell wall such as cellulose, hemicellulose, lignin, and pectin [20,21]. The polyphenolic
composition of peas is predominantly interesting with respect to metabolic health, given their alleged
protective properties against oxidative stress [15,22]. According to Campos-Vega [11] and Rochfort [23],
isoflavone polyphenols are linked with biological pathways in the lessening of osteoporosis and
cardiovascular disease, the deterrence of cancer, and treating symptoms related to menopause.
Phenolic compounds also display anti-nutritional effects, and related research showed a decrease in
the bioavailability of proteins triggered by phenolic compounds [24]. Phytate functions as a storage for
phosphate and minerals in seeds that can be recovered during germination process [25]. Phytate was
recognized as an anti-nutrient due to its ability to chelate with multivalent ions, specifically Zn, Ca,
and Fe, inhibiting the body’s capability to absorb dietary minerals by limiting their bioavailability [24].
There is increasing interest in utilizing pulses in wheat-based products with blends [26]. The demand
for gluten-free products led to investigation of the nutritional characteristics of baked products from
pulses like chickpea and lentil [27], as well as peas [28]. The rheological properties of pea flour,
including the gelation properties of starch, may be considered when exploring the potential application
of pea flour in baked goods. Recent uses for pulses could increase the demand for pulses with specific
nutritional and rheological properties, which will increase the need to investigate the components
affecting the nutritional and functional properties of pulses. It was previously demonstrated that
low-phytate pea lines had higher Fe bioavailability than regular or standard pea [29]; in addition,
pea varieties which were low-phytate combined with relatively higher carotenoid concentration in
some cases resulted in a further increase in Fe bioavailability in vitro [30].
Biofortified staple foods are an effective instrument through which to address micronutrient
deficiencies worldwide, with emphasis on Fe and Zn, in numerous target populations [1,31–35].
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The in vivo (Gallus gallus) model was established as an excellent model to assess dietary Fe and
Zn bioavailability [33–39]. Hence, the objective of the current study was to evaluate the ability
of low-phytate pea varieties in the context of a complete meal to improve Fe bioavailability and
absorption, physiological status, intestinal BBM functionality, and intestinal microbial populations
in vivo (Gallus gallus). We suggest the further use of in vivo screening model to guide future studies
aimed to investigate biofortified staple food crops, as this method will allow proceeding to human
efficacy studies with superior confidence and success.
2. Materials and Methods
2.1. Plants Materials—University of Saskatchewan Pea Varieties
The pea varieties evaluated in this research arose from the Crop Development Center, University of
Saskatchewan (Canada) pea breeding program (Figure 1). Low-phytate line 1-2347-144 was derived
from cultivar CDC Bronco [39,40] through chemical mutagenesis [41]. Varieties 4802-8-46Y-L,
4802-8-60G-L, and 4802-8-87Y-L resulted from the cross 1-2347-144/CDC 2235-4 made in 2011.
CDC 2235-4 was later registered as CDC Raezer [42]. Variety 4803-4-78G-L resulted from the cross
1-150-81/CDC 2336-1 made in 2011. Line 1-150-81 is a second low-phytate line derived from CDC
Bronco [41]. CDC 2336-1 was later registered as CDC Limerick [43]. The varieties from crosses 4802
and 4803 were previously described [30].
 
Figure 1. High-resolution photographs depicting six varieties used to evaluate the iron bioavailability
of the Saskatchewan peas. To compare the differences in seed sizes, all photographs were taken to scale
under standardized lighting conditions.
2.2. Growing Conditions and Post-Harvest Handling
All six pea varieties that were used in this experiment were grown at the Sutherland farm,
located 10 km east of Saskatoon (Canada), with planting in May 2017 and harvest in August 2017.
The harvested samples were stored in a non-heated warehouse, with temperature ranging between 15
and 20 ◦C based on the season, until shipment to Ithaca for dietary processing.
2.3. Ingredient Preparation and Diet Composition
For this study, raw pea seeds were rinsed and cleaned thoroughly in distilled water to remove
dust, debris, and non-edible material. Peas were pre-soaked in distilled water (1:6 w/w) for 12 h at
room temperature prior to cooking. Peas were cooked in boiling distilled water in stainless-steel
steam kettles. Cooked peas were then stored at −20 ◦C for 24 h prior to freeze-drying (VirTis Research
Equipment, Gardiner, NY, USA). Basmati rice and wheat were purchased from a local food store located
in Ithaca, New York, USA. Our rationale with regard to the inclusion of basmati rice, wheat, and carrots
in the tested pea-based diets was to approximately simulate the ingredients of a pea-based meal in
India, which is one of the key consumers of pea, and where dietary Fe deficiency is a major health
concern. Cooked rice was stored at −20 ◦C for 24 h before freeze-drying. Cooked/air-dried carrots were
purchased from North Bay Trading Co. (Brule, WI, USA). Dried ingredients were milled into a course
powder using a Waring Commercial® CB15 stainless-steel blender (Torrington, CT, USA). Other dietary
ingredients included chicken Vitamin Mixture (#330002) and chicken Mineral Mix (#230000, no added
iron) (Dyets Inc., Bethlehem, PA, USA), dl-methionine, and choline chloride (Sigma-Aldrich, St. Louis,
MO, USA). The compositions of the experimental diets are shown in Table 1
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2.4. Iron Analysis
Iron analysis was conducted as previously described [14,33,36,38,39]. For the analysis, a 500-mg
sample of dietary ingredient, a 500-mg sample of pea-based diets, or a 100-mg sample of tissue (wet
weight) was analyzed.
2.5. Phytate Analysis
Phytate (phytic acid) determination was conducted as previously described [14,33–39]. For the
analysis, a 500-mg sample of dietary ingredients and a 500-mg of pea-based diets were analyzed,
according to a phosphorous kit (K-PHYT; Megazyme International, Ireland).
2.6. Protein and Fiber Analysis
Analysis was conducted as previously described [36,43–45].
2.7. Animals and Feeding Trial Design
Cornish-cross fertile broiler eggs were delivered from a commercial hatchery (Moyer’s Chicks,
Quakertown, PA, USA). The eggs were incubated under ideal conditions at the Cornell University
Animal Science poultry farm incubator. Upon hatch (hatchability = 98%), hatchlings were arbitrarily
divided into seven treatment groups (n = 15) (Table 1), with ad libitum access to food and water
(Fe concentration < 0.4 μg/L). Chicks were kept in a total confinement building (two animals per 1-m2
metal cage) under controlled temperature and humidity with 16 h of light. Cages were equipped with
an automatic watering system and a manual self-feeder. Feed intakes were documented daily, and,
as of day of hatch, body weights were documented weekly. Animal protocols were approved by the
Cornell University Institutional Animal Care and Use Committee (protocol number 2007-0129).
2.7.1. Blood Collection, Hemoglobin, and Physiological Fe Status Parameters
Blood samples were collected and hemoglobin (Hb) assays were conducted according to the Hb
kit manufacturer’s instructions (BioAssay Systems, Hayward, CA, USA). Total body hemoglobin Fe
(Hb-Fe), a parameter of iron absorption, was calculated from Hb concentrations and blood volume
according to specific body weight (85 mL per kg of body weight) [33–36,39,46].
Hemoglobin maintenance efficiency (HME) was calculated as the cumulative difference in total
body Hb Fe from the start of the study, divided by total dietary Fe intake. [33–36,39,46].
Upon the conclusion of the study (42 days), animals were euthanized by CO2 exposure and blood,
small intestine, cecum, and liver samples were collected. Tissue samples were instantly frozen in liquid
nitrogen and stored at −80 ◦C in a freezer until analyzed.
2.7.2. Liver Iron and Ferritin
The quantifications of liver Fe and ferritin were conducted as previously described [46–48].
2.7.3. Isolation of Total RNA from Duodenum
Total RNA extraction was conducted as previously described [14,33–39,46,49], according to the
manufacturer’s protocol (RNeasy Mini Kit, Qiagen Inc., Valencia, CA, USA).
2.7.4. Real-Time Polymerase Chain Reaction (RT-PCR)
The complementary DNA (cDNA) reaction was conducted as previously described (BioRad C1000
touch thermocycler using the Improm-II Reverse Transcriptase Kit, Promega Corp., Madison, WI,
USA) [37–39].
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2.7.5. Primer Design for Duodenal Gene Expression
Primers sequences were designed and selected using the Real-Time Primer Design Tool software
(IDT DNA, Coralvilla, IA, USA). The Gallus gallus primers (forward/reverse) that were used in this
study are indicated in Table 2.
Table 2. Sequences of primers used in this study.
Gene 1 Forward Primer (5′–3′) Reverse Primer (5′–3′) Length (bp) GI
ID
DMT-1 TTGATTCAGAGCCTCCCATTAG GCGAGGAGTAGGCTTGTATTT 101 206597489
Ferroportin CTCAGCAATCACTGGCATCA ACTGGGCAACTCCAGAAATAAG 98 61098365
DcytB CATGTGCATTCTCTTCCAAAGTC CTCCTTGGTGACCGCATTAT 103 20380692
ZnT1 GGTAACAGAGCTGCCTTAACT GGTAACAGAGCTGCCTTAACT 105 54109718
AP CGTCAGCCAGTTTGACTATGTA CTCTCAAAGAAGCTGAGGATGG 138 45382360
SGLT-1 GCATCCTTACTCTGTGGTACTG TATCCGCACATCACACATCC 106 8346783
SI CCAGCAATGCCAGCATATTG CGGTTTCTCCTTACCACTTCTT 95 2246388
18S rRNA GCAAGACGAACTAAAGCGAAAG TCGGAACTACGACGGTATCT 100 7262899
1 DMT-1, divalent metal transporter-1; DcytB, duodenal cytochrome b; ZnT1, zinc transporter 1; AP, amino peptidase;
SGLT-1, sodium-glucose transporter-1; SI, sucrose isomaltase; 18S rRNA, 18S ribosomal RNA subunit.
2.7.6. Real-Time qPCR Design
Isolated cDNA was used for the reaction (Cat. #1725274, Hercules, CA, USA) as previously
indicated [36–39].
2.7.7. Collection of Microbial Samples and DNA Isolation of Intestinal Contents
The cecum was removed and stored at −80◦C until analyzed. Microbial DNA isolation was
conducted as previously described [36–38].
2.7.8. Primer Design and PCR Amplification of Bacterial 16S rRNA
Primers for Bifidobacterium, Lactobacillus, Escherichia coli, and Clostridium were used in accordance
with previously published data [46].
2.7.9. Glycogen Analysis
At the conclusion of the study (day 42), the pectoral muscle (200 mg) was removed, and glycogen
contents were determined as previously described [50–52].
2.8. Statistical Analysis
Statistical analyses were conducted using IBM SPSS Statistics 25 (IBM Analytics, Armonk, NY,
USA). Measured parameters were found to have a normal distribution and equal variance, and they
were acceptable for ANOVA. Mean separations for measured parameters were determined using
ANOVA with the model including dietary treatment (seven levels) as the fixed effect, followed by a
Duncan post hoc test. Differences with p-values ≤0.05 were considered statistically significant.
3. Results
3.1. Seed Iron and Phytate Concentrations in Experimental Peas Varieties
Iron concentrations of dietary ingredients are shown in Table 1. Differences in seed Fe contents in
the pea varieties were significant (p≤ 0.05), ranging from 37μg/g in 1-2347-144 to 42μg/g in 4803-4-78G-L
(Table 1). Phytate concentrations and molar ratios of dietary ingredients of the pea-based diets are
indicated in Table 1. Significant (p ≤ 0.05) differences in phytate concentrations were measured between
peas varieties, from 3.7 mg/g in 4803-4-78G-L to 5.82 mg/g in CDC Bronco (Table 1). Phytate-to-Fe
molar ratios varied significantly (p ≤ 0.05), from a ratio of 7.4 in 4803-4-78G-L to a ratio of 12.4 in CDC
Bronco (Table 1).
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3.2. Protein and Fiber Contents
Table 3 indicates the total crude protein content in experimental tested pea varieties, with significant
differences (p ≤ 0.05) between pea varieties, ranging from 22.5 g/100 g in CDC Bronco to 26.75 g/100 g in
4803-4-78G-L. Concentrations of insoluble, soluble, and total fiber for experimental peas are shown in
Table 3, with significant differences (p ≤ 0.05) in each of the fiber fractions between experimental peas.
The lowest concentrations of the insoluble, soluble, and total fiber were detected in the 4803-4-78G-L
pea variety. Significantly (p ≤ 0.05) higher concentrations of all three fiber fractions were measured
in 1-2347-144. As a reference, the total protein content in the control diet (no pea) was measured at
10.72 g/100 g ± 0.16 g/100 g of total protein.
Table 3. Protein and fiber concentrations (g/100 g) of tested peas varieties 1.
Variety Insoluble Fiber Soluble Fiber Total Fiber Total Protein
1-2347-144 22.37 ± 1.26 a 1.31 ± 0.18 a 23.68 ± 1.43 a 22.69 ± 0.06 d
4803-4-78G-L 16.49 ± 1.32 c 0.94 ± 0.39 a 17.43 ± 1.71 c 26.75 ± 0.35 a
4802-8-46Y-L 19.52 ± 1.10 abc 1.08 ± 0.06 a 20.60 ± 1.05 abc 23.22 ± 0.31 c
4802-8-60G-L 20.20 ± 1.87 ab 1.12 ± 0.30 a 21.32 ± 2.17 abc 22.94 ± 0.09 cd
4802-8-87Y-L 17.94 ± 0.12 bc 1.13 ± 0.26 a 19.07 ± 0.14 bc 24.78 ± 0.13 b
CDC Bronco 20.66 ± 1.93 ab 1.30 ± 0.16 a 21.97 ± 1.77 ab 22.50 ± 0.90 d
1 Values are means ± standard error of the mean (SEM) (n = 3 replicates). a–d Treatment groups not indicated by the
same letter are significantly different (p ≤ 0.05).
3.3. Iron–Phytate Analysis of Pea Based Diets
The final composition of the six pea-based diets and no-pea diet are shown in Table 3.
Iron concentrations amongst the pea-based diets were significantly different (p≤ 0.05). Diets formulated
from 4802-8-87Y-L and 4803-4-78G-L had the highest iron concentrations (38 μg/g and 39 μg/g,
respectively) relative to the control diet (no-pea diet) (27 μg/g). Final phytate concentrations also
varied between experimental diets ranging from 1.57 mg/g in 1-2347-144 to 2.66 mg/g in the no-pea
diet. Significant (p ≤ 0.05) differences in phytate–Fe molar ratios were observed between the pea-based
diets, ranging from 3.79 mg/g in 1-2347-144 to 8.66 mg/g in CDC Bronco (Table 1).
3.4. In Vivo Assay (Gallus gallus Feeding Trial)
3.4.1. Growth Rates, Hemoglobin (Hb), Total Body Hemoglobin Fe (Hb-Fe), and Hemoglobin
Maintenance Efficiency (HME)
Feed intakes and Fe intakes were higher (p < 0.05) in all pea-based dietary treatment groups
relative to the no-pea dietary treatment group (Tables 4 and 5).
Table 4. Experimental cumulative feed intake 1.
Feed Intake (g)
Pea Diet Day 7 Day 14 Day 21 Day 28 Day 35 Day 42
1-2347-144 329.6 ± 26.7 a 699.2 ± 55.4 a 1210.9 ± 120.7 a 1773.1 ± 105.8 a 2511.2 ± 86.4 a 3272.1 ± 115.6 a
4803-4-78G-L 331.1 ± 21.2 a 706.7 ± 50.6 a 1229.6 ± 95.6 a 1579.6 ± 328.0 a 2370.9 ± 348.9 a 3266.8 ± 340.3 a
4802-8-46Y-L 390.8 ± 11.6 a 797.7 ± 58.5 a 1420.9 ± 134.6 a 2051.6 ± 180.1 a 2822.3 ± 230.4 a 3691.3 ± 225.5 a
4802-8-60G-L 351.6 ± 7.8 a 729.8 ± 17.8 a 1283.5 ± 30.3 a 1898.6 ± 5.8 a 2698.8 ± 13.1 a 3644.7 ± 35.7 a
4802-8-87Y-L 370.4 ± 17.1 a 742.0 ± 74.2 a 1312.2± 158.6 a 1934.7 ± 167.2 a 2781.9 ± 182.2 a 3769.6 ± 186.9 a
CDC Bronco 353.3 ± 12.2 a 735.1 ± 28.9 a 1299.4 ± 73.6 a 1901.0 ± 56.6 a 2664.4 ± 49.8 a 3530.4 ± 60.9 a
No pea 224.6 ± 29.1 b 293.9 ± 28.8 b 428.3 ± 48.2 b 609.5 ± 66.3 b 799.5 ± 105.2 b 930.6 ± 133.1 b
1 Values are means ± SEM (n = 15 animals per treatment group). a,b Treatment groups not indicated by the same
letter are significantly different (p ≤ 0.05).
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Table 5. Experimental cumulative iron intake 1.
Iron Intake (mg)
Pea Diet Day 7 Day 14 Day 21 Day 28 Day 35 Day 42
1-2347-144 11.77 ± 0.95 b 24.97 ± 1.98 a 43.25 ± 4.31 a 63.33 ± 3.78 a 89.69 ± 3.09 a 116.87 ± 4.13 b
4803-4-78G-L 13.07 ± 0.84 ab 27.89 ± 2.00 a 48.53 ± 3.78 a 62.35 ± 12.95 a 93.59 ± 13.77 a 128.95 ± 13.43 ab
4802-8-46Y-L 14.07 ± 0.42 a 28.73 ± 2.11 a 51.18 ± 4.85 a 73.89 ± 6.49 a 101.65 ± 8.30 a 132.95 ± 8.13 ab
4802-8-60G-L 12.75 ± 0.28 ab 26.47 ± 0.65 a 46.56 ± 1.10 a 68.87 ± 0.21 a 97.89 ± 0.48 a 132.21 ± 1.29 ab
4802-8-87Y-L 14.11 ± 0.65 a 28.26 ± 2.83 a 49.98 ± 6.04 a 73.69 ± 6.37 a 105.96 ± 6.94 a 143.57 ± 7.12 a
CDC Bronco 13.14 ± 0.46 ab 27.35 ± 1.07 a 48.35 ± 2.74 a 70.73 ± 2.11 a 99.14 ± 1.85 a 131.36 ± 2.27 ab
No pea 6.20 ± 0.80 c 8.11 ± 0.80 b 11.82 ± 1.33 b 16.82 ± 1.83 b 22.07 ± 2.18 b 25.69 ± 3.67 c
1 Values are means ± SEM (n = 15 animals per treatment group). a–c Treatment groups not indicated by the same
letter are significantly different (p ≤ 0.05).
Also, as from day 35 of the study, body weights were consistently higher (p < 0.05) in several of
the low phytate pea based dietary groups (4803-4-78G-L, and 4802-8-87Y-L), relative to the CDC Bronco
and no-pea dietary groups (Table 6). Hemoglobin (Hb) values did not differ between treatment groups;
however, significant differences in total body Hb-Fe, a physiological biomarker of Fe bioavailability
and status, were detected as of week five of the study (Table 7), demonstrating an improvement in
Fe status in the 4802-8-87Y-L group, relative to CDC Bronco and no-pea diet groups. In addition,
the standard pea variety treatment group (CDC Bronco) had a lower HME (p < 0.05) at each time
point when compared to the group receiving the lower-phytate pea-based diets (groups 1-2347-144,
4803-4-78G-L), indicating a higher dietary Fe bioavailability and increased absorbable Fe (Table 8).
Table 6. Experimental body weights 1.
Body Weights (kg)
Pea Diet Day 7 Day 14 Day 21 Day 28 Day 35 Day 42
1-2347-144 0.133 ± 0.004 a 0.327 ± 0.010 a 0.547 ± 0.009 a 0.904 ± 0.031 b 1.326 ± 0.082 bc 1.820 ± 0.130 b
4803-4-78G-L 0.137 ± 0.006 a 0.334 ± 0.013 a 0.576 ± 0.022 a 0.997 ± 0.037 ab 1.447 ± 0.058 ab 2.040 ± 0.100 ab
4802-8-46Y-L 0.137 ± 0.011 a 0.337 ± 0.025 a 0.578 ± 0.043 a 0.994 ± 0.067 ab 1.384 ± 0.085 bc 1.880 ± 0.110 ab
4802-8-60G-L 0.136 ± 0.005 a 0.334 ± 0.026 a 0.563 ± 0.044 a 0.974 ± 0.050 ab 1.393 ± 0.076 bc 1.930 ± 0.110 ab
4802-8-87Y-L 0.131 ± 0.006 a 0.322 ± 0.016 a 0.561 ± 0.037 a 1.024 ± 0.049 a 1.536 ± 0.059 a 2.140 ± 0.070 a
CDC Bronco 0.131 ± 0.002 a 0.317 ± 0.006 a 0.541 ± 0.008 a 0.922 ± 0.019 b 1.300 ± 0.006 c 1.840 ± 0.020 b
No pea 0.072 ± 0.003 b 0.090 ± 0.005 b 0.118 ± 0.006 b 0.161 ± 0.009 c 0.201 ± 0.011 d 0.240 ± 0.010 c
1 Values are means ± SEM (n = 15 animals per treatment group). a–d Treatment groups not indicated by the same
letter are significantly different (p ≤ 0.05). Body weights averaged 38 g at the start of the experiment.
Table 7. Experimental total body hemoglobin iron (Hb-Fe) 1.
Hb-Fe (mg)
Pea Diet Day 7 Day 21 Day 35 Day 42
1-2347-144 4.981 ± 0.152 a 20.845 ± 0.339 a 55.186 ± 3.392 bc 97.790 ± 7.150 b
4803-4-78G-L 5.496 ± 0.245 a 23.452 ± 0.914 a 56.839 ± 2.276 ab 107.280 ± 5.140 ab
4802-8-46Y-L 5.539 ± 0.444 a 22.967 ± 1.727 a 51.886 ± 3.200 bc 96.610 ± 5.600 ab
4802-8-60G-L 5.301 ± 0.207 a 21.814 ± 1.668 a 48.939 ± 2.659 bc 96.980 ± 5.480 ab
4802-8-87Y-L 4.730 ± 0.223 a 19.886 ± 1.314 a 57.088 ± 2.198 a 116.910 ± 3.590 a
CDC Bronco 4.177 ± 0.062 a 17.249 ± 0.268 a 45.414 ± 0.209 c 100.450 ± 1.250 b
No pea 2.354 ± 0.090 b 4.048 ± 0.206 b 6.447 ± 0.348 d 9.480 ± 0.550 c
1 Values are means ± SEM (n = 15 animals per treatment group). a–d Treatment groups not indicated by the same
letter are significantly different (p ≤ 0.05). Total body hemoglobin iron averaged 0.65 milligrams at the start of
the experiment.
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Table 8. Experimental hemoglobin maintenance efficacy (HME) 1.
HME (%)
Pea Diet Day 21 Day 35 Day 42
1-2347-144 37.44 ± 3.81 a 56.21 ± 4.66 a 80.58 ± 8.13 a
4803-4-78G-L 39.82 ± 3.85 a 57.37 ± 8.61 a 78.90 ± 7.61 a
4802-8-46Y-L 34.35 ± 2.52 ab 45.72 ± 0.79 ab 70.18 ± 0.23 ab
4802-8-60G-L 37.29 ± 4.09 a 44.56 ± 2.31 ab 71.66 ± 4.45 ab
4802-8-87Y-L 32.22 ± 2.51 ab 49.66 ± 2.29 ab 61.10 ± 1.26 b
CDC Bronco 27.24 ± 1.85 b 41.63 ± 0.96 b 62.92 ± 1.40 b
No pea 14.57 ± 1.33 c 19.04 ± 2.18 c 28.53 ± 3.03 c
1 Values are means ± SEM (n = 15 animals per treatment group). a–c Treatment groups not indicated by the same
letter are significantly different (p ≤ 0.05).
3.4.2. Hepatic Iron and Ferritin Concentrations
The contents of liver iron and ferritin (day 42) are shown in Table 9. Significant (p≤ 0.05) differences
in liver iron were detected among the seven treatment groups with concentrations ranging from 73 μg/g
in the group receiving the 4803-4-78G-L diet to 96 μg/g in the 1-2347-144 diet. Significant (p ≤ 0.05)
differences in liver ferritin concentrations were also measured between the seven dietary treatment
groups (Table 9).
Table 9. Hepatic iron and ferritin protein concentrations 1.
Pea Diet Liver Iron (μg/g) Liver Ferritin (AU)
1-2347-144 96.49 ± 6.52 a 1.078 ± 0.014 a
4803-4-78G-L 73.30 ± 7.58 b 1.084 ± 0.015 a
4802-8-46Y-L 77.61 ± 17.72 b 1.063 ± 0.009 a
4802-8-60G-L 87.46 ± 4.98 ab 1.050 ± 0.005 a
4802-8-87Y-L 71.88 ± 4.79 b 0.469 ± 0.160 b
CDC Bronco 91.34 ± 9.79 ab 0.257 ± 0.017 c
No pea 75.71 ± 6.29 b 0.280 ± 0.007 c
1 Values are means ± SEM (n = 12 animals per treatment group). a–c Treatment groups not indicated by the same
letter are significantly different (p ≤ 0.05). Total iron concentrations were measured as micrograms per gram of liver
tissue (wet weight). Liver ferritin concentrations were measured as arbitrary units of liver tissue (wet weight).
3.4.3. Serum Iron Concentrations
Significant differences (p ≤ 0.05) in serum iron concentrations were detected on day 21 and 35 of
the study. On day 21, the lowest concentration of serum iron was 1.526 μg/μL in the no-pea dietary
group, while the highest concentration was in the 4802-8-87Y-L pea-based dietary group (2.812 μg/μL).
On day 35, the lowest concentration of serum iron was 1.488 μg/μL (no-pea dietary group), while the
highest concentration was detected in the 4803-4-78G-L dietary group (2.633 μg/μL) (Table 10).
Table 10. Serum iron concentrations 1.
Serum Iron (μg/μL)
Pea Diet Day 7 Day 21 Day 35 Day 42
1-2347-144 2.089 ± 0.161 a 1.682 ± 0.120 b 2.226 ± 0.243 ab 2.116 ± 0.183 a
4803-4-78G-L 1.604 ± 0.108 a 2.322 ± 0.198 ab 2.633 ± 0.451 a 2.104 ± 0.280 a
4802-8-46Y-L 3.029 ± 0.636 a 2.596 ± 0.700 ab 1.795 ± 0.225 b 2.349 ± 0.289 a
4802-8-60G-L 2.383 ± 0.282 a 2.058 ± 0.170 b 1.583 ± 0.106 b 2.240 ± 0.218 a
4802-8-87Y-L 2.767 ± 0.774 a 2.812 ± 0.425 a 1.578 ± 0.144 b 2.132 ± 0.178 a
CDC Bronco 1.936 ± 0.237 a 1.829 ± 0.223 b 1.670 ± 0.190 b 2.292 ± 0.224 a
No pea 2.248 ± 0.490 a 1.526 ± 0.215 ab 1.488 ± 0.088 b 2.105 ± 0.187 a
1 Values are means ± SEM (n = 12 animals per treatment group). a,b Treatment groups not indicated by the same
letter are significantly different (p ≤ 0.05).
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3.4.4. Glycogen Concentrations in Pectoral Muscle
As an indicator of energetic status [52,53], pectoral muscle glycogen concentrations were measured
on days 21 and 42 of the study (Table 11). No significant differences were detected on day 21; however,
significant differences (p ≤ 0.05) were measured on day 42 in the abundance of glycogen stored in
pectoral muscles. The highest values of glycogen were in the 4802-8-60G-L pea-based dietary group,
and the lowest concentration of glycogen was in the no-pea dietary group.
Table 11. Pectoral muscle glycogen concentrations (AU) 1.
Pea Diet Day 21 Day 42
1-2347-144 0.020 ± 0.012 a 0.044 ± 0.010 ab
4803-4-78G-L 0.023 ± 0.012 a 0.037 ± 0.006 b
4802-8-46Y-L 0.040 ± 0.011 a 0.041 ± 0.026 ab
4802-8-60G-L 0.031 ± 0.008 a 0.055 ± 0.011 a
4802-8-87Y-L 0.024 ± 0.007 a 0.053 ± 0.005 a
CDC Bronco 0.029 ± 0.034 a 0.034 ± 0.003 a
No pea 0.023 ± 0.004 a 0.033 ± 0.008 b
1 Values are means ± SEM (n = 5 animals per treatment group. a,b Treatment groups not indicated by the same letter
are significantly different (p ≤ 0.05).Glycogen concentrations were measured as milligrams per milliliter of pectoral
tissue (wet weight).
3.4.5. Duodenal Gene Expression
The duodenal gene expression of iron- and zinc-related proteins, as well as BBM functional
proteins, is shown in Figure 2. Significant (p ≤ 0.05) differences in the expression of DcytB and
ferroportin were identified, with no significant differences in divalent metal transporter-1 (DMT1)
expression between treatment groups.
 
Figure 2. Gene expression of iron proteins in the duodenum after six weeks of consuming pea-based
diets. Values are means ± SEM (n = 10 per treatment group). a–c Treatment groups not indicated by the
same letter are significantly different (p < 0.05). DMT-1, divalent metal transporter-1; DcytB, duodenal
cytochrome b; ZnT1, zinc transporter 1; AP, amino peptidase; SGLT-1, sodium-glucose transporter 1;
SI, sucrose isomaltase.
3.4.6. Cecum Content Bacterial Populations Analysis
As shown in Figure 3, the relative abundance of Bifidobacterium was significantly higher (p < 0.05)
in the 4802-8-87Y-L and CDC Bronco groups relative to all other treatment groups. Furthermore,
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the abundance of Lactobacillus was significantly higher (p < 0.05) in the 1-2347-144 and 4803-4-78G-L
groups relative to all other treatment groups.
Figure 3. Genus- and species-level bacterial populations (AU) from cecal contents after six weeks of
consuming pea-based diets. Values are means ± SEM (n = 10 per treatment group). a–c Treatment
groups not indicated by the same letter are significantly different (p < 0.05).
4. Discussion
The objective of the current study was to investigate the effects of low-phytate peas, in the context
of a complete meal, on Fe bioavailability, absorption, physiological status, intestinal BBM functionality,
and gastrointestinal microbial populations in vivo (Gallus gallus).
In studies of biofortification, the process via which the nutritional quality of food crops is improved
through agronomic practices, conventional plant breeding, or modern biotechnology [2], it is necessary
and advantageous to utilize in vivo screening tools that are capable of assessing biofortified varieties
of staple crops, as well as in relation to the diet in which they are consumed [1,33,36,38,39,46,54–56].
The present study, for the first time, presents a demonstration of how the Gallus gallus model of Fe
(and Zn) bioavailability could be useful in the design of the current study aimed at assessing the
potential nutritional benefit of lower-phytate versus standard peas. The chosen dietary composition was
specifically formulated in accordance to a potential target population (Indian/Bangladeshi pea-based dal
meal), similar to previous in vivo studies aimed at assessing dietary Fe bioavailability in beans [35,55]
and wheat [38] (Table 1). Overall, our data agree with previously published knowledge [1,39,49,55],
demonstrating that this in vivo screening approach is effective in the evaluation process of nutritional
qualities of the low-phytate pea varieties. Furthermore, the data suggested that lower-phytate pea-based
diets were able to moderately improve Fe physiological status in vivo.
Peas are a common staple food crop consumed worldwide, primarily in India, China, Russia,
Ethiopia, and Bangladesh. Global dry pea production increased from 9.9 million tons in 2012 to
16.2 million tons in 2017 [7]. Currently, the leading producers are Canada, Russia, China, Ukraine,
and India. In Canada, a leading producer and exporter of dry peas, pea was grown on 1.6 million ha in
western Canada (Saskatchewan, Alberta, and Manitoba) in 2017, indicating a significant alteration in
cropping practices from the 300 ha reported in 1967. Pea was the major alternative crop as farmers
shifted toward a more diversified crop production. Pea varieties (yellow and green cotyledon) are
grown, with an average of 80% production in yellow cotyledon varieties. The five-year (2013–2017)
average pea yield in western Canada is 2.6 tons/ha (38 bu/ac) [57]. As for their nutritional value,
it was previously demonstrated that pea seeds are high in protein, carbohydrates, fiber, B vitamins,
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and minerals (potassium, magnesium, calcium, iron), and they are considered an inexpensive source
of energy-dense, nutrient-rich food [58–60]. In addition, pea seeds are low in fat and cholesterol-free.
Because of these nutritional benefits, worldwide pea utilization is expected to continue to grow.
Plant seeds, such as pea, contain a high concentration of phosphorus. However, about 60–80%
of the total phosphorus in seeds is stored in the form of phytate, a mixed-cation salt of phytic
acid [59]. This introduces a nutritional challenge, as negatively charged sites of phytic acid bind
and form salts with K+, Mg2+, Ca2+, Mn2+, Zn2+, or Fe3+ [61]. Phytate causes multiple difficulties,
as non-ruminant animals including pig, poultry, fish, and humans, are unable to digest phytate due
to lack of a phytase enzyme [61]; as a result, important micronutrients (as Zn2+ and Fe3+) bound
to phytate are also excreted and not absorbed, potentially leading to micronutrient deficiencies [62].
Recently, the development of cultivars with low-phytate content became an effective approach to
potentially reducing nutritional concerns ascending from the consumption of phytate-rich grains.
Low-phytate varieties were chemically persuaded in maize (Zea mays L.) [63], soybean (Glycine max (L.)
Merr.) [64], barley (Hordeum vulgare L.) [63,65], rice (Oryza sativa L.) [66], wheat (Triticum aestivum L.) [67],
bean (Phaseolus vulgaris L.) [68], and pea [41]. The concentration of phytate phosphorus is significantly
reduced in the mutants with an associated increase in available phosphorus. Wilcox et al. [65] reported
an 80% reduction in phytate phosphorus content in a low-phytate soybean mutant, as compared with
its nonmutant sibling, and this reduction was matched by an equal increase in inorganic phosphorus.
It was previously demonstrated that low-phytate crops increase the bioavailability of phosphorus
and several important nutritional cations, including Fe. These crops could assist in increasing the
health of a large proportion of the global population, which is dietary Fe-deficient, primarily in target
regions where dietary peas are consumed regularly. For example, in a previous study focused on
the nutritional evaluation of low-phytate pea diets in vivo, it was demonstrated that animals fed the
low-phosphorus diets had lower weight gain and feed intake (p < 0.01) than those fed the higher
phosphorus level. Bone strength was higher (p < 0.01) for animals fed diets based on low-phytate pea
than for those fed diets based on normal pea or soybean meal. The authors concluded that increasing
the availability of the phosphorus in peas could mean that less inorganic phosphorus would be required
in order to meet the nutritional requirements of broilers [59].
In the context of the current study, the results indicated that, despite Hb levels not being significantly
higher in the lower-phytate pea groups, significant differences in total body Hb-Fe, the physiological Fe
status biomarker [33–36,39,46,55], were observed (Table 8), representing an enhancement in Fe status
in the 4802-8-87Y-L dietary group, relative to CDC Bronco and the no-pea dietary group. In addition,
the standard pea variety (CDC Bronco) treatment group had a lower HME (p < 0.05) ratio compared to
the group receiving the lower-phytate pea-based diets (groups 1-2347-144, 4803-4-78G-L) (Table 8),
indicating improved dietary Fe bioavailability and increased absorbable Fe [36,46,54]. The CDC Bronco
diet presented a higher PA–Fe ratio compared to the all low-phytate pea-based diets (Table 1), which was
associated with increased dietary Fe bioavailability in these pea-based diets [69–71]. These results
agree with preceding experiments intended to assess Fe bioavailability in Fe-biofortified legumes,
such as black beans [72], red mottled beans [33], Carioca beans [36], and pearl millet [73], as well as
in the context of a complete diet. Thus, several intrinsic factors, including phytates, may influence
the bioavailability of Fe from these pea varieties and other crops [56,74–76], potentially limiting their
nutritional benefit.
Previous research suggested that increased Fe content alone in biofortified crops may not
be adequate to produce a significant physiological improvement in Fe status and in Fe-deficient
populations [36,55,76]. In the current study, it appears that, although Fe contents of all tested pea
varieties were similar, the consumption of lower-phytate peas was able to moderately improve Fe
status and storage, as further suggested by the hepatic ferritin contents of lower-phytate groups relative
to CDC Bronco and no-pea diets. Furthermore, the duodenal brush border membrane (BBM) gene
expression of ferroportin (FPN) was significantly upregulated, while DcytB was downregulated in
the groups receiving the lower-phytate pea-based diets, relative to the CDC Bronco dietary group
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(p < 0.05, Figure 2). However, no significant alterations in the expression of BBM functional proteins
were detected amongst treatment groups. Previous studies showed a downregulation of the gene
expression of Fe-related BBM proteins (DMT-1, FPN, and Dcytb) in Fe-biofortified diets compared to
the Fe-standard diets [36,46,55]. Ferroportin is the Fe exporter that transfers Fe across the enterocyte’s
basolateral membrane [77]. Hence, since the lower-phytate pea-based dietary groups had a higher
expression of FPN, more Fe could be transported from the enterocyte into the blood and target tissue;
therefore, this mechanism indicates the potential increased amount of absorbable Fe and, hence,
the total body Hb-Fe increased in some of the low phytate groups compared to the CDC Bronco and
no-pea dietary groups.
Similar to humans and most animals, the Gallus gallus model harbors a complex and active
intestinal microbiota [78], significantly and directly influenced by host genetics, environment,
and diet [79]. There is a significant resemblance at the phylum level between the gut microbiota
of Gallus gallus and humans, with Bacteroidetes, Firmicutes, Proteobacteria, and Actinobacteria
representing the dominant bacterial phyla in both [80]. In this study, a genus- and species-level
bacterial population delineation among the low-phytate, standard (CDC Bronco), and no-pea dietary
groups was observed. Results indicated that the abundance of Bifidobacterium was significantly
higher (p < 0.05) in the 4802-8-87Y-L and CDC Bronco groups relative to all other treatment groups.
Furthermore, the abundance of Lactobacillus was significantly higher (p < 0.05) in the 1-2347-144 and
4803-4-78G-L treatment groups relative to all other treatment groups (Figure 3). These results suggest
that the above lower-phytate pea-based diets may potentially improve the host overall gut health
by promoting the abundance of beneficial bacterial populations. Moreover, some of the low-phytate
pea varieties (as 1-2347-144) presented a higher (p < 0.05) total fiber content (soluble and insoluble)
compared to the standard CDC Bronco pea (Table 3). It was previously demonstrated that soluble fiber
can increase villi height by elevating intestinal cell proliferation [81]. In the current study, some of
the low-phytate pea dietary groups (such as 4803-4-78G-L, 4802-8-46Y-L, and 4802-8-87Y-L) presented
higher (p < 0.05) protein content compared to the standard CDC Bronco pea (Table 3), where a
higher dietary protein content was shown to increase villi height and intestinal cell proliferation [82].
Furthermore, indigested dietary proteins and fibers are fermented in the lower intestine, and this action
produces short-chain fatty acids (SCFAs), such as acetate, propionate, and butyrate. Production of
SCFAs affects metabolism and gastrointestinal health [83]. Acetate and propionate are energy substrates
for peripheral tissues, and butyrate is referentially used as an energy source by colonocytes [84,85].
In summary, the current study focused on the performance of low-phytate pea varieties in
chicken diets. Phytate phosphorus concentration was reduced by approximately 40% in these varieties.
The low-phytate pea variety-based diets were able to moderately improve the Fe status in vivo,
suggesting that low-phytate field pea has the potential to improve Fe bioavailability in human diets,
particularly in the Indian subcontinent, as one of the major importing regions for Canadian peas,
and a region where dietary Fe deficiency is a major health concern. Furthermore, as the abolition of
micronutrient malnutrition remains a widespread global health problem in developing countries, the
current study suggests that increasing micronutrient intake in food through food-based approaches is
a sustainable method for the potential prevention of micronutrient deficiencies. Biofortification offers a
long-term, sustainable, food-based solution for a world population, and breeding programs may aim to
improve grain Zn and Fe concentrations; however, as previously suggested, improving Fe or Zn content
may not necessarily result in the desired outcome (i.e., breeding toward increased mineral content may
also lead to increased potential dietary inhibitors) and, hence, may not be as effective. In low-income
countries, breeding for mineral solidity may remain the only agricultural involvement available to
improve the nutritional content of staple crops, and, as suggested in the current study, the genetic
improvement of staple food crops, specifically the development of low-phytate pea verities, resulted in
improved nutritional quality and dietary Fe bioavailability, including in a complete diet context.
Additionally, as previously demonstrated, the current study presents a cost-effective approach
designed to assess the effectiveness of biofortified pea varieties in vivo, as these varieties were
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developed with an aim to reduce the inhibitory effect of dietary phytate on Fe bioavailability. Therefore,
our findings suggest that the use of lower-phytate biofortified peas may be an effective and sustainable
approach to decreasing the global abundance of Fe deficiency, with added improvements in intestinal
bacterial population structure and intestinal BBM functionality.
5. Conclusions
Nutritional approaches aimed to ease global Fe deficiency, such as Fe supplementation or
fortification, are moderately successful at achieving optimal Fe status. This study showed how
biofortified low-phytate pea affects dietary Fe bioavailability, physiological status, and the composition
and metagenome of the gut microbiota and intestinal function. Animals (Gallus gallus) that consumed
the low-phytate pea-based diets had increased abundance of beneficial bacteria, with associated
surges in SCFA-producing bacteria with known phenolic catabolic capability, which resulted in an
improvement in intestinal functionality. In addition, some of the low-phytate peas presented a higher
protein content versus the standard CDC Bronco pea, which can possibly improve Fe bioavailability
and intestinal functionality. Furthermore, parallel to preceding data, the current research suggests that
a key aspect to include is the in vivo measurement of dietary Fe bioavailability in biofortified crop
variety-based diets, as part of the plant breeding procedure.
Overall, our discoveries provide further evidence that, unlike other nutritional approaches to
improving Fe status, the low-phytate pea varieties appear to improve Fe physiological status and gut
microbiota in vivo, and they present an option for this strategy to further advance the efficacy and
safety of crop biofortification and mineral bioavailability. We recommend the application of in vivo
screening tools to guide studies aimed at developing and appraising Fe bioavailability in biofortified
food crops, as well as their possible nutritional benefit. Based on the data presented in the current
study, a human efficacy study will be conducted to compare the 4802-8-87YL (low phytate) and CDC
Bronco (standard/normal phytate) varieties, along with a no-pea control.
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Abstract: Modulation of the gut microbiome as a means to improve human health has recently
gained increasing interest. In this study, it was investigated whether cRG-I, a carrot-derived pectic
polysaccharide, enriched in rhamnogalacturonan-I (RG-I) classifies as a potential prebiotic ingredient
using novel in vitro models. First, digestion methods involving α-amylase/brush border enzymes
demonstrated the non-digestibility of cRG-I by host-derived enzymes versus digestible (starch/maltose)
and non-digestible controls (inulin). Then, a recently developed short-term (48 h) colonic incubation
strategy was applied and revealed that cRG-I fermentation increased levels of health-promoting
short-chain fatty acids (SCFA; mainly acetate and propionate) and lactate comparable but not
identical to the reference prebiotic inulin. Upon upgrading this fermentation model by inclusion of
a simulated mucosal environment while applying quantitative 16S-targeted Illumina sequencing,
cRG-I was additionally shown to specifically stimulate operational taxonomic units (OTUs) related to
health-associated species such as Bifidobacterium longum, Bifidobacterium adolescentis, Bacteroides dorei,
Bacteroides ovatus, Roseburia hominis, Faecalibacterium prausnitzii, and Eubacterium hallii. Finally, in a
novel model to assess host–microbe interactions (Caco-2/peripheral blood mononuclear cells (PBMC)
co-culture) fermented cRG-I increased barrier integrity while decreasing markers for inflammation.
In conclusion, by using novel in vitro models, cRG-I was identified as a promising prebiotic candidate
to proceed to clinical studies.
Keywords: prebiotic; microbiome; SCFA; colon; bifidobacteria; pectin; rhamnogalacturonan;
transepithelial electrical resistance (TEER)
1. Introduction
The colon contains a vast number of bacteria that largely impact human health. Next to preventing
pathogen colonization through secretion of antimicrobial agents [1–3], the gut microbiota is involved
in food processing, synthesis of essential vitamins and production of health-promoting short-chain
fatty acids (SCFA), including acetate, propionate and butyrate [4], upon anaerobic fermentation
of for instance dietary fibers [5]. While butyrate is an important energy source for colonocytes
with anti-inflammatory and intestinal barrier-protecting effects, propionate exerts anti-lipogenic and
cholesterol-lowering effects in the liver [6]. In addition, as with butyrate, propionate has been reported
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to exert anti-cancer effects in the colon [7,8]. Finally, acetate is used in the liver as a substrate for
cholesterol and fatty acid synthesis [9,10]. In terms of composition, the human gut microbiome mainly
consists of the Firmicutes, Bacteroidetes, Actinobacteria, Proteobacteria, Fusobacteria, and Verrucomicrobia
phyla [11]. Despite having provided key insights, many studies have been limited to (descriptive)
analysis of fecal samples as in situ samples from the site of fermentation are difficult to obtain. To allow
in-depth research focusing on not only luminal, but also gut wall-associated mucosal microbes, a novel
in vitro model (M-SHIME®; Mucosal Simulator of the Human Intestinal Microbial Ecosystem) was
recently developed as a complementary in vitro tool [12]. In this model, the mucosal microbiota was
enriched with butyrate-producing Clostridium cluster XIVa members, correlating with in vivo findings
from biopsies [13–18].
Modulation of the human gut microbiome as a route to improve human health has gained a lot of
interest over recent years. Prebiotics are defined as non-digestible food ingredients that selectively
stimulate health-promoting bacteria [19]. A key feature of prebiotics is their resistance to upper
gastro-intestinal digestion so that they reach the colon where they are fermented by the gut microbiome.
To assess potential digestibility of polysaccharides, two complementary enzyme sources are to be
considered, i.e., amylases [20] and brush border enzymes [21]. α-amylase is present in both saliva
and pancreatic juice and can liberate maltose from starch [20]. Furthermore, sucrase-isomaltase and
maltase-glycoamylase, collectively known as α-glucosidases, are complexes consisting of 4 enzymes
that release glucose from oligosaccharides present at the intestinal brush border [21]. These host-derived
enzymes jointly digest carbohydrates and hence their specificity determines whether carbohydrates
reach the colon and can exert prebiotic effects. Although critical to the definition of potential prebiotic
ingredients, studies confirming their indigestibility are scarce.
Fructans, such as fructooligosaccharides (FOS) and inulin are considered to be “gold standard”
prebiotics, with human clinical trials supporting their beneficial effect in acute and chronic diseases such
as obesity and type 2 diabetes (T2D), allergy, inflammatory bowel disease (IBD), Traveler’s diarrhea and
constipation (an overview is given in [19]). As many health-related species belong to the Bifidobacteriaceae,
prebiotic potential has often been related to an increase of this family. There is however increasing
understanding that prebiotics can be fermented by a wider range of gut microbes. Inulin can e.g., also
be rapidly fermented by health-promoting Bacteroidaceae members, such as Bacteroides caccae [22,23].
Currently, there is growing interest to develop novel prebiotics. A specific class of candidates includes
pectin-derived polysaccharides enriched in the branched part of pectin, i.e., the rhamnogalacturonan-I
(RG-I) domains, which can be extracted from several food crops including carrot. The backbone of
RG-I is a repeating unit of the disaccharide [-2)-α-L-rhamnose-(1,4)-α-D-galacturonic acid-(1] and
RG-I side-chains consist of galactans (β-1,4-D-galactose (D-Gal) units) and/or arabinans (α-1,5-linked
L-arabinofuranose (L-Araf) units with additional L-Araf side-chains), with varying length and
composition [24]. Given their structural complexity, RG-I extracts would require fermentation by
a consortium of gut microbes with complementary metabolic capabilities [25].
Gut microbial modulation is linked to human health with the concept of a “leaky gut” having
gained attention, not only in the context of inflammatory bowel disease, but also in a wider range of
psychological and metabolic disorders [26]. Increased intestinal epithelial permeability would allow
translocation of bacterial cell wall components, metabolites, or even whole bacteria into the systemic
circulation, hence contributing to inflammation and injury, not only in the gut but also in remote organs
such as the liver and the brain. Host–microbe interaction studies are increasingly being performed
to document this. As an example, microbial fermentation samples can be combined with a human
co-culture model [27], including intestinal epithelial cells (Caco-2) and monocytes (THP-1) [28], which
demonstrated the gut barrier protective effects together with immuno-modulatory capacity of several
prebiotics, including arabinoxylo-oligosaccharides (AXOS) [29], inulin, FOS [30] and a dried yeast
fermentate [31]. Despite its usefulness, this model has the limitation that monocytes are only one of the
cell lineages involved in the immune response. Therefore, using a co-culture model including Caco-2
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cells and peripheral blood mononuclear cells (PBMCs), containing lymphocytes (T-cells, B-cells, and
NK-cells), monocytes and dendritic cells [32], could increase the in vivo relevance.
Therefore, the present study investigated whether a carrot-derived RG-I enriched extract (cRG-I)
classifies as a potential prebiotic ingredient using a combination of novel in vitro models (Figure 1).
First, potential digestion by amylase/brush border enzymes was investigated (Test 1). Then, a recently
developed short-term colonic incubation strategy was applied [29] to assess the potential impact of cRG-I
on microbial metabolic activity including inulin as a reference (Test 2). Subsequently, after upgrading the
fermentation model by inclusion of a simulated mucosal microbiota [12], more in-depth fermentation
tests were performed to characterize the prebiotic potential of two carrot RG-I formulations that differed
in absence (cRG-I) or presence of low molecular weight carbohydrates (cRG-I+LMWC) (Test 3). To obtain
detailed insights in modulation of microbial composition, a novel technique was used where flow
cytometry was combined with 16S-targeted Illumina sequencing to obtain quantitative information at
high phylogenetic resolution [33]. Finally, fermentation samples were screened for potential beneficial
effects on gut barrier integrity and immune modulation in a newly optimized Caco-2/PBMC co-culture
model (test 4).
Figure 1. Schematic representation of the integrated in vitro approach to investigate the prebiotic
potential of cRG-I (carrot-derived rhamnogalacturonan-I). First, potential digestion of cRG-I by
amylase/brush border enzymes was investigated (Test 1). In Test 2, short-term colonic batch incubations
were used to assess the prebiotic potential on microbial metabolic activity of cRG-I compared to inulin.
In Test 3, the prebiotic potential of two formulations that differed in absence (cRG-I) or presence
of low molecular weight carbohydrates (cRG-I+LMWC) was assessed in both conventional luminal
incubations (L) and incubations including a mucosal compartment (M). Samples were collected to
evaluate the effect of the test products on microbial activity, community composition and on intestinal
permeability and immunity (Test 4, Caco-2/PBMC co-culture model).
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2. Materials and Methods
2.1. Products
The two carrot RG-I preparations used in this study (cRG-I [34] and cRG-I+LMWC) were
provided by NutriLeads (Wageningen, The Netherlands). Both are pectin-derived polysaccharides and
cRG-I+LMWC differs from cRG-I by containing small size sugars, mainly mono- and disaccharides
of galactose, glucose, and uronic acids. Pectin is a linear homogalacturonan (HG) interspaced with
branched rhamnogalacturonan (RG) regions. HG consists of α-1,4-linked D-galacturonic acid (GalA)
monomers while the RG-I backbone is a repeating unit of the disaccharide [-2)-α-L-rhamnose-1,4)-
(α-D-galacturonic acid-(1]. The RG-I backbone is decorated with galactans (β-1,4-D-galactose (D-Gal)
units) and/or arabinans (α-1,5-linked L-arabinofuranose (L-Araf) units [25]. Inulin (Orafti® HP, 100%
inulin, 0% sweetness level, average DP ≥ 23) was generously provided by Beneo GmbH (Mannheim,
Germany).
2.2. Digestion by Amylase and Brush Border Enzymes (Test 1)
Digestion with amylase was performed as described previously [20]. Briefly, cooked starch
(positive control), inulin (negative control) and cRG-I were suspended in distilled water at 15 g/L.
A stock solution of 1500U α-amylase/mL (10080, Sigma–Aldrich, Bornem, Belgium) was prepared and
added to the substrates to simulate the small intestinal phase, while respecting the ratio of units of
amylase versus amount of test product according to the Infogest consensus method (1300 units per
gram test product [20]). Samples were incubated for 60′ at 37 ◦C. Furthermore, digestion with brush
border enzymes was performed as previously described in [21]. Briefly, intestinal aceton powder from
rat (Sigma–Aldrich, Bornem, Belgium) was dissolved in 0.9% NaCl solution, vortexed, and sonicated.
15 g/L stock solutions of inulin (negative control) and maltose (positive control) were prepared in
sodium phosphate buffer (pH 7), while cRG-I was prepared in distilled water. 100 μL enzyme solution
and 50 μL substrates were mixed with 100 μL phosphate buffer and incubated for 90′ at 37 ◦C. High
Performance Anion Exchange Chromatography with Pulsed Amperometric Detection (HPAEC-PAD)
was used to measure rhamnose, arabinose, galactose, fructose, glucose, maltose, and galacturonic acid
in both digestion experiments. All tests were done in technical triplicate.
2.3. Short-Term Colonic Batch Incubations (Tests 2 and 3)
Short-term colonic incubations were performed as described in [29]. Briefly, freshly collected fecal
material of a healthy human donor (f, 26) was collected and after preparation of an anaerobic fecal slurry
inoculated at 10 vol% in a sugar-depleted nutritional medium containing 5.2 g/L K2HPO4, 16.3 g/L
KH2PO4, 2.0 g/L NaHCO3 (Chem-lab NV, Zedelgem, Belgium), 2.0 g/L Yeast Extract, 2.0 g/L pepton
(Oxoid, Aalst, Belgium), 1.0 g/L mucin (Carl Roth, Karlsruhe, Germany), 0.5 g/L L-cystein and 2.0 mL/L
Tween80 (Sigma–Aldrich, Bornem, Belgium). When mucin-coated carriers were added to the reactors
during Test 3, 1.0 g/L mucin was omitted from the nutritional medium. Five mucin-coated carriers were
added per reactor after being prepared according to Van den Abbeele et al. (2013) [12]. Test products
were dosed at 5 g/L and reactors were anaerobically incubated at 37 ◦C for 48 h. All experiments were
performed in technical triplicate.
2.4. Microbial Metabolic Activity (Tests 2 and 3)
Samples were collected upon 0 h, 6 h, 24 h, and 48 h of incubation from each colon reactor.
Gas production was measure with a pressure meter (Hand-held pressure indicator CPH6200; Wika, Echt,
The Netherlands) and pH measurements were performed with a Senseline pH meter F410 (ProSense,
Oosterhout, The Netherlands). Total SCFA were determined as the sum of acetate, propionate, butyrate
and branched-chain fatty acids (bCFA; isobutyrate, isovalerate and isocaproate) levels, and were
measured as described previously [35]. Lactate production was assessed with a commercially available
kit (R-Biopharm, Darmstadt, Germany), according to manufacturer’s instructions.
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2.5. Microbial Community Composition (Test 3)
After 48 h of incubation, samples from both lumen and mucus were collected for analysis
of the microbial community composition through quantitative polymerase chain reaction (qPCR)
and 16S-targeted Illumina sequencing. DNA was isolated as described in [36] from either 1 mL
luminal samples or 0.1 g mucus samples. Subsequently, qPCR was performed on a QuantStudio
5 Real-Time PCR system (Applied Biosystems, Foster City, CA, USA). Each sample was run in
technical triplicate and outliers with more than 1 CT difference were omitted. The qPCRs were
performed as described previously for the following groups: Lactobacillus spp. [37], Bifidobacterium
spp. and Eubacterium rectale/Clostridium coccoides [38], Akkermansia muciniphila [39], Bacteroidetes [40],
Enterobacteriaceae [41], Faecalibacterium prausnitzii [42], Roseburia and Eubacterium hallii [43]. In addition,
microbiota profiling was performed using 16S-targeted Illumina sequencing analysis (LGC genomics
GmbH, Berlin, Germany) as described in [44] to obtain proportional abundances (%) at different
phylogenetic levels (phylum, family, and operational taxonomic unit (OTU) level). Briefly, library
preparation and sequencing were performed on an Illumina MiSeq platform with v3 chemistry. The 16S
rRNA gene V3-V4 hypervariable regions were amplified using primers 341F (5′-CCT ACG GGN GGC
WGC AG-3′) and 785Rmod (5′-GAC TAC HVG GGT ATC TAA KCC-3′) [45]. As described in [46,47],
the 16S-targeted sequencing analysis was adapted from the MiSeq protocol for read assembly and
cleanup using the mothur software (v. 1.39.5) as follows: (1) reads were assembled into contigs,
(2) alignment-based quality filtering was performed by alignment to the mothur-reconstructed SILVA
SEED alignment (v. 123), (3) chimeras were removed, (4) taxonomy was assigned via a naïve Bayesian
classifier [48] and RDP release 14 [49] and (5) contigs were clustered into OTUs at 97% sequence
similarity. Sequences classified as Eukaryota, Archaea, Chloroplasts, Mitochondria, and non-classified
sequences were also removed. For each OTU, representative sequences were selected as the most
abundant sequence within that OTU. Finally, the obtained high-resolution proportional phylogenetic
information (i.e., proportional abundances (%)) was combined with an accurate quantification of total
bacterial cells via flowcytometry to obtain quantitative data at phylum, family, and OTU level. This was
done by multiplying the proportional abundances with absolute cell numbers (cells/mL) obtained
via flowcytometry. For flowcytometry analysis, 10-fold serial dilutions were prepared in Dulbecco’s
Phosphate-buffered Saline (DPBS) (Sigma–Aldrich, Bornem, Belgium) of all samples and stained with
0.01 mM SYTO24 (Life Technologies Europe, Merelbeke, Belgium) for 15′ at 37 ◦C in the dark. Samples
were analyzed on a BD Facsverse (BDBiosciences, Erembodegem, Belgium) using the high-flow-rate
setting and bacteria were separated from medium debris and signal noise by applying a threshold
level of 200 on the SYTO channel. Flowcytometry data were analyzed using FlowJo, version 10.5.2.
2.6. Caco-2/PBMC Co-Culture Model (Test 4)
Caco-2 cells (HTB-37; American Type Culture Collection) were cultured in Dulbecco’s Modified
Eagle Medium (DMEM) containing glucose and glutamine (Sigma–Aldrich, Bornem, Belgium)
and supplemented with HEPES (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid) and 20% (v/v)
heat-inactivated (HI) fetal bovine serum (FBS) (Gibco, Life Technologies Europe, Merelbeke, Belgium).
PBMCs were isolated from buffy coats of healthy donors (Red Cross, Ghent, Belgium) using
LymphoprepTM (STEMCELL technologies SARL, Grenoble, France). In brief, blood was collected and
diluted (1/5, v/v) in DPBS without Ca/Mg (Sigma–Aldrich, Bornem, Belgium). Then, LymphoprepTM
solution was added and samples were centrifuged at 1027× g for 20′ at room temperature (RT) to
separate the mononuclear cells (MNCs) and red blood cells by density-gradient centrifugation. MNCs
were collected and washed 3 times with ice-cold DPBS (340× g, 7′). Aliquots of PBMCs were frozen in
liquid nitrogen. Baseline IL-8 levels were determined by enzyme-linked immunosorbent assay (ELISA)
(Invitrogen, Thermo Fisher Scientific, Merelbeke, Belgium) to eliminate donors with high basal cytokine
levels. For experiments, Caco-2 cells were seeded on 24-well semipermeable inserts (0.4 μm pore size)
at a density of 1 × 105 cells/insert and cultured for 14 days until a functional cell monolayer with a
transepithelial electrical resistance (TEER) of more than 300 Ωcm2 was obtained. PBMCs, stimulated
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with 2.5 μg/mL pokeweed mitogen (PWM) were added to the basolateral chamber at a concentration
of 1 × 106 cells/well. PBMCs without PWM stimulation were included as negative control. At the same
time, colonic suspensions (filter-sterilized (0.22 μm) and diluted 1/5 (v/v) in culture medium) or 5 mM
sodium butyrate (NaB) (Sigma–Aldrich, Bornem, Belgium) were added to the Caco-2 cells at the apical
side. Caco-2 cells were also treated with medium as negative control. Cells were incubated for 48 h at
37 ◦C in a humidified atmosphere of air/CO2 (95:5, v/v). TEER was measured at start (0 h timepoint)
and after 48 h of incubation using a Millicell ERS2 Voltohmmeter (EMD Millipore, Sigma–Aldrich,
Bornem, Belgium). All 48 h values were normalized to their own 0 h value after subtraction of the
empty insert value and are presented as percentage of initial value. In addition, basolateral supernatant
was collected after 48 h of incubation for cytokine analysis. Human IFN-γ, IL-17A, IL-21, IL-22, IL-4,
and IL-9 levels were determined by Luminex® multiplex (Procartaplex, Invitrogen, Thermo Fisher
Scientific) and IL-10 levels were measured by ELISA (Invitrogen, Thermo Fisher Scientific), according
to the manufacturers’ instructions. All experiments were performed in triplicate.
2.7. Statistics
To evaluate differences in microbial metabolites (tests 2 and 3) and microbial community
composition at phylum level between blank and treatment incubations (Test 3), a two-way analysis of
variance (ANOVA) with Dunnett’s multiple comparisons test was performed. Statistically significant
differences between the blank and treatments are presented by (*, Δ0 h–6 h), ($, Δ6 h–24 h) or (#, Δ24
h–48 h). 1 sign = p < 0.05, 2 signs = p < 0.01, 3 signs = p < 0.001 and 4 signs = p < 0.0001. Statistical
analysis was performed with the GraphPad Prism software (version 8.3.0, San Diego, USA). To evaluate
differences in microbial community composition at family and OTU level between blank and treatment
incubations (Test 3), a Student’s t-test was performed (Excel Software). Differences were found
significant if p < 0.05. To evaluate differences between PWM+ and PWM- or NaB in the Caco-2/PBMC
co-culture assay (Test 4), an ordinary one-way ANOVA with Dunnett’s multiple comparisons test
was performed; while differences between blank and treatment incubations were assessed with an
ordinary one-way ANOVA with Tukey’s multiple comparisons test. Statistically significant differences
are presented by (*). (*) = p < 0.05, (**) = p < 0.01, (***) = p < 0.001 and (****) = p < 0.0001. Statistical
analysis was performed with the GraphPad Prism software (version 8.3.0, San Diego, USA).
3. Results
3.1. cRG-I is Resistant to Digestion in the Human Upper Gastro-Intestinal Tract (GIT) (Test 1)
One of the characteristics of a prebiotic is its non-digestibility by host enzymes upon passage along
the upper GIT [19]. First, upon exposure to amylase, the positive control cooked starch was readily
degraded into maltose, demonstrating its known digestibility (Figure 2A), while the negative control
inulin and also cRG-I were not digested to any of the simple sugars measured. Likewise, maltose was
digested by brush border enzymes into glucose (Figure 2B), in contrast to the negative control inulin
and cRG-I. Therefore, cRG-I can be considered to be a polysaccharide that likely escapes upper GIT
digestion in vivo thereby reaching the colon where it could be fermented by the gut microbiota.
3.2. Effect of cRG-I on Microbial Metabolic Activity in Short-Term Colonic Incubations (Test 2)
Short-term colonic incubations were performed to investigate the potential prebiotic effect of cRG-I
on microbial activity, including inulin as a positive control. A first indication of cRG-I fermentation
by the gut microbiota followed from the significant pH decrease and enhanced gas production
during the first 6 h of incubation (Δ0–6 h) versus the blank (Figure 3A,B). These changes were even
stronger compared to inulin. Between 6 h and 24 h, cRG-I significantly and strongly decreased pH
while increasing gas production. pH decreases and gas production were more excessive for inulin.
Finally, during the 24 h to 48 h time interval, relatively stable pH values and gas levels indicated
substrate depletion.
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Figure 2. Digestion of cRG-I (carrot-derived rhamnogalacturonan-I) by amylase (A) and brush border
enzymes (B) versus inulin, cooked starch, and maltose. Blank incubations containing all reagents in
absence of a substrate were included. Average (± st. dev.) concentrations of different monosaccharides
and maltose were measured by High Performance Anion Exchange Chromatography (HPAEC) (n = 3).
Figure 3. Effect of fermentation of cRG-I on microbial metabolic activity in short-term colonic
incubations. Average changes (± st. dev.) in pH (A), gas production (B), total short-chain fatty acids
(SCFA) (C), acetate (D), propionate (E), butyrate (F), branched CFA (bCFA) (G) and lactate (H) levels
between 0 and 6 h (light gray), 6 h and 24 h (dark gray) and 24 h and 48 h (stripes) upon dosing cRG-I
and inulin to the gut microbiota versus a blank incubation (n = 3). Statistically significant differences
between blank and treatments for different time intervals are presented by * for Δ0 h–6 h, $ for Δ6 h–24
h or # for Δ24 h–48 h. (*, $, #) = p < 0.05, (**, $$, ##) = p < 0.01, (***, $$$, ###) = p < 0.001 and (****, $$$$,
####) = p < 0.0001.
Upon measuring lactate and SCFA production, acids responsible for aforementioned pH changes
were elucidated. During the 0 h to 6 h time interval, cRG-I, but not inulin, significantly increased
the production of total SCFA (Figure 3C) which resulted from more strongly elevated acetate levels
(Figure 3D) next to significant raises in lactate production for cRG-I (Figure 3H). Furthermore, both
treatments strongly augmented total SCFA production during the 6 h to 24 h time interval (merely
due to increases in acetate and propionate (Figure 3D,E)), which were more profound for cRG-I
compared to inulin. cRG-I, unlike inulin, also stimulated butyrate production during this interval
(Figure 3F), which coincided with lactate consumption. Finally, during the 24 h to 48 h time interval,
total SCFA production only increased upon treatment with inulin, which was related to increases of
acetate, propionate, and butyrate levels, thus indicating slower fermentation of inulin versus cRG-I
(Figure 3C–F). The stimulation of butyrate by inulin between 24–48 h correlated with the consumption
of lactate during this time interval. Overall, lactate was entirely consumed at the end of the incubations,
suggesting optimal conversion to propionate and/or butyrate [50]. Finally, bCFA result from protein
fermentation by the gut microbiota [51,52], which is associated with detrimental health effects [51].
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bCFA were mainly produced during the 6 h to 48 h time frame (Figure 3G), with both cRG-I and
especially inulin significantly decreasing bCFA production.
3.3. Effect of cRG-I and cRG-I +LMWC on Microbial Metabolic Activity in Short-Term Colonic Incubations
with or without a Mucosal Compartment (Test 3)
An in-depth characterization of the effects of cRG-I on microbial metabolic activity (Figure 4A–H)
was performed by testing both cRG-I and a modified formulation containing small sugars (cRG-I
+LMWC), dosed to colonic incubations including solely a luminal (L) or additionally also a mucosal
(M) environment. In consistency with Test 2, cRG-I significantly decreased the pH during the first
6 h of incubation versus the blank due to enhanced acetate and lactate levels. Furthermore, the main
fermentation occurred between 6 h and 24 h with strong increases in gas production and further
decreases of pH due to stimulation of acetate, propionate, and to a lesser extent butyrate. The latter
could again be linked to coinciding lactate consumption. Finally, the absence of marked changes of
aforementioned parameters between 24 h and 48 h again indicated substrate depletion, while bCFA
were significantly decreased thus illustrating the potential protective effects of cRG-I against toxic
by-products of proteolytic fermentation.
cRG-I+LMWC exerted similar effects on microbial activity versus cRG-I with some minor
differences. These included a more profound pH decrease for cRG-I+LMWC during the first 6 h of
incubation due to enhanced acetate and lactate levels. Furthermore, acetate and propionate production
between 6–24 h was less strongly increased with cRG-I+LMWC compared to cRG-I.
Overall, while no major differences were observed between incubations with or without mucosal
environment, inclusion of mucus beads led to a tendency to higher gas production, with higher
butyrate levels for the blank incubation, suggesting colonization of butyrate-producing bacteria on the
mucin-coated carriers.
3.4. Effect of cRG-I and cRG-I +LMWC on Microbial Community Composition in Short-Term Colonic
Incubations with or without a Mucosal Compartment (Test 3)
The data at phylum level are presented both as proportional (Figure 5A) and absolute values
(Figure 5B). This demonstrated that for the luminal microbiota, quantitative data revealed greater
insight in the true compositional changes since both cRG-I and cRG-I+LMWC largely increased total
cell numbers. In contrast, due to the large variation in total cell numbers within identical replicates for
the mucosal microbiota resulting in large variations of quantitative numbers, proportional abundances
were preferred to draw conclusions on modulation of the mucosal microbiota. Therefore, abundances
at the family level are presented as absolute data for the luminal microbiota, whereas they are presented
as proportional values for the mucosal compartment (Table 1). Furthermore, proportional abundance
of the 25 most abundant OTUs and 7 additional OTUs affected by at least one of the treatments are
shown in Supplementary Table S1 to get insights at the highest phylogenetic resolution possible.
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Figure 4. Effect of fermentation of cRG-I and cRG-I+LMWC on microbial metabolic activity in
short-term colonic batch simulations in absence or presence of a mucosal compartment. Average
changes (± st. dev.) in pH (A), gas production (B), total short-chain fatty acids (SCFA) (C), acetate (D),
propionate (E), butyrate (F), branched CFA (bCFA) (G) and lactate (H) levels between 0 and 6 h (light
gray), 6 h and 24 h (dark gray) and 24 h and 48 h (stripes) upon dosing cRG-I and cRG-I + LMWC to
the gut microbiota versus a blank incubation (n = 3). Statistically significant differences between the
blank and treatments for different time intervals are presented by * for Δ0 h–6 h, $ for Δ6 h–24 h or # for
Δ24 h–48 h). (*, $, #) = p < 0.05, (**, $$, ##) = p < 0.01, (***, $$$, ###) = p < 0.001 and (****, $$$$, ####) =
p < 0.0001. L = colonic incubations only simulating lumen; M = incubations simulating both lumen
and mucus.
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Figure 5. Effect of fermentation of cRG-I and cRG-I+LMWC on microbial community composition
at phylum level in short-term colonic incubations in absence or presence of a mucosal compartment.
Average (± st. dev.) proportional (%) (A) and absolute (16S gene copies/mL) (B) abundance of the
different phyla in the original (diluted) inoculum (INO) and after 48 h of incubation upon dosing of
cRG-I and cRG-I+LMWC versus a blank control (n = 3). Statistically significant differences between the
blank and treatments are presented by *. (*) = p < 0.05, (**) = p < 0.01, (***) = p < 0.001 and (****) =
p < 0.0001. L = colonic incubations only simulating lumen; M = incubations simulating both lumen
and mucus.
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First, upon comparing the luminal and mucosal microbiota, it followed that the Firmicutes phylum
was enriched in the mucosal compartment, while Actinobacteria, Proteobacteria and Verrucomicrobia
were enriched in the lumen (Figure 5A), in accordance to what has been published for the M-SHIME®
model [12]. At family level, the mucosal Firmicutes enrichment was due to a marked enrichment in
Clostridiaceae cluster I and Lachnospiraceae (Table 1). At OTU level, this was reflected by an enrichment
of OTU14 (related to Clostridium butyricum), OTU10 (related to Clostridium tertium), OTU8 (related
to Clostridium paraputrificum), OTU12 (related to Ruminococcus torques), OTU3 (related to Roseburia
hominis) and OTU19 (related to Ruminococcus lactaris) (Table S1). Furthermore, the decreased mucosal
levels of Actinobacteria, Proteobacteria and Verrucomicrobia were solely related to a decreased mucosal
colonization of members of the Eggerthellaceae, Enterobacteriaceae, and Akkermansiaceae. Another overall
finding of the in vitro model was that the luminal microbiota of blank incubations in absence and
presence of a mucosal environment were highly similar. The introduction of mucin beads only resulted
in an enrichment of the luminal Verrucomicrobia levels (Figure 5A,B). At family level, this was due to an
increased luminal abundance of Akkermansiaceae (+0.55 log copies/mL) (Table 1).
With respect to treatment effects in the lumen, cRG-I and cRG-I+LMWC both increased the absolute
levels of Actinobacteria, Bacteroidetes and Proteobacteria compared to the blank (Figure 5B). Although
the increase of Actinobacteria and Bacteroidetes was strongest for cRG-I, the increase in Proteobacteria
was strongest for cRG-I+LMWC. cRG-I additionally increased luminal Firmicutes levels. The luminal
increase in Actinobacteria by cRG-I was due to a significant increase of OTUs related to Bifidobacterium
longum (OTU7) and Bifidobacterium adolescentis (OTU21) (Table S1), thus also strongly increasing
Bifidobacteriaceae levels upon cRG-I treatment (Table 1). Furthermore, cRG-I also stimulated mucosal
Bifidobacteriaceae, mostly due to the stimulation of the Bifidobacterium longum-related OTU7. The luminal
Bacteroidetes increase upon treatment with both products was due to the stimulation of the Bacteroidaceae
and Prevotellaceae families, with again the highest levels being reached for cRG-I. At OTU level, a wide
spectrum of Bacteroidaceae members were stimulated upon dosing both cRG-I and cRG-I+LMWC,
including OTUs related to B. ovatus (OTU22), B. plebeius (OTU6), B. xylanisolvens (OTU18) and especially
B. dorei (OTU2). As a remark, a decrease in abundances of OTUs related to B. caccae (OTU13), B. fragilis
(OTU11) and B. uniformis (OTU17) upon cRG-I and cRG-I+LMWC treatment was noted, but these
decreases were less profound compared to observed increases in other OTUs. The increased abundance
in Proteobacteria related to an enrichment of Desulfovibrionaceae and Enterobacteriaceae, which was most
pronounced upon dosing of cRG-I+LMWC. Finally, the luminal increase in Firmicutes with cRG-I and
cRG-I+LMWC was due to increased levels of Erysipelotrichaceae, Peptostreptococcaceae, Streptococcacae,
Ruminococcaceae, and Veillonellaceae. The enrichment in Streptococcacae was most pronounced upon
dosing cRG-I+LMWC and linked to an increase in OTU26 (related to Streptococcus aginosus). In contrast,
the increase in Veillonellaceae was more pronounced upon dosing of cRG-I and was attributed to an
increase in OTU9 (related to Dialister succinatiphilus). Within the Ruminococcaceae, two OTUs related
to Faecalibacterium prausnitzii (i.e., OTU83 and OTU5) increased upon cRG-I, while only OTU5 was
stimulated by cRG-I+LMWC and this to a lesser extent.
In the mucosal compartment, both treatments slightly increased Firmicutes, while decreasing
Bacteroidetes levels (Figure 5A). Both cRG-I and cRG-I+LMWC strongly enriched Lachnospiraceae
(Table 1), due to a marked stimulation of OTU3 (related to Roseburia hominis) that increased from 9.8%
in the blank control incubations to 64.3% and 74.2%, respectively (Table S1). Although both treatments
also significantly increased the proportion of Streptococcacae in the mucosal environment, only cRG-I
increased mucosal Actinobacteria abundances.
To confirm several of the above-mentioned observations obtained through 16S-targeted Illumina
sequencing, qPCRs on specific bacterial groups of interest were performed (Supplementary Table S2).
This confirmed the key aforementioned conclusions obtained through 16S-targeted Illumina sequencing
including that both cRG-I and cRG-I+LMWC stimulated levels of (i) luminal/mucosal Bifidobacteriaceae
(and not Lactobacillaceae); (ii) luminal Bacteroidetes; (iii) luminal Faecalibacterium prausnitzii; (iv) mucosal
Roseburia (and Eubacterium rectale/Clostridium coccoides group to which it belongs); while not affecting
84
Nutrients 2020, 12, 1917
Akkermansia muciniphila. In addition, both products, but mostly cRG-I+LMWC, increased colonization
of Eubacterium hallii in the simulated mucus layer.
3.5. Effect of Fermented cRG-I on Intestinal Epithelial Barrier (Test 4)
As cRG-I fermentation enriched several health-associated species and increased production of
SCFA, it might exert favorable effects at the host level. To address this question, a Caco-2/PBMC
co-culture model was developed. Inflammation-induced barrier disruption was obtained upon 48 h
co-culturing of Caco-2 cells with PWM-activated PBMCs and measured as a significant decrease in
TEER of the Caco-2 monolayers (Figure S1A). In addition, apical treatment with the positive control
sodium butyrate (NaB) prevented this TEER decrease. Likewise, apical treatment with fermented cRG-I
showed a significant increase in TEER compared to the blank controls (Figure 6A). Furthermore, effects
on T-cell dependent cytokine production were assessed. As shown in Figure S1, NaB significantly
decreased the secretion of interferon (IFN)γ, interleukin (IL)-17A, IL-21, IL-4, and IL-9; while increasing
the secretion of IL-22; a cytokine involved in maintenance of barrier integrity, wound healing and
antimicrobial responses [53]. However, in contrast to its positive effects on IL-10 secretion in the
Caco-2/THP1 co-culture assay [29], NaB significantly decreased IL-10 secretion possibly due to toxicity
of NaB on IL-10 producing cells at the concentration used [54,55]. Compared to the blank control,
fermented cRG-I reduced the secretion of IL-17A, IL-4, and IL-9; reaching statistical significance
for IL-17A and IL-4 upon luminal incubations and upon both incubations for IL-9 (Figure 6D,F,G).
Furthermore, luminal fermentation of cRG-I tended to increase the secretion of IL-22 and IL-10; of which
the latter was already increased upon treatment with the blank controls (Figure 6E,H). In addition,
all colonic suspensions completely abolished PWM-induced IL-21 secretion (Figure 6C); while no
significant differences were observed on IFNγ secretion (Figure 6B). Hence, metabolites generated
from colonic fermentation of cRG-I displayed anti-inflammatory and gut barrier protective properties.
Figure 6. Effect of fermented cRG-I on transepithelial electrical resistance (TEER) and cytokine
production in a Caco-2/PBMC co-culture system. Caco-2 cells, cultured 14 days on transwell inserts,
were placed on top of pokeweed mitogen (PWM)-activated PBMCs and incubated for 48 h at the apical
side with blank or treatment samples collected during the colonic batch incubations containing only
a luminal (L) or also a mucosal (M) environment. Average (±SEM) TEER of the Caco-2 monolayers
(A) and concentration of secreted interferon (IFN)γ (B), interleukin (IL)-17A (C), IL-21 (D), IL-22 (E),
IL-4 (F), IL-9 (G) and IL-10 (H) in the basolateral medium are shown (n = 3). Statistically significant
differences to PWM are represented by (*). (*) = p < 0.05, (**) = p < 0.01, (***) = p < 0.001.
Overall, some minor effects of the incorporation of a mucosal compartment were observed as
both blank and treatment colonic suspensions slightly increased TEER; while decreased the secretion
of all tested cytokines compared to luminal suspensions (Figure 6).
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4. Discussion
In the current study, novel in vitro models and analytical techniques were implemented to
investigate whether cRG-I classifies as a potential prebiotic ingredient. First, upon exposure to
α-amylase and brush border enzymes (Test 1), unlike the positive controls (cooked starch and maltose,
respectively), cRG-I (like the negative control inulin) was not digested to any of the simple sugars
measured. This suggests that cRG-I can be considered to be a polysaccharide that likely escapes upper
GIT digestion in vivo, thus fulfilling the definition of a prebiotic ingredient that should reach the colon
where it could be fermented by the gut microbiota. Secondly, a recently described short-term colonic
incubation strategy [29] was upgraded with a simulation of the mucosal microbiota (Test 3). By applying
a novel technique to analyze the microbial community composition, i.e., quantitative 16S-targeted
Illumina sequencing [33], in-depth quantitative information was obtained at high phylogenetic
resolution. Besides elucidating treatment effects of cRG-I, this allowed to validate the implementation
of mucin-coated carriers in the short-term incubations by demonstrating a relevant species-specific
colonization of the mucosal environment. Indeed, consistent with the well-established long-term
M-SHIME® model [12], a wide spectrum of (potential butyrate-producing) Firmicutes members
specifically colonized the mucosal environment (e.g., OTUs related to Clostridium butyricum and
Roseburia hominis). Furthermore, inclusion of the mucosal environment did not alter the luminal
microbiota (except for a minor enrichment in Akkermansiaceae), nor did it alter the treatment effects
towards luminal microbiota activity and community composition. Overall, including the mucin beads
in the current colonic simulations allowed to maintain a higher diversity, thus allowing observation of
more complete treatment effects of cRG-I. Finally, application of a model combining gut epithelial and
immune cells allowed to point out the gut protective effect of cRG-I fermentation-derived metabolites
against an inflammatory stressor (Test 4).
In a first series of short-term colonic incubations (Test 2), cRG-I was found to display prebiotic
potential comparable but not identical to that of inulin in modulating microbial activity [19], as followed
from increases in health-promoting SCFA (acetate and propionate) and lactate and decreases of bCFA.
A side effect of inulin fermentation is the production of high amounts of gas that has been observed
in in vitro experiments and clinical studies. Depending on the dose, this can result in mild negative
gastro-intestinal symptoms [56–58]. Interestingly, gas production upon dosing of cRG-I was milder
compared to inulin, which suggests that in vivo consumption of cRG-I could be less accompanied by
adverse side-effects such as bloating and abdominal pain.
Upon fermentation in both short-term colonic incubations (Tests 2/3), cRG-I stimulated acetate,
and lactate production which was accompanied with a strong reduction in pH. At community level,
this correlated with increases in OTUs related to Bifidobacterium longum (OTU7) and Bifidobacterium
adolescentis (OTU21). Bifidobacteriaceae are indeed key acetate and lactate producers [59,60]. Although
health effects are to be considered strain-specific, multiple Bifidobacterium strains have been associated
with beneficial effects on the host health and some strains are widely used as probiotics. A first
mechanism by which Bifidobacteriaceae contribute to health is by indirectly promoting butyrate
production via cross-feeding mechanisms involving for instance Faecalibacterium prausnitzii and
Eubacterium hallii [59,61,62], taxa of which related OTUs were indeed found to be increased upon cRG-I
treatment in the current study. In addition, acetate produced by bifidobacteria was also shown to
play a key role in their anti-infectious properties against enteropathogens [63]. In terms of host effects,
a specific B. longum strain has e.g., been shown to exert protective effects in a DSS-induced colitis
model in mice by reducing inflammation and enhancing the intestinal epithelial barrier [64]. Moreover,
a specific B. longum strain reduced chronic mucosal inflammation in ulcerative colitis (UC) patients in
a double-blinded, randomized-controlled clinical trial [65]. Likewise, a specific B. adolescentis strain
protected mice from DSS-induced colitis by increasing IL-10 levels, up-regulation of regulatory T-cells
(Treg) and decreasing IL-17A positive T-cells [66]. The strong bifidogenic effect exerted by cRG-I thus
supports the prebiotic potential of this novel food ingredient.
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Next to acetate and lactate, fermentation of cRG-I increased the production of propionate, which
correlated with a stimulation of Prevotellaceae and Bacteroidaceae due to the stimulation of a wide spectrum
of Bacteroidaceae OTUs related to e.g., B. ovatus, B. plebeius, B. xylanisolvens and especially B. dorei. Indeed,
Bacteriodetes spp. are known primary fiber degraders that are capable of producing propionate [50].
In the colon, health-related effects of propionate are related to anti-cancer effects [7,8]. Furthermore,
propionate was shown to exert anti-lipogenic and cholesterol-lowering effects in the liver [6]. Finally,
propionate is a satiety-inducing agent affecting energy intake and feeding behavior [67]. Besides the
beneficial effects of propionate, the aforementioned stimulations of specific Bacteroidaceae members
have also been related to particular health benefits. As an example, in a mouse model of atherosclerosis,
B. dorei reduced plaque inflammation and decreased intestinal epithelial permeability and systemic
endotoxemia [68]. Furthermore, B. ovatus reduced mucosal inflammation and stimulated epithelial
proliferation and mucin production in a DSS-induced colitis model in mice [69]. Another microbial
modulation that could have boosted propionate production upon cRG-I treatment was the increase
in Veillonellaceae that was solely attributed to an increase in OTU9 (related to Dialister succinatiphilus).
Interestingly, D. succinatiphilus is a succinate-converting, propionate-producing species [70] and as
many Bacteroidetes spp. are known succinate producers [50], its increase might have contributed to the
stronger increase in propionate levels upon dosing of cRG-I. As a final remark, not all Bacteroidaceae
members increased upon cRG-I treatment, with OTUs relating to B. caccae and B. fragilis decreasing in
abundance upon cRG-I treatment. These species are considered to be opportunistic pathogens carrying
virulence factors: enterotoxigenic B. fragilis strains secrete the B. fragilis toxin (BFT) [71] and B. caccae
contains the ompW gene [72]. Besides its strong bifidogenic effect, cRG-I could further exert health
benefits by targeted modulation of specific propionate-producing taxa.
In contrast to propionate, butyrate was not significantly increased upon dosing of cRG-I. However,
cRG-I did strongly stimulate Lachnospiraceae, containing several butyrate-producing species, in the
mucosal compartment. The increase in Lachnospiraceae was related to a strong stimulation of an OTU
related to Roseburia hominis, which has been associated with beneficial effects on barrier function and
immune regulation in the gut [73]. Indeed, R. hominis showed protective effects in a DSS-model for
colitis in mice by reducing pro-inflammatory cytokine expression. Moreover, increased Treg levels were
observed in both germ-free and conventional mice fed a supplement containing live R. hominis. Also,
a significant reduction of R. hominis and F. prausnitzii was observed in UC and Crohn’s disease (CD)
patients [74,75]. Interestingly, cRG-I increased the abundance of OTUs related to butyrate-producing
species such as F. prausnitzii and Eubacterium hallii. Like R. hominis, F. prausnitzii was shown to
exert anti-inflammatory potential by increasing IL-10 and promoting Treg differentiation in mice [76].
On the other hand, E. hallii improved insulin sensitivity in a mouse model for diabetes [77]. Of note,
discrepancy between the stimulation of butyrate producers in the mucosal environment with cRG-I
versus the absence of treatment effects on butyrate levels might be explained by the fact that the biofilm
which develops on the mucin-coated carriers during short-term colonic incubations (48 h) is still
developing during cRG-I treatment. Hence, by the time the biofilm is developed (48 h), all substrate
has been consumed (in fact already after 24 h). This may potentially limit the detection of treatment
effects resulting from modulation of mucosal microbes on metabolic activity (particularly butyrate
production) during short-term incubations. Therefore, testing the impact of cRG-I in a long-term
M-SHIME® study could further elucidate the potential impact of cRG-I on butyrate production.
The stimulation of several health-related microbial species and the concomitant increase in
health-promoting metabolites suggested that cRG-I may display interesting host beneficial properties
in terms of intestinal barrier protection and reduction of inflammation. This hypothesis was confirmed
using a Caco-2/PBMC co-culture model in which treatment with fermented cRG-I significantly
increased the TEER, indicative for the protective effects of fermentation-derived cRG-I metabolites
on inflammation-induced intestinal permeability. To further strengthen this observation, it would be
interesting to perform in-depth analysis of the expression and localization of tight junction proteins
including occludin, ZO-1, and claudins upon cRG-I treatment in this system. Furthermore, fermented
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cRG-I metabolites decreased the secretion of the pro-inflammatory cytokines IL-17A, IL-4, and IL-9,
while increasing the secretion of IL-22 and of the anti-inflammatory IL-10. This is suggestive of a possible
immunoregulatory effect of cRG-I metabolites on the Treg/TH17 axis; favoring down-regulation of
excessive inflammation as IL-10 is necessary for Treg functions [78]. Th17 cells have a dual role in
human health as although required for clearance of extracellular pathogens, an elevated frequency of
Th17 cells associated with impaired Treg functions has been reported in IBD and other extraintestinal
autoimmune disorders [79]. Furthermore, IL-22 plays a role in maintaining the integrity of the mucosal
barrier by promoting wound healing and activating antimicrobial responses [53]. Finally, increased
levels of IL-4 and IL-9 were associated with UC [80,81]. In addition, IL-9 inhibits wound healing in the
intestinal mucosa and impairs intestinal epithelial barrier functions. Also, IL-9 directly regulates tissue
recruitment and inflammatory functions of mast cells. Together, these data suggest an interesting
immuno-modulatory role of cRG-I metabolites in the gut in terms of increasing barrier tightness and
prevention of a “leaky gut”.
Finally, a modified formulation of cRG-I was tested which contained small size sugars, i.e.,
cRG-I+LMWC. Interestingly, the short-term colonic incubation strategy applied in this study was
highly sensitive to pick up differences in closely related product compositions. For instance, the presence
of these simple sugars resulted in a stronger initial pH decrease upon dosing of cRG-I+LMWC, related
to an initial increased production of lactate, which could be linked to a stronger enrichment in
a Streptococcacae OTU related to Streptococcus aginosus. Also, Enterobacteriaceae levels were higher
upon cRG-I+LMWC treatment. Like Streptococcaceae, Enterobacteriaceae are expert fermenters of
simple sugars [82], specifically present at higher levels in this preparation. Finally, Coriobacteriaceae
(OTU15 related to Collinsella aerofaciens) and Desulfovibrionaceae tended to be higher in incubations with
cRG-I+LMWC. This suggested a potential co-existence of e.g., C. aerofaciens and Desulfovibrio piger,
based on the fact that the main products of C. aerofaciens fermentation (i.e., lactate, H2, and formate)
serve as substrates for D. piger, which is the main sulfate-reducing bacterial species in the human
gut microbiome [83]. This might also indicate that cRG-I+LMWC might contain small quantities of
sulfur (sulfate or sulfur-containing amino acids). These data altogether stress the relevance of testing
prebiotic candidates in short-term colonic in vitro incubations to understand their potential impact on
the human gut microbiome and to support structure-function studies.
In conclusion, the implementation of novel in vitro models simulating the human colonic
environment coupled to cell-based assays mimicking the host gut barrier, allowed to establish the
prebiotic potential of cRG-I. This novel fiber is not digested by host enzymes characteristic of the upper
gastro-intestinal tract but rapidly fermented by the human colonic microbiota leading to selective
stimulation of the growth and activity of intestinal bacterial species associated with human health.
cRG-I displays unique properties as it was fermented more rapidly than inulin leading to production
of SCFA, especially acetate and propionate, and less gas than inulin. It increases the abundance of
several bacterial species reputed for their “anti-inflammatory” profile. In line with this, the metabolites
resulting from cRG-I fermentation exhibited a protective effect in an in vitro model of inflamed gut
barrier. Overall, the data obtained during this study support future research to further investigate
this novel prebiotic candidate in long-term SHIME® models with different fecal sample donors and in
clinical trials to confirm the beneficial effect of cRG-I on the microbiota and its impact on human health.
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Abstract: Background: Prebiotics used as a dietary supplement, stimulate health-related gut
microbiota (e.g., bifidobacteria, lactobacilli, etc.). This study evaluated potential prebiotic effects
of an artichoke aqueous dry extract (AADE) using in vitro gut model based on the Simulator of
Human Intestinal Microbial Ecosystem (SHIME®). Methods: Short-term colonic fermentations (48 h)
of AADE, fructo-oligosaccharides (FOS), and a blank were performed. Microbial metabolites were
assessed at 0, 6, 24, and 48 h of colonic incubation via measuring pH, gas pressure, lactate, ammonium,
and short-chain fatty acids (SCFAs) levels. Community composition was assessed via targeted qPCRs.
Results: After 24 and 48 h of incubation, bifidobacteria levels increased 25-fold with AADE (p < 0.05)
and >100-fold with FOS (p < 0.05) compared to blank. Lactobacillus spp. levels only tended to increase
with AADE, whereas they increased 10-fold with FOS. At 6 h, pH decreased with AADE and FOS and
remained stable until 48 h; however, gas pressure increased significantly till the end of study. Acetate,
propionate, and total SCFA production increased significantly with both at all time-points. Lactate
levels initially increased but branched SCFA and ammonium levels remained low till 48 h. Conclusion:
AADE displayed prebiotic potential by exerting bifidogenic effects that stimulated production of
health-related microbial metabolites, which is potentially due to inulin in AADE.
Keywords: bifidobacteria; colon; fermentation; microbiota; prebiotic; SHIME®; artichoke
1. Introduction
Human gut microbiota consist of over 35,000 bacterial strains, encompassing beneficial
and pathogenic species; however, the predominance of positively affecting microbes ensure
our well-being [1]. Human gut microbiota are dominated by two main phyla, Firmicutes
(including Lactobacillus spp.) and Bacteroidetes that are susceptible to alterations. Other phyla
are Actinobacteria (including Bifidobacterium spp.), Proteobacteria, Fusobacteria, and Verrucomicrobia.
Spatial and temporal discrepancies in gut microbial distribution contribute toward specific metabolic,
immunological, and gut-protective functions throughout an individual’s life span [2,3]. Characterization
of such discrepancies can help identify gut-related abnormalities and play an important role in ensuring
good health [4].
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Prebiotics were first defined as, “Nondigestible food ingredients that beneficially affect a host by
selectively stimulating growth and/or activity of one or a limited number of bacteria in the colon that
are recognized to improve host health” [5]. Dysbiosis of microbial populations has been postulated as
one of the reasons for metabolic disorders such as obesity, type 2 diabetes, and nonalcoholic fatty liver
diseases. As prebiotics alter microbiota positively, their use as dietary supplements could effectively
improve overall host health [6]. Fructo-oligosaccharides (FOS) are prebiotics that are plant-derived,
naturally occurring oligosaccharides, indigestible by human enzymes, and can thus reach the colon
unaltered [7]. Daily intake of FOS can increase bifidobacteria counts, a member of the indigenous
gut microbiota. However, certain individuals are more sensitive to effects of FOS and suffer side
effects such as itching in the throat; puffiness in the eyes, face, and mouth; dizziness; light headedness;
fainting; gas; bloating; and itching of the skin [8,9].
There is a constant need for new prebiotics that can target specific bacterial species and most
approaches have focused on non-digestible oligosaccharides, such as galacto-oligosaccharides,
soya-oligosaccharides, isomaltooligosaccharides, gluco-oligosaccharides, xylo-oligosaccharides,
lacto-sucrose, and inulin-type fructans. However, they are known to have varied prebiotic potential.
Inulin has been demonstrated to positively alter gut microbiota in a dose range of 4 to 40 g/d [10–16].
Whole food sources, such as artichoke (Cynara scolymus L.), chicory (Cichorium intybus) roots, and
garlic (Allium sativum) are rich in inulin and dietary fibers. Inulin from artichoke is recognized
to have the highest degree of polymerization known in plants. Degree of polymerization directly
contributes to prebiotic effects and persistence in the colon [17]. Inulin promotes host health by
positively altering the bacterial metabolites mediated via stimulation of different metabolic pathways
within the gut microbial community. Acetate, propionate, and butyrate are the most crucial metabolites.
By acidifying the colonic environment, short-chain fatty acids (SCFA) promote growth of beneficial
bacteria such as bifidobacteria and lactobacilli, which inhibit the growth of pathogenic bacteria [18].
Additionally, bifidobacteria and lactobacilli exert immunomodulatory activity that contributes to the
host defense [19]. Prebiotic potential of artichoke has been demonstrated in several clinical studies and
the effect was mainly mediated via increase in Bifidobacterium spp. in the gut [20,21]. In addition to
inulin, artichoke contains polyphenols, such as dicaffeoylquinic acids and flavonoids, which provide
additional nutritional values proposing a novel holistic approach to whole digestive health [22,23].
In the present study, we aimed to evaluate the prebiotic effects of artichoke aqueous dry extract
(AADE) through an in vitro approach of highly controlled conditions using short-term colonic
incubations based on the Simulator of Human Intestinal Microbial Ecosystem (SHIME®) model [18].
In vitro models offer certain advantages, first they allow dynamic monitoring of gut microbiome at
the site of fermentation under a controlled environment and second, in vitro models help avoid large
variability that arise during in vivo evaluations owing to host-derived factors such as amount of food
intake, immune system, enzyme levels, or transit time. Lastly, using molecular detection methods,
microbial changes can be evaluated in detail. Artichoke aqueous dry extract is a standardized herbal
powder extract prepared from the edible part of artichoke (Cynara scolymus L.); cultivated in Spain,
and extracted by the Pure-Hydro Process™ using only water (instead of organic solvents), AADE can
be safely used in foods and food supplements.
2. Materials and Methods
2.1. Chemicals and Reagents
All chemicals were obtained from Sigma-Aldrich (Overijse, Belgium), unless stated otherwise.
The test product AADE, also known as Cynamed™, was provided by Euromed S.A. (Mollet del
Valles, Barcelona, Spain). It is derived from the edible part of the artichoke plant (Cynara scolymus L.)
cultivated in Mediterranean regions of Spain. The AADE was prepared in accordance with the
European Pharmacopoeia monograph extracts (Extracta) (No. 0765) using a proprietary water-based
extraction process [24]. This process starts with the milling of dried Artichoke immature edible
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inflorescences that are extracted with ultrapure water at a temperature between 80 ◦C and 90 ◦C. The
miscella of extract is filtered until transparency and concentrated under vacuum until a soft paste
is obtained that is subsequently dried in a vacuum belt dryer and finally milled to a fine powder.
The AADE used in the current study has an exact content of 9.1% caffeoylquinic acids expressed as
chlorogenic acid by HPLC and an exact content of 32.2% inulin determined by HPLC. As a nutritional
analysis of the AADE, the amount of total carbohydrates is 77% and the amount of protein 8.1% with
a negligible content of fat. The FOS preparation used as a positive control in the current study had
a purity of 89% FOS with 8% sugar residues. While the degree of polymerization of the ingredient
varied between 2 and 10, it was on average 4.
2.2. Short-Term Colonic Fermentation
Short-term colonic fermentations were performed as described recently [18]. Briefly, colonic
background medium containing 5.2 g/L K2HPO4, 16.3 g/L KH2PO4, 2.0 g/L NaHCO3 (Chem-lab NV,
Zedelgem, Belgium), 2.0 g/L Yeast Extract, 2.0 g/L pepton (Oxoid, Aalst, Belgium), 1.0 g/L mucin (Carl
Roth, Karlsruhe, Germany), 0.5 g/L L-cystein, and 2.0 mL/L Tween80 (Sigma-Aldrich, Bornem, Belgium)
was added to incubation reactors (90 vol%), already containing the correct amount of the test products
for obtaining a final concentration of 0 g/L (Blank) or 5 g/L (for both AADE and FOS), respectively.
The reactors were sealed and anaerobiosis was obtained by flushing with N2. Subsequently, fresh
fecal material of a healthy human donor (no history of antibiotic use in the six months preceding the
study) was collected (according to the ethical approval of the University Hospital Ghent with reference
number B670201836585; 06/08/2018). After preparation of an anaerobic fecal slurry, this was inoculated
at 10 vol% in the aforementioned medium. All incubations were performed in biological triplicate for
48 h at 37 ◦C under anaerobic conditions with continuous shaking (90 rpm).
2.3. Microbial Metabolic Activity Analysis
Microbial metabolic analyses were performed on samples collected at 0, 6, 24, and 48 h of colonic
incubation and levels of pH (Senseline F410; ProSense, Oosterhout, The Netherlands), gas pressure
(hand-held pressure indicator CPH6200; Wika, Echt, The Netherlands), lactate, ammonium, and
short-chain fatty acids (SCFAs) were measured. Acetate, propionate, butyrate, and branched CFAs
(BCFAs) (isobutyrate, isovalerate, and isocaproate) were quantified as described by De Weirdt et al. [25]
via GC-FID after performing a diethyl ether extraction. Lactate determination was performed
using a commercially available enzymatic assay kit (R-Biopharm, Darmstadt, Germany) as per the
manufacturer’s instructions. Ammonium analysis was performed using a KjelMaster K-375 device
(Büchi, Hendrik-Ido-Ambacht, The Netherlands), wherein ammonium in the sample was liberated as
ammonia by addition of 32% NaOH. The released ammonia was then distilled from the sample into a
2% boric acid solution and was titrimetrically determined with a 0.02 M HCl solution.
2.4. Microbial Community Analysis
At the start of colonic incubation and after 24 and 48 h, samples were collected for microbial
community analysis. DNA was isolated using the protocol as described by Vilchez-Vargas et al. [26],
starting from pelleted cells originating from 1 mL luminal sample. Subsequently, quantitative
polymerase chain reaction (qPCR) assays for Bacteroidetes, Firmicutes, Lactobacillus spp. (Firmicutes
phylum), Bifidobacterium spp. (Actinobacteria phylum), and Akkermansia muciniphila (Verrucomicrobia
phylum) were performed using a StepOnePlus™ real-time PCR system (Applied Biosystems, Foster City,
CA, USA). Each sample was analyzed in triplicate. Standard curves for all the different runs had
efficiencies between 90–105%. All protocols were initiated for 10 min at 95 ◦C and terminated with a
melting curve from 60 ◦C to 95 ◦C. Cycling programs included 40 cycles with a denaturation step of
15 s at 95 ◦C, an annealing step of 30 s at 60 ◦C, and an elongation step of 30 s at 72 ◦C in each cycle.
Descriptions of primers used are presented in Table 1.
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Table 1. Primers used for quantitative polymerase chain reaction (qPCR) quantification of
species-specific 16S rDNA.





Lactobacillus spp. [20] AGCAGTAGGGAATCTTCCA
CGCCACTGGTGTTCYTCCATATA
Bifidobacterium spp. [28] TCGCGTCYGGTGTGAAAG
CCACATCCAGCYTCCAC
Akkermansia muciniphila [29] CAGCACGTGAAGGTGGGGAC
CCTTGCGGTTGGCTTCAGAT
Besides presenting the absolute levels of the different groups, the ratio between the obtained
levels at 24 h and 48 h versus 0 h were calculated for the blank, AADE, and FOS-treated microbiota.
2.5. Statistics
To evaluate differences in microbial metabolites and microbial community composition between
blank and treatment incubations at the different time points, a two-way ANOVA with Tukey multiple
comparisons test was performed. Differences were found significant if p < 0.05. Statistical analysis was
performed with the GraphPad Prism software (version 8.3.0, San Diego, USA).
3. Results
3.1. Microbial Composition
While the absolute levels of each of the five targeted microbial groups (Bifidobacterium spp.,
Lactobacillus spp., Bacteroidetes, Firmicutes, and Akkermansia muciniphila) at each of the three time
points (0/6/48 h) are presented in Table 2, the factor increase versus 0 h is presented in Figure 1 for
the four microbial groups for which there were significant changes between the treatments (all except
Akkermansia muciniphila). First, both at 24 h and 48 h, bifidobacteria levels were significantly increased
versus the blank for AADE but especially for FOS (Table 2). This was reflected by ~25-fold and
~100-fold increased levels versus 0 h for AADE and FOS, respectively; both after 24 h and 48 h of
incubation (Figure 1A). Additionally, Lactobacillus spp. were stimulated more profoundly for FOS with
~10-fold increased levels versus 0 h at 24 and 48 h (Figure 1B). AADE exerted more attenuated effects on
Lactobacillus spp. levels with only statistically significantly increased absolute levels at 48 h. Incubation
with FOS increased absolute Firmicutes levels at all time points, while for AADE the increase was
only significant at 24 h (Table 2 and Figure 1C). Finally, AADE increased Bacteriodetes levels versus
the blank at 48 h (Table 2 and Figure 1D), while FOS decreased Akkermansia muciniphila levels versus
AADE after 48 h of incubation (Table 2).
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Table 2. Mean (±standard deviation) levels of microbial groups as measured via quantitative polymerase
chain reaction (qPCR) after 0, 24, and 48 h of treatment of a simulated colonic microbiota with 5 g/L
AADE (artichoke aqueous dry extract) or FOS (fructo-oligosaccharides). For each microbial group and
within each time point (24 h or 48 h), a value indicated with a different letter (a, b, or c) indicates a
statistical difference between AADE, FOS, and/or the blank, as tested with a two-way ANOVA with
post-hoc Tukey test (p < 0.05). In contrast, when at least one letter is shared between two treatments,
there was no significant between these groups.
Levels of Microbial Groups (log (16S rRNA Copies/mL))
Incubation Time (h) 0 h 24 h 48 h
Blank AADE FOS Blank AADE FOS
Firmicutes 9.96 ± 0.36 10.36 ± 0.13 a 10.83 ± 0.06 b 11.00 ± 0.03 b 10.44 ± 0.14 a 10.70 ± 0.25 a 11.08 ± 0.10 b
Bacteroidetes 9.73 ± 0.46 10.64 ± 0.47 11.09 ± 0.05 10.72 ± 0.04 10.44 ± 0.10 a 10.99 ± 0.23 b 10.87 ± 0.06 a,b
Bifidobacteria 8.26 ± 0.25 8.94 ± 0.13 a 9.71 ± 0.06 b 10.24 ± 0.06 c 9.12 ± 0.14 a 9.60 ± 0.22 b 10.32 ± 0.04 c
Lactobacillus spp. 6.58 ± 0.19 6.84 ± 0.10 a 7.06 ± 0.03 a 7.54 ± 0.03 b 6.87 ± 0.06 a 7.01 ± 0.15 b 7.63 ± 0.06 c
Akkermansia mucinphila 7.02 ± 0.51 8.23 ± 0.39 8.30 ± 0.03 7.72 ± 0.08 8.08 ± 0.17 a,b 8.19 ± 0.25 b 7.85 ± 0.08 a
Figure 1. Mean (±standard deviation) ratios of (A) Bifidobacterium spp., (B) Lactobacillus spp.,
(C) Firmicutes, and (D) Bacteroidetes levels after 24 h or 48 h of treatment of a simulated colonic
microbiota with 5 g/L AADE (artichoke aqueous dry extract) or FOS (fructo-oligosaccharides) versus
the initial levels (24 h/0 h or 48 h/0 h, respectively) as measured via quantitative polymerase chain
reaction (qPCR). For each microbial group and within each time point (24 or 48 h), a bar indicated with
a different letter (a, b, or c) indicates a statistical difference between AADE, FOS, and/or the blank at a
given time point, as tested with a two-way ANOVA with post-hoc Tukey test (p < 0.05). In contrast,
when at least one letter is shared between two bars, there was no significant between these treatments.
3.2. pH
A more profound decrease in pH was observed with FOS and to a lesser extent also with AADE
compared with blank at 6 h (p < 0.05). The pH continued to decrease until 24 h and remained stable
thereafter, indicating continued microbial fermentation (Table 3).
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Table 3. Mean (±standard deviation) pH and gas pressure after 0, 6, 24, and 48 h of treatment
of a simulated colonic microbiota with 5 g/L AADE (artichoke aqueous dry extract) or FOS
(fructo-oligosaccharides). For each time point (0, 6, 24, or 48 h), a value indicated with a different letter
(a, b, or c) indicates a statistical difference between AADE, FOS, and/or the blank as tested with a




0 6.49 ± 0.02 6.51 ± 0.00 6.51 ± 0.00
6 6.39 ± 0.01 a 6.22 ± 0.01 b 5.64 ± 0.13 c
24 6.46 ± 0.02 a 6.21 ± 0.01 b 5.66 ± 0.02 c




6 h 13.2 ± 0.2 a 22.8 ± 1.6 b 29.9 ± 1.6 c
24 h 27.3 ± 0.6 a 45.5 ± 0.5 b 52.0 ± 2.8 c
48 h 31.4 ± 0.6 a 48.8 ± 0.6 b 54.2 ± 1.1 c
3.3. Gas Pressure
As noted in Table 3, as compared with the blank, gas pressure was significant with AADE and
FOS on all the time points along the incubation. On all time points, gas production was significantly
higher for FOS versus AADE (Table 3).
3.4. Lactate and Carbohydrate (SCFAs, Acetate, Butyrate, and Propionate) and Protein Metabolites (BCFAs
and Ammonium)
Compared with the blank, total SCFAs were significantly increased with AADE and FOS at all
time-points of incubation (p < 0.05), which reflected enhanced microbial metabolic activity upon
AADE/FOS administration. However, the overall increase in total SCFAs was higher with FOS
compared with AADE (Table 4). Similar patterns of increase in acetate and propionate levels were
observed with AADE and FOS as for the total SCFA (Table 4). In contrast, butyrate concentrations
were only significantly increased for FOS, and this after 24 h and 48 h.
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As shown in Table 4, no BCFAs were produced during the initial 6 h of incubation in AADE and
FOS. After 24 h of incubation, there was a similar production of BCFAs in the blank (1.34 ± 0.24) and
upon AADE treatment (1.70 ± 0.37). In contrast, no BCFAs were produced upon FOS administration at
the 24 h time point. After 48 h of incubation, BCFAs were produced but were significantly (p < 0.05)
lower for both AADE (3.42 ± 0.02) and especially FOS (0.34 ± 0.26) when compared with the blank
(4.01 ± 0.13). The results for ammonium, another marker for protein fermentation, were similar to those
for BCFAs, indicating reduced protein fermentation upon AADE and especially FOS administration.
Lactate levels were high (p < 0.05) with AADE and even further increased for FOS compared with blank
after the initial 6 h of incubation. Thereafter, lactate levels decreased indicating lactate consumption.
4. Discussion
In the present study, although the effects of AADE on microbial activity and composition were
milder as compared to the “gold standard” prebiotic FOS, AADE demonstrated marked prebiotic
potential. First, AADE significantly decreased pH and increased gas production, which indicated
overall increased microbial activity upon administration of the test product. Saccharolytic metabolites
such as acetate and propionate, and thus also total SCFAs, increased, while levels of proteolytic
metabolites, BCFAs, and ammonium, significantly decreased upon AADE administration at 48 h.
A key finding of this study was the growth-promoting action of AADE, mostly on bifidobacteria which
are regarded as health-related members of the intestinal microbiome. Further, AADE also affected
Bacteroidetes, Firmicutes, and Lactobacillus spp. levels.
Based on results of this study, bifidogenic effects of AADE were milder, yet in the same order
of magnitude as those of FOS. These findings were similar to those of a previous in vitro study
conducted by Barszcz M et al. [28]. Bifidogenic effects were also reported in healthy volunteers [20,21].
The bifidogenic effect of artichoke has been attributed to its inulin content. Inulin exerts most
physiological changes through the bacterial metabolites. SCFAs are some of the important metabolites
that acidify the colonic environment promoting growth of beneficial bacteria, such as Lactobacillus spp.
and bifidobacteria, and prevent growth of pathogenic bacteria [30,31].
Moreover, in our study, lactate was produced during the initial 6 h of incubation. Subsequently,
lactate was consumed and coincided with an increase in propionate levels for both AADE and
FOS, with most marked stimulations being noted for FOS. Butyrate was not stimulated by AADE,
suggesting that the majority of lactate (that can be used as a substrate for both propionate and butyrate),
was cross-fed to propionate upon AADE supplementation. Some Negativicutes (family Veillonellaceae,
phylum Firmicutes) are shown to form propionate [32] and could potentially explain the increase of
Firmicutes that was observed for AADE after 24 h in our study. Bacteroidetes also contain potent
propionate producers [33,34] and could have further contributed to propionate production upon
AADE supplementation since AADE also stimulated this phylum in our study. These alterations
in propionate levels correlate with the inulin content of the artichoke [18]. Propionate metabolites
have been shown to reduce cholesterol and fatty acid synthesis in liver, improve glucose metabolism,
and regulate immune status in adipose tissue, and thus elicit health-promoting activities [18,35].
Finally, another key propionate producer is the mucin-degrading, acetate and propionate producing,
Akkermansia muciniphila. This taxon was not increased for either AADE or FOS and even decreased
upon FOS administration. This was likely due to the fact that FOS more strongly decreased the pH
(to 5.66 within 24 h), which is a pH at which Akkermansia muciniphila is unable to grow [36]. In vivo,
such lower pH could however boost mucin secretion and result in enhanced mucin degradation by
Akkermansia muciniphila in the distal colon, as shown for inulin in humanized rats [37].
Similarly, acetate and lactate can be cross-fed to butyrate by members of the Ruminococcaceae,
Lachnospiraceae, Clostridiaceae, Eubacteriaceae, all members of the Firmicutes phylum [18,38].
Butyrate is a major energy source for the gut microbiota and may also reduce oxidative stress, improve
gut function, and restrict inflammatory response. In this study, butyrate levels were increased majorly
with FOS and were usually produced during the later stage of incubation period. As our study duration
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was limited to 48 h, additional studies with longer incubation periods are warranted to make accurate
conclusions. Moreover, cross-feeding between microbial communities should be taken into account
when drawing definite conclusions [39].
Furthermore, propionate and acetate have been shown to stimulate release of peptide hormones
leading to short-term signaling of satiation and satiety to appetite centers in the brain, resulting
in reduced food intake by the host [35,40,41]. Several metabolic disorders such as obesity, insulin
resistance, and metabolic syndrome are associated with impaired carbohydrate and lipid metabolism
by the host, and are accompanied by changes in the gut microbiota [32]. Inulin could stimulate
different metabolic pathways within the gut microbial community and could potentially elicit varied
health-promoting activities [18].
Ammonia and BCFAs are toxic metabolites produced from protein fermentation [39]. In this
investigation, the reduction in BCFAs and ammonia production in part explains the increase in
carbohydrate metabolism. In vivo studies have also demonstrated that generation and accumulation
of ammonia can be reduced by lowering protein supply and by colonic fermentation of suitable
non-digestible carbohydrates from food [39,42].
Short-term colonic incubations have often been used to gather information on the prebiotic
potential of novel ingredients. Results of the present study using an incubation strategy based on the
SHIME® model indicate the prebiotic potential of AADE. These findings could be further validated
using different models, such as M-SHIME® (Mucosal Simulator of the Human Intestinal Microbial
Ecosystem) which focuses not only on luminal but also mucosal gut-colonizing microbes [43]. Moreover,
studies with repeated administration are required in order to simulate gradual changes that occur
in vivo with long-term use and to assess any beneficial microbial shift.
5. Conclusions
The present preliminary evaluation, conducted using the SHIME® model, demonstrated that
AADE has promising prebiotic potential. Incubation with AADE resulted in an increase of beneficial
microbes, which was correlated with their metabolite profile. The promising results of this study justify
future investigations using multiple doses in upgraded models to further validate these findings.
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Abstract: The interaction of different food ingredients is now a very important and often emerging
topic of research. Pesticides and their breakdown products, which may be carcinogenic, are one of the
frequently occurring food contaminants. Compounds like traumatic acid (TA), which originates from
plants, are beneficial, antioxidant, and anticancer food ingredients. Previously obtained results from
our research group indicated antioxidative in normal human fibroblasts and prooxidative in cancer
cells activity of TA. Since the literature data show an undoubted connection between the presence of
pesticides in food and the increased incidence of different types of cancers, we attempted to clarify
whether TA can abolish the effect of mesotrione stimulating the growth of cancer cells. In order
to study the influence of mesotrione on breast cancer cells, we decided to carry out cytotoxicity
studies of environmentally significant herbicide concentrations. We also analyzed the cytotoxicity
of TA and mixtures of these two compounds. After selecting the most effective concentrations of
both components tested, we conducted analyses of oxidative stress parameters and apoptosis in
ZR-75-1 cells. The obtained results allow us to conclude that traumatic acid by stimulating oxidative
stress and apoptosis contributes to inhibiting the growth and development of cells of the ZR-75-1
line strengthened by mesotrione. This may mean that TA is a compound with pro-oxidative and
proapoptotic effects in cancer cells whose development and proliferation are stimulated by the
presence of mesotrione. The presented results may be helpful in answering the question of whether
herbicides and their residues in edibles may constitute potential threat for people diagnosed with
cancer and whether compounds with proven pro-oxidative effects on cancer cells can have potential
cytoprotective functions.
Keywords: mesotrione; traumatic acid; breast cancer; herbicide; antioxidant; oxidative stress
1. Introduction
Different chemical substances from the group of pesticides are used in the food production process
to ensure seasonal availability and good quality of products. However, it should be mentioned that the
frequent and widespread use of pesticides carries the risk of their penetration into the human body.
Pesticides are a group of chemical compounds, both natural and synthetic, that are used in order to
destroy plant and animal parasites, reduce the risk of plant diseases, and control weeds. The massive
use of pesticides results from the growing number of consumers, and thus from an increased demand
for food. Pesticide residues may remain in food after their application to crops. The maximum
permissible levels of pesticides residues in food are determined by the regulatory authorities in the
European Union, mostly at the level of the European Commission. Exposure of a given population to
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pesticides and their residues most often occurs as a result of the consumption of processed food or
close contact with pesticide treated areas, such as farms [1,2].
Mesotrione (Mes) is an herbicide which controls most broadleaf weeds and weed grasses in
crops cultivation. Due to its frequent use in agriculture, the detectable level of this compound in
countries such as North America and Canada fluctuates around 4.1μg/L [3,4]. According to its chemical
structure, Mes is 2-[4-methylsulfonyl-2-nitrobenzoyl]-1,3-cyclohexanedione and it belongs to the family
of triketone. Its main role is an inhibition of the enzyme 4-hydroxy-phenyl-pyruvate-dioxygenase,
which converts tyrosine to plastoquinone (PQ) and alpha-tocopherol [5]. Mes is a quite water
soluble compound, which, in combination with its widespread application and soil retention capacity,
contributes to the fact that this herbicide easily contaminates surface and groundwater [6]. According to
Bonnet et al., Mes decomposition products appear to be more dangerous and harmful than the parent
compound [7].
The endocrine-disrupting influence of selected pesticides has caused great concerns due to the
hormonal activity of many well-documented risk factors for breast cancer. Literature data suggest that
selected pesticides could be related to an increase in breast cancer risk and urge researchers to examine
environmental risk factors and possible compounds, preferably of natural origin, that could reduce side
effects of pesticide use and thus the incidence of this disease [8–10]. Many pesticides are considered
as analogues of human hormones. They may exert influence through estrogen receptors. Therefore,
we chose to examine the ZR-75-1 breast cancer cell line, which is commonly used for endocrine-based
research, rather than choosing on the other breast cancer cell line or nonhuman cell line. Discordances
in scientific data regarding possible herbicides cancerogenic properties may result from the different
test models. Therefore, for the experiment, we decided to choose the human estrogen-dependent breast
cancer cell line, which is characterized by the presence of the estrogen receptor (ER+). The aim of this
paper was to study the mutual interaction mechanisms of two opposite compounds, one of which
is highly undesirable food contaminant (Mes), and traumatic acid (TA), which is a promising food
ingredient. In already published papers, we indicated that TA is characterized by antioxidative activity
in normal human fibroblasts and pro-oxidative properties in malignant cells [11,12]. In our preliminary
studies on the toxicological effects of Mes and TA in various breast cancer lines, we showed that TA,
depending on the concentration used, has an effect on the selected herbicides including Mes [13].
The literature, which has documented relationship between the consumption of food contaminated with
pesticides and the increased incidence of different types of cancers, led us to investigate whether TA can
counteract the stimulating influence of mesotrione on the proliferation and growth of malignant cells.
2. Materials and Methods
2.1. Reagents
Phosphate buffered saline (PBS), without Ca and Mg, was provided PAN Biotech (Aidenbach,
Germany). SDS (Sodium dodecyl sulphate), TCA (trichloroacetic acid), TBA (thiobarbituric acid), Folin-
Ciocalteu reagent, and Mesotrione were provided by Sigma-Aldrich and DTNB (dithiobis-2-nitrobenzoic
acid, Ellman’s reagent) by Serva. Dichlorodihydrofluorescein diacetate assay (DCFH-DA) and cell stain
double staining kit containing propionium iodide and calcein AM was provided by Sigma-Aldrich,
St. Louis, MO, USA. The fluorescein isothiocyanate (FITC) Annexin V Apoptosis Detection Kit I was
purchased from BD Pharmingen (San Diego, CA, USA). The Cayman’s Catalase Assay Kit, Cayman’s
Superoxide Dismutase Assay Kit, and Cayman GPx Assay were obtained from Cayman Chemical
(Ann Arbor, MI, USA).
2.2. Cell Culture
The effect of herbicide, TA (Cayman Chemical Company (1180 East Ellsworth Road, Ann Arbor,
MI, USA), purity ≥ 98%; formal name: 2E-dodecenedioic acid; CAS number: 6402-36-4; formulation:
A crystalline solid) and the mix of herbicide with TA was studied in the ZR-75-1 cell line, which was
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obtained from American Type Culture Collection (ATCC, Manassas, VA, USA). The ZR-75-1 cells
were cultured in RPMI-1640 Medium containing glucose at 4.5 mg/mL (25 mM) supplemented with
10% fetal bovine serum (FBS) (PAN Biotech), penicillin (100 U/mL) (PAN Biotech), and streptomycin
(100 μg/mL) (PAN Biotech) at 37 ◦C in a humidified atmosphere of 5% CO2 in air.
2.3. Cytotoxicity Assay
Cytotoxicity were studied according to the method of Carmichael using 3-(4,5-dimethylthiazol-
2-yl)-2,5-diphenyltetrazolium bromide (MTT) (Sigma-Aldrich, St. Louis, MO, USA) [14].
TA cytotoxicity was studied at selected concentrations of 0.5 μM, 0.75 μM, 1 μM, 10 μM, 20 μM,
50μM, 100μM, 200μM, 500μM, 750μM, and 1000μM. Mes cytotoxicity was estimated at concentrations
of 0.01μM, 0.025μM, 0.05μM, 0.1μM, 0.5μM, 1μM, 5μM, 10μM, 25μM, and 50μM. The concentrations
of both compounds selected for the analysis of the effect of the tested chemicals mixture on the cells
have been chosen on the basis of MTT cytotoxicity tests performed. The concentration of Mes with the
highest stimulating effect on the ZR-75-1 cells was selected. The control cells were cultured without
test compounds.
Breast cancer cells were seeded in a 96-well plate at a density of 2 × 104 cells/well. Cells cultured
for 24 h and 48 h were first treated with TA in the concentration range from 0.5 μM to 1000 μM,
then Mes in the concentration range from 0.01 μM to 50 μM, and finally TA mixed with Mes: TA in the
concentration range from 0.5 μM to 1000 μM mixed with 0.05 μM Mes. The analysis was conducted
according to Jabłońska-Trypuć et al. using a microplate reader GloMax®-Multi Microplate Multimode
Reader (Promega Corporation, Madison, WI, USA) [13]. The viability of breast cancer cells was
presented as a percentage of control cells. All the experiments were done in triplicate.
2.4. Caspase 3/7 Activity Assay
The activity of caspases 3/7 was examined at TA concentrations of 100μM and 200 μM,
Mes concentration of 0.05 μM, and the combination of two compounds (TA +Mes, concentrations:
100 μM + 0.05 μM and 200 μM + 0.05 μM, respectively) after 24 h and 48 h of incubation. Breast cancer
cells were seeded in 96-well white plate at a density of 2× 104 cells/well. Luminescent assay was applied
according to manufacturer’s instructions (Promega Corporation, Madison, WI, USA) as described
previously [15]. A microplate reader GloMax®-Multi Microplate Multimode Reader was used and the
experiments were done in triplicate.
2.5. Fluorescent Microscopy Analysis
For the analysis of apoptotic and necrotic cells nuclear morphology, two fluorescent dyes,
propionium iodide and calcein-AM, were applied. Cells were seeded on cell imaging dishes with
coverglass bottoms at a density of 2 × 105 cells/well with 200 μM TA, 0.05 μM Mes, the mix of two
compounds, and without the tested compound for 24 h. Subsequently, cells were washed twice
with PBS and then stained with dyes solution in the dark in 37 ◦C for 15 min. The mixture of
dyes was removed and the cells were washed with phosphate buffer and analyzed with the use of
Olympus IX83 fluorescent microscope with SC180 camera with Cell Sens Dimension 1.17 program
(200 ×magnification). Calcein-AM stains viable cells and PI pass only through damaged membrane in
dead cells. The following criteria were used: Living cells were characterized by regularly distributed
green chromatin nucleus and are stained with green color. Dead cells, probably apoptotic cells,
were characterized by red nuclei with chromatin condensation or fragmentation. Necrotic cells showed
red-stained cell nuclei.
2.6. Analysis of Apoptosis Using Flow Cytometry
Breast cancer cells were seeded in six-well plates at a density of 2 × 105 cells/well. Cells were
exposed to 100 μM TA, 200 μM TA, 0.05 μM Mes, and the mix of two compounds (TA + Mes,
concentrations: 100 μM + 0.05 μM, 200 μM + 0.05 μM, respectively) and incubated for 24 h and
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48 h. Apoptosis was studied by flow cytometry on FACSCalibura II cytometer (Becton-Dickinson).
After trypsinization, cells were resuspended in RPMI-1640. Then, cells were suspended in binding buffer
for staining with FITC (Annexin V) and propidium iodide (PI) for 15 min at room temperature in the
dark following the manufacturer’s instructions (FITC Annexin V apoptosis detection Kit I). The signal
obtained from cells stained with Annexin V or PI alone was used for fluorescence compensation.
Data were analyzed with FACStationTM software (BD PharmingenTM, San Diego, CA, USA).
2.7. Total Protein Content
ZR-75-1 cells were exposed to 100 μM TA, 200 μM TA, 0.05 μM Mes, and the mix of two compounds
(TA +Mes, concentrations: 100 μM + 0.05 μM, 200 μM + 0.05 μM, respectively) and incubated for
24 h and 48 h. ZR-75-1 cells (2.5 × 105 cells/mL) were cultured with tested compounds. The protein
concentration was determined as described previously [15]. All the experiments were done in triplicate.
2.8. Determination of SH Groups
SH groups content was analyzed using Rice-Evans method (1991) as described previously [15].
ZR-75-1 cells were exposed to 100 μM TA, 200 μM TA, 0.05 μM Mes, and the mix of two compounds
(TA +Mes, concentrations: 100 μM + 0.05 μM, 200 μM + 0.05 μM, respectively) and incubated for 24 h
and 48 h. ZR-75-1 cells (2.5 × 105 cells/mL) were cultured with tested compounds. All the experiments
were done in triplicate.
2.9. Determination of TBA Reactive Species (TBARS) Level
The Rice-Evans method (1991) was used for measuring membrane lipid-peroxidation products
level (TBARS), as described previously [15]. ZR-75-1 cells were exposed to 100 μM TA, 200 μM
TA, 0.05 μM Mes, and the mix of two compounds (TA + Mes, concentrations: 100 μM + 0.05 μM,
200 μM + 0.05 μM, respectively) and incubated for 24 h and 48 h. ZR-75-1 cells (2.5 × 105 cells/mL)
were cultured with test compounds. All the experiments were done in triplicate.
2.10. Determination of GSH/GSSG
GSH/GSSG (GSH–reduced form of glutathione, GSSG–oxidized form of glutathione) ratio was
examined at TA concentrations of 100 μM and 200 μM, Mes concentration of 0.05 μM, and the mixture
of these two compounds (TA + Mes, concentrations: 100 μM + 0.05 μM and 200 μM + 0.05 μM,
respectively) after 24 h and 48 h of incubation. Breast cancer cells were seeded in 96-well white plates
at a density of 2 × 104 cells/well. GSH/GSSG ratio was assayed in triplicate via GSH/GSSG-Glo™ kit
(Promega Madison, WI, USA) following manufacturer’s instructions as described [15].
2.11. Intracellular ROS Detection
Intracellular ROS level was examined at TA concentrations of 100 μM and 200 μM, Mes concentration
of 0.05 μM, and the mixture of these two compounds (TA +Mes, concentrations: 100 μM + 0.05 μM and
200 μM + 0.05 μM, respectively) after 24 h and 48 h of incubation. Breast cancer cells were seeded in
96-well white plates at a density of 2× 104 cells/well. Dichlorodihydrofluorescein diacetate (DCFH-DA),
(Sigma, St. Louis, MO, USA) and GloMax®-Multi Detection System (Promega Corporation, Madison,
WI, USA) were used in order to measure the level of intracellular reactive oxygen species (ROS) [16].
The method was described previously [12]. All the experiments were done in triplicate.
2.12. Catalase Activity
Catalase is an enzyme which is involved in the detoxification processes, mainly the metabolism
of hydrogen peroxide, which originates during normal aerobic metabolism and pathogenic reactive
oxygen species (ROS) generation. Cells were cultured in six-well plates at 1 × 105 cells/well (Sarstedt),
treated with 100 μM and 200 μM TA, 0.05 μM Mes, and the mix of two compounds (TA + Mes,
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concentrations: 100 μM + 0.05 μM, 200 μM + 0.05 μM, respectively) for 24 h and 48 h. For the determination
of catalase activity, the Catalase Assay Kit (Cayman Chemical Company Ann Arbor, MI, USA) was
used following manufacturer’s instructions. The absorbance of final product was read at 540 nm using
the GloMax®-Multi Microplate Multimode Reader. All the experiments were done in triplicate.
2.13. Glutathione Peroxidase Activity
Glutathione peroxidase is involved in cells protection against oxidative stress by catalyzing the
reduction of hydroperoxides by reduced GSH. Cells were cultured in six-well plates at 1 × 105 cells/well
(Sarstedt), and treated with 100 μM and 200 μM TA, 0.05 μM Mes, and the mix of two compounds
(TA +Mes, concentrations: 100 μM + 0.05 μM, 200 μM + 0.05 μM, respectively) for 24 h and 48 h.
Prior to the analysis, cells were washed with phosphate buffer. Cells were collected using rubber
policeman and homogenized in a cold buffer, then centrifuged at 10,000× g for 15 min at 4 ◦C.
Supernatant was used for the assay. For the determination of glutathione peroxidase activity GPx
Assay kit (Cayman Chemical Company Ann Arbor, MI, USA) was used following manufacturer’s
instructions. The absorbance at 340 nm was read using the GloMax®-Multi Microplate Multimode
Reader. All the experiments were done in triplicate.
2.14. Superoxide Dismutase Activity
Superoxide dismutases belong to the group of metalloenzymes. They catalyze the superoxide
anion dismutation to molecular oxygen and hydrogen peroxide and therefore play an important role
in the cellular antioxidant defense system. Cells were seeded in six-well plates at 1 × 105 cells/well
(Sarstedt), and treated with 100 μM and 200 μM TA, 0.05 μM Mes, and the mix of two compounds
(TA +Mes, concentrations: 100 μM + 0.05 μM, 200 μM + 0.05 μM, respectively) for 24 h and 48 h.
Prior to the analysis, cells were washed with phosphate buffer. Cells were collected using rubber
policeman and homogenized in a cold buffer, then centrifuged at 10,000× g for 15 min at 4 ◦C.
Supernatant was used for the assay. For the determination of SOD activity, the Superoxide Dismutase
Assay Kit (Cayman Chemical Company Ann Arbor, MI, USA) was applied following manufacturer’s
instructions. The absorbance (440–460 nm) was read using the GloMax®-Multi Microplate Multimode
Reader. All the experiments were done in triplicate.
2.15. Statistical Analysis
Statistical analysis for the obtained results was performed. The effect of TA, Mes, and the
combination of TA and Mes on apoptosis and oxidative stress parameters in ZR-75-1 cells was
calculated as a means and compared in analysis of variance using the post-hoc test of ANOVA.
The significant differences were estimated by Tukey test at p < 0.05. A biplot graph was used in order




An MTT assay was applied in order to estimate potential TA cytotoxicity (Figure 1A). The analyzed
compound caused significant decreases in relative ZR-75-1 cell viability, which was observed right
after 24 h treatment. It was effective even in lower concentrations. At 1 μM TA concentration, a 37%
decrease was noticed after 24 h treatment. Concentrations of 100 μM and 200 μM decreased the
viability of cells by about 40% and more than 50%, respectively, after 24 h treatment. None of the
tested TA concentrations stimulated studied cells viability. On the other hand, Mes significantly
increased relative cell viability. The most significant increase in the relatively shorter time of incubation
was observed under the influence of 0.05 μM of Mes, which is presented in Figure 1B. Therefore,
one of Mes concentrations, 0.05 μM, was selected for further analysis, and was applied together
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with all of the studied concentrations of TA. We noticed significant decline in relative cell viability
in both incubation times, especially in combination of Mes with TA in 0.05 μM + 100 μM and
0.05 μM + 200 μM, respectively (Figure 1C). Taking into account the results of the above-mentioned
experiments, we decided to choose two combinations of analyzed compounds for further analysis of
the mechanisms by which they affect breast cancer cells. TA concentrations of 100 μM and 200 μM
are close to IC50 value, and more importantly, TA concentrations higher than 400 μM could be
potentially cytotoxic for the human organism. For studying oxidative stress parameters and apoptosis,
we analyzed the influence of 0. 05 μM Mes + 100 μM TA and 0.05 μM Mes + 200 μM TA.
Figure 1. Relative cell viability. The ZR-75-1 cell line was exposed to (A) graded concentrations of TA
(traumatic acid), (B) graded concentrations of Mes (mesotrione), and (C) graded concentrations of TA
mixed with 0.05 μM of Mes. Mean values from three independent experiments ± standard deviation
(SD) are shown.
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3.2. Apoptosis
Before conducting the Caspase-Glo® 3/7 Assay, cells were subjected to 0.05 μM Mes, 100 μM
TA, 200 μM TA, and the combination of 0.05 μM of Mes with 100 μM TA and 0.05 μM of Mes with
200 μM of TA (Figure 2A). Mes treatment did not induce apoptosis in studied cell line. TA slightly
enhanced the activity of analyzed caspases, especially after 48 h of treatment. However, the most
significant changes in caspases 3/7 activity caused by two mixed compounds were observed when TA
concentration was about 200 μM.
Figure 2. The effect of TA, Mes, and the combination of TA+Mes on apoptosis in ZR-75-1 cells, which were
incubated with 100 μM of TA, 200 μM of TA, 0.05 μM of Mes, and a mix of 100 μTA + 0.05 μM Mes,
200 μM TA + 0.05 μM Mes. (A) Caspase 3/7 activity in ZR-75-1 cells under the influence of TA, Mes and
TA + Mes on, (B) Bar graphs presenting the percentage of apoptotic cells. Mean values from three
independent experiments ± SD are shown. Different letters indicate statistical differences (p ≤ 0.05)
between treatments estimated by Tukey’s test.
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Apoptosis was also estimated using flow cytometry, and the results are presented in Figure 2B.
In Figure 2B, the percent of apoptotic cells cultured for 24 h and 48 h with TA, Mes, and the mixture of
TA and Mes is depicted. The values obtained for herbicide treatment indicate that tested compound
did not enhance apoptosis. However, TA treatment, both alone and in combination with Mes,
enhanced apoptosis. The results obtained in the flow cytometry experiment confirmed the studied
caspases activity.
A fluorescent microscopy assay was used in order to confirm the occurrence of apoptosis
(Figure 3). We evaluated apoptotic and necrotic cells morphology using fluorescent staining. Similar to
luminescence and flow cytometry analysis, we observed differences between control, TA, and TA +Mes
treatments. We did not observe differences between control and pesticide-treated cells. Calcein—AM
stained only viable cells, while propidium iodide stained viable and death cells.
Figure 3. The influence of TA (200 μM), Mes (0.05 μM), and the mix of TA +Mes (200 μM + 0.05 μM)
on apoptosis and necrosis in the ZR-75-1 cell line estimated using fluorescence microscope assay
(200 ×magnification). The cells were cultured with TA and Mes for 24 h and stained with Calcein-AM
and propidium iodide. Three independent experiments were conducted and representative images
are depicted.
3.3. Oxidative Stress
In the combination of Mes and TA, unsaturated dicarboxylic fatty acid demonstrates anticancer
properties against Mes-induced breast cancer development by enhancing the stimulatory effect on
oxidative stress parameters.
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The influence of TA and Mes on the amount of SH groups is presented in Figure 4A. A statistically
significant increase in thiol group content by approximately 68% was noticed under the influence of
Mes after 24 h. Exposure to TA after 24 h incubation also caused an increase in analyzed parameter.
However, 48 h incubation with tested compounds caused a significant decrease in thiol group content.
Notably, the decrease was observed in case of the TA pretreatment of cells. The obtained results
indicate that 100 μM of TA delayed the antioxidative effect of Mes on breast cancer cells, because we
noticed a decrease in thiol group content caused by 0.05 μM Mes in the culture pretreated with 100 μM
TA. The presented data may indicate that TA could be a compound, which intensifies oxidative stress
in cancer cells, even in the presence of herbicide.
Lipid peroxidation in cancer cells is a very important process, which consists a source of free
radicals inevitable for fast cancer cell proliferation (Figure 4B). Incubation with all of the analyzed
compounds after 24 h caused an increase in TBARS content, which was analyzed as an index of lipid
peroxidation. However, statistically significant changes in tested parameter were observed after 48 h
treatment. Both TA alone and 100 μM TA in combination with Mes caused a very high increase in
TBARS level. However, 200 μM TA mixed with Mes caused a decrease of about 75% as compared to the
first analyzed mix, which could be explained by the presence of the other lipid peroxidation products,
for example HNE. The obtained results suggest that TA may demonstrate protective properties by
increasing membrane phospholipid peroxidation to such a high level, which is toxic to cancer cells.
Figure 5B shows the influence of TA and Mes on the production of ROS in the ZR-75-1 breast
cancer cells. The intensity of fluorescence of 2′7′-dichlorodihydrofluorescein (DCF) for the ZR-75-1 cells
cultured with TA and Mes for 24 h and 48 h is shown as a relative ROS amount. An incubation of cells
with tested compounds caused an increase in ROS content in both analyzed times. At a concentration
of 200 μM, TA caused an increase, which was very high, at about 95% after 24 h. Treatment with
100 μM and 200 μM of TA significantly reduced the ROS amount in the Mes-treated cell culture as
compared to TA-treated cells. The presented data show an enhancing effect of TA on ROS formation.
The influence of Mes, TA, and the mixture of Mes with TA on GSH/GSSG ratio is depicted in
Figure 5A. Reduced glutathione belongs to the group of very important antioxidants, which maintain
oxidative balance within the cell. At a concentration of 200 μM, TA significantly decreased GSH/GSSG
ratio after 24 h of incubation, while 100 μM of TA combined with 0.05 μM Mes significantly increased
the tested parameter after 48 h incubation time compared to the control. Treatment with 200 μM of
TA caused a reduced ratio of GSH/GSSG after 24 h and 48 h of culturing, even after addition of Mes.
Treatment with the Mes and TA mixture for 24 h reduced the level of GSH compared to untreated
cells. Based on the results obtained, we conclude that TA had a rather inhibitory effect and Mes had a
stimulatory effect on the GSH/GSSG ratio in the ZR-75-1 cell line.
The first line of antioxidant defense that plays a key role in maintaining redox homeostasis in
the cell are enzymes such as GPx, catalase and SOD. A significant increase in catalase activity under
the influence of TA combined with 0.05 μM Mes was observed after 48 h incubation only (Figure 6A).
At concentrations of 100 μM and 200 μM, TA, applied as a pretreatment before adding Mes, increased
catalase activity by about 40% and 23%, respectively, as compared to the control untreated cells. At a
concentration of 0.05 μM, Mes decreased catalase activity in both treatment times, however statistically
insignificantly. The opposite results were observed in case of glutathione peroxidase (Figure 6B).
The GPx activity was the highest under the influence of 100 μM TA + 0.05 μM Mes after 24 h incubation.
Longer treatment with all of the tested compounds caused declines in GPx activity, but statistically
insignificant. Our results showed that SOD activity was enhanced not only by the action of Mes,
but also TA. The combination of these two compounds revealed decreases in SOD activity as compared
to free Mes or free TA (Figure 6C).
In Figure 7, PCA analysis is depicted. It presents the correlation between the studied variables
concerning the oxidative stress and apoptosis resulting from the activity of tested compounds and their
mixture in the ZR-75-1 cell line. Figure 7 shows that 24 h treatment with TA was positively correlated
with TBARS content, ROS content, and SOD activity, and was also correlated with the first component,
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which explains the 48.82% variability. However, Mes treatment was correlated with GSH/GSSG ratio,
which is represented by the second component, explaining the 36.49% variability. After 48 h treatment,
the previously observed correlation between TA and ROS content and TA +M and caspase 3/7 activity
was maintained.
Figure 4. The influence of TA, Mes, and the mix of TA and Mes on SH group content (A) and TBARS
content (B) in ZR-75-1 cells. The cells were cultured with 100 μM of TA, 200 μM of TA, 0.05 μM of Mes,
mix of 100 μM TA + 0.05 μM Mes, and 200 μM TA + 0.05 μM Mes for 24 h and 48 h. Mean values
from three independent experiments ± SD are shown. Different letters indicate statistical differences
(p ≤ 0.05) between each treatment estimated by Tukey’s test.
116
Nutrients 2020, 12, 1343
Figure 5. The influence of TA, Mes and the mix of TA and Mes on GSH/GSS (GSH–reduced form of
glutathione, GSSG–oxidized form of glutathione) ratio (A) and reactive oxygen species (ROS) content
(B) in ZR-75-1 cells. The cells were cultured with 100 μM TA, 200 μM TA, 0.05 μM Mes, and a mix
of 100 μTA + 0.05 μM Mes, 200 μM TA + 0.05 μM Mes for 24 h and 48 h. Mean values from three
independent experiments ± SD are shown. Different letters indicate statistical differences (p ≤ 0.05)
between each treatment estimated by Tukey’s test.
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Figure 6. The influence of TA, Mes, and the mix of TA and Mes on catalase activity (A) GPx (glutathione
peroxidase) activity (B) and SOD (superoxide dismutase) activity (C) in ZR-75-1 cells. The cells were
cultured with 100 μM of TA, 200 μM of TA, 0.05 μM of Mes, and a mix of 100 μM TA + 0.05 μM Mes,
200 μM TA + 0.05 μM Mes for 24 h and 48 h. Mean values from three independent experiments ± SD
are shown. Different letters indicate statistical differences (p ≤ 0.05) between each treatment estimated
by Tukey’s test.
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Figure 7. Biplot showing variables (SH groups (thiol groups), TBARS (thiobarbituric acid reactive
species) content, GSH/GSSG ratio, ROS content, SOD, catalase, GPX activity, caspase 3/7 activity,
cytotoxicity) and cases (tested compounds: Mes, TA, and TA+Mes—mix of two analyzed compounds)
in two dimensions.
4. Discussion
Due to the increasing popularity of diets based mainly on products of plant origin, we should be
aware of the presence in everyday meals of both ingredients having a beneficial effect on the human
body, but also compounds that are residues from the method of growing and preserving food of plant
origin. The first group of compounds mentioned above includes TA, which is a plant hormone with
beneficial antioxidant and probably anticancer effects. While the second group of compounds present
in the crop plants are undoubtedly pesticides, an example of which is analyzed Mes. Taking into
account its chemical structure TA belongs to the group of unsaturated fatty acids, whose positive effect
on the human body has been quite well documented in the scientific literature. Although unsaturated
fatty acids are fairly well known and their anti-cancer properties are investigated and described, there is
literally scarce of literature data on TA. Our previous papers have shown that TA has a positive effect
on healthy human fibroblasts by reducing oxidative stress level and that TA exhibits toxicity towards
breast cancer cells by stimulating apoptosis through an increased level of oxidative stress [11,12]. In our
preliminary study we also did an experiment regarding the mixtures of TA with selected herbicides
frequently used in Poland and in EU on three breast cancer cell lines and one normal healthy cell
line obtained from mammary gland [13]. Based on conducted experiments we concluded that TA in
a dose–dependent manner may exert some toxicological effects in analyzed cells subjected also to
herbicides. Therefore, as a next step, in this study we want to start investigating the mechanisms
by which these two compounds may interact with each other and therefore influence growth and
development of breast cancer cells.
First, the influence of analyzed compounds on the ZR-75-1 cell line proliferation was investigated.
The MTT test was the basic experiment on the basis of which the concentrations were selected for further
determinations. Cells under analysis were subjected to wide range of TA and Mes concentrations for
24 h and 48 h. The relative cell viability was monitored, and subsequently, one of Mes concentrations
(0.05 μM) was selected for the experiment with the combination of two tested compounds. In the third
part of the experiment, cells were pretreated with TA in the wide range of concentrations, and then Mes
in the concentration of 0.05 μM was added. The most significant declines in Mes-treated cells viability
were noticed as a result of 100 μM and 200 μM of TA treatment. The presented results are in agreement
with our previously published data regarding TA influence on MCF-7 cells, where we indicated a decline
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in cancer cell proliferation and viability caused by TA [12]. Literature data has indicated that pesticides
may stimulate cancer cells proliferation through different mechanisms, e.g., glyphosate stimulates
human breast cancer cells growth through estrogen receptors pathways, diuron acts in a tissue-specific
manner and ROS play a role in its toxicity, and bifenox and dichlobenil exhibit enhancing effects on
oxidative stress, simultaneously stimulating cancer cell proliferation and inhibiting apoptosis [17–19].
There is a large amount of literature data indicating a link between elevated levels of oxidative stress
and a simultaneous increase in tumor cell proliferation [20–22]. Therefore, in our work, we focused
primarily on the analysis of various parameters of oxidative stress. Cancer cells of different types
are characterized by high level of ROS as compared to normal cells. This is primarily due to genetic
disorders which appear in cancer cells, resulting in uncontrolled proliferation. In order to analyze the
possible inhibiting effect of TA on the proliferation of Mes-treated cells, we conducted an MTT assay.
The results indicate that TA exhibits antiproliferative properties.
In our studies, we noticed a decline in the amount of ROS in Mes-treated cells preincubated with
TA, which may be associated with the cytotoxic effect of TA in cancer cells. Cancer cells usually use
elevated level of oxidative stress caused, among others, by ROS generation in order to reduce the
body’s antioxidant protection. This allows the initial defeat of the first defense line against metastasis
and angiogenesis, which are key stages in the development and progression of cancer [23,24]. This is
in agreement with our research results indicating the relationship between an observed increase in
ROS content and an increase in proliferation in Mes-treated cells and the decrease in ROS content in
TA preincubated cells with a decrease in their proliferation level.
Many compounds of natural origin from the cytokinin group have antioxidant activity in healthy
cells and pro-oxidative in cancer cells, which we also showed in our previous papers [12,25]. TA, as an
unsaturated fatty acid, shows an increased susceptibility to oxidative processes. According to the
literature, breast cancer cells are also definitely predisposed to oxidation of the macromolecules,
which build them as compared to healthy cells. Unsaturated fatty acids have been shown to induce
increased synthesis in inter alia lipid hydroperoxides in lipids that are part of cell membranes [26,27].
According to O’Shea M. et al., conjugated linoleic acid causes an increase in lipid peroxidation in breast
cancer cells with a simultaneous decrease in cell proliferation [28]. We observed similar results in our
research. We noticed increases in TBARS levels, which are correlated with changes in the content
of SH groups. Incubation with TA for 48 h caused a decrease in thiol groups, even in Mes-treated
cells. Mes stimulates the growth of cancer cells and causes an increase in the level of SH groups,
which can probably also increase their resistance to oxidative stress and possible damage and enhance
proliferation. Changes in the level of TBARS content and SH groups were also accompanied by changes
in the GSH/GSSG ratio, particularly decreases under the influence of preincubation with 200 μM TA in
cells treated with Mes. The correspondingly high level of GSH, which is one of the most important
low molecular weight antioxidants in breast cancer cells, is usually correlated with the resistance of
these cells to the induction of apoptosis and with their increased proliferation [29]. Our results indicate
statistically significant decreases in GSH level under the influence of 200 μM TA in cells treated with
Mes, with simultaneous statistically significant increases in the level of effector caspases 3/7 activity.
The analysis of the activity of caspases 3/7, confirmed by the results obtained from flow cytometry and
fluorescence microscopy, demonstrates that, at a concentration of 0.05 μM, Mes induces a decrease in
the percentage of apoptotic cells as compared to control and to TA-treated cells. After both 24 h and
after 48 h, we observed that TA at 200 μM significantly induced apoptosis even in combination with
Mes, which may mean that TA is capable of overcome activity of pesticide and stimulate apoptosis in
breast cancer cells.
Due to the application of TA, especially at a concentration of 200 μM, we noticed a significant
increase in the activity of caspase 3/7, a decrease in ROS content, and a decrease in GSH content.
However, it should be noted that the cells antioxidant defense system are divided into two parts:
Enzymatic and nonenzymatic. Primary endogenous antioxidants are superoxide dismutase (SOD),
catalase and glutathione peroxidase [30]. Our results clearly show that TA caused an increase in
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oxidative toxicity in Mes-treated ZR-75-1 cells. It was manifested by a decrease in GPx activity and
GSH/GSSG ratio and increase in TBARS content. Lipid hydroperoxides and other ROS are a major
cause of oxidative damage within the cell membrane lipids, leading to increase in TBARS content.
The GSH pool in the cells decreases due to an excessive generation of lipid peroxidation products and
other oxygen species [31]. In turn, an excess in TA-induced ROS generation causes a significant decline
in GSH synthesis and inhibition of antioxidant enzymes [32]. The reduced form of glutathione is an
antioxidant low in molecular mass for appropriate cell integrity and redox balance, although GPx is
an antioxidant enzyme, which contains selenium and its main role is scavenging of ROS. Catalase in
breast cancer cells is characterized by high activity and expression level [33]. In our research, a decrease
in catalase activity was observed under the influence of Mes and both analyzed concentrations of
TA. However, under the influence of TA mixed with Mes, significant increases were noticed in both
analyzed TA concentrations, especially after 48 h incubation. The presented results are consistent with
literature data, indicating that catalase activity is induced in MCF-7 breast cancer cell line exposed to
conjugated linoleic acid [34]. However, SOD activity, similar to GPx activity under the influence of Mes
in TA-preincubated cells, was significantly lower as compared to the control or to the TA-treated and
Mes-treated cells. Mes enhanced the activity of both SOD and GPx, but TA was effective enough to
withstand the stimulating effect of the Mes and reduce the activity of the enzymes studied. Ding WQ
et al. also observed that cancer cell treatment with docosahexaenoic acid reduced significantly SOD1
expression [35]. Literature data describing in vivo studies have shown divergent results of analyses
regarding the effect of fatty acids on antioxidant enzyme activity. Some studies have indicated higher
activity of antioxidant enzymes analyzed in animals consuming PUFA-enriched feed, while others have
indicated that PUFAs caused a decline in the activity of these enzymes in the tissues of noncancerous
rats [36,37]. In the present study, we found that TA inhibits SOD activity in Mes-treated ZR-75-1 cells,
which has not been reported previously. Selected unsaturated fatty acids are known to modulate genes
expression in malignant cells [38]. After being transported into cell nucleus, fatty acids such as TA are
bounded to peroxisome proliferator-activated receptor [39]. This receptor response element is in the
SOD1 gene promoter in rats [40]. Therefore, the transcription of the SOD1 gene could be influenced by
TA in ZR-75-1 cells. On the other hand, SOD1 mRNA destabilization could be influenced by DHA,
which subsequently causes its lower expression. The target reduction of SOD activity was a way
to increase intracellular peroxide amount, hence causing an increase in mitochondrial damage and
stimulating apoptosis in cancer cells [41].
In our experiments, we observed a 45% decrease of SOD activity in the ZR-75-1 cells treated with
200 μM TA and incubated with Mes. According to our biplot analysis results, this was not correlated
the growth rate of cells but was significantly correlated with the effect on TA-induced lipid peroxidation
and ROS content after 24 h and with GPx activity, GSH/GSSG ratio, and SH group content. Our results
support the idea that compounds, which influence antioxidant enzymes activity and oxidative balance
in cancer cells, could be applied in the elimination of tumor cells through the induction of apoptosis.
5. Conclusions
The presented results allow us to conclude that TA may act as pro-oxidative and pro-apoptotic
agent against Mes-stimulated breast cancer growth and development. TA could be considered as a
plant, alternative source of unsaturated fatty acids that can eliminate the positive effect of pesticides
on the growth and development of breast cancer cells. By stimulating oxidative stress and inhibiting
the enzymatic antioxidative defense system in cancer cells, this compound can inhibit the growth
and development of breast cancer. It should be also mentioned that TA acts as a pro-oxidative and
pro-apoptotic agent in other breast cancer cell lines, simultaneously acting as antioxidant in normal
human cells. Due to its unique properties, it could be considered as an important food ingredient.
Exposure to herbicides present in food is dangerous for both healthy people and certainly for women
diagnosed with breast cancer. This is also evidenced by the results of our research showing the positive
and stimulating effect of Mes on the development and growth of cancer cells. However, TA seems to
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be a compound with high anti-cancer potential, which may endure the negative impact of herbicides
on the human body.
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Abstract: The impact of acrylamide (AA) on microorganisms is still not clearly understood as AA
has not induced mutations in bacteria, but its epoxide analog has been reported to be mutagenic in
Salmonella strains. The aim of the study was to evaluate whether AA could influence the growth
and viability of beneficial intestinal bacteria. The impact of AA at concentrations of 0–100 μg/mL
on lactic acid bacteria (LAB) was examined. Bacterial growth was evaluated by the culture method,
while the percentage of alive, injured, and dead bacteria was assessed by flow cytometry after 24 h
and 48 h of incubation. We demonstrated that acrylamide could influence the viability of the LAB,
but its impact depended on both the AA concentration and the bacterial species. The viability of
probiotic strain Lactobacillus acidophilus LA-5 increased while that of Lactobacillus plantarum decreased;
Lactobacillus brevis was less sensitive. Moreover, AA influenced the morphology of L. plantarum,
probably by blocking cell separation during division. We concluded that acrylamide present in food
could modulate the viability of LAB and, therefore, could influence their activity in food products or,
after colonization, in the human intestine.
Keywords: lactic acid bacteria; probiotic; acrylamide; viability; flow cytometry
1. Introduction
Acrylamide (AA) is a chemical compound used in many industries. It is produced as a substrate
for the synthesis of polymers widely used in the paper, chemical, and cosmetics industries. In 1994,
the International Agency for Research on Cancer (IARC) included acrylamide in a group of compounds
“probably carcinogenic to humans” after laboratory tests in mice and rats [1].
Acrylamide in foods is formed mainly by the reaction of free asparagine with reducing sugars
(especially fructose and glucose) during the Maillard reaction, but it can also be formed by other
pathways, e.g., the acrolein pathway [2]. The most important factors for AA formation are time and
the temperature of the thermal processing of food products, and it is thought that a prerequisite for AA
formation is temperature exceeding 120 ◦C.
Acrylamide has been shown to be a reproductive toxicant in animal models [3,4]. It exerts
neurotoxic activity [5–7], and many studies have proved that AA also has genotoxic, cytotoxic, and
carcinogenic impacts on the human organism [6,8–10]. However, due to the fact that acrylamide does
not exert a mutagenic effect in bacterial cells [3,11], it has been agreed that its carcinogenic activity is
related to glycidamide (GA)—an acrylamide metabolite formed in mammalian cells. The mutagenic
and genotoxic effects of GA have already been confirmed in various in vitro and in vivo studies,
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showing that this AA metabolite can induce the formation of DNA adducts, resulting in mutagenesis
and the development of cancers [6,8,9,12].
The impact of AA on microorganisms is still unclear. The results of many assays made by various
laboratories are consistent in showing that AA is not a mutagen in Salmonella Typhimurium tested strains
at concentrations up to 5 mg/plate, with or without metabolic activation [3]. However, three epoxide
analogs of acrylamide, e.g., glycidamide, have been reported to be mutagenic in Salmonella strains
± S9 activation [11,13]. Tsuda et al. [14] reported that AA did not induce any gene mutations in
Salmonella/microsome test systems (TA98, TA100, TA1535, TA1537) and in Escherichia coli/microsome
assays (WP2 uvrA−) up to a dose of 50 mg AA/plate, but acrylamide did show a strong positive
response in a Bacillus subtilis spore-rec assay (induced DNA damage) at 10–50 mg/disc. According to
the authors, the results suggested that AA had the potential to induce gross DNA damage rather than
point mutations detected by the Ames test. There are also studies demonstrating that after introducing
1%–3% acrylamide into the growth medium, Escherichia coli cells undergo various changes, such as
blockage of cell division, elongation of cells, inhibition of DNA synthesis, decreased osmotic stability,
and ultrastructural alterations of the outer membrane [15].
Taking into account eukaryotic cells, it is worth citing the research of Kwolek-Mirek et al. [16].
They demonstrated that acrylamide caused impairment of growth of Saccharomyces cerevisiae yeast
deficient in Cu, Zn-superoxide dismutase (Δsod1) in a concentration-dependent manner. This
inhibitory effect was not due to cell death but to decreased cell vitality and proliferative capacity.
Exposing Δsod1 yeast to acrylamide caused the increased generation of reactive oxygen species and
decreased glutathione levels.
It has also been proven that some microorganisms have the ability to use acrylamide as a carbon
and nitrogen source for their growth and that amidases are the main factor involved in AA degradation.
Amidases are enzymes (EC. 3.5.1.4) that occur ubiquitously in nature and are characterized by a broad
spectrum of catalyzed reactions [17]. Classification on the basis of catalytic activity takes into account
the substrate specificity profile of the particular amidase and divides known amidases into six classes.
During the amidase-catalyzed deamination reaction of acrylamide, acrylic acid and ammonia are
formed. Then, acrylic acid can be reduced to propionate or transformed into β-hydroxypropionate,
lactate, or CO2, in a pathway involving coenzyme-A [2,5,8].
To date, laboratory tests have shown the ability to degrade AA by many environmental
microorganisms, mainly bacteria, such as Ralstonia eutropha [18], Pseudomonas chlororaphis [19],
Enterobacter aerogenes [20], Pseudomonas aeruginosa [21,22], Bacillus cereus [23], Rhodococcus sp.,
Klebsiella pneumoniae [24,25], and Burkholderia sp. [26]. It is worth highlighting that among the amidase
producers are certain species that naturally occur in human organisms or are delivered with food,
such as Escherichia coli [27], Bacillus clausii [28], Enterococcus faecalis [29], and Helicobacter pylori [30,31].
However, the substrate specificity of their amidases and the potential for reaction with acrylamide
have not yet been confirmed. In some cases, it has even been proved that those bacteria produce only
cell wall amidases, such as N-acetylmuramoyl-L-alanine amidase [32], with no affinity to acrylamide.
Either way, there is a possibility that members of microbiota could degrade acrylamide directly in the
human intestine.
Lactic acid bacteria (LAB) constitute very important members of intestinal microbiota and
play an important role in proper organism functioning and maintenance of our health [33–36].
Representatives of LAB are also important in the food industry, both as starter culture added during
production and as native microbiota of raw materials used for food production [37–39]. The positive
role of LAB could also be related to their ability to reduce AA levels in organisms or foodstuffs.
To date, the possibility of degrading AA by amidase production has not been confirmed, although
synthesis of N-acetylmuramoyl-L-alanine amidase, involved in the degradation of peptidoglycan
and hydrolysis of the amide bond between N-acetylmuramic acid and L-amino acids of the bacterial
cell wall, has been reported in LAB [40,41]. Other studies [42,43] have shown that Lactobacillus reuteri
NRRL 14171 and Lactobacillus casei Shirota are able to remove acrylamide in aqueous solution by
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physically binding the toxin to the bacterial cell wall, probably with a significant role of the teichoic
acid structure. Later, Rivas-Jimenez [44] demonstrated that both mentioned bacterial strains were able
to remove dietary AA (commercial potato chips with an average AA content of ~34,000 μg/kg) under
different simulated gastrointestinal conditions. The percentage of AA removed by each bacterium
exposed to different concentrations of the toxin (10–350 μg/mL) had a similar tendency; the lower the
concentration of AA, the higher the percentage of toxin removed. The results showed that L. casei
Shirota showed a higher percentage (68%) of AA removed than L. reuteri (53%) when bacteria were
exposed to the lowest concentration of toxin (10 μg/mL), but no significant differences (p < 0.05) were
observed in the percentage of toxin removed by both strains (~2%) when ≥100 mg/mL of AA was
used. These findings proved that strains of the genus Lactobacillus could be employed to reduce the
bioavailability of dietary AA. However, the strong dependence on AA concentration suggests that the
mechanism of AA reduction is still the physical binding of AA by bacteria.
To the best of our knowledge, no one has investigated how acrylamide affects the viability
of lactic acid bacteria so far, and this is an important issue considering their important role in the
human body. First of all, lactic acid bacteria can be exposed to acrylamide just in food products.
There are many fermented milk products that contain various “additives” rich in AA, such as
biscuits, muesli, roasted almonds, nuts and seeds, dried fruit, breakfast cereals, and bran flake cereals.
Also, so-called pro-health foods, such as probiotic bars and cereals, contain live strains of LAB, as well
as crispy cereals, roasted nuts, almonds and seeds, almond and peanut butter, dried fruits, flakes, etc.
Moreover, intestinal LAB can also be exposed to dietary acrylamide after intake of various fried, grilled,
toasted, roasted, or baked foods. Although acrylamide is rapidly absorbed from the intestine, there are
studies suggesting that some food matrices (or components) can reduce the intestinal absorption of
AA. For example, a high protein concentration in the human diet may reduce acrylamide uptake [45],
causing unmetabolized acrylamide to reach the colon. Therefore, the aim of this study was to evaluate
whether acrylamide could influence the growth and viability of lactic acid bacteria belonging to the
Lactobacillus genus.
2. Materials and Methods
2.1. Bacteria
Pure cultures of lactic acid bacteria belonging to the Lactobacillus genus were used in the study.
For the experiments, 4 strains constituting a typical microbiota of fermented milk products and
2 probiotic strains were chosen: Lactobacillus plantarum DSMZ 20205, Lactobacillus brevis DSMZ 20054,
Lactobacillus lactis subsp. lactis DSMZ 20481, and Lactobacillus casei DSMZ 20011. All were purchased
from Leibniz Institut DSMZ (Deutsche Sammlung von Mikroorganismen und Zelkulturen GmbH,
Braunschweig, Germany). Two probiotic strains—Lactobacillus acidophilus LA-5 and L. casei LC01—were
obtained from Christian Hansen (Hørsolm, Denmark).
Bacteria were delivered as freeze-dried cultures and were handled according to supplier protocol.
Briefly, after opening the ampoule, bacteria were rehydrated and then transferred to a tube with sterile
liquid De Man, Rogosa, and Sharpe (MRS) agar medium (BioMaxima, Lublin, Poland) and incubated
at a temperature optimal for strain. For L. acidophilus LA-5 and both L. casei strains, the optimal
temperature was 37 ◦C, while, for other Lactobacillus species, it was 30 ◦C.
2.2. Measurement of Optical Density of Bacterial Suspension: Calibration
To tubes containing 5 mL of sterile MRS medium, a volume of 0.1 mL of 24-h liquid bacterial
culture was added, the contents were mixed, and the tubes were incubated for 24 h at the optimum
temperature for the tested strain. After incubation, bacterial cultures were centrifuged at 194× g
for 15 min (MPW-35JR centrifuge, MPW MED Instruments, Warsaw, Poland), and the supernatant
was discarded. The pellets were rinsed by mixing with 5 mL of sterile distilled water followed by
centrifugation (using previous parameters). The resulting pellets were resuspended in sterile water so
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as to obtain an optical density of the bacterial suspensions equal to McFarland standard 1.0 (using
a Den-1B densitometer, Biosan, Latvia). Then, serial 10-fold dilutions were made in sterile water,
and 1 mL of subsequent dilution was spread over the surface of the MRS medium (in triplicate).
After 72 h of incubation at an optimal temperature, bacterial colonies were counted, mean bacterial cell
density in cfu/mL from 3 replicates was calculated for each tested strain, and the relationship between
the optical density of McFarland = 1 and bacterial cell density was determined. The relationships
obtained for individual strains were as follows (1 McFarland unit equivalent): L. plantarum, 1.55 × 108
cfu/mL; L. brevis, 4.5 × 107 cfu/mL; L. lactis subsp. lactis, 1.6 × 108 cfu/mL: L. casei, 4.9 × 107 cfu/mL;
L. acidophilus LA-5, 4.45 × 107 cfu/mL; L. casei LC01, 4.8 × 107 cfu/mL. Before each experiment, a 24 h
culture of adequate Lactobacillus strain was centrifuged, washed in sterile water, and resuspended (as
described above). The optical density of the bacterial suspension was adjusted to a value corresponding
to 2 × 107 cfu/mL.
2.3. Model Medium for Experiments
All experiments were carried out in carbon- and nitrogen-limiting conditions because model
medium composed of 0.45% NaCl (POCh, Gliwice, Poland), and 0.45% bacteriological peptone
(BioMaxima, Lublin, Poland) was used. If a solid medium was required, bacteriological agar was
added in a final concentration of 2% (BioMaxima, Lublin, Poland). All media were sterilized using
a Microjet Microwave Autoclave (process parameters: 135 ◦C, 80 s, 3.6 bar; Enbio Technology Sp. z
o.o., Gdynia, Poland).
2.4. Preparation of Acrylamide “Stock” Solution
Concentrated (20 g/L) aqueous solution of acrylamide (purum, ≥98% (GC) provided by
Sigma-Aldrich Sp. z o.o, Poznan, Poland) was sterilized by filtering through a sterile membrane filter
(pore ϕ = 0.22 μm; PES Millex-GP, Bionovo, Poland) and diluted (if needed) with sterile distilled water
to obtain “stock” solutions of acrylamide (concentrations: 0.5, 1.0, 2.0, 5.0, 10.0, and 20.0 g/L).
2.5. Preliminary Assessment of Acrylamide Impact on Lactobacillus Growth
The impact of acrylamide on Lactobacillus was assessed by evaluating visible bacterial growth on
the solid model medium containing acrylamide at various concentrations: 10, 50, 100, 250, 500, and
1000 μg/mL. Serial 10-fold dilutions of the suspension of tested bacteria (2 × 107 cfu/mL) were made in
sterile water. Then, a volume of 1 mL of acrylamide “stock” solution of adequate concentration was
added to 18 mL of sterile, cooled, but still, liquid, model medium and poured into a sterile Petri plate
containing 1 mL of the diluted bacterial suspension. Positive controls were Petri plates with 19 mL of
the model medium (without acrylamide) mixed with 1 mL of a diluted suspension of tested bacteria.
After media solidification, all plates were incubated for 72 h at a proper temperature optimal for the
tested strain, and then the bacterial growth was assessed according to the following scale:
++++ very intense growth (colonies cover the whole surface, creating lawn plates)
+++ intense growth (too many colonies to count, but they are distinguishable)
++ good growth (30–300 colonies/plate)
+ only a few colonies (<30 colonies/plate)
− no growth
First, the growth of bacteria on plates with positive control was evaluated, and the dilution of
bacterial suspension with good growth (30–300 colonies/plate) was chosen. For the same dilution,
growth in the presence of AA was assessed. The experiment was performed in 5 replicates.
2.6. Determination of Cell Concentration and Viability by Flow Cytometry
The Lactobacillus strains whose growth was influenced by acrylamide in the preliminary analysis
were chosen for this stage of the experiment. A volume of 1 mL of bacterial suspension (containing
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2 × 107 cfu/mL) was inoculated into 19 mL of liquid model medium, with the addition of acrylamide
to a final concentration of 7.5, 15, 30, or 100 μg/mL, and incubated for 48 h. The final bacterial cell
density was 106 cells/mL, which corresponded to the average number of LAB cells found in fermented
milk drinks (FAO/WHO Food Standards). The proposed AA concentrations were selected based on
the literature [42,46], and the 100 μg/mL concentration is higher than the possible level reached in the
human gastrointestinal tract or in food products. The positive control was medium with 1 mL of sterile
distilled water added instead of an acrylamide “stock” solution (marked as 0 μg/mL). Immediately after
adding bacteria to the medium (marked as 0 h, but taking into account staining times and cytometric
measurement, the analysis was actually done about 2 h after adding the bacteria), after 24 h and 48 h of
incubation at an optimal temperature, the cell concentration (cell/mL) was evaluated by flow cytometry
(BD AccuriTM C6 Flow cytometer, BD Biosciences, Bio-Rad, Poland) equipped with fluorescence
detectors FL1 533/30, FL2 585/40, FL3 670LP. For this purpose, the commercially available BD™ Cell
Viability Kit with BD Liquid Counting Beads (cat. # 349480, Becton, Dickinson and Company, BD
Biosciences, San Jose, CA, USA) was used. According to the protocol, cells were stained with provided
dyes, and cytometric analysis was conducted using the following parameters: fluidic flow rate 14
μL/min, the threshold set at 10,000 on (Forward Scatter-Height), sample volume set at 10 μL. The
bacterial cells and counting beads were gated based on (Side Scatter) parameters and FL2, while the
populations of alive, injured, and dead bacteria were discriminated based on an FL1 (thiazole orange)
vs. FL3 (propidium iodide) plot. In live cells, the membrane is intact and impermeable to dyes, such as
propidium iodide (PI), while when cells are injured or dead, the propidium iodide can leak into the
cells because of their compromised membranes. PI is a nucleic acid intercalator, so it stains nucleic
acids. On the other side, thiazole orange is a permeant dye that also reacts with nucleic acids but enters
all cells—alive, injured, and dead, to varying degrees. Therefore, it will stain all cells containing nucleic
acids. Thus a combination of these two dyes provides a rapid and reliable method for discriminating
live, injured, and dead bacteria. To determine the concentrations of cell populations (expressed as
cell/mL), Equation (1) was used:
# o f events in cell region
# o f events in bead region
× # o f beads per test
∗
test volume
× dilution f actor = concentration o f cell population (1)
* This value was found on the vial of BD Liquid Counting Beads and could vary from lot to lot.
In the case of Lactobacillus plantarum, changes in cell morphology under the influence of acrylamide
were noted, which manifested in the form of cells with twice or several times stronger FL1 signal.
Analysis of microscopic preparations stained by the Gram method confirmed that they were Lactobacillus
plantarum cells appearing individually (bacillus), in pairs (diplobacillus), or in the form of chains
(streptobacillus).
2.7. Statistical Analysis
All experiments were carried out in 5 replicates, and results are expressed as mean ± standard
deviation (SD). When the impact of acrylamide on bacterial cell number was assessed, one-way analysis
of variance (ANOVA) with Tukey’s honest significant difference (HSD) posthoc test was used to
compare mean values and determine the significance of differences. The Brown–Forsythe test was
used to verify the hypothesis of homogeneity of variances, while Shapiro–Wilk test was used to test
the normality of distribution. A p-value < 0.05 was considered statistically significant. This part of
statistical analysis was carried out in Dell Statistica (Data Analysis Software System, version 13, 2016,
software.dell.com). Two-way ANOVA in a mixed model was used to assess data from flow cytometry,
which means the interrelationship of two independent variables (incubation times and acrylamide
concentrations) with a dependent variable (% of particular cell types), using IBM SPSS Statistics for
Windows (2017, Version 25.0; IBM Corp., Armonk, NY, USA). Bonferroni posthoc test was used, and the
differences were considered significant when p-value < 0.05.
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3. Results
3.1. Impact of Acrylamide on LAB Growth on Solid Medium
The model medium used for experiments was low nitrogen and low carbon; therefore, the growth
of Lactobacillus was significantly limited compared to the MRS medium. Acrylamide added to such
medium did not show bactericidal or bacteriostatic activity against tested bacteria from the Lactobacillus
genus even in very big concentrations, not reported in food (Table 1).
Table 1. Impact of acrylamide on the growth of Lactobacillus strains on solid medium.
Bacteria Strain AA Concentration (μg/mL)
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Scale: ++++ very intense growth (colonies cover whole surface creating lawn plates); +++ intense growth (too
many colonies to count, but they are distinguishable); ++ good growth (30–300 colonies/plate); + only a few colonies
(<30 colonies/plate); – no growth. AA, acrylamide.
Moreover, it was surprising that AA could stimulate the growth of L. plantarum and probiotic
strain L. acidophilus LA-5 at a concentration of 1000 μg/mL, while L. brevis and L. lactis sp. lactis growth
was more intense compared to control in the presence of 500 μg and 1000 μg of acrylamide per mL.
The acrylamide concentration used in that part of the study was much higher than that detected in
food. The concentrations of acrylamide reported in the literature vary from <10 to even 80,920 μg/kg,
with the highest levels in potato chips, French fries, roasted coffee, and coffee extract [44,47–50].
Considering the quantities of particular foodstuffs we consume each day, it has been estimated that
total AA uptake varies from 0.3 to 1.4 μg per kg body weight per day [48], depending on the age
group (high consumption of coffee in adults) and eating habits. In particular cases, it can reach up to
5 μg/kg/day [5].
The obtained results suggested that some lactic acid bacteria probably could utilize acrylamide as
a source of carbon and nitrogen if they lack in the environment (medium). The possibility of acrylamide
degradation (not binding) by LAB has been suggested by the results of a study conducted on rats fed
with acrylamide 3 h after consumption of four species of Bifidobacterium. A significant reduction in the
degree of liver damage [51] has been observed. Other studies have demonstrated that in portions of
potatoes prepared for French fries subjected to 15 min of fermentation before frying, the AA level is
reduced by 90% [52]. However, these results only confirm that lactic acid bacteria can utilize substances
that are precursors of acrylamide for their own use; the possibility of AA degradation by LAB has not
been studied.
Another strategy to reduce acrylamide formation in bread was proposed by Nachi et al. [53]
by using selected lactic acid bacteria strains for dough fermentation. When the LAB was used to
inoculate sourdough, the acrylamide concentration in the bread was reduced. This was due to the
lower pH of the LAB-inoculated sourdough after fermentation for 16 h compared to the spontaneous
sourdough (using only baker’s yeast). The acidification was accompanied by a significant increase in
the concentration of reducing sugars, which were then used as electron acceptors by LAB and reduced
to mannitol. The lack of sugar and low pH prevented the Maillard reaction. The most pronounced
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reduction of acrylamide formation (by 84.7%) was obtained in bread made with Pediococcus acidilactici
strain S16.
3.2. Impact of AA on Lactic Acid Bacteria Concentration in Medium
Three LAB strains were chosen for further experiments: L. brevis, L. plantarum, and probiotic strain
L. acidophilus LA-5. The bacteria concentration was measured by flow cytometry immediately and after
24 h and 48 h of acrylamide addition at various concentrations (Figure 1). The number of bacteria cells
in the medium was determined according to Equation (1) using the number of events in the bacteria
and bead regions and expressed as cell number per 1 mL.
Figure 1. Impact of acrylamide (AA) concentration in medium (0, 7.5, 15, 30, and 100 μg/mL) on
bacterial cell number in culture (cells/mL) determined by cytometric method immediately after AA
addition and after 24 h and 48 h incubation. (A) L. acidophilus LA-5, (B) L. brevis, (C) L. plantarum. Values
in graphs with different letters differ from each other at the level of p < 0.05 (Tukey’s HSD test).
Already at 0 h, some influence of AA on the number of bacteria in the limiting medium could
be seen. It should be recalled that preparing cells for cytometric analysis takes about 2 h from the
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addition of AA to the medium, so the bacteria have time to change their metabolism and can already
start using AA as a source of carbon or nitrogen. The presence of AA in the medium resulted in
a decrease in L. brevis number after 24 h and 48 h incubation, but not significantly correlated with the
AA concentration used (Figure 1B). For L. acidophilus LA-5, differences in population size compared
to controls and between AA doses were not statistically significant (Figure 1A). The initial increase
in cell number in the sample with 7.5 μg AA might have resulted from the use of small amounts of
AA, but the concentration was too low to guarantee adequate conditions for bacterial growth and
multiplication over a longer period of time. After 24 h, very large fluctuations in culture were reported,
but after 48 h, the observed differences were not statistically significant, except for incubation in the
presence of 15 μg/mL AA, when LA-5 was lower than in other samples.
These results suggested that L. acidophilus LA-5 was sensitive to AA because of decreased
cell numbers, which would be consistent with the results of studies on other bacteria.
However, these studies have used a medium-low in nitrogen and carbon, and not, as in most other
studies, an optimal medium for LAB growth. Therefore, the LAB number also decreased in the
medium without the addition of AA. This environment is, therefore, ideal for assessing the impact
of AA in the absence of other, more absorbable sources of carbon and nitrogen. In milk, lactic acid
bacteria use casein as a source of amino acids, thanks to having appropriate proteolytic enzymes [54].
Gene encoding the cell-wall bound proteinase (PrtP) is only found on the chromosome of L. acidophilus;
neither L. plantarum nor L. brevis [55] has it. Also, some peptidases are unique to individual species.
The presence of these enzymes, however, is important primarily in the environment typical for these
microorganisms (milk) and affects the rate of multiplication of individual bacteria due to various
assimilation possibilities of proteins available in the environment, as well as the final effect of the
fermentation process, including the resulting secondary metabolites.
In the medium used in this experiment, the only source of carbon and nitrogen was 0.45% of
peptone obtained as enzymatic meat tissue hydrolysate, while, in MRS, usually about 2.5% of nitrogen
compounds and 2% glucose are present. Furthermore, L. acidophilus and L. brevis possess all three
known LAB peptide transport systems: the di/tripeptide Dpp and DtpT systems and the oligopeptide
Opp system [55]. LAB are auxotrophs relative to amino acids, and, depending on the species, they can
synthesize only a few amino acids, while the others must be provided with the medium. This means
that a medium-low in protein and amino acids will quickly become a factor that limits bacterial growth
because bacterial growth and multiplication require the assimilation of substrates to supply the cell
with the necessary energy, carbon, and nitrogen to build new structures. That is why the ability to
degrade acrylamide to be used as a source of nitrogen (released by NH4+ amidase) and carbon was so
important in this experiment.
It should be recalled that in this part of the study, all cells were counted: those that were alive and
able to function properly and further divide, those that were damaged and whose metabolism was
temporarily switched to repair the damage, and dead cells that had not yet broken down.
The situation differed in the case of L. plantarum (Figure 1C). After 24 h in the control medium
without AA, an increase in the number of bacteria was observed; however, by analyzing their
morphology, it was clear that this correlated with the grouping type in which these cells occurred.
In the initial population (0 h), 92.55 ± 0.08% of cells appeared as single bacilli and 7.41 ± 0.08% as
diplobacilli, while no streptobacilli were observed. After 24 h, the number of cells in culture without
AA increased slightly; however, this was mainly due to the fact that the diplobacilli split into single
cells. A lack of division meant that after another 24 h, 99% of the population were single rods, and their
numbers significantly decreased compared to the initial value.
3.3. Acrylamide Impact on LAB Viability
Cell concentration and viability were measured by flow cytometry immediately and 24 h and
48 h after acrylamide addition at various concentrations. Populations of dead, injured, and alive
bacteria were discriminated based on fluorescence signal after staining with thiazole orange (FL1) and
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propidium iodide (FL2) provided in the assay. The concentrations of various cell populations were
determined using counting beads.
First, it was checked whether incubation time, regardless of acrylamide concentration,
had a significant impact on the percentages of specific cell types (main effect of incubation time).
All tested main effects of incubation time were statistically significant, except for dead cells of
Lactobacillus brevis (Table 2). The viability of L. brevis increased after AA addition, while the percentage
of injured cells was significantly diminished. Contrary to that was the viability of Lactobacillus
acidophilus LA-5. The highest percentage of live cells was at the beginning of the experiment, while the
lowest was after 24 h. Tracking changes in the percentage of injured cells, it appeared that some were
repaired, and after 48 h, they were considered to be fully viable. Moreover, some dead cells underwent
autolysis, and the cell content released in the medium was utilized by survivors. Lactic acid bacteria
are characterized by differentiated autolytic activity, but the process allows them to eliminate weak or
impaired cells from the population [56]. In the mentioned study, L. plantarum strains were autolyzed
more than other LAB strains; however, the authors did not test the autolytic activity of L. brevis or
L. acidophilus [56]. It is well known that some lactic acid bacteria can undergo enzymatic cleavage
of cell wall peptidoglycans by peptidoglycan hydrolases present in the bacterial cells and that the
autolysis depends on factors, such as carbon source, temperature, osmotic concentration, and pH [56].
It has also been demonstrated that N-acetylmuramidase has a critical function in Lactobacillus bulgaricus
autolysis [57] as one of the major degraders of the cell wall.
Table 2. The main effect of incubation time: impact of time on percentage of specific cell types,
regardless of AA concentration.
Bacteria Strain % of Cells
Time
F p
0 h 24 h 48 h
Lactobacillus
acidophilus LA-5
alive 99.6 ± 0.35 a 91.92 ± 2.08 b 93.04 ± 3.43 c 761.35 <0.001
injured 0.39 ± 0.35 a 6.60 ± 1.85 b 5.34 ± 2.57 c 937.62 <0.001
dead 0.02 ± 0.02 a 1.48 ± 0.48 b 1.63 ± 0.93 b 183.83 <0.001
Lactobacillus brevis
alive 98.76 ± 0.27 a 99.51 ± 0.25 b 99.54 ± 0.10 b 107.44 <0.001
injured 0.89 ± 0.26 a 0.16 ± 0.06 b 0.14 ± 0.03 b 227.62 <0.001
dead 0.35 ± 0.03 0.33 ± 0.20 0.32 ± 0.08 0.47 0.630
Lactobacillus
plantarum
alive 97.42 ± 0.51 a 97.62 ± 0.89 a 95.09 ± 1.23 b 143.33 <0.001
injured 1.00 ± 0.17 a 1.20 ± 0.36 b 3.70 ± 1.33 c 851.52 <0.001




bacillus 95.09 ± 2.35 a 98.15 ± 0.50 b 73.46 ± 15.96 c 3358.82 <0.001
diplobacillus 4.91 ± 2.35 a 1.77 ± 0.50 b 24.03 ± 13.47 c 2909.62 <0.001
streptobacillus 0 ± 0.01 a 0.08 ± 0.02 b 2.52 ± 3.18 c 1078.97 <0.001
a, b, c—Means indicated with different letters differ from each other at the level of p < 0.05 (Bonferroni test).
Values given are mean ± SD of the percentage of cells of a certain type.
In our experiment, the percentage of live L. plantarum cells was significantly lower after 48 h than
at the beginning or after 24 h. Moreover, significant differences in L. plantarum morphology were
observed. After 48 h of incubation in the presence of acrylamide, fewer cells were present in the form of
single bacilli, while the amounts of diplobacilli and streptobacilli were significantly increased (Table 2
and Figure 2). Such an effect was not observed in other LAB strains.
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Figure 2. Impact of acrylamide concentration on the morphology of Lactobacillus plantarum. (A) 0 h,
(B) 24 h, (C) 48 h.
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Then, it was tested whether the acrylamide concentration, regardless of the time of incubation,
had a significant effect on the percentage of specific cell types (alive, injured, dead) or L. plantarum
morphology (main effect of acrylamide concentration). The ANOVA results are presented in Table 3
and posthoc tests in Table 4.
Table 3. The main effect of acrylamide concentration: influence of acrylamide concentration on the




























































































































(0.01) a 420.58 <0.001
a, b, c—Means with different letters differ from each other at the level of p < 0.05 (Bonferroni test).
The analysis showed that the main effect of acrylamide concentration did not occur in the L. brevis
strain, which meant that in this case, acrylamide (regardless of the incubation time) had no effect on
their viability. The AA impact was observed in other tested strains and when the morphology of
L. plantarum was taken into account. Posthoc analysis showed that acrylamide significantly increased
the percentage of alive cells of L. acidophilus LA-5 strain, but this was only observed at a concentration
of 30 μg/mL and was accompanied by a significant decrease in the number (percentage) of injured
cells. In the L. plantarum strain, acrylamide at each concentration significantly reduced viability while
also significantly increasing the number of injured cells. In addition, morphological examination of
L. plantarum showed a decrease in the proportion of single cells (bacilli), mainly in favor of increasing
their frequency in pairs (diplobacilli). The number of cells in the form of chains (streptobacillus) also
increased, but to a lesser extent.
Finally, the interaction effects (simultaneous impact) of incubation time and acrylamide
concentration were tested. Acrylamide significantly increased the viability of L. acidophilus LA-5
cells at a concentration of 30 μg/mL after 24 h incubation and at 0, 30, and 100 μg/mL after 48 h,
when compared to the model medium without acrylamide (Table 5). The increase in alive cells was
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mainly accompanied by a reduction in injured cells, rather than dead ones. In turn, the viability of
L. acidophilus LA-5 decreased at an acrylamide concentration of 15 μg/mL after 48 h.























0 vs. 7.5 −0.93 0.182 0.68 0.197 0.26 0.898
0 vs. 15 0.38 1.000 0.03 1.000 −0.42 0.093
0 vs. 30 −3.32 <0.001 2.91 <0.001 0.42 0.093
0 vs. 100 −1.10 0.067 0.95 0.020 0.15 1.000
Lactobacillus
brevis
0 vs. 7.5 −0.19 0.187 0.12 0.332 0.06 1.000
0 vs. 15 −0.16 0.460 0.13 0.223 0.02 1.000
0 vs. 30 −0.09 1.000 0.01 1.000 0.08 0.724
0 vs. 100 −0.19 0.180 0.08 1.000 0.10 0.197
Lactobacillus
plantarum
0 vs. 7.5 1.05 0.002 −0.78 <0.001 −0.27 1.000
0 vs. 15 1.97 <0.001 −1.57 <0.001 −0.40 0.186
0 vs. 30 1.30 <0.001 −1.19 <0.001 −0.11 1.000




0 vs. 7.5 10.04 <0.001 −9.05 <0.001 −1.00 <0.001
0 vs. 15 6.60 <0.001 −6.34 <0.001 −0.27 0.034
0 vs. 30 14.52 <0.001 −11.78 <0.001 −2.74 <0.001
0 vs. 100 8.20 <0.001 −8.19 <0.001 −0.01 1.000
* In a morphological study, percentages of bacillus, diplobacillus, and streptobacillus cells were compared.
Table 5. The interaction effect of incubation time and concentration of acrylamide on the viability of





















0 vs. 7.5 −0.10 <0.001 0.08 0.001 0.02 1.000
0 vs. 15 0.01 1.000 −0.02 1.000 0.01 1.000
0 vs. 30 −0.02 0.334 0.01 1.000 0.01 1.000
0 vs. 100 0.83 <0.001 −0.83 <0.001 0 1.000
24
0 vs. 7.5 0.58 1.000 −0.38 1.000 −0.20 1.000
0 vs. 15 −2.15 0.149 2.23 0.015 −0.08 1.000
0 vs. 30 −3.89 0.001 3.83 <0.001 0.06 1.000
0 vs. 100 0.02 1.000 0.27 1.000 −0.29 1.000
48
0 vs. 7.5 −3.28 <0.001 2.33 <0.001 0.96 0.003
0 vs. 15 3.29 <0.001 −2.12 <0.001 −1.17 <0.001
0 vs. 30 −6.06 <0.001 4.88 <0.001 1.18 <0.001
0 vs. 100 −4.13 <0.001 3.40 <0.001 0.73 0.029
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In the case of Lactobacillus brevis, acrylamide at each concentration decreased the percentage of
injured cells after 24 h and 48 h incubation (compared to control), although a statistically significant
reduction in the percentage of alive bacteria was observed only after 48 h at 100 μg/mL (Table 6).
All other changes were not statistically significant.
Table 6. The interaction effect of incubation time and concentration of acrylamide on the viability of





















0 vs. 7.5 −0.11 1.000 0.15 1.000 −0.04 0.365
0 vs. 15 −0.20 1.000 0.21 1.000 −0.01 1.000
0 vs. 30 0.19 1.000 −0.15 1.000 −0.04 0.561
0 vs. 100 −0.06 1.000 0.06 1.000 0.00 1.000
24
0 vs. 7.5 −0.32 0.435 0.15 <0.001 0.16 1.000
0 vs. 15 −0.17 1.000 0.12 0.001 0.05 1.000
0 vs. 30 −0.29 0.633 0.12 0.001 0.17 1.000
0 vs. 100 −0.33 0.401 0.13 <0.001 0.20 1.000
48
0 vs. 7.5 −0.13 0.352 0.06 0.004 0.06 1.000
0 vs. 15 −0.10 1.000 0.06 0.001 0.03 1.000
0 vs. 30 −0.15 0.121 0.05 0.015 0.10 0.540
0 vs. 100 −0.18 0.046 0.06 0.004 0.12 0.277
After 24 h and 48 h of incubation in the presence of acrylamide at concentrations higher than
7.5 μg/mL, reduced viability of L. plantarum cells was observed, while the number of injured cells
increased compared with medium without acrylamide (Table 7).
Table 7. The interaction effect of incubation time and concentration of acrylamide on the viability of





















0 vs. 7.5 1.01 0.009 −0.09 1.000 −0.92 0.002
0 vs. 15 0.75 0.098 −0.21 0.373 −0.53 0.149
0 vs. 30 0.44 1.000 −0.04 1.000 −0.39 0.648
0 vs. 100 0.48 0.789 −0.26 0.115 −0.22 1.000
24
0 vs. 7.5 1.00 0.153 −0.55 0.001 −0.45 1.000
0 vs. 15 2.08 <0.001 −0.88 <0.001 −1.20 0.007
0 vs. 30 1.46 0.010 −0.77 <0.001 −0.69 0.311
0 vs. 100 1.44 0.011 −0.37 0.049 −1.07 0.019
48
0 vs. 7.5 1.12 0.260 −1.70 <0.001 0.57 0.481
0 vs. 15 3.07 <0.001 −3.61 <0.001 0.53 0.652
0 vs. 30 2.00 0.004 −2.76 <0.001 0.76 0.115
0 vs. 100 1.58 0.028 −1.10 0.001 −0.48 0.911
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We observed that the morphology of one of the tested bacteria, Lactobacillus plantarum,
was significantly influenced by acrylamide. Based on the fact that cells with both twofold and several
times stronger FL1 fluorescence signal (thiazole orange) appeared in the population, we concluded
that acrylamide did not inhibit or even stimulate the division of L. plantarum but blocked cell
separation; hence bacteria in the form of diplobacilli and streptobacilli were present in the population.
This conclusion was confirmed by microscopic preparations. A statistically significant reduction in
the number of single rods (bacilli) in the presence of AA in amounts of 7.5 and 15 μg/mL after 24 h
incubation and in all AA concentrations after 48 h was demonstrated compared to the medium without
acrylamide. This was mainly accompanied by a significant increase in the number of cells found in pairs
(diplobacilli) and to a much lower extent in chains (streptobacilli). For each analyzed concentration of
AA, this increase was especially significant after 48 h, reaching even ~50% at 30 μg/mL (Table 8).
Table 8. The interaction effect of incubation time and concentration of acrylamide on the morphology





















0 vs. 7.5 −1.51 1.000 1.52 1.000 0 1.000
0 vs. 15 −2.77 0.140 2.77 0.140 0 1.000
0 vs. 30 −5.42 <0.001 5.42 <0.001 0 1.000
0 vs. 100 −2.82 0.127 2.81 0.127 0 1.000
24
0 vs. 7.5 0.87 0.024 −0.86 0.023 −0.01 1.000
0 vs. 15 0.98 0.008 −0.98 0.007 0 1.000
0 vs. 30 0.59 0.280 −0.57 0.313 −0.02 0.417
0 vs. 100 0.48 0.692 −0.45 0.791 −0.02 0.598
48
0 vs. 7.5 30.77 <0.001 −27.80 <0.001 −2.98 <0.001
0 vs. 15 21.60 <0.001 −20.81 <0.001 −0.80 0.033
0 vs. 30 48.37 <0.001 −40.18 <0.001 −8.19 <0.001
0 vs. 100 26.95 <0.001 −26.93 <0.001 −0.01 1.000
4. Discussion
In this study, we demonstrated that the tested lactic acid bacteria strains were tolerant of acrylamide
even at high concentrations (up to 1 g/mL). Moreover, the growth of Lactobacillus plantarum, L. lactis sp.
Lactis, and L. brevis, as well as probiotic strain L. acidophilus LA-5, was more intense in the presence of
acrylamide at high concentration than in medium with limited accessibility of carbon and nitrogen
compounds. The obtained results suggested that: (1) acrylamide had no toxic impact on LAB; (2) some
lactic acid bacteria probably could utilize acrylamide as a source of carbon and nitrogen if they lack
in the environment/medium. Of course, fermented milk beverages and the human gut cannot be
considered nutrient-poor environments, as the availability of easily digestible food for bacteria is large,
but the possibility of using acrylamide by lactic acid bacteria might be beneficial for both bacteria and
the human intestine where the LAB reside.
Our results proved that acrylamide not only influenced the number of lactic acid bacteria but also
their viability. The impact of acrylamide on LAB viability depended on both the AA concentration and
the bacteria species. First of all, when the impact of incubation time on bacterial viability was analyzed,
all the main effects were statistically significant, except the percentage of dead cells of Lactobacillus brevis.
Secondly, the main effect of acrylamide concentration on the percentage of alive, injured, and dead
cells was not observed only in L. brevis. This suggested that L. brevis was less sensitive to acrylamide
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among the tested bacteria strains, and it was confirmed in the further analysis as almost all observed
differences were not statistically significant.
The posthoc tests showed that acrylamide caused a significant increase in the percentage of alive
cells of probiotic strain L. acidophilus LA-5 at an AA concentration of 30 μg/mL compared to the cultures
without AA. This increase was mainly accompanied by a reduction in the number of injured cells rather
than dead ones. On the other side, acrylamide reduced the viability of L. plantarum cells after 24 h and
48 h incubation at each AA concentration except 7.5 μg/mL, simultaneously increasing the amount of
injured cells. Moreover, we observed a strong influence of acrylamide (especially at a concentration
of 30 μg/mL) on the morphology of bacteria only in L. plantarum. Based on the fact that cells with
both twofold and several times stronger FL1 fluorescence signal (thiazole orange) appeared in the
population, we concluded that acrylamide had no impact on the division of L. plantarum, but at the
same time, it inhibited cell separation, as cells in the form of diplobacilli and streptobacilli were present
in the population (confirmed in microscopic preparations). This suggested that in this case, acrylamide
could have a harmful or even mutagenic impact on L. plantarum.
It is known that many proteins and hydrolytic enzymes are involved in the proper growth and
division of bacteria. Various enzymes participate in turnover (remodeling) of peptidoglycan, and their
proper activity and specificity are critical, as bacterial division requires both localized hydrolysis and de
novo biosynthesis of the peptidoglycan layer. For example, amidase and glucosaminidase displaying
murein hydrolase activity are necessary for the generation of the equatorial ring on the staphylococcal
cell surface and complete cell division and separation [58]. Escherichia coli division requires the activity
of amidases—AmiA, AmiB, and AmiC [59]. It is important that muralytic enzymes distinguish elements
of peptidoglycan of specific species. Generally, these enzymes are secreted into the surrounding
medium, so they need to distinguish between the cell walls of other species and their own. It seems
likely that the targeting mechanisms of murein hydrolases employ species-specific receptors for either
physiological cell-wall turnover or the bacteriolytic killing of competing microorganisms [58,60,61].
Most Gram-positive bacteria contain a structurally similar peptidoglycan layer [62]. Thus, targeting of
muralytic enzymes cannot be achieved by simple enzyme-substrate interactions but requires specific
surface receptors [63]. For example, choline within teichoic acid moieties serves as a receptor for the
LytA enzyme of Streptococcus pneumoniae [64]. A mutant of S. pneumoniae showing complete deletion in
the lytA gene coding for N-acetylmuramyl-L-alanine amidase has been isolated. It shows a normal
growth rate, and the most remarkable biological consequences of the absence of amidase are the
formation of short chains (six to eight cells) and the absence of lysis in the stationary phase of growth.
In our study, L. plantarum morphology changed in the presence of acrylamide, and bacteria started
to form diplobacilli and streptobacilli. It is possible that acrylamide reacted with the active site of
muralytic amidases and, therefore, blocked cell separation during division.
Different influence of AA on Lactobacillus species tested in the study could also be caused by
the diversity of their teichoic acid (TA) structure. Teichoic acids in lactic acid bacteria consist of
poly(ribitol phosphate) polymers with attached glucose, D-alanine, and/or glycerol molecules, among
others [43]. Their structure is highly variable; thus, even closely related strains can differ in their ability
to bind toxins. This is coincident with our results, showing that L. brevis was less and L. plantarum
most sensitive to acrylamide among tested LAB strains. Serrano-Nino et al. [43] proved a significant
correlation between the binding percentage of acrylamide and the content of some constituents of cell
wall TAs. They proposed that H-bonds could occur between the carbonyl oxygen and the amino group
(NH ··· OC) between adjacent acrylamide and D-alanine attached to the ribitol. Moreover, the amine
group of D-alanine might react with acrylamide units by means of a Michael addition, while hydrogen
bonds might also occur between carbonyl (C=O) oxygens of acrylamide and the hydroxyl groups
of glucose residue or glycerol phosphate substituents attached to the poly (ribitol phosphate) chain.
Moreover, they demonstrated that acrylamide binding to teichoic acids in Lactobacillus was irreversible.
The role of teichoic acids in cell division and morphogenesis has been investigated in some
bacteria species, and it appears that wall teichoic acids (WTAs) are involved in elongation of bacteria,
140
Nutrients 2020, 12, 1157
while lipoteichoic acids (LTAs) participate in the cellular division [65]. By obtaining the mutants of
L. plantarum, it has been revealed that WTAs are not essential for survival, but they are required for
proper cell elongation and cell division [66]. Therefore, the reaction of acrylamide with teichoic acids
could impede division and cause that L. plantarum remains in the form of chains and diplobacillus.
Studies of Zhang [67] showed that the ability of acrylamide binding also depended on the
peptidoglycan structure. The peptidoglycan of L. plantarum (strain 1.0065) had the highest affinity
for AA binding (87.14%), whereas peptidoglycans of L. casei ATCC393 and L. acidophilus KLDS1.0307
showed lower affinity (75.50% and 56.75%, respectively). This binding ability of L. plantarum positively
correlated with the carbohydrate content in peptidoglycan and the contents of four amino acids
(alanine, aspartic acid, glutamic acid, and lysine). Additionally, it was demonstrated that C–O
(carboxyl, polysaccharides, and arene), C=O amide, and N–H amines groups were involved in the
AA binding.
Analyzing the interaction of acrylamide with peptidoglycan, one should take into account the
differences in the structure of cell wall stem peptides. The amino acid sequence of stem peptide
involved in linking glycan chains in LAB peptidoglycan is L-Ala–D-Glu–X–D-Ala. The third amino acid
(X) is a diamino acid, which in LAB usually is L-Lys (e.g., L. lactis and most lactobacilli), but can also
be meso-diaminopimelic acid (mDAP) (e.g., in L. plantarum) or L-ornithine (e.g., in L. fermentum) [62].
Peptidoglycan with mDAP is typical for Gram-negative bacteria, and in such cell walls, a direct
cross-connection between neighboring stem peptides takes place (the mDAP in position 3 of one peptide
chain binds to D-Ala in position 4 of another chain). In lactic acid bacteria with Lys-type peptidoglycan,
an additional interpeptide bridge made of one D-amino acid (e.g., D-Asp or D-Asn in L. lactis, L. casei,
and most lactobacilli) is included [62]. It means that the structure of L. plantarum is unusual among LAB
peptidoglycans, and it is different from the structure of other tested species. Additionally, this bacterium
is characterized by a unique process among bacteria—O-acetylation of peptidoglycan [66]—which
has an impact on L. plantarum autolysis. O-acetylation of N-acetylglucosamine (GlcNAc) inhibits
the N-acetylglucosaminidase Acm2 (which is required for the ultimate step of cell separation of
daughter cells), while O-acetylation of N-acetylmuramic acid (MurNAc) has been shown to activate
autolysis through the activity of the N-acetylmuramoyl-L-alanine amidase LytH [68]. It is possible
that acrylamide interacts with the mentioned enzymes (amidases) and hence influences cell division
and separation. In our study, we observed that in the presence of AA, the L. plantarum morphology
was changed, i.e., the percentage of cells in pairs or chains increased. It is worth mentioning that
in L. plantarum, almost all the mDAP side chains are amidated. Defects of mDAP amidation in the
L. plantarum mutant strain strongly affect the growth and cell morphology, causing filamentation
and long-chain formation, suggesting that mDAP amidation may play a critical role in controlling
the septation process [69]. Further studies are needed to explain whether acrylamide interacts with
the amidation of mDAP or the activity of muralytic amidases. It is also possible that the presence
of AA in low-carbon and low-nitrogen medium induces the synthesis of other amidases necessary
for acrylamide degradation to acrylic acid and ammonia, but also able to cleave the amide bound in
mDAP, influencing cell morphology.
The impact of acrylamide on LAB morphology should also be discussed in terms of the importance
of bacterial aggregation on their functioning. First of all, bacterial aggregation (auto-aggregation)
may facilitate biofilm formation by favoring bacterial attachment to surfaces or other microbes
(co-aggregation). It also implicates better survival of LAB in the gut. Some studies indicate that
biofilms are a stable point in a biological cycle that includes initiation, maturation, maintenance, and
dissolution. According to O’Toole et al. [70], microbe development involves changes in form and
function that play prominent roles in the life cycle of the organism, and biofilm formation is a prominent
part of the lifestyle of microbes. Moreover, bacteria seem to initiate the development of biofilm in
response to specific environmental conditions, such as nutrient availability. It has been proposed
that the starvation response pathway can be subsumed as a part of the overall biofilm development
cycle [70]. Secondly, when growing in biofilm, organisms become more resistant to higher deliverable
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levels of antibiotics or other antimicrobial compounds compared to single “suspended” cells [71].
The last matter is that aggregation and co-aggregation among bacteria are important in the prevention
of colonization of surfaces by pathogens. It has been proved that some lactic acid bacteria are also able
to control biofilm formation by pathogens and can, therefore, prevent the colonization of food-borne
pathogens [72]. It is true, for example, for some Lactobacillus plantarum strains showing an aggregation
phenotype [73].
5. Conclusions
In conclusion, we can assume that the tested strains of lactic acid bacteria found in the human
digestive tract or in fermented milk drinks are tolerant to high concentrations of acrylamide (up to
1 g/mL). Some show better growth in medium with AA than in medium with limited carbon and
nitrogen sources, suggesting the possibility that they use AA for their own metabolism. Of course,
in the digestive tract, especially in the initial sections of the intestine, there is sufficient availability of
easily digestible food, but the possibility of using AA is beneficial for both the lactic acid bacteria and
the human in whose intestine the LAB resides.
Moreover, we can assume that eating AA-containing products with a properly functioning
microbiota will be less harmful to human organs than previously thought. It is also good information
for producers of food (e.g., yogurt) with the addition of AA-containing ingredients, such as roasted
coffee, almond or nuts, muesli, baked biscuits, or cornflakes because it should not negatively affect the
microorganisms necessary for their production.
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Abstract: Cichoric acid (CA) belongs to the group of polyphenols, which occurs in a variety of
plant species and it is characterized by anticancer, antibacterial, and antiviral properties. Selected
polyphenols have the ability to combine with metal ions to form chelate complexes that reveal greater
biological activity than free compounds. In order to study possible antimicrobial and anticancer effect
of CA and its complexes with copper(II)/zinc(II)/nickel(II)/cobalt(II) we decided to conduct cytotoxicity
tests to estimate the most effective concentrations of tested compounds. The results of the presented
study demonstrated, for the first time, that the treatment with newly synthesized CA-metal complexes
has anticancer and antimicrobial effects, which were examined in seven different cell lines: MCF-7,
MDA-MB-231, and ZR-75-1 breast cancer cell lines, A375 melanoma cell line, DLD-1 cell line, LN-229
cell line, FN cell line; five bacterial strains: Escherichia coli, Pseudomonas aeruginosa, Staphylococcus
epidermidis, Proteus vulgaris, Lactobacillus rhamnosus, yeast Sacchcaromyces boulardii, and pathogenic
yeast-like fungi Candida albicans. The presented study indicates that CA-metal complexes could be
considered as a potential supplementary tool in anticancer therapy, however, because of their possible
toxic activity on fibroblasts, they should be used with caution. Some of the tested complexes have
also preservative properties and positive influence on normal non-pathogenic microorganisms, which
was demonstrated in selected microbial strains, therefore they may serve as food preservatives of
natural origin with cytoprotective properties.
Keywords: cichoric acid; metal complexes; cytotoxicity; cancer; bacterial strains; fungi; human
cell culture
1. Introduction
Cichoric acid belongs to the group of polyphenols and according to its chemical formula it is
a dicaffeyltartaric acid, a tartaric acid ester of two caffeic acids (a hydroxycinnamic acid). Because
of its biological properties it is a very promising natural compound, which occurs in a variety of
plant species such as Cichorium intybus L., Ocimum basilicum L., Bidens tripartita L., Crepis capillaris L.
Wallr., Lactuca sativa L., Taraxacum officinale F.H. Wigg., Cucurbita pepo L., Equisetum hybrids, Borago
officinalis L., Posidonia oceanica L. Delile, Rabdosia rubescens, and Echinacea purpurea [1]. According to
the literature data cichoric acid plays an important role in plant defense against different diseases
caused by viruses, bacteria, fungi, nematodes, and insects [2,3]. A variety of phenolics, including
cichoric acid, are being investigated for their possible human health benefits. Cichoric acid (CA) is
one of the polyphenol compounds with strong antioxidant capacities. It also exhibits free radical
scavenger properties, antiviral and phagocyte promoting activity, and it protects selected structural
Nutrients 2020, 12, 154; doi:10.3390/nu12010154 www.mdpi.com/journal/nutrients147
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proteins, such as collagen, against free radical damage [4]. CA has many biological activities including
anti-inflammatory, antiatherosclerotic, and antidiabetic properties, which were confirmed in mouse
models. Animal diabetes models indicated that CA significantly influenced insulin sensitivity, glucose
tolerance, mitochondrial function, and hyperglycemia in obese mice [5–7].
Among the tested substances of natural origin, the ones that can be used in food as preservatives
or pharmaceutical industry are the most popular. This is important in the context of the negative effects
of drugs on human health and the increasing resistance of microorganisms to commercially available
drugs and preservatives [1,8]. In addition, commonly used food preservatives such as nitrates, sodium
benzoate, or monosodium glutamate may have potentially harmful effects on human health. Therefore,
new alternatives that are easily accessible, safe for humans, and exhibiting antimicrobial activity are
highly desirable in food industry and pharmacy. Candida albicans, Escherichia coli, Proteus vulgaris,
Pseudomonas aeruginosa, and Staphylococcus epidermidis are examples of pathogen indicators that
determine food quality and safety [8].
However, to date, a direct effect of metal complexes of CA on human cancer cells, normal healthy
cells, and bacterial strains have not been investigated. Considering the stability of polyphenols, it is
usually higher after binding them to a metal ion [5,9]. Also anticancer activity of metal complexes is
widely used in therapy of different types of cancer; however, the utility of metal-polyphenols complexes
as anticancer agents is yet to be fully realized, especially regarding some of the polyphenols such as
cichoric acid [9].
According to the literature data, selected polyphenols have the ability to combine with metal
ions to form chelate complexes that reveal greater biological activity than free compounds [10–12].
Out of all ions, copper seems very interesting and promising because of its biological importance and
properties. It is essential in the photosynthesis process and respiration and it consists of an active
center of many enzymes [13,14]. Therefore copper was one of the metals subjected to our research
to determine biological activity of its complexes with CA. In complexes with fisetin–polyphenolic
compound from the group of isoflavonoids, it revealed high antibacterial and antifungal activity [14].
On the other hand copper complexed with resveratrol acts as a factor, which promotes fragmentation
of nuclear DNA in human cells [15]. Oleuropein, which is a non-flavonoid polyphenol, shows copper
complexing properties and these copper–oleuropein complexes are probably involved in the toxic
activity of analyzed polyphenolic compounds towards neuroblastoma cells, depending on their copper
level [16]. The other important and biologically active metal ion which forms chelate complexes with
polyphenolic compounds is zinc. Dias K et al. suggested that the combination of zinc with resveratrol
enhances antioxidant activity of the polyphenolic compound [17]. The flavonoid derivative kaempferol
in 1:1 coordination with Zn(II) increased phenol acidity of plant polyphenols. It may explain the very
important and unique function of Zn(II) as a biologically active antioxidative compound and may help
in designing new metal–polyphenol complex-based drugs derived from naturally occurring bioactive
molecules [18].
Antioxidative, anti-inflammatory, and neuroprotective properties of polyphenols have been
known for many years, but the discovery of their complexes with selected metals changed the course of
medical chemistry and toxicology. In 2010 it was found out that complexes of biochanin with nickel(II)
and copper(II) have antiviral, anticancer, and antioxidative properties [19]. Quercetin, which has in its
structure hydroxyl groups capable of forming complexes with metal ions, chelates metals via 3′ or
and 4′ phenolic group. Cobalt(II)–quercetin complexes have higher antioxidant activity than the free
compound [20,21].
Our research group has shown in recent years that CA exhibits cytoprotective activity against
Doxorubicin induced oxidative stress in human skin fibroblasts [22]. Furthermore we have shown
that polyphenol–metal complexes exhibit better biological and antioxidative properties than free
polyphenols [23]. Therefore, in order to study possible antimicrobial and anticancer effects of CA and
its complexes with selected metals we decided to conduct a cytotoxicity tests to estimate the most
effective concentrations of tested compounds.
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2. Materials and Methods
2.1. Chemical Synthesis
2.1.1. Sample Preparation
All reagents were from Sigma–Aldrich. Sodium salt of CA was prepared as follows: 9.96 mg of
cichoric acid (MW = 474,371 g/mol) was weighed, i.e., 0.021 mmol, and dissolved in 0.42 mL NaOH
solution at a concentration of 0.1 M. Deionized water (2 mL) was added to the mixture. The solution
was stirred in a water bath at 50 ◦C to dissolve the acid. The molar ratio of ligand:metal was 1:2.
The solution was allowed to evaporate slowly and the precipitate was air-dried at 30 ◦C.
The copper(II)/zinc(II)/nickel(II)/cobalt(II) complexes were prepared in the following way: 19.92 mg
of cichoric acid was dissolved in 0.84 mL NaOH (0.1 M). Then 2 mL of deionized water and water
solutions containing 0.084 mmol of copper(II), zinc(II), nickel(II), and cobalt(II) chlorides were added
to the mixtures. The solutions were mixed with the use of a shaker for 2 hours at room temperature.
In the obtained mixture, the molar ratio of sodium salt of cichoric acid to the transition metal cation
was 1:2. After several days a precipitate occurred which was filtered from the solution on filter paper
and washed with deionized water until the residual chlorides were washed out. The precipitate was
air-dried at 30 ◦C. The yield of the synthesis processes was about 70–85%. Table 1 presents the results
of elemental analysis. The sodium salt was dihydrated, while the complexes of copper, zinc, cobalt,
and nickel were tetrahydrated.
Table 1. Elemental analysis for metal complexes with cichoric acid.
Empirical Formula Yield %H (Theoret) %C (Theoret) %H (Exp) %C (Exp)
[C22O12H16Zn2] ·4H2O 70–75% 3.60 39.59 3.69 39.80
[C22O12H16Ni2] ·4H2O 70–80% 3.67 40.41 3.56 39.76
[C22O12H16Cu2] ·4H2O 70% 3.62 39.81 3.57 39.13
[C22O12H16Co2] ·4H2O 70–75% 3.67 40.38 3.59 40.05
2.1.2. FTIR (Fourier Transform Infrared) Study
The FTIR spectra were recorded with an Alfa (Bruker) spectrometer within the range of
400–4000 cm−1. Samples in the solid state were measured in KBr matrix pellets. FT-Raman spectra of
solid samples were recorded in the range of 400–4000 cm−1 with a MultiRam (Bruker) spectrometer.
2.1.3. Calculations
To calculate the optimized structures quantum-mechanical methods were used: density functional
(DFT) hybrid method B3LYP with non-local correlation provided by Lee–Young–Parr expression and
HF (Hartree–Fock). All calculations were carried out with functional base 6-311++G(d,p). Calculations
were performed using the Gaussian 09 (Frisch et al., 2009) package [24]. Experimental spectra were
interpreted in terms of HF method calculations. Theoretical wavenumbers were scaled according to
the formula: νscaled = 0.89·νcalculated for HF/6-311++G(d,p) level.
2.1.4. Job’s Study
The composition of complexes in aqueous solutions was determined by the Job’s method. Chloride
solutions of CoCl2, CuCl2, ZnCl2, and NiCl2 were prepared at concentrations of 0.01 M by dissolving
the appropriate weight of metal chloride salts in deionized water. A solution of CA (0.1 M) was
prepared by dissolving a sample of acid in 50 mL of Tris HCl buffer (pH = 7.2). To the 10 mL flasks,
5 mL of the CA solution was added, followed by the addition of a metal chloride solution in the range
of 10 to 200 μL. Then the solutions were filled to 10 mL with Tris HCl buffer. The solutions were mixed
and left for 1 hour. Then, the absorption spectra of the analyzed solutions in the UV range (190–400 nm)
were recorded. The measurements were taken on a HACH 5000 DR spectrophotometer.
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2.2. Toxicological Studies
2.2.1. Reagents
Dulbecco’s modified Eagle’s medium (DMEM), containing glucose at 4.5 mg/mL (25 mM) with
Glutamax and Leibovitz’s L-15 medium with Glutamax, penicillin, streptomycin, trypsin–EDTA, FBS
(Fetal Bovine Serum) Gold, and PBS (Phosphate Buffer Saline) (without Ca and Mg) were provided
by Gibco (San Diego, CA, USA). RPMI-1640 medium with high glucose and with L-glutamine was
provided by ATCC. Cell Titer-GloTM 2.0 Assay was provided by Promega, Madison, WI, USA.
2.2.2. Microbial Strains
Escherichia coli (ATCC 25922), Pseudomonas aeruginosa (ATCC 27853), Staphylococcus epidermidis
(ATCC 12228), Candida albicans (ATCC 10231), Saccharomyces boulardii, and Lactobacillus rhamnosus
(ATCC 53103) were obtained from the American Type Culture Collection (Manassas, VA, USA). Proteus
vulgaris (PCM 2269) strain was purchased from Polish Collection of Microorganisms (PCM, Wroclaw,
Poland). Strains of bacteria and fungi were selected for antimicrobial tests. E. coli, P. aeruginosa,
P. vulgaris (Gram negative bacteria), S. epidermidis, L. rhamnosus (Gram-positive bacteria), and C. albicans
and S. boulardii (fungi) were grown overnight in Mueller Hinton II Broth at 37 ◦C (E. coli, P. vulgaris
and S. epidermidis, L. rhamnosus, S. boulardii) and 27 ◦C (P. aeruginosa and C. albicans). Next day, the
overnight cultures were diluted in fresh MH II Broth to obtain 108 CFU/mL (CFU—colony forming
units). For the antimicrobial activity, the inoculum of the tested bacteria reached the final concentration
value of 106 CFU/mL, while the inoculum of C. albicans and S. boulardii were about 104 CFU/mL.
2.2.3. Cell Culture
The effect of CA and its metal complexes were examined in MCF-7, MDA-MB-231, and ZR-75-1
breast cancer cell lines, A375 melanoma cell line, DLD-1 cell line, LN-229 cell line, and FN cell line, which
were obtained from American Type Culture Collection (ATCC). MCF-7 cells, A-375 melanoma cell line,
LN-229 glioblastoma cell line, and FN fibroblasts cell line were maintained in DMEM supplemented
with 10% FBS, penicillin (100 U/mL), and streptomycin (100 μg/mL) at 37 ◦C in a humidified atmosphere
of 5% CO2 in air. ZR-75-1 cells and DLD-1 colorectal adenocarcinoma cell line were maintained in
RPMI-1640 supplemented with 10% FBS, penicillin (100 U/mL), and streptomycin (100 μg/mL) at 37 ◦C
in a humidified atmosphere of 5% CO2 in air. MDA-MB-231 cells were maintained in Leibovitz’s L-15
medium supplemented with 10% FBS, penicillin (100 U/mL), and streptomycin (100 μg/mL) at 37 ◦C in
a humidified atmosphere.
MCF-7 cells, MDA-MB-231 cells, ZR-75-1 cells, A-375 cells line, DLD-1 cells, LN-229 cells, and
FN cells (2 × 104 cells/ml) in 200 μL of culture medium were incubated without and with the test
compounds in tissue culture treated white 96-well plates for the Cell Titer Glo™ 2.0 Assay. The
cytotoxicity was estimated for CA and its complexes at concentration of 50 μM, 100 μM, 200 μM,
300 μM, 400 μM, and 500 μM.
2.2.4. CA and Its Metal Complexes Antimicrobial Activity
Initially, two-fold microdilutions of analyzed compounds in a liquid growth media (MH II Broth)
in 96 well-plates were prepared. Next, the indicator fungi (concentration of 104 CFU/mL) and bacteria
strain (concentration of 106 CFU/mL) suspensions were added into each well of a 96 well-plate, and
then incubated for 24 h at 37 ◦C (E. coli, P. vulgaris, S. epidermidis, L. rhamnosus, and S. boulardii) and
27 ◦C (P. aeruginosa and C. albicans). The final concentrations of CA and its complexes in each well were:
800 μM, 400 μM, 200 μM, 100 μM, and 50 μM.
Cell viability of tested microorganisms treated with CA and its metal complexes were estimated
using the BacTiter-Glo™ (Promega, Madison, WI, USA) according to the manufacturer’s instruction.
In brief, the assay uses a thermostable luciferase to enable reaction conditions that produce a stable
“glow-type” luminescent signal while simultaneously inhibiting endogenous enzymes released during
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cell lysis. The homogenous assay procedure involves addition of a single reagent directly to cells
cultured in serum-supplemented medium. Luminescence was measured with a GloMax®-Multi
Microplate Multimode Reader. The cytotoxicity of CA and its complexes with metals was expressed a
relative cell viability (%) in relation to un-treated control. The study was performed in triplicate in
order to ensure that consistent results were obtained.
2.2.5. Estimation of CA and Its Metal Complexes Cytotoxicity
To measure CA and metal complexes cytotoxicity CellTiter-Glo™ 2.0 Assay (Promega) was used.
The measurement was conducted according to manufacturer’s protocol. Luminescence was measured
with a GloMax®-Multi Microplate Multimode Reader. The study was performed in triplicate taken to
ensure consistent results were obtained.
2.2.6. Statistical Analysis
All data are given as mean values ±SD (standard deviation). Differences between treatments and
untreated control human cells were analyzed by one-way ANOVA, followed by Dunnett’s procedure
for multiple comparisons. Significant effects are represented by p ≤ 0.05 (*), p ≤ 0.01 (**), p ≤ 0.001 (***).
To compare the means for treatments and tested cell lines two-way analysis of variance (ANOVA)
followed by the Tukey test were applied. Significance was considered when p ≤ 0.05. Cluster analysis
was used to the group the examined elements (individual microorganisms treated with metal, CA and
its complexes with metal) into similar categories. Two-way joining method of clustering was applied.
3. Results
3.1. Chemical Synthesis Results
Composition and Structure of Examined Complexes
Elemental analysis showed that the metals Zn(II), Cu(II), Ni(II), and Co(II) are complexed with
cichoric acid in a 2:1 molar ratio (metal:ligand) (Table 1). All complexes were hydrated and contained
4 water molecules. The yield of the synthesis oscillated around 70%–80% (based on the synthesis of
complexes three times).
The composition of the complexes in aqueous solutions was determined using the Job’s method
for pH = 7.2. The analysis showed that in aqueous solutions cichoric acid complexes with metals in a
molar ratio of 1:2. Figure 1 presents UV spectra for aqueous solutions of cichoric acid with copper
(II) ions (mixed in molar ratios from 5:1 to 1:5) measured in a Tris–HCl buffer solution with pH = 7.2.
Figure 2 shows the dependence of the maximum absorbance of a copper complex with cichoric acid
depending on the composition of the complex. Similar results were noted for the remaining studied
metal complexes with cichoric acid.
The type of metal ligand coordination was determined based on spectroscopic data analysis (FTIR).
The spectra of cichoric acid and metal complexes were recorded in the KBr matrix, and theoretically
calculated for the optimized structure of the acid, sodium salt, and copper complex.
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Figure 1. Absorption spectra of cichoric acid in the presence of various amounts of copper in Tris–HCl
buffer pH 7.2 (different types of lines are labeled with a molar ratio of cichoric acid:metal 5:1–1:5).
Figure 2. Absorbance as a function of [cichoric acid]: [copper] molar ratio at 320 nm.
In the spectrum of the acid the bands at 1746 and 1716 cm−1 were interpreted as vibrations of
the carboxyl group of the tartaric acid fragment present in the cichoric acid molecule. After binding
the metal ion to the ligand, these bands disappeared, which indicates that the metal is bound to the
cichoric acid through the carboxylate group of the tartaric acid. In the spectra of the sodium salt and
complexes, characteristic wide bands originating from vibrations of the carboxylate anion appeared.
The bands derived from the stretching vibrations of the symmetric carboxylate anion νsymCOO−
were identified: at the wavenumbers: 1385 cm−1 IR and 1381 cm−1 Raman in sodium salt, 1384 cm−1
IR in the copper complex, 1385 cm−1 IR in the nickel complex, 1384 cm−1 IR in the zinc complex,
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and 1385 cm−1 IR in the complex cobalt, and stretching asymmetric νasCOO: at the wavenumbers:
1626 cm−1 IR in sodium salt, 1626 cm−1 IR in the copper complex, 1630 cm−1 IR in the nickel complex,
1629 cm−1 IR in the zinc complex, and 1605 cm−1 IR in the cobalt complex (Table 2). In the spectra
of complexes intense bands assigned to the symmetric bending in-plane (βsCOO−) occurred: at the
wavenumbers: at 853 cm−1 IR and 860 cm−1 Raman in sodium salt, 868 cm−1 in the copper complex,
851 cm−1 in the nickel complex, 853 cm−1 in the zinc complex, and 851 cm−1 in the cobalt complex,
and asymmetric bending βasCOO−: at 521 cm−1 IR in sodium salt, 521 cm−1 in the copper complex,
520 cm−1 in the nickel complex, 520 cm−1 in the zinc complex, and 521 cm−1 in the cobalt complex
(Table 2). On the basis of the position of the νasCOO− and νsCOO− bands in the IR spectra of the
studied complexes compared to the position of these bands in the sodium salt, it was found that the
bidentate chelation coordination mode is present in the copper and cobalt complexes (Figure 3) and
monodentate for nickel and zinc complex (Figure 4) (ΔνCOO− of the complexes < ΔνCOO− of the
sodium salt; ΔνCOO− means the difference between the wavenumber of the bands assigned to the
asymmetric and symmetric vibration of the carboxylate anion).
Figure 3. The propoedl structures of copper and cobalt cichoriate structures.
Figure 4. The proposed structures of nickel and zinc cichoriate structures.
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3.2. Toxicological Studies Results
3.2.1. Antibacterial and Antifungal Activity of CA and Its Metal Complexes
Figures 5 and 6 show the influence of CA and its complexes with selected metals on all tested
microbial and fungal strains. In all analyzed concentrations, P. aeruginosa incubation with CA–Co
complex leads to statistically significant decreases in cell viability. The lowest tested concentration of
CA–Co complex of 50 μM caused a decrease of approximately 50% after 24 h treatment. At higher
concentrations of CA–Co complex, i.e., from 200 μM to 800 μM, decreases in cell viability by
approximately 97% as compared to the control untreated cells were observed. Similar effects were
noticed in the case of CA–Co treatments in S. epidermidis and P. vulgaris, in which all applied
concentrations caused decreases in relative cell viability in S. epidermidis from 40% at 50 μM to 80% at
800 μM and P. vulgaris from 20% at 50 μM to 70% at 400 μM. In turn, using the lowest concentration of
CA–Co complex caused an increase in relative cell viability of E. coli of approx. 20%.
At all investigated treatments, the CA–Cu and CA–Ni complexes resulted in a decrease in cell
viability in both S. epidermidis and P. vulgaris. The CA–Cu complex in all analyzed concentrations
caused an increase in P. aeruginosa viability by approximately 50% as compared to the control untreated
cells. The treatment of E coli with CA–Cu and CA–Ni did not cause any significant decreases in relative
cell viability at lower tested concentrations. The decrease was observed only at 800 μM in relative
cell viability by about 40% and 50% respectively. After introducing CA–Ni and CA–Zn complexes
on P. aeruginosa we observed a decrease in cell viability with simultaneous increase in concentrations
used. In the case of S. epidermidis, at lower tested concentrations of CA–Zn complex (50 and 100 μM)
there was an increase in the viability by about 7%, while at other concentrations, i.e., from 200 to 800
μM a decrease by approximately 15% at 200 μM, 20% at 400 μM, and 25% at 800 μM was observed.
The highest concentration of CA–Zn complex caused over 20% decline in E. coli cell viability, whereas
lower concentrations stimulated cell viability by nearly 60% after 24 h incubation.
The application of CA and its complexes with selected metals on C. albicans caused a decrease in
relative cell viability after 24 h. The highest (800 μM) concentration of CA complexed with selected
metals caused a decrease in relative cell viability by approximately 60% for CA–Zn, 80% for CA–Cu,
and 95% for CA–Co and CA–Ni as compared to the control untreated cells. In CA–Cu and CA–Zn, the
lowest analyzed concentration did not cause any significant changes in relative cell viability, since it
achieved the value of approximately 3% (Figure 5).
The application of CA on nonpathogenic microorganisms such as L. rhamnosus and S. bouldardii
caused an increase in relative cell viability in L. rhamnosus by approximately 26% at 50 μM and 12%
at 100 μM and in S. bouldardii by approximately 34% at 50 μM, 14% at 100 μM, and 4% at 200 μM.
After introducing CA–Zn complexes on L. rhamnosus an increase in relative cell viability from 40% at
50 μM to 10% at 200 μM was observed, while in S. bouldardii a decrease in relative cell viability from
29% at 50 μM to 40% at 800 μM was noticed. L. rhamnosus incubation with CA–Co complexes lead to
decreases in cell viability after 24 h treatment as compared to the control untreated cells. In turn, using
the 50 μM CA–Co and CA–Cu complex caused an increase in relative cell viability of S. bouldardii by
approximately 18%. Similar effects were noticed in the case of CA–Cu and CA–Ni complexes, i.e.,
by approximately 30% in L. rhamnosus.
Summarizing, cytotoxic effect of tested compounds on selected microorganisms decreases in the
following sequence:
C. albicans: Ca–Co > Ca–Ni > Ca–Cu > Ca–Zn > CA
E. coli: CA–Co > CA–Cu > CA > CA–Ni > CA–Zn
P. vulgaris: CA–Ni > CA–Co > CA–Cu > CA–Zn > CA
P. aeruginosa: CA–Co > CA–Zn > CA >CA–Ni > CA–Cu
S. epidermidis: CA–Co > CA–Cu > CA–Ni > CA > CA–Zn.
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Figure 5. Cytotoxicity of cichoric acid (CA) and its complexes with Co (CA–Co), Cu (CA–Cu), Ni
(CA–Ni) and Zn (CA–Zn) on fungi (C. albicans and S. boulardii) and bacteria strains (E. coli, P. vulgaris,
P. aeruginosa, S. epidermidis, L. rhamnosus) expressed as relative cell viability (%) as compared to
non-treated control (C). Each value on the graph is the mean of three independent experiments and
error bars show the standard deviation (SD).
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Figure 6. Cluster analysis for relative fungi and bacteria cells viability (%) after treatment of CA and its
complexes with metals.
Based on resulted of cluster analysis (Figure 6), we can distinguish the groups that contain
microorganisms with similar sensitivity/resistance to individuals treatments. For example, the similar
highest inhibitory effect was observed for C. albicans, P. aeruginosa, and S. epidermidis treatment with
the CA–Co complex. On the other hand, the similar stimulatory effects for E. coli treated with CA–Zn,
P. aeruginosa with CA–Cu, and P. vulgaris with CA and CA–Zn were noted.
3.2.2. Cytotoxicity of Analyzed Compounds in Human Cancerous and Non-Cancerous Cells
As shown in Figure 7 both CA and its complexes with selected metals exert cytotoxic effect in all
tested cell lines. In the LN-229 glioblastoma cell line incubation with especially CA–Co complexes
in all analyzed concentrations leads to statistically significant decreases in cell viability. Even the
lowest tested concentration of CA–Co complexes—50 μM—caused a decrease by about 60% after 24 h
treatment and by about 70% after 48 h treatment. A similar effect was observed in the case of CA–Zn
treatment in both incubation times. The lowest analyzed concentration caused a decrease in relative cell
viability by about 50% after 24 h and 48 h treatment. Higher concentrations of CA–Zn complex caused
more than 90% decline in LN-229 cells viability. CA treatment did not cause any significant decreases
in relative cell viability in LN-229 cell line. DLD-1 colorectal adenocarcinoma cells treated with CA and
CA–metal complexes also exhibited statistically significant decreases in relative cell viability. An effect
comparable with the LN-229 cell line was observed. CA complexed with Co already in the lowest
concentration caused almost 50% decline in DLD-1 cell viability after 24 h incubation. Ca complexed
with Zn in both analyzed incubation times caused statistically significant decreases in cell viability in
all tested concentrations. The most inhibitory effect on cell viability was noticed for CA–Co and CA–Zn
complexes causing decreases higher than 90%. In the case of CA–Zn complex all of the analyzed
concentrations, except 50 μM, caused decline in cell viability. The influence of CA on the DLD-1 cell
line was more significant that on the LN-229 cell line; however we did observe significant effects only
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in higher concentrations such as 300 μM. In the A-375 melanoma cell line CA–metal complexes also
caused significant decreases in cell viability. Co, Zn, and Cu complexes were characterized by the
greater inhibitory activity towards melanoma cells. After 48 h treatment, the CA–Zn complex in the
lowest concentration of 50 μM caused a decrease by about 95% in relative cell viability. Cytotoxicity
assay revealed also that statistically significant changes in cell number were observed in analyzed
breast cancer cell lines, especially in the MCF-7 cell line after 48 h treatment. CA–metal complexes
were more cytotoxic to breast cancer cells than free cichoric acid. An especially active compound was
CA–Zn complex in 200 μM, 400 μM, and 500 μM concentration. In the MDA-MB-231 cell line we
did observe only slight significant changes in cell viability under the influence of tested compounds.
Only the CA–Co complex in 400 μM concentration after 48 h treatment caused significant changes
in cell viability. In the ZR-75-1 cell line CA–Cu and CA–Zn were especially active in 400 μM and
500 μM concentrations. In fibroblasts, which represent normal, healthy cells, significant declines in
cell viability were observed. Only free CA exhibited stimulatory activity against fibroblasts. It caused
insignificant increases in relative cell viability in the concentration range 50 μM to 300 μM. Higher
concentrations such as 400 μM and 500 μM inhibited cell proliferation by about 20% as compared to
control untreated cells.
Summarizing, the influence of CA and CA-metal complexes on cancerous and non-cancerous
cells is depicted in Figure 8. Presented results are shown as a percentage of live cells compared to
control, untreated cells set at 100 percent, with no regard both to the concentration of CA or to the
concentration of CA-metal complexes. The differences in relative cell viability are especially easily
visible in CA–metal complexes. In case of CA treatment, significant changes and differences between
analyzed cell lines were observed after 48 h incubation. From the presented graph it can be deducted
that every analyzed CA–metal complex, without considering concentration, caused decrease in cell
viability in three cancer cell lines: A-375, DLD-1, and LN-229. Interestingly, breast cancer cell lines,
especially MDA-MB-231 and MCF-7, were more resistant to CA–metal complexes as compared to other
cancer cell lines and to ZR-75-1 breast cancer cell line. Unfortunately, CA–metal complexes, especially
CA–Ni and CA–Co after 48 h incubation, were cytotoxic to fibroblasts, which represent normal healthy
cell lines. Free CA did not exhibit toxicity against fibroblasts and after 48 h treatment it was toxic to
the MCF-7 cell line. In every tested concentration, except for free CA, after 48 h treatment the level of
viable cells did not exceed 100% control untreated cells.
Summarizing, cytotoxic effect of tested compounds on selected human cancerous and non-cancerous
cell lines decreases in the following sequence:
LN-229: CA–Zn > CA–Co > CA–Ni > CA–Cu > CA
DLD–1: CA–Zn > CA–Cu > CA–Co > CA–Ni > CA
A–375: CA–Zn > CA–Co > CA–Cu > CA–Ni > CA
MCF–7: CA–Zn > CA–C > CA–Ni > CA–Cu > CA
MDA–MB–231: CA–Zn > CA–Co > CA–Cu > CA–Ni > CA
ZR–75–1: CA–Cu > CA–Zn > CA–Ni > CA–Co > CA
FN: CA–Ni > CA–Co > CA–Cu > CA–Zn > CA
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Figure 7. Cell viability results for MCF-7, MDA-MB-231, ZR-75-1, A375, DLD-1, LN-229, and FN cell
lines exposed to different concentrations of CA and CA complexed with metals (Cu, Zn, Co, Ni) for
24 h and 48 h calculated as a percentage of control, untreated cells. Each value on the graph is the
mean of three independent experiments and error bars show the standard deviation (SD). * p < 0.05,
** p < 0.01, and *** p < 0.001 represent significant effects between treatments and control followed by a
Dunnett’s test.
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Figure 8. The viability of LN-229, DLD-1, A-375, FN, MCF-7, MDA-MB-231, and ZR-75-1 cell lines
treated with different concentrations of CA and CA–metal (Cu, Zn, Ni, Co) complexes for 24 and
48 h. The results represent means for pooled triplicate values from three independent experiments.
Significant alterations are expressed relative to control untreated cells (marked with asterisks). Statistical
significance was considered if * p < 0.05.
4. Discussion
Cichoric acid, due to its numerous beneficial biological properties, is a valuable product of natural
origin. Literature data indicate its immunostimulatory and antiviral activity, and the capacity of
stimulating the effect of phagocytosis in vitro and in vivo. In addition, CA inhibits hyaluronidase
activity, which is a key enzyme in the course of bacterial infection [25]. In the present study we examined
the effect of CA and its complexes with metals against foodborne pathogenic microorganisms such as
E. coli, P. vulgaris, P. aeruginosa, S. epidermidis, and C. albicans as well as nonpathogenic microorganisms
like L. rhamnosus and S. boulardii. In literature, there are limited numbers of studies about the influence
of CA on bacteria or fungi. However, several data indicate that polyphenolic acids have antibacterial
and antifungal properties against foodborne pathogens [26–28]. Furthermore, it has been reported that
chemical complexes with selected heavy metals such as Co, Cu, Zn, and Ni may improve antibacterial
and antifungal potential [29].
According to obtained results, antimicrobial effect varies depending on studied microorganism
as well as on applied agent. Generally, CA complexed with Co was the strongest antibacterial and
antifungal compound, whereas the least efficient in reducing tested bacteria and fungi viability were
CA and CA–Zn complexes. Inhibitory or stimulatory effects of studied compounds on individual
bacterial strains and fungi may be explained by the different structure of cell membranes, as reported by
many authors [30,31]. Gram-negative bacteria are generally most resistant to antibacterial compounds
due to the presence of the outer cell membrane. In Gram-negative bacteria the molecules are
transported through the outer lipopolysaccharide membrane rich in porins, which significantly hinder
the penetration of antibacterial agents. Our data indicate that free CA exhibited a similar impact against
S. epidermidis (Gram-positive) and P. aeruginosa (Gram-negative). These results are not consistent
with previous studies reporting that polyphenolic acids have a higher antibacterial potential against
Gram-positive than Gram-negative bacteria [28]. However, research conducted by Cueva et al. showed
that selected phenolic compounds (e.g., gallic acid, caffeic acid) may inhibit the growth of both
Gram-positive (S. aureus) and Gram-negative bacteria (P. aeruginosa), which is in agreement with
our results regarding to CA [32]. Kavak and Kacec (2019) also drew similar conclusions in study
about arbutin (polyphenols extracted from Pyrus elaeagrifolia), which was an effective antibacterial
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agent against Bacillus cereus (Gram-positive), Staphylococcus aureus (Gram-positive), and Escherichia
coli (Gram-negative) [30]. According to Mokhtar et al. antimicrobial properties of some polyphenolic
acids may be associated with irreversible changes in the structure and properties of the bacteria cell
membrane [8]. These compounds may cause changes in hydrophobicity and the formation of local
ruptures or pores resulting in leakage of cell components. Furthermore, polyphenols can destroy
the bacteria membrane proteins and disrupt bacterial metabolic processes [33]. In addition, Lou et al.
(2015) showed that phenolic acids like p-coumaric acid may increase membrane permeability as well
as may bind to genomic DNA and disrupt major processes such as replication, transcription, and
translation [34].
In the present study we tested antifungal properties of free CA. It was found that CA inhibited
fungi cell growth by approximately 20% as compared to control. It has been reported the transfer of
molecules is associated with the ultrastructure of the chitin wall, membrane ergosterols, and genetic
material. Therefore, a complex structure of fungal cell walls could hinder the transport of antifungal
agents [31].
In our research free cichoric acid was not effective in reducing the tested microorganisms’ growth.
The maximum inhibitory effect of CA (20%) was observed for S. epidermidis, C. albicans, and P. aeruginosa.
As reported by Prasad et al. and Świsłocka et al. (poli)phenolic compounds are characterized by low
antimicrobial activity as compared to their combinations with other molecules [23,35]. In our research
we proposed determining the antimicrobial properties of one from polyphenol acids, cichoric acid, in
combination with metals such as Co, Cu, Ni, and Zn. Antimicrobial and antifungal properties of metal
ions have been known and explored for many years [36]. The antimicrobial activity of the metal ions is
linked with the cell membrane destabilization and disruption of the bacterial membrane permeability.
Whereas the antifungal effect of the metal ions is mainly due to the disorder of ergosterol biosynthesis.
The application of metal ions alone as a preservative agent or drug compound is problematic because
they exhibit cytotoxic activity to human cells. The combination of metal ions and CA may be a
promising strategy to obtain antimicrobial agent safety for humans.
In our study, among examined complexes, CA–Zn exhibited the weakest antimicrobial effect,
especially against L. rhamnosus, E. coli, and P. vulgaris, when complex CA–Co is characterized by the
strongest inhibitory effect against the all of tested microorganism with the exception of E. coli and
S. boulardii. Gałczyńska et al. pointed the fact that Co and Cu-based complexes have an antibacterial
and antifungal effect [37]. These properties depend on the mechanism of transport through the
bacterial/fungal cell membrane and more precisely, through Ca2+ channels in cellular membranes.
In addition, it should be noted that, the transport of a substance into a bacterial cell depends on the
relationship between the individual metals. For example Co may have antagonistic effect against Fe(III).
As a result of interaction of Co with a siderophore (pyoverdine) which is produced by P. aeruginosa,
decrease in ferric ion availability for bacteria cells may be observed. This phenomenon could be
connected with the highest CA–Co toxicity observed for P. aeruginosa. In our study C. albicans appears to
be the most sensitive on CA–Co and CA–Ni treatments. Castillo et al. indicate that chemical complexes
with Co and Cu have better antimicrobial effect as compared to those containing zinc [38]. In our
study, the similar results for CA–Cu were obtained for C. albicans, E. coli, P. vulgaris, and S. epidermidis.
The probable cytotoxicity effect of metal complexes against bacteria and fungi may be connected with
metal complex–membrane components interaction. The study by Lv et al. showed that ergosterol
present in C. albicans cell membrane together with numerous proteins creates lipid rafts, which are
responsible for hyphae morphogenesis, polarization, and membrane fusion during endocytosis [39].
Therefore, treatment of cells with antifungal agents may result in the destruction of lipid rafts in
filamentation and thus disrupt the synthesis of ergosterol and hyphae. In turn, antibacterial ability of
metal complexes with CA may be connected with changes in membrane properties such as its rigidity
and permeability due to membrane protein destruction [33].
The previous studies have indicated that the antimicrobial capacity of polyphenolic compounds
depends on their properties and structure. As reported by Murcia et al., antibacterial and antifungal
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responses to treatments may due to different lipophilic properties and dipole moments of examined
complexes [40]. Moreover, research conducted by Wu et al. (2013) demonstrated that antimicrobial
ability is associated with a negative correlation between the relative hydrophobicity and the numbers
of hydroxyl groups in some polyphenolic compounds (flavonoids) [33].
Phenolic compounds, such as cichoric acid, consist of a group of compounds of natural plant
origin with significant and proved antioxidant activity. They prevent many diseases, including cancer,
and cardiovascular and neurodegenerative diseases, mainly by reducing oxidative stress [41–43].
Polyphenolic compounds can prevent oxidative stress by inhibiting ROS (Reactive Oxygen Species),
but on the other hand they may also act as a prooxidant mainly in the presence of transition metals.
Prooxidant activity of polyphenolic compounds is conditioned by many factors, including high
concentration of polyphenolic compound, high pH, and the presence of transition metals, such as Cu
and Fe [44,45]. Two of the above mentioned factors are especially important—an acidic pH and the
number of hydroxyls in aromatic rings. The solubility and stability of reduced forms of transition
metals is determined by acidic pH of the solution and the higher number of hydroxyl substitutions,
mainly in ortho position, determines stronger prooxidant properties [46].
Among trace minerals, chromium, cobalt, selenium, iron, manganese, molybdenum, copper, and
zinc can be mentioned. Some of them, particularly transition metal ions such as copper, are involved
in oxidative reactions in the presence of other compounds, such as polyphenols [47]. One of the most
important microelements is copper, which plays an important role in various physiological functions.
In cancer cells its concentration is significantly higher than in normal cells, which subsequently makes
them less resistant to the prooxidant activity of polyphenols [48,49]. It is in accordance with our results
indicating that copper complexed with cichoric acid significantly decreases relative cell viability in
every analyzed cell line except for MCF-7 after 24 h incubation. We observed that CA complexed with
Cu as compared to free CA caused significantly higher declines in cell viability. It is in agreement
with literature data indicating that in the presence of copper prooxidant activity of polyphenols is
supposed to progress through the generation of a high level of ROS. It is well known that cancer cells
generate oxidative stress, which stimulates their proliferation, but significantly high level of ROS and
RNS (Reactive Nitrogen Species) may cause cancer cell damage and death. In the presence of Cu and
polyphenols such as CA, cancer cells produce large amount of free radicals which cause DNA damage
and apoptosis in cancer cells. The vast majority of studies regarding possible prooxidant activity
of polyphenols were conducted in vitro and in the presence of copper as a catalyzer of oxidative
reactions [47].
Obtained results indicate that the most biologically active compound was CA complexed with Zn.
It was especially cytotoxic against melanoma, colorectal adenocarcinoma, and glioblastoma cell lines.
Although, according to the literature data zinc is rather an antioxidant, its overdoses may result in
prooxidant activity [50]. Borovansky et al. indicated that melanoma cells are uniquely susceptible
to increases of certain divalent metal salts, for example Zn(II). They demonstrated that compounds
containing zinc in their structure may induce melanoma cell death at concentrations several times
lower than those that are lethal to melanocytes [51]. We observed that zinc complexed with CA was
very effective in decreasing relative melanoma cell viability even at lower analyzed concentrations. In
fact, the CA–Zn complex was the most efficient from all the analyzed complexes. It could be related
with the high susceptibility of melanoma to Zn activity, which was also mentioned by Farmer et al. [52].
Similar results were observed for Ni and Co complexes with CA. Both of them are essential trace
elements for the human body, but scarce data is available on the cytotoxic and prooxidant activity
of Co and Ni in the presence of natural antioxidants such as polyphenolic compounds. Chen et al.
indicated that Ni complexes with polyphenolic ligands exhibited three times stronger responses than a
parent compound in the human colon carcinoma cell line (SW620) and the lowest IC50 values against
the human breast carcinoma cell line (MDA-MB-435) [19]. Our results indicated statistically significant
response in MDA-MB-231 breast cancer cell line viability observed as a decrease in analyzed parameter
especially after 24 h treatment with CA–Ni complexes. Chen et al. noticed also that anti-proliferative
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activities of polyphenol–metal complexes were stronger than cisplatin, which was used as a positive
control in this experiment. Nickel complexes with CA, similarly as in the case of CA–Zn complexes,
were significantly efficient against melanoma, colorectal adenocarcinoma, and glioblastoma cell lines,
as compared to three analyzed breast cancer cell lines, which were more resistant to studied compounds.
Song et al. suggested that affinity of Ni complexes to DNA may play an important role in determining
their anticancer activity [53]. It is possible that complexes synthesized in our laboratory also act
through inducing alterations in the DNA structure. However, even though literature data indicate that
complexes of polyphenols with selected metals are selective towards cancerous cells over normal cells,
we observed different effects. In normal healthy fibroblasts CA–metal complexes exhibited a significant
toxicity level as compared to control untreated cells and as compared to free CA. Similarly, as we have
shown in our previous work, CA has positive influence on normal healthy cells, stimulating their
proliferation and decreasing oxidative stress level, even in the presence of strong prooxidants [22].
According to Baile et al. the most effective are copper complexes where pyridine-type ligands
(pyridine, bipyridine, phenanthroline, etc.) are present and such where copper(I) ion is coordinated
to phosphine ligands. Copper complexes exhibit an excellent antiproliferative effects in cancer cells,
which may result from their ability to generate reactive oxygen species [4]. Our results are also in
accordance with the other literature data indicating that cichoric acid has a strong growth inhibitory
effect against cancer cells resulting from pro-apoptotic effect [54]. We observed that the addition of
metals significantly enhanced antiproliferative activity of CA, therefore we conclude that CA–metal
complexes have higher efficacy than free polyphenol compound. Literature data showed that daily
consumption of Echinacea, which is a main source of CA, may be a prophylactic and attenuates leukemia
studied in mouse models [55]. In conclusion, the most significant response for CA and CA–metal
complexes treatment among three breast cancer cell lines we observed in MCF-7 and ZR-75-1 cell
lines. In the MDA-MB-231 cell line we didn’t observe any significant changes as compared to control
untreated cells. In general, among all tested cancer cell lines, breast cancer cells were more resistant to
studied compounds that the other types of cancer cells.
Although cichoric acid reveals many beneficial properties and its complexes with selected
metals exhibit anticancer and antibacterial properties, it should be mentioned that according to the
literature data bioavailability of hydroxycinnamic acids is rather low. Majority of studies regarding
hydroxycinnamic acids bioavailability are focused in caffeic acid and chlorogenic acid. The definition
of bioaccessibility consists mainly of the estimation of relative amounts of compound which could
be released from the food matrix during digestion and could be available for absorption. Literature
data indicate that cichoric acid is characterized by rather low bioaccessibility, which is very low in the
mouth and stomach steps, but it recovers during the intestinal digestion phase, probably because of
the pH changes [56].
Complexing drugs with metals is a well-known and common procedure that has been gaining more
and more attention in recent years. Complexing some therapeutic compounds, such as polyphenols,
can improve their physicochemical and pharmacological properties or reduce their potential side
effects. In general, phenolic compounds are often and effectively used to form chelate complexes with
various metal ions [57,58].
5. Conclusions
In conclusion, the results of the presented study demonstrated, for the first time, that the treatment
with newly synthesized CA-metal complexes has anticancer and antimicrobial effects, which was
demonstrated in seven different cell lines, five bacterial strains, and pathogenic yeast-like fungi
C. albicans and yeast S. boulardii. The presented study indicates that CA–metal complexes could be
potentially effective supplementary tools in anticancer therapy; however they should be used with
caution and their activity should be analyzed in other normal healthy cell lines. This is due to their
potentially toxic action in fibroblast cells. They have also preservative properties and positive influence
on normal non-pathogenic microorganisms, which was demonstrated in selected microbial strains,
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therefore they may serve as food preservatives of natural origin with cytoprotective properties. There
is a huge amount of research and literature data on the anti-tumor effects of polyphenolic compounds.
However, although complexing these compounds with selected metals significantly improves their
anti-cancer activity, the amount of research conducted on complexes of polyphenols with metals is
much smaller. Moreover, none of these complexes have yet entered the phase of clinical trials. This
may be due to many problems caused by the presence of a metal ion; among others, an important
problem is the stability of such compounds and their solubility in physiological solvents. Therefore,
further studies are necessary to determine the mechanisms by which the analyzed compounds affect a
reduction in viability of tumor cells and in normal cells, and cells of bacterial and fungal origins.
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Abstract: This study assessed and compared the effects of the intra-amniotic administration of various
concentrations of soluble extracts from chia seed (Salvia hispanica L.) on the Fe and Zn status, brush
border membrane functionality, intestinal morphology, and intestinal bacterial populations, in vivo.
The hypothesis was that chia seed soluble extracts will affect the intestinal morphology, functionality
and intestinal bacterial populations. By using the Gallus gallus model and the intra-amniotic
administration approach, seven treatment groups (non-injected, 18 Ω H2O, 40 mg/mL inulin,
non-injected, 5 mg/mL, 10 mg/mL, 25 mg/mL and 50 mg/mL of chia seed soluble extracts) were
utilized. At hatch, the cecum, duodenum, liver, pectoral muscle and blood samples were collected for
assessment of the relative abundance of the gut microflora, relative expression of Fe- and Zn-related
genes and brush border membrane functionality and morphology, relative expression of lipids-related
genes, glycogen, and hemoglobin levels, respectively. This study demonstrated that the intra-amniotic
administration of chia seed soluble extracts increased (p < 0.05) the villus surface area, villus length,
villus width and the number of goblet cells. Further, we observed an increase (p < 0.05) in zinc
transporter 1 (ZnT1) and duodenal cytochrome b (Dcytb) proteins gene expression. Our results
suggest that the dietary consumption of chia seeds may improve intestinal health and functionality
and may indirectly improve iron and zinc intestinal absorption.
Keywords: intra amniotic (in ovo) administration; zinc gene expression; iron gene expression; brush
border membrane functional genes; intestinal bacterial populations; villus surface area
1. Introduction
Micronutrient deficiency affects approximately two billion people worldwide. Iron (Fe) and zinc
(Zn) deficiencies are the most prevalent, affecting approximately 45% and 17%, respectively, of the
world population [1–3]. Both mineral deficiencies are more prevalent in Africa, South East Asia and
Latin America [4,5]. Among the dietary factors that contribute to Fe and Zn deficiencies is their low
bioavailability due to dietary potential inhibitors, such as phytic acid and phenolic compounds [2,6,7].
Dietary Fe and Zn deficiencies affect normal cell division and differentiation, as well as growth and
development, impair physical and cognitive development, and increase the risk of infection [4,7,8].
We have previously established the Gallus gallus as a model to assess dietary Fe and Zn
bioavailability [9–15]. In addition, this experimental model presents a complex gut microbiota [16], as the
phylum level was shown to be similar to humans [17,18]. Further, the intra amniotic administration
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method has been widely used and demonstrates the potential prebiotic effects of soluble fibers
from beans, chickpeas, lentil and wheat, with demonstrated effects on the intestinal functionality,
morphology, and microbial populations [10,13,15].
Prebiotics are dietary substrates that selectively promote the proliferation and/or activity of
health-promoting bacterial populations in the colon [19,20]. The soluble extracts are obtained by the
isolation process of the prebiotics of the food matrix and are composed for the most part of soluble
fiber. The most commonly used prebiotics, as inulin, raffinose and stachyose, are dietary fibers with
a well-investigated and proven ability to promote the abundance of intestinal bacterial populations,
which may provide additional health benefit to the host [21]. It is known that soluble extracts are
responsible for improving gastrointestinal motility [22,23], intestinal functionality and intestinal
morphology [10,13,24,25], and improving mineral absorption [10,26]. Recent Studies have shown that
the consumption of plant seed origin soluble extracts can up regulate the gene expression of brush
border membrane (BBM) proteins that contribute to the digestion and absorption of nutrients, such as
sucrase-isomaltase, aminopeptidase and sodium glucose cotransporter-1 [10,11,13]. Further, soluble
extracts can positively affect intestinal health by increasing mucus production, goblet cell number,
goblet cell diameter, villus surface area, villus height, villus width, and crypt depth [10,13,15,27,28].
These functional and morphological effects appears to occur due to the increased motility of the
digestive tract by the soluble extracts, leading to hyperplasia and/or hypertrophy of muscle cells [29].
In addition, plant origin soluble extract (with high fiber content and, therefore, potential prebiotic
properties) administration may act, directly or indirectly, as a factor that increases iron and zinc
bioavailability [30–32]. This event occurs due the lower intestine (colon) fiber fermentation process
and the bacterial production of short-chain fatty acids (SCFAs) that reduce the intestinal pH, inhibiting
the growth of potentially pathogenic bacterial populations and increasing the solubility and, therefore,
the absorption of minerals [10,26]. The SCFAs can increase the proliferation of epithelial cells,
which, in return, increases the absorptive surface area, which contributes to the absorption of dietary
minerals [33]. Also, it was previously shown that the consumption of soluble extracts has a synergistic
effect, as it promotes the metabolic interactions within the gastrointestinal microbial community via the
production of organic acids, which provide an acidic environment in the colon, indirectly suppressing
the growth of pathogens [34].
The use of iron- and zinc-rich foods may be a good strategy aimed to reduce the prevalence of
iron and zinc deficiencies, respectively. Chia (Salvia hispanica L.) is an herbaceous plant with good
nutritional and functional value with high concentrations of bioactive compounds such as dietary fiber
and minerals, including iron and zinc [35]. Although iron and zinc are present in high concentrations,
it is important to take into account the bioavailability of these minerals [36]. In the present study,
chia was chosen as the soluble extract source, since the consumption of chia bacame extensively
common worldwide, and specifically consumed with increasing amounts in Mexico, Argentina, Chile,
New Zealand, Japan, USA, Canada and Australia [37], as in some of these geographical regions (e.g.,
South America), dietary Fe and Zn deficiencies are a major health concern [4,5]. Thus, the primary
objective of this study was to assess the effects of the intra-amniotic administration of chia soluble
extracts with a putative prebiotic effect on Fe and Zn status and brush border membrane functionality,
in vivo. A secondary objective was to evaluate the effects of the tested extracts on intestinal bacterial
populations. The third objective was to evaluate the effects of the chia soluble extracts on intestinal
morphology. We hypothesized that the chia soluble extracts will affect the intestinal morphology,
functionality and bacterial populations.
2. Material and Methods
2.1. Sample Preparation
Chia seeds (Salvia hispanica L.) grown in the state of Mato Grosso (Brazil) were used for this study.
To obtain the flour, the seeds were ground up in three replicates, using a knife mill (Marconi Equipment,
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Algodoal, Brazil), to a particle size of 850 μm. Subsequently, chia flour was packed in polyethylene
aluminum bags and stored in a freezer (−20 ◦C) until analysis.
2.2. Polyphenols Analysis
2.2.1. Chia Sample Preparation
A volume of 5 mL of methanol:water (50:50 v/v) was added to 0.5 g of chia flour. The resulting
slurry was vortexed for 1 min before incubation in a 24 ◦C sonication water bath for 20 min at room
temperature. Samples were again vortexed and placed on a rocker at room temperature for 60 min
before centrifuging at 4000× g for 15 min. Supernatants were filtered with a 0.2 μm PTFE syringe filter
and stored at −20 ◦C for later use.
2.2.2. Liquid Chromatography–Mass Spectrometry (LC-MS) Analysis
Extracts and standards were analyzed by an Agilent 1220 Infinity Liquid Chromatograph (LC;
Agilent Technologies, Inc., Santa Clara, CA, USA) coupled to an Advion expressionL® compact
mass spectrometer (CMS; Advion Inc., Ithaca, NY, USA). Ten-microliter samples were injected and
passed through an XBridge Shield RP18 3.5 μm 2.1 × 100 mm column (Waters, Milford, MA, USA)
at 0.6 mL/min. The column was temperature-controlled at 40 ◦C. The mobile phase consisted of
ultra-pure water with 0.1% formic acid (solvent A) and acetonitrile with 0.1% formic acid (solvent
B). Polyphenols were eluted using linear gradients of 94.0 to 84.4% A in 1.50 min, 84.4 to 81.5% A
in 2.25 min, 81.5 to 77.0% A in 6.25 min, 77.0 to 55.0% in 1.25 min, 55.0 to 46.0% in 2.25 min, 46.0 to
94.0% in 2.25 min and hold at 94.0% A for 2.25 min for a total run time of 18 min. From the column,
the flow was directed into a variable wavelength Ultraviolet (UV) detector set at 280 nm. The flow was
then directed into the source of an Advion expressionL® CMS, and Electrospray ionization (ESI) mass
spectrometry was performed in the negative ionization mode using selected ion monitoring with a scan
time of 200 ms. The capillary temperature and voltages were 250 ◦C and 180 volts, respectively. The ESI
source voltage and gas temperature were 2.5 kilovolts and 250 ◦C, respectively. The desolvation gas
flow was 240 L/h. Advion Mass Express™ software (Advidon, Ithaca, USA) was used to control the LC
and compact mass spectrometers (CMS) instrumentation and data acquisition. Individual polyphenols
were identified and confirmed by comparison of m/z and LC retention times with authentic standards.
The analysis of MS and UV data was performed using Advion Data Express™ software (Advidon,
Ithaca, USA).
2.3. Extraction of Soluble Extracts from Chia
The extraction of prebiotics was performed according to Tako et al. [14], Hou et al. [13] and Pacific
et al. [10]. Chia flour samples were dissolved in distilled water (50 g/L) (60 ◦C, 60 min) and centrifuged
at 3000 rpm (4 ◦C) for 25 min, and then the supernatant was collected. The supernatant was then
dialyzed (MWCO 12–14 kDa) (48 h) against distilled water. The dialysate was collected and lyophilized
to yield a fine off-white powder [12].
2.4. Phytate, Dietary Fiber, Iron and Zinc Analysis in Chia Seeds and Chia Extract
Dietary phytic acid (phytate)/total phosphorous was measured as phosphorus released by
phytase and alkaline phosphatase, according to manufacturer’s instructions (n = 5) (K-PHYT 12/12.
Megazyme International, Bray, Ireland). The determination of total fiber and soluble and insoluble
fractions was performed by the enzymatic-gravimetric method according to AOAC [38], using
enzymatic hydrolysis for a heat-resistant amylase, protease and amyloglucosidase (Total dietary fiber
assay Kiyonaga, Sigma®, Kawasaki, Japan). For the determination of iron and zinc, chia seed and chia
extract (0.5 g) were treated with 3.0 mL of a 60:40 HNO3 and HClO4 mixture in a Pyrex glass tube and
left overnight to destroy organic matter. The analyses were performed using an inductively coupled
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plasma atomic emission spectrometer (ICP-AES) (Thermo iCAP 6500 series, Thermo Jarrell Ash Corp.,
Franklin, MA, USA) [12,28].
2.5. Animals and Design
Cornish-cross fertile broiler eggs (n = 105) were obtained from a commercial hatchery (Moyer’s
chicks, Quakertown, PA, USA). The eggs were incubated under optimal conditions at the Cornell
University Animal Science poultry farm incubator. All animal protocols were approved by the Cornell
University Institutional Animal Care and Use committee (ethic approval code: 2007-0129).
Intra Amniotic Administration
Lyophilized soluble extracts were diluted in 18 Ω H2O and for sample osmolarity determination
(≤320 OSM). At 17 days of embryonic incubation, eggs containing viable embryos were weighed and
divided into 7 groups (n = 15). All treatment groups were assigned eggs of a similar weight frequency
distribution. Each group was then injected with the specified solution (1 mL per egg), using a 21 gauge
needle into the amniotic fluid, which was identified by candling. The 7 groups were assigned as
follows: (1) non-injected; (2) 18 Ω H2O; (3) inulin (40 mg/mL); (4) chia seed extract 0.5% (5 mg/mL);
(5) chia seed extract 1% (10 mg/mL); (6) chia seed extract 2.5%; (7) chia seed extract 5% (50 mg/mL).
After the injections, the holes were sealed with cellophane tape and the eggs were placed in hatching
baskets. Immediately after hatch (21 days), the chicks were euthanized by CO2 exposure and their
small intestine, blood, pectoral muscle, cecum and liver were collected.
2.6. Iron and Zinc Content in Serum and Liver
Liver (0.5 g) and serum (50 μL) were treated with 3.0 mL of a 60:40 HNO3 and HClO4 mixture
in a Pyrex glass tube and were incubated overnight. The mixture was then heated to 120 ◦C for two
hours and 0.25 mL of 40 μg/g Yttrium was added as an internal standard. Next, the temperature
of the heating block was raised to 145 ◦C for 2 h. Then, for 10 min, the temperature of the heating
block was raised to 190 ◦C. The cooled samples were then diluted to 20 mL, vortexed and transferred
into autosampler tubes to be analyzed via inductively coupled plasma atomic emission spectrometer
(ICP-AES). (Thermo Jarrell Ash Corp., Franklin, MA, USA) [12,28].
2.7. Isolation of Total RNA from Duodenum and Liver
Total RNA was extracted from 30 mg of the proximal duodenal tissue or liver tissue (n = 10)
using Qiagen RNeasy Mini Kit (RNeasy Mini Kit, Qiagen Inc., Valencia, CA, USA) according to the
manufacturer’s protocol. Total RNA was eluted in 50 μL of RNase-free water. All steps were carried
out under RNase-free conditions. RNA was quantified by absorbance at A 260/280 and the integrity
of the 18S ribosomal RNAs was verified by 1.5% agarose gel electrophoresis followed by ethidium
bromide staining. RNA was stored at −80 ◦C.
2.8. Real Time Polymerase Chain Reaction (RT-PCR)
To create the cDNA, a 20 μL reverse transcriptase (RT) reaction was completed in a BioRad
C1000 touch thermocycler using the Improm-II Reverse Transcriptase Kit (Catalog #A1250; Promega,
Madison, WI, USA). The concentration of cDNA obtained was determined by measuring the absorbance
at 260 and 280 nm using an extinction coefficient of 33 (for single stranded DNA). Genomic DNA
contamination was assessed by a real-time RT-PCR assay for the reference gene samples [12].
2.9. Primer Design
The primers used in the real-time qPCR were designed based on 13 gene sequences from the
Genbank database, using Real-Time Primer Design Tool software (IDT DNA, Coralvilla, IA, USA).
The sequences and the description of the primers used in this work are summarized in Table 1.
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The specificity of the primers was tested by performing a BLAST search against the genomic National
Center for Biotechnology Information (NCBI) database. The Gallus gallus primer 18S rRNA was
designed as a reference gene. Results obtained from the qPCR system were used to normalize those
obtained from the specific systems as described below.
Table 1. The sequences of the primers used in this study.
Analyte Forward Primer (5′–3′) Reverse Primer (5′–3′) Base Pair GI Identifier
DMT1 TTGATTCAGAGCCTCCCATTAG GCGAGGAGTAGGCTTGTATTT 101 206597489
Ferroportin CTCAGCAATCACTGGCATCA ACTGGGCAACTCCAGAAATAAG 98 61098365
Dcytb CATGTGCATTCTCTTCCAAAGTC CTCCTTGGTGACCGCATTAT 103 20380692
Hepcidin * GAGCAAGCCATGTCAAGATTTC GTCTGGGCCAAGTCTGTTATAG 132 8056490
ZnT1 GGTAACAGAGCTGCCTTAACT GGTAACAGAGCTGCCTTAACT 105 54109718
SI CCAGCAATGCCAGCATATTG CGGTTTCTCCTTACCACTTCTT 95 2246388
AP CGTCAGCCAGTTTGACTATGTA CTCTCAAAGAAGCTGAGGATGG 138 45382360
SGLT1 GCATCCTTACTCTGTGGTACTG TATCCGCACATCACACATCC 106 8346783
LPL * TGCTCAGATGCCCTACAAAG TCTCGTCTAGAGTGCCATACA 119 396219
CEL * ATGCTGCTGACATCGACTAC TTCTGAAGTGGACGGTTGATAG 97 417165
18S rRNA * GCAAGACGAACTAAAGCGAAAG TCGGAACTACGACGGTATCT 100 7262899
DMT1, Divalent metal transporter 1; Dcytb, Duodenal cytochrome b; Znt 1, Zinc transporter 1; SI, Sucrose isomaltase;
AP, Amino peptidase; SGLT1, Sodium-Glucose transport protein 1; LPL, Lipoprotein lipase; CEL, Carboxyl ester
lipase; 18S rRNA, 18S Ribosomal subunit. * liver analyses.
2.10. Real-Time qPCR Design
All procedures were conducted as previously described [10–13]. The specific primers that were
used are shown in Table 1.
2.11. Collection of Microbial Samples and Intestinal Content DNA Isolation
The cecum contents were removed under sterile conditions, placed into a sterile tube containing
9 mL of Phosphate buffered saline (PBS) and homogenized by vortexing with glass beads for 3 min [27,39].
All procedures were conducted as previously described [10–14].
2.12. Primer Design and PCR Amplification of Bacterial 16S rDNA
Primers for Lactobacillus, Bifidobacterium, Clostridium and Escherichia coli were used [16,39].
The universal primers were designed with the invariant region in the 16S rRNA of bacteria and
were used as internal standards. The proportions of each bacterial group are presented. The PCR
products were loaded on 2% agarose gel stained with ethidium bromide and quantified by Quantity
One 1-D analysis software (Bio-Rad, Hercules, CA, USA) [12]. The evaluation of the relative abundance
of each examined bacterium was conducted as previously described [10–14].
2.13. Glycogen Analysis
At hatch, the pectoral muscle (20 mg) was collected for glycogen analysis. The tissue samples
were homogenized in 8% perchloric acid, and glycogen concentration was determined as previously
described [40]. After homogenization, the samples were centrifuged at 12,000 rpm at 4 ◦C for 15 min.
The supernatant was removed, and 1.0 mL of petroleum ether was added. After mixing, the petroleum
ether fraction was removed, and samples from the bottom layer were transferred to a new tube
containing 300 μL of color reagent. All samples were read at a wavelength of 450 nm in an ELISA
reader and the amount of glycogen was calculated according to a standard curve. The amount of
glycogen present in pectoral sample was determined by multiplying the weight of the tissue by the
amount of glycogen per 1 g of wet tissue.
2.14. Morphological Examination
As previously described [10,41], liver and intestine samples were collected at the conclusion of this
study. Samples were fixed in 4% (v/v) buffered formaldehyde, dehydrated, cleared, and embedded in
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paraffin. Serial sections of 5 μm were obtained and were deparaffinized in xylene, rehydrated in a different
concentration of alcohol, stained with hematoxylin/eosin or Alcian Blue/Periodic acid-Schiff, and examined
by light microscopy. The following variables were measured in the intestine: villus height, villus width,
depth of crypts, goblet cell number and goblet cell diameter in each segment, performed with a light
microscope using EPIX XCAP software (Standard version, Olympus, Waltham, MA, USA). Four segments
for each biological sample and five biological samples per treatment group were used. Villi height was
measured using the lamina propria as the base; villi width, depth of the crypt and the number of goblet cell
were measured per side of a longitudinal section through the villus; goblet cell size was measured as the
diameter of the goblet cells (μm2). Villi surface area was calculated from the villus height and width at
half height as according to Uni et al. [42]. For the Alcian Blue and Periodic acid-Schiff stain, the segments
were only counted for the types of goblet cells in the villi epithelium, goblet cells within the crypts and
the mucus layer thickness. Goblet cells were enumerated on 10 villi/sample, and the means were utilized
for statistical analysis. The liver was stained with hematoxylin-esoin (H&E) for standard microscopy
and visualized using the same light microscope. Mean adipocyte diameter was determined by random,
utilizing the EPIX XCAP software (standard version, Olympus, Waltham, MA, USA), by enumerating
10 adipocytes/segment/sample, and the means were utilized for statistical analysis.
2.15. Statistical Analysis
All values are expressed as the means and standard deviations. Experimental treatments for the in
ovo assay were arranged in a completely randomized design. The results were analyzed by ANOVA.
For significant “p-value”, post hoc Duncan test was used to compare test groups. Statistical analysis
was carried out using SPSS version 20.0 software (IBM, Armonk, USA). The level of significance was
established at p < 0.05.
3. Results
3.1. Concentration of Iron, Zinc, Phytic Acid and Dietary Fiber and the Phytate:Iron Ratio in Chia Flour and in
Chia Extract
The iron and zinc concentrations, insoluble fiber content, phytic acid and the phytate:iron ratio
were higher (p < 0.05) in the chia seed compared to the chia extract (Table 2). However, the content of
soluble fiber was significantly greater (p < 0.05) in the chia extract relative to chia seed.















Chia seed 110.25 ± 4.97 a 57.82 ± 0.40 a 34.67 ± 1.84 a 4.01 ± 0.21 b 0.71 ± 0.02 a 5.47 a
Chia extract 41.46 ± 0.89 b 31.29 ± 0.89 b 23.53 ± 1.74 b 19.68 ± 0.76 a 0.08 ± 0.00 b 1.60 b
Values are the means ± SEM, n = 5. a,b Treatment groups not indicated by the same letter are significantly different
(p < 0.05).
3.2. Polyphenol Profile in Chia Flour
The concentration of the five most prevalent polyphenolic compounds found in chia is presented
in Table 3. Chia presented high concentrations of rosmarinic acid and rosmarinyl glucoside. In addition,
we observed the presence of ferulic acid, caffeic acid and protocatechuic acid.
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Table 3. Polyphenol profile present in chia flour.
Polyphenolic Compounds Mean Peak Area (mAU-min/106)
Rosmarinic acid 42.30 ± 1.90
Rosmarinyl glucoside 57.70 ± 0.02
Ferulic acid 1.19 ± 0.06
Caffeic acid 0.76 ± 0.38
Protocatechuic acid 0.21 ± 0.03
Values are the means ± SEM, n = 10. mAU: milli absorbance unit; min: minutes.
3.3. In Ovo Assay (Gallus Gallus Model)
3.3.1. Hb Concentration
The Hb values were significantly (p< 0.05) higher in the “2.5% chia” extract treatment group compared
to the 18 Ω H2O and non-inject group. The other treatments did not differ from each other (Table 4).
Table 4. Blood hemoglobin (Hb) concentrations (g/dL).
Treatment Group Hb (g/dL)
Non-injected 5.93 ± 0.00 b
18 Ω H2O 5.52 ± 1.49 b
Inulin 7.76 ± 1.16 a,b
0.5% Chia 7.08 ± 1.16 a,b
1.0% Chia 9.51 ± 1.34 a,b
2.5% Chia 10.41 ± 1.37 a
5.0% Chia 10.06 ± 2.48 a,b
Values are the means ± SEM, n = 10. a,b Treatment groups not indicated by the same letter are significantly different
(p < 0.05).
3.3.2. Iron and Zinc Concentration in Liver and Serum
As shown in Table 5, there were no significant (p > 0.05) differences in liver iron concentration and
serum zinc concentration between treatment groups. However, “1% chia” extract treatment increased
(p < 0.05) the zinc liver content compared to non-inject treatment. In addition, we observed that “5%
chia” extract treatment showed a lower (p < 0.05) serum iron concentration when compared to the
18 Ω H2O and inulin groups. In general, different concentrations of chia extract did not affect iron and
zinc concentrations in liver and serum.
Table 5. Iron and zinc concentrations (ppm).
Treatment Group
Liver Serum
Iron (μg/g) Zinc (μg/g) Iron (μg/g) Zinc (μg/g)
Non-injected 35.28 ± 2.52 a 14.77 ± 1.26 b 3.14 ± 0.25 a,b,c 0.001 ± 0.000 a
18 Ω H2O 41.00 ± 3.24 a 16.10 ± 1.57 a,b 4.04 ± 0.52 a,b 0.002 ± 0.000 a
Inulin 40.92 ± 3.32 a 16.39 ± 2.43 a,b 4.24 ± 0.96 a 0.001 ± 0.000 a
0.5% Chia 35.57 ± 3.16 a 18.45 ± 1.13 a,b 2.99 ± 0.44 a,b,c 0.002 ± 0.000 a
1.0% Chia 43.17 ± 4.08 a 21.63 ± 2.59 a 2.36 ± 0.24 a,b 0.003 ± 0.001 a
2.5% Chia 33.52 ± 1.67 a 16.60 ± 1.41 a,b 3.23 ± 0.63 a,b,c 0.001 ± 0.000 a
5.0% Chia 35.88 ± 2.81 a 17.87 ± 2.52 a,b 1.59 ± 0.29 c 0.002 ± 0.000 a
Values are the means ± SEM, n = 10. a,b,c Treatment groups not indicated by the same letter are significantly different
(p < 0.05).
3.3.3. Gene Expression of Fe- and Zn-Related Genes
The gene expression of DMT1 was lower (p < 0.05) in the group treated with 2.5% chia soluble
extract compared to the inulin and 18 Ω H2O groups (Figure 1). However, other various concentrations
of chia soluble extract did not affect the expression of DMT1 (p > 0.05). The relative expression of DcytB
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and hepcidin was significantly up-regulated (p < 0.05) in the 1%, 2.5% and 5% chia extract. The groups
treated with 1%, 2.5% and 5% chia extract showed lower (p > 0.05) ferroportin gene expression
compared to the 18 Ω H2O injected group. However, no differences (p > 0.05) were observed between
chia treatment groups. The relative expression of ZnT1 was significantly up-regulated (p < 0.05) in the
1%, 2.5% and 5% chia extract.
Figure 1. Effect of the intra-amniotic administration of experimental solutions on intestinal and liver
gene expression. Values are the means ± SEM, n = 10. a–c Per gene, treatments groups not indicated
by the same letter are significantly different (p < 0.05). DMT1, Divalent metal transporter 1; Dcytb,
Duodenal cytochrome b; ZnT1, Zinc transporter 1; AP, Amino peptidase; SGLT1, Sodium-Glucose
transport protein 1; SI, Sucrose isomaltase; CEL, Carboxyl ester lipase; LpL, Lipoprotein lipase.
3.3.4. Gene Expression of BBM Functional Proteins
The gene expression of aminopeptidase (AP), sodium-glucose transport protein 1 (SGLT1) and
sucrase isomaltase (SI) are used as biomarkers of brush border membrane digestive and absorptive
functions. AP and SGLT1 gene expression did not differ (p > 0.05) between groups treated with chia
extract. However, the gene expression of SI was higher (p < 0.05) in “5% chia” extract treatment group
compared to the “2.5% chia” extract treatment group (Figure 1).
3.3.5. Gene Expression of Lipids Metabolism Protein
The gene expressions of carboxyl ester lipase (CEL) and lipoprotein lipase (LpL) are used as
biomarkers of lipid metabolism. As shown in Figure 1, the “2.5% chia” extract treatment group
presented higher (p > 0.05) CEL expression compared to the control groups. However, the gene
expression of LpL did not differ between chia extract groups and control groups (p < 0.05).
3.3.6. Cecum-to-Body-Weight Ratio
As shown in Figure 2, the chia soluble extract treatment groups showed a higher (p < 0.05)
cecum weight (B) and cecum weight/body weight ratio (C) compared to control groups (p < 0.05).
However, no significant difference (p > 0.05) was observed in body weight (A) among treatment groups
and controls.
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Figure 2. The effect of chia on the: (A) body weight; (B) cecum weight; and (C) cecum weight/body
weight ratio (%). Values are the means ± SEM n = 15. a,b Within a column, means without a common
letter are significantly different (p < 0.05).
3.3.7. Microbial Analysis
As shown in Figure 3, the relative abundance of both Bifidobacterium and Lactobacillus genera,
increased (p < 0.05) in the “0.5% chia” treatment, relative to the 18 Ω H2O group and non-injected
group. The “5% chia” treatment group showed a lower (p < 0.05) concentration of these bacterial
populations compared to the other groups. The relative abundance of E. coli significantly decreased
(p < 0.05) in the 1%, 2.5% and 5% chia extract treatment groups compared to the control groups.
The relative abundance of Clostridium was significantly (p < 0.05) lower in the non-inject group, 18 Ω
H2O group and “5% chia” treatment group. These results suggest that a lower concentration of chia
extract may positively affect gut health.
Figure 3. Genera- and species-level bacterial populations (AU) from cecal contents measured on the
day of hatch. Values are the means ± SEM, n = 10. a–d Per bacterial category, treatment groups not
indicated by the same letter are significantly different.
3.3.8. Glycogen Analysis
No significant difference was observed in pectoral muscle glycogen content between groups
(Table 6, p > 0.05).
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Table 6. Concentration of glycogen in pectoral muscle.
Treatment Group Glycogen Concentration (mg/g)
Non-injected 0.17 ± 0.04 a
18 Ω H2O 0.21 ± 0.05 a
Inulin 0.29 ± 0.06 a
0.5% Chia 0.13 ± 0.03 a
1.0% Chia 0.31 ± 0.06 a
2.5% Chia 0.26 ± 0.08 a
5.0% Chia 0.29 ± 0.15 a
Values are the means ± SEM, n = 10. a Treatment groups not indicated by the same letter are significantly different
(p < 0.05).
3.3.9. Morphometric Data for Villi, Depth of Crypts and Goblet Cell
The villus surface areas, villi length, width and the number of goblet cells were significantly
(p < 0.05) higher in all chia extract treatment groups compare to controls (Tables 7 and 8), indicating that
soluble extracts from chia had a positive effect on intestinal development, through the proliferation of
enterocytes, and the increased number in mucus-producing cells. However, there were no significant
(p > 0.05) differences in crypt depth and mucus layer width between treatment groups. Further, all chia
extract treatments increased (p < 0.05) the diameter of goblet cells compared to controls. In relation
to the types of goblet cells observed (acidic, neutral, mixed), we can note that the administration of
2.5% chia soluble extracts reduced (p < 0.05) the number of neutrals goblet cells compared to the
control groups. In addition, the administration of 2.5% and 5% chia soluble extracts increased (p < 0.05)
the number of acidic goblet cells, whereas the administration of 1% and 2.5% chia extract caused an
increase (p < 0.05) in mixed goblet cells, compared to controls. In relation to the types of goblet cells in
the crypt epithelium, the administration of 0.5% chia soluble extract increased (p < 0.05) the number
of neutrals goblet cells compared to controls. In addition, the administration of 2.5% chia extracts
increased (p < 0.05) the number of mixed goblet cells compared to controls. The number of acid goblet
cells did not differ (p > 0.05) between groups (Figure 4). No significant differences between treatment
groups were measured in fat cell diameter (p > 0.05, Figure 5).
Table 7. Effect of the intra-amniotic administration of experimental solutions on the duodenal small













Non-injected 170.29 ± 5.33 c 248.64 ± 2.83 c 43.26 ± 0.42 c 12.76 ± 0.10 a 2.21 ± 0.27 a
18 Ω H2O 127.13 ± 8.16 c 204.30 ± 3.40 d 39.24 ± 0.37 d 12.60 ± 0.09 a 2.32 ± 0.15 a
Inulin 130.00 ± 9.42 c 208.90 ± 3.63 d 41.20 ± 0.56 c,d 13.01 ± 0.10 a 2.36 ± 0.1 a
0.5% Chia 237.53 ± 7.98 b 323.85 ± 3.51 b 46.42 ± 0.40 b 12.49 ± 0.08 a 2.41 ± 0.25 a
1.0% Chia 234.78 ± 7.36 b 298.82 ± 2.43 b 49.70 ± 0.51 b 13.08 ± 0.09 a 2.22 ± 0.10 a
2.5% Chia 264.95 ± 2.74 b 334.44 ± 5.62 b 50.15 ± 0.57 b 12.83 ± 0.10 a 2.20 ± 0.13 a
5.0% Chia 343.93 ± 9.38 a 374.47 ± 5.50 a 58.18 ± 0.59 a 12.71 ± 0.11 a 2.15 ± 0.14 a
Values are the means ± SEM, n = 5. a–d Treatment groups not indicated by the same letter are significantly different
(p < 0.05).







Villus Goblet Cell Number (Unit) Crypts Goblet Cell Number (Unit)
Neutral Acid Mixed Neutral Acid Mixed
Non-injected 4.20 ± 0.03 c 21.23 ± 0.24 c 2.50 ± 0.33 a,b 8.77 ± 0.23 b 9.11 ± 0.33 c 0.01 ± 0.00 b 10.36 ± 0.57 a 0.47 ± 0.15 c
18 Ω H2O 4.10 ± 0.03 c 20.18 ± 0.26 c 2.14 ± 0.24 b 8.05 ± 0.74 c 9.62 ± 0.47 c 0.10 ± 0.00 b 9.69 ± 0.55 a 1.64 ± 0.16 a
Inulin 4.89 ± 0.06 b 24.88 ± 0.20 b 3.90 ± 0.99 a 8.67 ± 0.48 b 11.02 ± 1.02 b,c 0.01 ± 0.00 b 10.32 ± 0.36 a 0.43 ± 0.14 c
0.5% Chia 5.48 ± 0.03 a,b 28.59 ± 0.32 a 3.63 ± 0.25 a,b 10.76 ± 0.71 a,b 14.26 ± 0.51 a 0.46 ± 0.12 a 10.02 ± 0.91 a 0.89 ± 0.06 b,c
1.0% Chia 5.36 ± 0.05 a,b 29.19 ± 0.29 a 2.07 ± 0.17 b 11.43 ± 0.61 a,b 15.55 ± 0.71 a 0.09 ± 0.05 b 9.65 ± 1.05 a 1.30 ± 0.11 a,b
2.5% Chia 5.61 ± 0.02 a 29.61 ± 0.40 a 1.63 ± 0.16 c 13.70 ± 1.53 a 13.72 ± 1.35 a 0.05 ± 0.02 b 9.45 ± 0.49 a 1.45 ± 0.30 a
5.0% Chia 5.42 ± 0.06 a,b 29.91 ± 0.39 a 2.55 ± 0.43 a,b 13.13 ± 1.35 a 13.20 ± 1.51 a,b 0.18 ± 0.06 a,b 9.88 ± 0.13 a 0.82 ± 0.21 b,c
Values are the means ± SEM, n = 5. a–c Treatment groups not indicated by the same letter are significantly different
(p < 0.05).
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Figure 4. Representations of the intestinal morphology of each treatment group are shown (Alcian Blue
and Periodic acid-Schiff Stain). The yellow circles indicate crypts within the villi and the red circles
indicate goblet cells on the villi. Bar = 50 μm.
Figure 5. Fat cell diameter. Values are the means ± SEM, n = 5. a Treatment groups not indicated by
the same letter are significantly different.
3.3.10. Hepatic Morphometric Measurement
As shown in Figure 4, no significant differences were observed in hepatic fat cell diameter between
all treatment groups (p > 0.05).
4. Discussion
Chia is a good source of dietary fiber, which was demonstrated to have a beneficial effect on
intestinal health [29]. However, until now, the potential effects of soluble extracts from chia seed on the
intestinal microbiota, intestinal morphology and mineral bioavailability, such as iron and zinc, were
not investigated. Further, it is important to highlight that the alterations in microbiota populations,
due the consumption of dietary fiber, may be associated, directly or indirectly, to the increased dietary
bioavailability of iron and zinc in vulnerable populations [13,15,18,27]. The present study indicates that
the in ovo administration of soluble extracts from chia seed increased the intestinal villus surface area,
villi length, villi width, goblet cell number and goblet cell size (diameter), as well as cecum weight (used
as biomarker of microbial presence and activity). In addition, the administration of chia seed soluble
extracts up-regulated the expression of proteins related to zinc metabolism. Further, the chia soluble
extract (0.5%) increased the Bifidobacterium and Lactobacillus relative abundance in cecum content.
According to our results, the hemoglobin concentration results corroborate with our findings
of serum iron. We did not observe a change in liver iron concentrations, due to the short time of
exposure of the soluble extracts, which was not sufficient to cause a modification in hepatic iron
storage. This was in agreement with previous observations that evaluated the effects of intra-amniotic
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raffinose and stachyose administration on Fe status, as the results showed no significant differences in
hemoglobin values between treatment groups [10]. Further, another study that assessed the effect of
the intra-amniotic administration of bean soluble extracts on iron status indicated that bean extracts
did not affect serum or liver iron concentrations [12]. A similar result was observed post intra-amniotic
administration of wheat extracts [14]. In addition, a BBM Fe metabolism-related gene expression
analysis of DcytB, DMT, ferroportin and hepcidin was conducted. DcytB is the protein responsible for
reducing Fe3+ to Fe2+ in the apical membrane of the enterocyte [10,43]. DMT1 plays a key role in Fe2+
transport into the enterocyte, being considered the major Fe intestinal transporter [10,43], whereas
ferroportin is the protein that transports Fe2+ from the enterocyte into the bloodstream [10,43]. In the
current study, the administration of 1%, 2.5% and 5% chia soluble extract solutions up-regulated the
expression of DcytB, which in return may increase the transportation of Fe by DMT1 into the enterocyte,
and as previously demonstrated, this effect can potentially increase iron absorption efficiency in a
long-term feed trial [12]. Further, we investigated hepcidin gene expression as the key iron-regulatory
hormone that controls systemic iron homeostasis, as hepcidin is able to down regulate the expression
of ferroportin [44,45]. Further, the increase in hepcidin production is stimulated by iron loading
and inflammation [46,47]. In the present study, hepcidin gene expression was lower (p < 0.05) in
the 1%, 2.5% and 5% chia soluble extract groups compared to the inulin and water groups, which
suggests that in a long-term feeding trial, the dietary inclusion of chia may have a positive effect on
Fe-related proteins.
ZnT1 is the only transporter of the ZnT transporters family that is localized on the enterocyte’s
basolateral membrane and functions by exporting cytosolic zinc into the extracellular space [48],
an up-regulation in ZnT1 mRNA gene expression may occur under increased cellular zinc levels [49].
In the current study, the groups treated with chia seed soluble extract (1%, 2.5% and 5%) shown a gene
expression up-regulation (p < 0.05) of ZnT1 compared to the other groups, although the zinc serum
concentrations did not differ between experimental groups.
Previous studies demonstrated the potential beneficial effects of soluble extract from various
sources and plant origin compounds (such as raffinose, stachyose, diadzein, bean, and wheat) on
BBM functionality and intestinal bacterial populations [10–13,27]. In the current study, the expression
of BBM functional genes (AP, SI and SGLT1) was not affected by the chia seed soluble extract
administration, due to the short exposure time. However, in relation to microbial populations, there
was an increasing abundance of Lactobacillus (p < 0.05), and Bifidobacterium (p < 0.05) in the cecal
contents of animals received 0.5% chia soluble extracts compared to the 18 Ω H2O and non-injected
group. Further, we observed an increased abundance in Lactobacillus (p < 0.05), Bifidobacterium (p < 0.05),
E. Coli (p < 0.05) and Clostridium (p < 0.05) in the cecal contents of the animals that received 0.5%
chia seed soluble extracts compared to other groups treated with chia seed extract. It is important
to highlight that the increase in Lactobacillus and Bifidobacterium abundance, due the consumption of
dietary fiber, may further contribute, directly or indirectly, to the increased bioavailability of iron and
zinc in vulnerable populations, as these bacterial genera produce short-chain fatty acids (SCFAs), which
reduce the intestinal pH, and therefore, may increase mineral (as Fe and Zn) solubility and therefore
absorption [50]. Bifidobacterium and Lactobacillus can break down non-digestible fiber (prebiotics),
due to their 1,2-glycosidase activity, leading to greater SCFA production [16,27,39], culminating with
the increase in the absorption of iron and zinc.
The morphological parameters described in the current study, including villi development
parameters and the crypt depth, are used as indicators of intestinal health, functionality and
development [51]. The administration of chia seed soluble extracts, regardless of the concentration
used, increased all parameters related to intestinal villi. These values (villus surface area, villus length
and width) were significantly higher (p < 0.05) in the 5.0% chia group and relative to all other groups.
This can be explained by the potential increased proliferation of intestinal cells in the short term,
due the presence of soluble fiber, leading to hyperplasia and/or hypertrophy of intestinal cells and
potentially enhancing the absorptive and digestive capacity of the villi BBM [29]. Another explanation
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is that the tested extracts had potentially increased butyrate production, which may lead to enterocyte
proliferation [52]. Added to these factors, the soluble extract of chia seed contains a high concentration
of phenolic compounds, among them are rosmarinic acid and rosmarinyl glucoside, which present the
ability to affect intestinal morphology [53], increasing the villus height, crypt depth ratio, and muscularis
thickness, as observed in the study that evaluated the administration of dietary polyphenol concentrate
previously performed in Gallus gallus [54]. The morphological results agree with our cecum weight
and cecum weight/body weight ratio observations. All experimental groups showed a higher (p >
0.05) cecal weight (Figure 2B) post intra-amniotic soluble extract administration, indicating, and as
previously suggested, increased cecal bacterial populations activity [10,12,13]. As for crypt depth,
no differences between the experimental groups were observed, since duodenal crypts require a longer
time to allow cellular proliferation. However, the intestinal crypts are meager and are able to rise to
the surface of the villus, increasing the number of enterocytes in intestinal villi [52]—a phenomenon
that was observed in the current study. Additionally, we observed increased goblet cell number and
goblet cell diameter, which suggests an increased production of mucus that coats the intestinal lumen.
As previously suggested, this may increase the intestinal BBM digestive and absorptive capabilities,
and may indirectly increase the bioavailability of dietary components as suggested by the effects
observed on the morphometric parameters [55–57]. The increase in “acidic goblet cells”, containing
acidic mucin due to the administration of 2.5% and 5% chia soluble extracts, may contribute to the
reduction of intestinal pH, which in the long term, may lead to increased solubilization and uptake
of iron and zinc and affect intestinal microbial profile [14,39]. The increase in “acidic goblet cells”
was previously observed in a study that evaluated the effects of the intra amniotic administration
of carbohydrate solution (containing maltose, sucrose and dextrin) on mucin content, goblet cell
development, and levels of mucin mRNA in the Gallus gallus small intestine [58].
In general, previous studies showed a positive effect of prebiotic administration on intestinal
morphology [10,13,25,51,52], for example, the intra-amniotic administration of raffinose and stachyose
increased villus surface area compared to the control [10]. Similar results were observed by Hou et
al. [13], who evaluated the effect of chickpea and lentil prebiotics administration in ovo. In another
study, the authors evaluated the development of morphological parameters in Gallus gallus, and the
results showed that the administration of a synthetic prebiotic increased the villus width and crypt
depth. The prebiotic had no impact on villus height, villus surface area, and muscular thickness
compared to the animals that received saline solution administration [51]. Bogucka et al. [52] evaluated
the effect of inulin administration on the development of the intestinal villi and the number of goblet
cells in the small intestine on the 1st and the 4th day post hatch (Gallus gallus) and the study indicated
that on day one, the villus height did not differ among experimental groups. However, the villus width,
villus surface area and crypt depth were lower in the prebiotic group. On day four, the inulin group
showed a lower villus width, villus surface area and crypt depth [52]. Another study that evaluated
the effect of the intra aminiotic administration of wheat bran prebiotic extract indicated increased villus
height, goblet cell diameter and number in all treatment groups [11]. Further, Mista et al. [25] evaluated
the effect of intra amniotic administered prebiotics on the development of the small intestine (Gallus
gallus) and found that prebiotics did not affect the villus length, but did increase the crypt depth.
The observations described in the current study suggest that dietary chia seed consumption
may be an effective strategy to reduce dietary iron and zinc deficiency and to potentially improve
intestinal health. Overall, the up-regulation of Zn gene expression and the DcytB-Fe metabolism
protein, the increase in villus surface area, villus length, villus width, goblet cell number and goblet cell
diameter as well as cecum weight suggest that chia is a promising food ingredient that may improve
mineral bioavailability and intestinal morphology. Hence, long-term feeding trials assessing the dietary
effects of chia are now warranted.
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5. Conclusions
The intra-amniotic (in ovo) administration of chia seed soluble extracts with putative prebiotic
effects improved the intestinal morphology and up-regulated Zn-related protein gene expression.
Further, chia seed soluble extract administration affected the intestinal microbiota and iron-related
gene expression. The current study is the first to investigate the effects of chia seed soluble extracts
with a potential prebiotic effect in vivo; thus, future studies aimed to assess dietary chia seed in a
long-term feeding trials should be conducted, since chia may be a viable dietary ingredient that may
improve intestinal health and contribute to intestinal mineral absorption.
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Abstract: In alignment with Hippocrates’ aphorisms “Let food be your medicine and medicine be
your food” and “All diseases begin in the gut”, recent studies have suggested that healthy diets
should include fermented foods to temporally enhance live microorganisms in our gut. As a result,
consumers are now demanding this type of food and fermented food has gained popularity. However,
certain sectors of population, such as those allergic to milk proteins, lactose intolerant and strict
vegetarians, cannot consume dairy products. Therefore, a need has arisen in order to offer consumers
an alternative to fermented dairy products by exploring new non-dairy matrices as probiotics carriers.
Accordingly, this review aims to explore the benefits of different fermented non-dairy beverages
(legume, cereal, pseudocereal, fruit and vegetable), as potential carriers of bioactive compounds
(generated during the fermentation process), prebiotics and different probiotic bacteria, providing
protection to ensure that their viability is in the range of 106–107 CFU/mL at the consumption time,
in order that they reach the intestine in high amounts and improve human health through modulation
of the gut microbiome.
Keywords: intestinal microbiota; vegetable drink; fermentation; beneficial microorganisms; lactic
acid bacteria; cereal; legume; pseudocereal; fruit; synbiotic
1. Introduction
Following Hippocrates’ aphorism “Let food be your medicine and medicine be your food”.
In recent years, consumers have become more aware of the relationship between health and diet, and
are now demanding healthier products with better nutritional characteristics and specific components
to prevent health problems and improve their quality of life and life expectancy. This trend offers
new opportunities for products with health benefits beyond basic nutrition, which meet consumer
expectations and at the same time, drives the growth of the functional food market [1–3]. Nowadays,
functional foods have been developed that incorporate different components with health benefits,
such as bioactive compounds isolated from plants, polyunsaturated fatty acids, probiotics, prebiotics,
minerals and vitamins, among others [4–7].
Twenty-five centuries ago, Hippocrates also stated that “All diseases begin in the gut” when
referring to the relevance of the gastrointestinal system for human health. Currently, scientists studying
the human microbiome suggest that healthy diets should include fermented foods to temporally
enhance live microorganisms in our gut. The intestinal microbiota is a huge and varied collection
of microorganisms. The large intestine hosts around 1013–1014 microorganisms (almost 10 times the
Nutrients 2020, 12, 1666; doi:10.3390/nu12061666 www.mdpi.com/journal/nutrients187
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number of cells that make up the human body) and most consist of the bacteria phyla Firmicutes
and Bacteroidetes. They play an important role in the health of the host, having effects on the
regulation of energy metabolism and maturation of the immune system [8]. The administration of live
probiotics maintains the balance of gut microbiota and contributes to the overall intestinal health. As a
result, fermented foods have gained popularity and are highly demanded by the population [9,10].
Products with probiotics which contribute to gut health represent one of the largest and fastest growing
sectors. Probiotics are defined as “live microorganisms that when are administered in an adequate
amount confer a beneficial effect on the host health” [11]. Probiotics can be consumed as part of
fermented foods or as dietary supplements. The most common genera that have been employed as
probiotics and are available on the food market are the lactic acid bacteria (LAB) Lactobacillus and
Bifidobacterium. Their species have mostly been given a generally-recognized-as-safe (GRAS) status
and qualified presumption of safety (QPS) status, as their consumption does not present risks for the
host’s health [11–13].
A probiotic must survive during gastrointestinal digestion and adhere to the intestinal epithelium
to exert its beneficial effects. The adherence ability depends on the hydrophobicity and autoaggregation
capacity of the probiotic microorganisms [14]. The period of survival and residence of probiotics in the
colon can be influenced by their duration and dose of probiotic, as well as by the matrix used as a
carrier of the probiotics (Figure 1) [15,16].
 
Figure 1. Summary of the beneficial effects of probiotics in different fermented non-dairy beverage
matrices. Primary effects: changes in non-dairy matrices during fermentation. Secondary effects:
changes in the intestinal epithelium. Tertiary effects: positive changes in health. SCFAs: short chain
fatty acids; EPS: exopolysaccharides; AOC: antioxidant capacity [14–16].
Dairy foods have traditionally been used as carriers for probiotic microorganisms. Therefore,
foods such as kefir, milk, yogurts, and cheese have been widely explored as dairy matrices for
probiotic bacteria [17–20]. However, certain sectors of the population such as those allergic to milk
proteins, those who are lactose intolerant, and those who are strictly vegetarian, cannot consume
dairy products. Therefore, a need has arisen to offer consumers an alternative to fermented dairy
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products by exploring new non-dairy matrices as probiotics carriers [21,22]. However, the viability of
probiotic microorganisms is more difficult to maintain in non-dairy matrices than in dairy matrices.
The physicochemical parameters must be carefully controlled to guarantee the probiotic viability
and to achieve adequate organoleptic properties (mainly aroma and flavor) that can be modified by
fermentation [23]. Nevertheless, to improve the probiotic viability in non-dairy beverages, prebiotics
could be used as a supplement. Prebiotics can be defined as “non-digestible food ingredients that
beneficially affect the host by selectively stimulating the growth and/or activity of one of a limited
number of bacteria in the colon” [24]; thus, they can improve the gut microbiome by specific beneficial
bacteria fermentation in the colon. Foods or beverages that contain probiotics and prebiotics are known
as synbiotic foods. Therefore, the proper selection of food matrices as potential carriers of probiotics
is an essential factor to consider in the development of probiotic foods. It is important to ensure the
viability of probiotics during processing and storage, in order to maintain their concentrations at high
levels (106–107 colony-forming units (CFU) per mL or g of food) at the time of consumption (Figure 2).
It is also essential to ensure their survival during gastrointestinal digestion, and thus a high viability
of the probiotics, so that a sufficient amount reach the large intestine to exert their beneficial effects.
Accordingly, this review aims to explore the potential of different fermented non-dairy beverages
(legume, cereal, pseudocereal, fruit, and vegetable), as carriers of bioactive compounds (also generated
during the fermentation process), prebiotics and different probiotic bacteria. This review will also
examine their effectiveness in providing protection to ensure high probiotic survival during processing,
storage and gastrointestinal digestion, in order to make sure that they reach the intestine in sufficient
amounts to improve human health.
 
Figure 2. Important factors to be considered when assessing afermented non-dairy beverage matrices
as potential carriers for the viability of probiotic bacteria.
2. Non-Dairy Fermented Beverages as Vehicles for Bioactive Compound, Probiotic, and Prebiotic
Delivery to the Gut and their Health Benefits
2.1. Fermented Legume Beverages
Several researchers have tried to produce non-dairy probiotic beverages based on legume, as a
food matrix for the delivery of bioactive compounds, probiotics, or prebiotics, in order to enhance
human intestinal health. Legumes are potential matrices as carriers of probiotics because they contain
non-digestible oligosaccharides that can be metabolized by the microorganisms. Soybean legume
(Glycine max, L.) is the most used since it has high quality proteins and minerals, and due to its
isoflavones contents it has the potential to reduce the incidence of osteoporosis and menopausal
symptoms [25]. However, due to soy allergies which affect about 0.5% of the general population, other
legumes, such as chickpeas (Cicer arietinum, L.), are also used [26]. Chickpeas contain a high amount
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of resistant starch and amylose and some studies have proved that they can reduce the risks of high
blood pressure and type-2 diabetes [27].
The production of soy beverages is one of the traditional unfermented food uses of soybeans.
Recently, some studies have developed fermented soy drinks with probiotics, in order to improve their
beneficial health properties and their flavor and texture [28]. Bedani et al. [29] prepared a soy beverage
fermented with probiotic cultures and studied the viability and resistance of probiotics to simulated
gastrointestinal digestion, as well as the effect of adding ingredients such as inulin as prebiotic and
okara flour, which is a by-product of the soy milk industry. This study concluded that soy milk is a
potential food matrix for the delivery of probiotics and prebiotics which could protect them against
gastrointestinal juices. The probiotics used, Bifidobacterium animalis Bb-12 and Lactobacillus acidophilus
La-5, survived at high concentrations maintaining their viability at above 8 Log CFU/mL during 28 days
of storage at 4 ◦C with an acidic pH between 4.30 and 4.70. However, the survival was not affected
by inulin and/or okara flour. In addition, during the in vitro gastrointestinal digestion, B. animalis
Bb-12 maintained populations above 7 Log CFU/mL, but L. acidophilus La-5 was very sensitive and its
viability was reduced, the final concentration being below 5 Log CFU/mL (the initial concentrations
of both probiotics were above 8 Log CFU/mL). Therefore, soybeans could be a potential vehicle
for probiotics, being able to maintain a high viability to exert their beneficial effects on human gut
microbiota, although further studies are required.
Other studies have combined soy milk with cereals (sprouted wheat, barley, and pearl millet) and
legumes (green gram), or with peanut milk, producing beverages with probiotic characteristics and high
cell concentrations after fermentation [30,31]. Mridula and Sharma [30] analyzed fermented beverages
based on soy milk combined with different cereals or legumes, such as green gram (Vigna radiata,
L.). In the beverage based on green gram, after the fermentation at 37 ◦C for 8 h by L. acidophilus
NCDC14, the probiotic count ranged from 10.36 to 11.32 Log CFU/mL with an acidity between 0.50%
and 0.80% and a pH of 4.2–4.4. Besides, a high sensory acceptability score was obtained. Therefore, this
fermented legume beverage might be a potential vehicle for probiotics. Santos et al. [31] developed
a fermented beverage of soy and peanut milk, using these two substrates to improve the nutrient
availability for probiotics. For the fermentation, six different LAB were used, including probiotic
strains (Pediococcus acidilactici UFLA BFFCX 27.1, Lactococcus lactis CCT 0360, Lactobacillus rhamnosus LR
32, and Lactobacillus acidophilus LACA 4) and yeasts, in a binary culture or in co-culture. L. acidophilus
LACA 4 and P. acidilactici UFLA BFFCX 27.1 reached counts above 8 Log CFU/mL after fermentation
for 24 h at 37 ◦C and another 24 h at ±4 ◦C.Higher lactic acid contents were also obtained by co-culture
with Saccharomyces cerevisiae yeast which might serve as a source of vitamin B and proteins. Therefore,
a beverage based on peanuts may be a good carrier of probiotics, since it allows larger populations of
the probiotic bacteria to be grown and maintained, but further studies are necessary.
There are few documented studies that have determined the effect of fermented legume beverages
on modulation of the gut microbiome in either animal or humaninvestigations. Cabello-Olmo et al. [32]
evaluated the impact of long-term supplementation with a non-dairy fermented beverage in the
development of type-2 diabetes in rats, which is related to the host’s intestinal microbiota since
diabetic individuals present a characteristic intestinal microbial community. The plant-based beverage
was composed of legumes and cereals such as alfalfa meal, soya flour, and barley sprouts with
other minor components. It was fermented at 37 ◦C after the incorporation of LAB and debittered
brewer’s yeast, and the Lactobacillus genus was the most predominant. This research analyzed the fecal
microbiota of rat feces collected at six months of study. The specimens had ad libitum access to food
supplemented with the fermented beverages whose composition included a high level of fermentable
carbohydrates. The study revealed that, at genus level, supplementation with the fermented beverage
enriched the abundance of Sutterella which includes commensal species found in healthy humans
and animals, and Proteus, for which there is no evidence for its function in diabetes. However some
studies have suggested its role in several pathological conditions. Some Barnesiella species and the
Anaerococcus genus were more numerous in the group treated with the beverage. The abundance
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of Barnesiella is related to a better glucose tolerance and important metabolic improvements, and
the relative abundance of Anaerococcus includes many bacterial species which produce butyrate in
experimental conditions. Butyrate, as well as acetate and propionate, are short-chain fatty acids
(SCFAs) which produce beneficial effects on the gastrointestinal tract. SCFAs are produced by the
probiotic fermentation of non-digestible carbohydrates and improve the intestinal barrier, inhibiting
the development of pathogens and the production of toxic elements, and they are used by intestinal
cells as colonocytes to grow [33]. Therefore, the administration of this plant-based beverage fermented
with probiotics leads to an enrichment of the gut microbiota population, improving glucose metabolism
and protecting against type-2 diabetes development in rats. These novel fermented beverages could be
potential vehicles of probiotics, prebiotics, and/or bioactive compounds to protect against metabolic
alterations of the diabetic pathology. However, further studies on microbial metabolites which are also
important and responsible for gut health are required.
Another study on the effect of the intake of a soy milk beverage fermented with Lactobacillus casei
Shirota on gut microbiota in sixty healthy premenopausal women twice a day for 8 weeks, reported that
there was an increase of Lactobacillaceae and Bifidobacteriaceae levels and a decrease of Enterobacteriaceae
and Porphyromonadaceae levels during the intake period. The results suggested that a daily intake
of fermented soy milk beverage beneficially contributes to modulation of the gut microbiota in
premenopausal healthy women [34].
Other studies have focused on the use of different legumes, such as chickpeas (Cicer arietinum,
L.), as alternatives to soy in fermented plant-based beverages, which could be a promising carrier of
probiotics. The results showed probiotic counts of about 6 Log CFU/mL after fermentation for 16 h
at 42 ◦C, but more optimization studies are required to minimize syneresis and improve the sensory
acceptability [35]. One study developed a non-dairy beverage fermented by Lactobacilli acidophilus
probiotics using germinated and ungerminated seeds of moth bean (Vigna aconitifolia, L.) and cereals,
obtaining promising results since the levels of microorganisms after fermentation for 6 h at 37 ◦C were
above 8 Log CFU/mL and a good sensory acceptability was obtained [36]. The main studies that have
been conducted to date on fermented legume beverages and their results are summarized in Table 1.
Table 1. Summary of fermented legume beverages as potential carriers for bioactive compound,
probiotic, and prebiotic delivery to the gut.
Legume Fermented Beverage Probiotic Bacteria Results Reference
Soy milk with inulin and okara flour L. acidophilus La-5, B. animalisBb-12
Probiotic viability above the minimum
recommended after 28 days of storage, high
probiotic viability after in vitro
gastrointestinal digestion
Bedani et al. [29]
Soy milk with green gram L. acidophilus NCDC14 High probiotic viability after fermentation,high sensory acceptability score Mridula and Sharma [30]
Peanut-soy milk
P. acidilactici UFLA BFFCX 27.1,
L. lactis CCT 0360, L. rhamnosus LR
32, L. acidophilus LACA 4
High probiotic viability after fermentation,
high acid lactic contents Santos et al. [31]
Soya flour, alfalfa meal, barley sprouts Different LAB, mostlyLactobacillus genus
Enrichment of the gut microbiota
population Cabello-Olmo et al. [32]
Soy milk L. casei Shirota Beneficial modulation of the gut microbiota Nagino et al. [34]
Chickpeas S. thermophilus,L. bulgaricus, L. acidophilus High probiotic viability after fermentation Wang et al. [35]
Germinated and ungerminated
cereals and legumes: barley, ragi,
moth bean, soybean
L. acidophilus High probiotic viability after fermentation,good sensory acceptability Chavan et al. [36]
2.2. Fermented Cereal Beverages
Cereals are consumed all over the world and are considered one of the most important sources of
carbohydrates, proteins, dietary fiber, minerals, and vitamins in our diet. Therefore, they are a good
option among non-dairy raw materials for producing fermented beverages [37]. Oat (Avena sativa,
L.) is a potential functional ingredient, due to its proteins, soluble fiber, and antioxidant properties,
with β-glucan being the most important carbohydrate fraction because of its prebiotic properties in the
gut [38]. Kedia et al. [39] investigated the prebiotic potential of oat through in vitro fermentation for
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24 h with human fecal cultures. Their results showed an increase in SCFAs and beneficial intestinal
bacteria such as Enterobacteria, and a reduction in harmful bacteria such as anaerobes and clostridia.
Oat beverages fermented with different Lactobacillus strains have also been reported to display a high
antioxidant capacity and an increase in polyphenol content with respect to non-fermented beverages.
However, only fermented oat with L. plantarum LP09 showed an in vitro decrease in the hydrolysis
index of starch (used as a measure of the glycemic index in healthy subjects). The fermentation
also increased the β-glucan content. However, the soluble and insoluble fiber ratio decreased after
fermentation. At the same time, the aroma and flavor were better than in the unfermented control
samples [40]. Other studies have also shown that fermented oat beverages may be potential probiotic
carriers. They resulted in optimization of the fermentation process and the beverage formulations,
reaching high microbial levels (>107 CFU/mL) during production and storage, and were able to
maintain the β-glucan content at the end of storage [41–45]. The viability and in vitro probiotic
potential were recently investigated by Funck et al. [46] in oat beverages fermented with L. curvatus P99.
The results showed a high probiotic viability (above 7 log CFU/mL) during 35 days of being refrigerated
at 4 ◦C. The acceptability of the fermented beverages was good, since most consumers gave high scores
for all sensory attributes evaluated. Regarding the probiotic properties, L. curvatus P99 showed high
gastrointestinal survival and antimicrobial activity against Gram-negative and Gram-positive bacteria.
Additionally, it has the capacity of auto-aggregation and of blocking the adhesion of pathogenic
bacteria to gut epithelial cells. Johansson et al. [47] carried out an in vivo controlled randomized
double-blind study with a rose-hip beverage supplemented with oats fermented with L. plantarum
DSM9843 in 48 healthy adults. The group receiving the administration of 400 mL/day of this beverage
for three weeks showed an increase of total fecal carboxylic acid (lactic, acetic, and propionic acid)
and the probiotic bacteria were found in feces at a high concentration, indicating their survival during
gastrointestinal digestion. Decreased flatulence and a softer stool consistency were also reported.
Among other cereals, rice (Oryza sativa, L.) is also used in the production of fermented beverages
that are very popular in Asian-Pacific countries. Ghosh et al. [48] demonstrated a probiotic role of
L. fermentum KKL1 in a fermented rice beverage. The beverages fermented at 37 ◦C for 4 days
consecutively in anaerobic conditions showed a strong antioxidant activity; the production of
glucoamylase, α-amylase and phytase (therefore, an increase of phytate bioavailability) and a mineral
increase (Ca, Fe, Mg, Mn and Na). Besides, the hydrosoluble vitamin content in fermented samples
was higher than in unfermented control samples such as folic acid, thiamine, ascorbic acid and
pyridoxine. However, riboflavin decreased due to bacterial metabolism during fermentation. At the
same time, rice was a good carrier for maintaining the L. fermentum KKL1 at a high concentration
after gastrointestinal digestion and showed sensitivity to the antibiotics tested, except for polymyxin.
Nevertheless, this strain showed a moderate cell surface hydrophobicity. Another study reported
similar results in fermented rice beverages, but with different species of Lactobacillus bacteria, such as
L. plantarum L7. This strain showed good in vitro characteristics, such as high survival to gastrointestinal
digestion, antimicrobial activity, autoaggregation to the intestinal cell surface, and susceptibility to
some antibiotics, the latter is a desirable characteristic because probiotics should not carry transmissible
antibiotic-resistance genes, in order to avoid the development of new antibiotic-resistant pathogens
The fermented beverages increased the lactic, succinic and acetic acids during fermentation for 6 days
under anaerobic conditions at 35 ◦C. At the same time, increases in phytase activity and minerals (Na,
Mg, Mn, Fe and Ca) were also observed. Furthermore, the fermented rice beverage presented a high
antioxidant capacity [49]. Therefore, rice is a good matrix for L. fermentum KKL1 and L. plantarum L7
growth and survival in adequate concentrations. Furthermore, these bacteria played an important role
in improving the functional properties of rice beverages. However, in vivo investigations are required
to explore and verify their probiotic properties.
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Maize (Zea mays, L.) is another highly consumed cereal that contains about 72% starch, 10% proteins,
and 4% fiber, together with vitamin B and essential minerals [50]. Menezes et al. [51] used the L. paracasei
LBC-81 with the yeast S. cerevisiae CCMA 0731 and L. paracasei LBC-81 with S. cerevisiae CCMA 0732
in combination, for the fermentation of maize beverages at 30 ◦C for 24 h. The results showed a
high microorganism viability of above 7 Log CFU/mL during fermentation and during 28 days of
refrigerated storage (4 ◦C). The beverages achieved a score of 5 out of 9 points for general acceptance,
corresponding to the descriptor “neither dislike nor like”. Lactic acid was the main organic acid
produced during the fermentation time and low concentrations of acetic acid and ethanol were also
detected. A total of 70 volatile compounds were identified. Although the physicochemical results
presented in this study were interesting, more in vivo studies on the viability and health benefits of
these microorganisms are needed.
The fermentation process can be used for the delivery of probiotic bacteria and for food
detoxification. Probiotic growth in the fermented food medium reduces toxins in raw materials.
Aflatoxins can suppress the activity of the human immune system, affect nutrient absorption, and induce
liver cancer. This was evaluated by Wacoo et al. [52] in a modification of the traditional method of
the production of the Kwete beverage (traditional African fermented maize). Kwete was produced
by fermentation with L. rhamnosus yoba 2012 and S. thermophilus C106 at 30 ◦C for 24 h. The results
showed that the beverage was stable for a month under refrigeration storage at 4 ◦C, with a mean pH
of 3.9 and titratable acidity of 0.6%; the bacteria could also reduce the aflatoxins to undetectable levels
during fermentation. The aflatoxins reduction is a novel approach to detoxification of this kind of
beverage widely consumed in Africa.
The use of cereal mixtures for the development of fermented beverages has also been investigated.
Rathore et al. [5] made comparisons of single and mixed cereal beverages fermented with different
strains of LAB. The results of this study indicated that the organic acid production in mixed cereal
substrates was lower than in the single cereal beverages. However, the microbial populations were
similar for all substrates. These results are very interesting for future investigations on sensorial
properties and consumer acceptance. Nevertheless, malt was the best substrate for microbial growth
used as single or mixed beverages. Freire et al. [53] developed mixed beverages from rice and maize
fermented with L. acidophilus LACA 4 and L. pantarum CCMA 0743 for 36 h at 37 ◦C and supplemented
with frutooligosaccharides (FOS). The FOS were an important prebiotic for maintaining the microbial
viability in high concentrations (>107 CFU/mL) during 28 days of refrigerated storage (4 ◦C). The main
organic acids were lactic and acetic acid. The sensory acceptance of the beverages was good with high
scores with respect to unfermented ones, indicating their high potential for the market.
Maize beverages have been shown to be a potential matrix for the growth and survival of the
bacteria studied, with important changes in their composition. However, in the future, further studies
focused on the identification, quantification and potential effect of bioactive compounds, as well as the
modulation of intestinal microbiota, will be of great interest to elucidate the functionality of maize
beverages in the human organism. A summary of the studies on fermented cereal beverages conducted
to date and their results is presented in Table 2.
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Table 2. Summary of fermented cereal beverages as potential carriers form bioactive compounds,
probiotics, prebiotics delivery to de gut.
Cereal Fermented
Beverage
Probiotic Bacteria Results Reference
Oat Human fecal cultures Increase in SCFAs
1, increase of healthy intestinal bacteria, reduction of
harmful bacteria
Kedia et al. [39]
Oat Different Lactobacillus strains
High levels of antioxidant capacity, high polyphenols content, increase
of β-glucan content during fermentation, decrease in the hydrolysis
index of starch, high probiotic viability
Luana et al. [40],
Bernat et al. [41],
Gupta et al. [42], Gupta
and Bajaj [43], Kedia et al.
[44], Wang et al. [45]
Oat L. curvatus P99
High probiotic viability after in vitro digestion, antimicrobial activity,
blocking of the adhesion of pathogenic bacteria to epithelial cells,
autoaggregation capacity
Funck et al. [46]
Oat L. plantarum DSM9843
In vivo study: increase of lactic, acetic and propionic acid, high
probiotic viability after digestion; decrease in flatulence; and softer stool
consistency
Johansson et al. [47]
Rice L. fermentum KKL1 Strong antioxidant capacity, glucoamylase and α-amylase production,phytase activity, high hydrosoluble vitamins, antibiotic susceptibility Ghosh et al. [48]
Rice L. plantarum L7
High antioxidant capacity; increase in lactic, succinic, and acetic acid
during fermentation; high probiotic viability after in vitro digestion;
antibiotic susceptibility; antimicrobial activities; increase in minerals
and phytase activity
Giri et al. [49]
Maize
L. paracasei LBC-81 with S.
cerevisiae CCMA 0731 and L.
paracasei LBC-81
S. cerevisiae CCMA 0732
Probiotic viability above the minimum recommended, high production
of lactic acid during fermentation, 70 volatile compounds identified Menezes et al. [51]
Kwete L. rhamnosus yoba 2012 and S.thermophilus C106 Decrease in aflatoxins content = detoxification of beverage Wacoo et al. [52]
Cereals mixing Mixed or single LAB Malt was the best substrate for microbial growth used as single ormixed beverages Rathore et al. [5]
Rice and maize
L. acidophilus LACA 4 and
L. pantarum CCMA 0743
supplemented with FOS
High probiotic viability, increase in lactic and acetic acids during
fermentation, good sensorial acceptance Freire et al. [53]
1 SCFAs: short chain fatty acids.
2.3. Fermented Pseudocereal Beverages
Several studies have focused on the development of non-dairy probiotic beverages using
pseudocereals as vehicles for the delivery of bioactive compounds, probiotics, and prebiotics.
Pseudocereals are viable potential substrates, as they contain nutrients easily metabolized by probiotic
microorganisms. They are a good source of high-quality proteins comparable to those of cereals,
minerals (Ca, Cu, Fe, Mg, Mn and Zn) in higher amounts than in conventional cereals, carbohydrates,
and fiber [54]. Quinoa (Chenopodium quinoa, L.) is the pseudocereal most widely used as a food
matrix. It is the only plant-based food that has all of the essential amino acids (lysine, methionine,
and threonine), trace elements and vitamins, and its protein quality to matches that of milk [55]. It can
also decrease the risk of type-2 diabetes and cardiovascular diseases [56]. Furthermore, it is gluten-free,
so its consumption is suitable for celiacs and people with gluten-allergy problems.
One study reported the use of two varieties of quinoa (Rosada de Huancayo and Pasankalla) as
suitable food matrices for the development of fermented beverages [57]. The fermentation was carried
out by the probiotics Lactobacillus plantarum Q823, Lactobacillus casei Q11, and Lactococcus lactis ARH74
for 6 h at 30 ◦C. After 28 days of storage (5–7 ◦C), L. plantarum Q823 and L. casei Q11 were detected at
levels higher than 9 Log CFU/mL, which is a concentration above the recommended minimum for
probiotic effects, with initial concentrations of 8 Log CFU/mL. Vera-Pingitore et al. [58] have previously
reported that L. plantarum Q823 can survive during the passage through the human gastrointestinal
tract. In this study, seven healthy female volunteers consumed 20 mL of quinoa-based beverage
containing 9.19 Log CFU/mL on a daily basis or 7 days, and microbial counts were analyzed in feces.
Levels between 5 and 7 Log CFU/mL were detected for at least 7 days after the end of the intake.
Therefore, quinoa-based fermented beverages contain high amounts of protein, fiber, vitamins and
minerals, with probiotics which could exert health benefits on the human gastrointestinal microbiota.
However, more long-term human clinical trial studies are needed to demonstrate that these beverages
have probiotic properties.
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There are few documented studies that have attempted to determine the in vivo effect of
fermented pseudocereal beverages on the modulation of the gut microbiome in either animal or
human investigations. However, one study has evaluated the impact of several beverages based on
aqueous extracts of soy and quinoa with prebiotics (FOS) and/or with probiotics (Lactobacillus casei
Lc-01) on the human intestinal microbiota, using the Simulator of the Human Intestinal Microbial
Ecosystem (SHIME®) [59]. The SHIME is a five-stage sequential reactor system simulating the different
parts of the gastrointestinal tract in vitro, representing the human gut microbiota [60]. The study of
Bianchi et al. [59] reported that a synbiotic beverage fortified with both a probiotic and a prebiotic
showed the best beneficial effect on the gut microbiota, as the oligosaccharides used were hydrocolloids,
which protected the microorganism. The concentration used in the SHIME was a proportion equivalent
to 8 Log CFU/mL in the beverage. L. casei Lc-01 of the synbiotic beverage survived the stomach and
intestinal conditions and reached the colon, maintaining its functionality, and the concentration of
SCFAs was stable during the in vitro gastrointestinal digestion. Furthermore, the growth of several
species of Lactobacillus spp. and Bifidobacterium spp. in the colon were stimulated by the synbiotic
beverage. At the same time, the growth of potential enteropathogenic bacteria such as Clostridium spp.,
enterobacteria and other pathogenic bacteria such as Bacteroides spp. and Enterococcus spp. was reduced.
Another positive effect of the beverage on the gastrointestinal tract was the significant decrease in the
ammonia ion production. Ammonia can stimulate the development of colon carcinogenesis, since
it can affect intestinal cells, changing their morphology and intermediary metabolism by increasing
DNA synthesis [61]. Therefore, this beverage based on quinoa and soybean with FOS and fermented
by L. casei Lc-01 positively modulates the gut microbiota improving the diversity and richness of
beneficial bacteria without affecting their functionality and reducing the growth of the pathogenic
ones, and decreasing the production of toxic elements such as ammonia.
Some studies have investigated the use of other pseudocereals, such as chia (Salvia hispanica,
L.), amaranth (Amaranthus, L.) or buckwheat (Fagopyrum esculentum, L.), as food carriers to develop
pseudocereal probiotic beverages, obtaining interesting results. In a study on the elaboration of a
beverage with the probiotic Lactobacillus rhamnosus GG (5–6 Log CFU/mL), using mashed buckwheat
previously fermented with LAB, the results showed that the levels of the microorganism were higher
than 6 Log CFU/mL after 14 days of cold storage at 6 ◦C [62]. Kocková and Valík [63] also produced
beverages based on buckwheat or dark buckwheat fermented with L. rhamnosus GG ATCC 53,103
(6 Log CFU/mL) at 37 ◦C for 10 h. This probiotic was able to grow and metabolize buckwheat and dark
buckwheat and to survive during 21 days of a refrigerated storage period at 5 ◦C, with the probiotic
counts being above the minimum recommended (>7 Log CFU/mL). Kocková et al. [64] studied the
use of different pseudocereals as substrates for the production of different beverages fermented with
L. rhamnosus GG (5 Log CFU/mL) for 10 h at 37 ◦C, using amaranth flour, amaranth grain, buckwheat
flour, or whole buckwheat flour. The results showed that the probiotic could grow and metabolize
these pseudocereals and after 21 days of storage at 5 ◦C, the probiotic levels were higher than 6 Log
CFU/mL, and thus over the limit required for probiotic food, except for the beverage with whole
buckwheat flour. Another study reported that chia can be fermented by L. plantarum C8, and that
after 24 h of fermentation, its overall characteristics were improved, such as the phenolic compound
concentration and antioxidant activity [65]. Therefore, this pseudocereal could be a good matrix for the
development of probiotic beverages. The main studies conducted to date on fermented pseudocereal
beverages and their results are summarized in Table 3.
2.4. Fermented Fruit and Vegetable Beverages
Fruit and vegetable beverages are an excellent source of vitamins, antioxidants, minerals, and
bioactives. At the same time they represent a good alternative to dairy matrices and a good choice for
the entire human population, because they have hydration properties, are refreshing and have attractive
flavors [21,66]. Therefore, different fruits and vegetable juices are used to develop fermented beverages
in combination or alone as an alternative to fermented dairy products. The fermentation process can
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increase the shelf life of fruit and vegetable beverages, improving their nutritional and functional
properties, with beneficial effects on health [16]. Recently, a wide variety of research has been focused
on the production of fermented non-dairy synbiotic beverages, including different types of vegetables
or fruits, such as blended carrot-orange juices and nectars with different inulin concentrations [67,68],
pomegranate juices, and Cornelian cherry beverages using delignified wheat bran [69,70], clarified
apple juice with oligofructose [71], orange juice with oligofructose [72], orange juices and hibiscus tea
mixed beverage with oligofructose [73], and blended red fruit beverages (strawberry, blackberry and
papaya) supplemented with three separate prebiotics: FOS, inulin and galactooligosaccharides [74].
Generally, the findings have indicated a good compatibility among prebiotic ingredients and vegetable
beverage matrices. Furthermore, prebiotic supplementation can improve the viability of the different
probiotic strains so that they are above the minimum concentration recommended during the beverages
processing and storage and are also able to survive during gastrointestinal digestion in order to reach
the colon, promoting the growth of beneficial bacteria. Furthermore, a recent randomized, controlled,
triple-blinded, parallel trial study of polycystic ovarian syndrome (POCS) showed the effect of synbiotic
pomegranate juice (containing inulin and three species of Lactobacillus) in terms of improving the
testosterone level, body mass index, insulin, insulin resistance, weight, and waist circumference in
POCS. However, neither group showed a significant change in the fasting blood sugar, luteinizing
hormone, and follicle-stimulating hormone [75].
Table 3. Summary of fermented pseudocereal beverages as potential carriers for bioactive compound,
probiotic, and prebiotic delivery to the gut.
Pseudocereal Fermented Beverage Probiotic Bacteria Results Reference
Two quinoa varieties (Rosada de
Huancayo, Pasankalla)
L. plantarum Q823, L. casei
Q11, L. lactis ARH74
Probiotic viability above the minimum
recommended after 28 days of storage Ludena-Urquizo et al. [57]
Quinoa L. plantarum Q823 High probiotic viability after thegastrointestinal digestion Vera-Pingitore et al. [58]
Aqueous extracts of soybean and quinoa
grains with FOS L. casei Lc-01
Positive modulation of the gut microbiota,
decrease in toxic elements (ammonia) Bianchi et al. [59]
Mashed buckwheat previously fermented
with LAB L. rhamnosus GG
High probiotic viability after 14 days of
cold storage, good sensorial acceptance Matejčeková et al. [62]
Buckwheat, dark buckwheat L. rhamnosus GG Probiotic viability above the minimumrecommended after 21 days of cold storage Kocková and Valík [63]
Amaranth flour, amaranth grain,
buckwheat flour, whole buckwheat flour L. rhamnosus GG
High probiotic viability after 21 days of
storage, except for the beverage with whole
buckwheat flour
Kocková et al. [64]
Several LAB can biotransform polyphenols into phenolic compounds with an improved
bioavailability and bioactivity during the fermentation time. Several studies have investigated
phenolic compound biotransformation during fermentation and gastrointestinal digestion. The studies
on fermented fruit or vegetable beverages have shown an improved antioxidant capacity and phenolic
composition modification. Apple juice fermented with L. plantarum ATCC14917 at 37 ◦C improved
the antioxidant capacity by increasing the quercetin, phloretin and 5-O-caffeoylquinic acid contents
during 24 h of fermentation [76]. Yang et al. [77] reported an increase of the total flavonoids content as
well as the antioxidant activity in fermented mixed beverages from apples, carrots, and pears during
fermentation with two commercial L. plantarum 115 L. plantarum Vege Start 60. On the other hand,
the biotransformation of phenolic compounds during fermentation and gastrointestinal digestion in
fermented pomegranate juices ensured the survival of L. plantarum CECT220, L. acidophilus CECT903,
B. longum subsp. infantis CECT4551, and B. bifidum CECT870, suggesting a prebiotic effect [78].
Furthermore, one study on a fermented tea infusion found an increase in the overall antioxidant
capacity, a modification in the phenolic composition and an increase in their cellular uptake after
in vitro digestion [79]. Oolong tea polyphenols have been reported to improve host health through the
generation of SCFAs and modulation of the human gut microbiota, leading to potential applications
for anti-obesity therapies [80]. Specifically, (-)-Epigallocatechin 3-O-(3-O-methyl) gallate showed a
prebiotic effect with the modulation of gut microbiota and obesity prevention in high-fat diet-fed
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mice [81,82]. Phenolic compounds are recognized as antioxidants, but some of them also exhibit
antimicrobial activity. Cueva et al. [83] showed that phenolic compounds generated from probiotic
metabolism (phenylpropionic, benzoic and phenylacetic) can inhibit the growth of intestinal pathogens
and prevent intestinal dysbiosis.
The ability of probiotic microorganisms to metabolize phenolic compounds is known to depend
on the species or strains. However, differences in the total polyphenol content and antioxidant capacity
have been shown between different vegetable beverages for the same probiotic strains. These differences
may be related to the variability in the phytochemical composition of the different vegetable and
fruit matrices [84,85]. In addition, the matrix also has an influence on the exopolysaccharides (EPS)
production during fermentation, improving the consistency and antioxidant capacity of fermented
juices [86]. At the same time, the EPS also have a significant role as prebiotics and can enhance probiotic
colonization in the gut. They have also been used as immunomodulatory, immunostimulatory,
antidiabetic, and hypocholesterolemic agents [87,88].
Bearing in mind the nutritional importance of fruit and vegetable beverages, some of them, such
as fresh prickly pear juices, present hazardous volatile components in negligible quantities. Therefore,
the reduction of risky compounds by modification or decomposition during the fermentation time
is an interesting strategy. Panda et al. [89] demonstrated prickly pear quality enhancement by
fermentation with Lactobacillus fermentum ATCC 9338 for 48 h at 28 ◦C. The study demonstrates the
decomposition of several risky organic compounds present in the fresh juice, such as 2-propenenitrile,
2-(acetyloxy); furfuryl alcohol; acetaldehyde; 2,2-diethyl-3-methyloxazolidine; 4h-Pyran-4-one;
3,5-dihydroxy-2-methyl; and furan.
Beyond the nutritional and physicochemical advantages, recent studies have shown that different
fermented fruit and vegetable beverages also have some physiological functions. For example,
some studies have shown a stable α-glucosidase inhibitory activity with an anti-hyperglycemic
in vitro effect in a pumpkin beverage fermented by L. mali K8 [90]. Gamboa-Gómez et al. [91] also
showed an anti-hyperglycemic effect with an infusion of oak leaves and fermented beverages from
Quercus convallata and Q. arizonica in vitro and in vivo studies with female mice. On the other hand,
blended fermented blueberry pomace by L. rhamnosus GG, L. plantarum-1, and L. plantarum-2 showed
in in vitro hypocholesterolaemic effect. In addition, this fermented beverage exhibited an outstanding
performance in terms of anti-fatigue in a mouse weight swimming experiment [92]. According to
Harima-Mizusawa et al. [93], citrus beverage fermented with L. plantarum YIT0132 had a good effect in
relieving the perennial allergic rhinitis symptoms in a double-blind, placebo-controlled trial. Other
fermented beverages, such as those of tomato, feijoa, blueberry-blackberry, cactus pear, and prickly pear
fruits exhibit a great in vitro anti-inflammatory capacity and help maintain the integrity of intestinal
barrier [85,86,94]. However, the results are influenced by the different vegetable beverage matrices. For
example, Valero-Cases et al. [94] showed the best improvement of the intestinal barrier with fermented
tomato juices with respect to fermented feijoa ones. The vasorelaxant capacity was proposed for
fermented jabuticaba berry beverages through an in vivo study of vascular reactivity in male Wistar
rats. Theses beverages could act as an interesting cardiovascular protector [95]. Cheng et al. [96]
reported an increase of SCFAs production and an improvement of the fecal microbiota community
structure in vitro with blueberry pomace fermented by L. casei CICC20280. Wang et al. [97] showed
that the consumption of fermented beverages of Changbai Mountain vegetables and fruits can reduce
the Firmicutes/Bacteroidetes ratio and increase the Bacteroidales S24–7 group, Bacteroidaceae, the
genus Bacteroides, and Prevotellaceae in a mouse model study. However, these are results from in vitro
and in vivo studies with animal models, so future research in humans is required to evaluate the
physiological effects on health improvement. A summary of studies conducted to date on fruit and
vegetable fermented beverages and their results is shown in Table 4.
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3. Conclusions and Future Perspectives
The studies carried out to date have provided useful information and a deeper understanding
of the metabolic mechanisms of growth, probiotic viability, and the microbial biotransformation or
production of bioactive compounds in fermented non-dairy beverages. Non-dairy matrices (legumes,
cereals, pseudocereals, fruits, and vegetables) represent potential carriers of probiotics, prebiotics, and
bioactive compounds. They are a good alternative to dairy matrices because it has been proven that the
fermentation of these vegetable matrices can improve the shelf life and their safety due to the organic
acids generated during the fermentation period, their nutritional and functional composition, and
their digestibility. Moreover, in all the matrices reviewed, the probiotic concentrations are above the
minimum recommended (>7 Log CFU/mL). Therefore, they are a good alternative to the dairy products
on the market that can also be consumed by people intolerant or allergic to milk proteins, those who
are hypercholesterolemic, or those who are vegetarian, among others. However, to corroborate the
health benefits of fermented non-dairy beverage consumption, further in vivo research, including
human clinical studies addressing matrix combinations and doses in different populations, is needed.
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